"Sample","QueryID","SubjectID","Identity","Evalue","Bitscore","AlignmentLength","Coverage","Species","Cancer_Association","Mechanism","Evidence_Level","Relevance_Level","Confidence"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_FKWV01000005",97.439,0,2728,1601,1559.99839,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_FKXF01000023",97.439,0,2728,1601,1559.99839,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_FKXL01000017",97.314,0,2717,1601,1557.99714,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_FKWV01000005",97.289,0,2314,1365,1327.99485,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_FKXF01000023",97.289,0,2314,1365,1327.99485,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_FKXL01000017",97.143,0,2303,1365,1326.00195,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_FKWV01000005",96.262,0,2095,1284,1236.00408,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_FKXF01000023",96.262,0,2095,1284,1236.00408,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_FKXL01000017",96.106,0,2084,1284,1234.00104,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_FKWV01000005",98.229,0,2073,1186,1164.99594,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_FKXF01000023",98.229,0,2073,1186,1164.99594,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_FKXL01000017",98.061,0,2061,1186,1163.00346,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_FKXL01000017",98.107,0,2025,1162,1140.00334,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_FKWV01000005",98.107,0,2025,1162,1140.00334,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_FKXF01000023",98.107,0,2025,1162,1140.00334,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_FKXL01000017",97.393,0,2023,1189,1158.00277,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_FKWV01000005",97.393,0,2023,1189,1158.00277,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_FKXF01000023",97.393,0,2023,1189,1158.00277,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_FKXL01000017",97.615,0,1940,1132,1105.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_FKWV01000005",97.615,0,1940,1132,1105.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_FKXF01000023",97.615,0,1940,1132,1105.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_FKWV01000005",98.113,0,1568,901,883.99813,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_FKXF01000023",98.113,0,1568,901,883.99813,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_FKXL01000017",97.891,0,1557,901,881.99791,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_FKWV01000005",97.542,0,1530,895,873.0009,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_FKXF01000023",97.542,0,1530,895,873.0009,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_FKXL01000017",97.43,0,1524,895,871.9985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FKXL01000017",97.743,0,1524,886,866.00298,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FKWV01000005",97.743,0,1524,886,866.00298,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FKXF01000023",97.743,0,1524,886,866.00298,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_FKXL01000017",96.417,0,1517,921,888.00057,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_FKWV01000005",96.417,0,1517,921,888.00057,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_FKXF01000023",96.417,0,1517,921,888.00057,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_20470","NZ_FKXL01000017",95.74,0,1511,939,898.9986,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_20470","NZ_FKWV01000005",95.74,0,1511,939,898.9986,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_20470","NZ_FKXF01000023",95.74,0,1511,939,898.9986,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLXP01000026",95.203,0,1476,938,893.00414,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLUB01000021",95.203,0,1476,938,893.00414,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLTT01000022",95.203,0,1476,938,893.00414,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRM01000021",95.203,0,1476,938,893.00414,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRF01000022",95.203,0,1476,938,893.00414,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_FKXL01000017",97.159,0,1190,704,683.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_FKWV01000005",97.159,0,1190,704,683.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_FKXF01000023",97.159,0,1190,704,683.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_FKWV01000005",95.994,0,1175,724,694.99656,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_FKXF01000023",95.994,0,1175,724,694.99656,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_FKXL01000017",95.856,0,1170,724,693.99744,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_14556","NZ_FKWV01000005",96.957,0,1157,690,669.0033,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_14556","NZ_FKXF01000023",96.957,0,1157,690,669.0033,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_14556","NZ_FKXL01000017",96.812,0,1151,690,668.0028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_FKXL01000017",96.006,0,1099,676,649.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_FKWV01000005",96.006,0,1099,676,649.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_FKXF01000023",96.006,0,1099,676,649.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_968","NZ_FKWV01000005",96.018,0,1061,653,626.99754,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_968","NZ_FKXF01000023",96.018,0,1061,653,626.99754,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_968","NZ_FKXL01000017",95.712,0,1050,653,624.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_FKWV01000005",97.254,0,1048,619,602.00226,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_FKXF01000023",97.254,0,1048,619,602.00226,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FKXL01000017",99.65,0,1046,572,569.998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FKWV01000005",99.65,0,1046,572,569.998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FKXF01000023",99.65,0,1046,572,569.998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_FKXL01000017",97.092,0,1042,619,600.99948,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_FKXL01000017",99.475,0,1038,571,568.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_FKWV01000005",99.475,0,1038,571,568.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_FKXF01000023",99.475,0,1038,571,568.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLXP01000026",98.311,0,1038,592,582.00112,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLUB01000021",98.311,0,1038,592,582.00112,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLTT01000022",98.311,0,1038,592,582.00112,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRM01000021",98.311,0,1038,592,582.00112,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRF01000022",98.311,0,1038,592,582.00112,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLWD01000035",98.142,0,1033,592,581.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_FKXL01000017",96.618,0,1031,621,599.99778,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_FKWV01000005",96.618,0,1031,621,599.99778,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_FKXF01000023",96.618,0,1031,621,599.99778,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_16285","NZ_FKWV01000005",96.885,0,1020,610,590.9985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_16285","NZ_FKXF01000023",96.885,0,1020,610,590.9985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_16285","NZ_FKXL01000017",96.557,0,1009,610,588.9977,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_FKXL01000017",97.59,0,996,581,566.9979,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_FKWV01000005",97.59,0,996,581,566.9979,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_FKXF01000023",97.59,0,996,581,566.9979,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLWD01000035",97.27,0,994,586,570.0022,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLWD01000035",98.868,0,946,530,524.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLXP01000026",98.868,0,946,530,524.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLUB01000021",98.868,0,946,530,524.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLTT01000022",98.868,0,946,530,524.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRM01000021",98.868,0,946,530,524.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRF01000022",98.868,0,946,530,524.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_FKXL01000017",96.441,0,928,562,541.99842,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_FKWV01000005",96.441,0,928,562,541.99842,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_FKXF01000023",96.441,0,928,562,541.99842,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLXP01000026",95.745,0,904,564,540.0018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLUB01000021",95.745,0,904,564,540.0018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLTT01000022",95.745,0,904,564,540.0018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRM01000021",95.745,0,904,564,540.0018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRF01000022",95.745,0,904,564,540.0018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_FKWV01000005",95.423,0,902,568,542.00264,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_FKXF01000023",95.423,0,902,568,542.00264,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLWD01000035",95.567,0,898,564,538.99788,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_FKXL01000017",95.246,0,896,568,540.99728,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FKXL01000017",97.49,0,885,518,504.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FKWV01000005",97.49,0,885,518,504.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FKXF01000023",97.49,0,885,518,504.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_FKXL01000017",95.88,0,865,534,511.9992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_FKWV01000005",95.88,0,865,534,511.9992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_FKXF01000023",95.88,0,865,534,511.9992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_13506","NZ_FKXL01000017",97.239,0,857,507,493.00173,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_13506","NZ_FKWV01000005",97.239,0,857,507,493.00173,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_13506","NZ_FKXF01000023",97.239,0,857,507,493.00173,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_FKWV01000005",96.654,0,843,508,491.00232,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_FKXF01000023",96.654,0,843,508,491.00232,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_FKXL01000017",96.457,0,837,508,490.00156,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_13877","NZ_FKWV01000005",96.275,0,835,510,491.0025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_13877","NZ_FKXF01000023",96.275,0,835,510,491.0025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_FKXL01000017",96.414,0,828,502,483.99828,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_FKWV01000005",96.414,0,828,502,483.99828,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_FKXF01000023",96.414,0,828,502,483.99828,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_13877","NZ_FKXL01000017",95.882,0,824,510,488.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_16020","NZ_FKWV01000005",95.669,0,815,508,485.99852,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_16020","NZ_FKXF01000023",95.669,0,815,508,485.99852,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1589","NZ_FKWV01000005",96.552,0,815,493,476.00136,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1589","NZ_FKXF01000023",96.552,0,815,493,476.00136,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_16020","NZ_FKXL01000017",95.276,0,804,508,484.00208,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1589","NZ_FKXL01000017",96.146,0,804,493,473.99978,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FKXL01000017",98.006,8.04e-173,610,351,344.00106,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FKWV01000005",98.006,8.04e-173,610,351,344.00106,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FKXF01000023",98.006,8.04e-173,610,351,344.00106,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11591","NZ_FNOE01000002",95.495,1.04e-42,178,111,105.99945,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_2081","NZ_FNOE01000002",96.04,7.35e-39,165,101,97.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_11311","NZ_FNOE01000002",95.833,6.32e-36,156,96,91.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLWD01000035",98.824,1.11e-34,152,85,84.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLXP01000026",98.824,1.11e-34,152,85,84.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLUB01000021",98.824,1.11e-34,152,85,84.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLTT01000022",98.824,1.11e-34,152,85,84.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRM01000021",98.824,1.11e-34,152,85,84.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRF01000022",98.824,1.11e-34,152,85,84.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FNPJ01000004",98.81,4.01e-34,150,84,83.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FNOE01000002",98.81,4.01e-34,150,84,83.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_12669","NZ_FKXL01000017",96.875,2.23e-21,108,64,62,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_14261","NZ_FKXL01000017",96.429,4.54e-17,93.5,56,54.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLWD01000035",96.154,7.03e-15,86.1,52,50.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXP01000026",96.154,7.03e-15,86.1,52,50.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLUB01000021",96.154,7.03e-15,86.1,52,50.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLTT01000022",96.154,7.03e-15,86.1,52,50.00008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRM01000021",96.154,7.03e-15,86.1,52,50.00008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRF01000022",96.154,7.03e-15,86.1,52,50.00008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_13464","NZ_FNPJ01000004",97.917,2.41e-14,84.2,48,47.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLXP01000026",95.652,1.47e-11,75,46,43.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLUB01000021",95.652,1.47e-11,75,46,43.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLTT01000022",95.652,1.47e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRM01000021",95.652,1.47e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRF01000022",95.652,1.47e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLXP01000026",95.652,1.45e-11,75,46,43.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLUB01000021",95.652,1.45e-11,75,46,43.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLTT01000022",95.652,1.45e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRM01000021",95.652,1.45e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRF01000022",95.652,1.45e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLXP01000026",95.652,1.34e-11,75,46,43.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLUB01000021",95.652,1.34e-11,75,46,43.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLTT01000022",95.652,1.34e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRM01000021",95.652,1.34e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRF01000022",95.652,1.34e-11,75,46,43.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLXP01000026",100,6.44e-10,69.4,37,37,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLUB01000021",100,6.44e-10,69.4,37,37,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLTT01000022",100,6.44e-10,69.4,37,37,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRM01000021",100,6.44e-10,69.4,37,37,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRF01000022",100,6.44e-10,69.4,37,37,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLXP01000026",100,2.36e-09,67.6,36,36,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLUB01000021",100,2.36e-09,67.6,36,36,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLTT01000022",100,2.36e-09,67.6,36,36,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRM01000021",100,2.36e-09,67.6,36,36,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRF01000022",100,2.36e-09,67.6,36,36,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLXP01000026",100,2.36e-09,67.6,36,36,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLUB01000021",100,2.36e-09,67.6,36,36,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLTT01000022",100,2.36e-09,67.6,36,36,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRM01000021",100,2.36e-09,67.6,36,36,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRF01000022",100,2.36e-09,67.6,36,36,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLWD01000035",97.436,4.06e-09,67.6,39,38.00004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLXP01000026",97.436,4.06e-09,67.6,39,38.00004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLUB01000021",97.436,4.06e-09,67.6,39,38.00004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLTT01000022",97.436,4.06e-09,67.6,39,38.00004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRM01000021",97.436,4.06e-09,67.6,39,38.00004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRF01000022",97.436,4.06e-09,67.6,39,38.00004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLXP01000026",100,8.09e-09,65.8,35,35,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLUB01000021",100,8.09e-09,65.8,35,35,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLTT01000022",100,8.09e-09,65.8,35,35,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRM01000021",100,8.09e-09,65.8,35,35,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRF01000022",100,8.09e-09,65.8,35,35,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLXP01000026",100,3.23e-08,63.9,34,34,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLUB01000021",100,3.23e-08,63.9,34,34,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLTT01000022",100,3.23e-08,63.9,34,34,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRM01000021",100,3.23e-08,63.9,34,34,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRF01000022",100,3.23e-08,63.9,34,34,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLWD01000035",97.222,1.13e-07,62.1,36,34.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLXP01000026",97.222,1.13e-07,62.1,36,34.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLUB01000021",97.222,1.13e-07,62.1,36,34.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLTT01000022",97.222,1.13e-07,62.1,36,34.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRM01000021",97.222,1.13e-07,62.1,36,34.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRF01000022",97.222,1.13e-07,62.1,36,34.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLWD01000035",97.222,1.33e-07,62.1,36,34.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLXP01000026",97.222,1.33e-07,62.1,36,34.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLUB01000021",97.222,1.33e-07,62.1,36,34.99992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLTT01000022",97.222,1.33e-07,62.1,36,34.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRM01000021",97.222,1.33e-07,62.1,36,34.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRF01000022",97.222,1.33e-07,62.1,36,34.99992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_6044","NZ_FKXL01000017",100,1.51e-06,58.4,31,31,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_6044","NZ_FKWV01000005",100,1.51e-06,58.4,31,31,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_6044","NZ_FKXF01000023",100,1.51e-06,58.4,31,31,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16090","NZ_FKXL01000017",83.838,0,1908,2048,1717.00224,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16090","NZ_FKWV01000005",83.773,0,1903,2046,1713.99558,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16090","NZ_FKXF01000023",83.773,0,1903,2046,1713.99558,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_26507","NZ_FNOE01000002",89.151,0,1832,1484,1323.00084,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_26507","NZ_FNPJ01000004",88.642,0,1788,1488,1318.99296,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FKXL01000017",85.355,0,1618,1591,1357.99805,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FKWV01000005",85.274,0,1613,1589,1355.00386,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FKXF01000023",85.274,0,1613,1589,1355.00386,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLWD01000035",86.029,0,1522,1453,1250.00137,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FKXL01000017",93.493,0,1472,999,933.99507,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FKWV01000005",93.493,0,1472,999,933.99507,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FKXF01000023",93.493,0,1472,999,933.99507,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FNOE01000002",87.195,0,1471,1312,1143.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FKXL01000017",84.268,0,1463,1551,1306.99668,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FKWV01000005",84.204,0,1458,1551,1306.00404,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FKXF01000023",84.204,0,1458,1551,1306.00404,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLWD01000035",94.67,0,1448,938,888.0046,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FKXL01000017",89.947,0,1447,1124,1011.00428,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FKWV01000005",89.947,0,1447,1124,1011.00428,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FKXF01000023",89.947,0,1447,1124,1011.00428,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLXP01000026",85.994,0,1445,1378,1184.99732,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLUB01000021",85.994,0,1445,1378,1184.99732,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLTT01000022",85.994,0,1445,1378,1184.99732,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRM01000021",85.994,0,1445,1378,1184.99732,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRF01000022",85.994,0,1445,1378,1184.99732,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FNPJ01000004",86.585,0,1426,1312,1135.9952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5178","NZ_FKXL01000017",87.987,0,1421,1232,1083.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5178","NZ_FKWV01000005",87.906,0,1415,1232,1083.00192,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5178","NZ_FKXF01000023",87.906,0,1415,1232,1083.00192,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5781","NZ_FKXL01000017",84.386,0,1386,1441,1216.00226,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5781","NZ_FKWV01000005",84.295,0,1380,1439,1213.00505,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5781","NZ_FKXF01000023",84.295,0,1380,1439,1213.00505,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_6663","NZ_FKXL01000017",83.84,0,1367,1479,1239.9936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_6663","NZ_FKWV01000005",83.773,0,1362,1479,1239.00267,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_6663","NZ_FKXF01000023",83.773,0,1362,1479,1239.00267,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_9299","NZ_FNOE01000002",88.476,0,1280,1076,952.00176,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FKXL01000017",83.774,0,1264,1362,1141.00188,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_9299","NZ_FNPJ01000004",88.056,0,1260,1080,951.0048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FKWV01000005",83.676,0,1258,1360,1137.9936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FKXF01000023",83.676,0,1258,1360,1137.9936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FNOE01000002",90.262,0,1245,955,862.0021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25987","NZ_FNOE01000002",87.873,0,1206,1039,913.00047,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FNPJ01000004",89.256,0,1205,968,863.99808,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14088","NZ_FKXL01000017",87.969,0,1203,1039,913.99791,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FNOE01000002",89.209,0,1201,973,868.00357,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14088","NZ_FKWV01000005",87.873,0,1197,1039,913.00047,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14088","NZ_FKXF01000023",87.873,0,1197,1039,913.00047,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLUB01000021",83.233,0,1181,1324,1102.00492,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRM01000021",83.233,0,1181,1324,1102.00492,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLUB01000021",87.948,0,1179,1004,882.99792,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRM01000021",87.948,0,1179,1004,882.99792,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FNPJ01000004",89.028,0,1179,957,851.99796,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FNPJ01000004",89.229,0,1177,947,844.99863,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FNOE01000002",89.274,0,1177,951,848.99574,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLWD01000035",83.157,0,1175,1324,1100.99868,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXP01000026",83.157,0,1175,1324,1100.99868,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLTT01000022",83.157,0,1175,1324,1100.99868,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRF01000022",83.157,0,1175,1324,1100.99868,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLXP01000026",87.849,0,1173,1004,882.00396,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLTT01000022",87.849,0,1173,1004,882.00396,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRF01000022",87.849,0,1173,1004,882.00396,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLWD01000035",87.761,0,1168,1005,881.99805,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25987","NZ_FNPJ01000004",87.14,0,1166,1042,907.9988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FKXL01000017",91.304,0,1158,851,776.99704,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FKWV01000005",91.304,0,1158,851,776.99704,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FKXF01000023",91.304,0,1158,851,776.99704,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FNPJ01000004",81.474,0,1144,1452,1183.00248,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FNOE01000002",81.159,0,1118,1449,1175.99391,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FKXL01000017",84.268,0,1116,1195,1007.0026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_5493","NZ_FKXL01000017",83.47,0,1112,1222,1020.0034,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FKWV01000005",84.184,0,1110,1195,1005.9988,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FKXF01000023",84.184,0,1110,1195,1005.9988,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_5493","NZ_FKWV01000005",83.361,0,1107,1220,1017.0042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_5493","NZ_FKXF01000023",83.361,0,1107,1220,1017.0042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FNPJ01000004",84.69,0,1107,1130,956.997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FNOE01000002",86.713,0,1098,1001,867.99713,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FNPJ01000004",86.647,0,1096,996,863.00412,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_14191","NZ_FNOE01000002",88.606,0,1094,904,800.99824,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLWD01000035",87.384,0,1094,967,845.00328,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLWD01000035",84.038,0,1085,1159,974.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_14191","NZ_FNPJ01000004",88.216,0,1074,908,801.00128,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FNOE01000002",90.759,0,1048,790,716.9961,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_21743","NZ_FKXL01000017",82.334,0,1044,1251,1029.99834,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_21743","NZ_FKWV01000005",82.254,0,1038,1251,1028.99754,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_21743","NZ_FKXF01000023",82.254,0,1038,1251,1028.99754,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FNPJ01000004",90.506,0,1038,790,714.9974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FKXL01000017",91.722,0,1037,749,686.99778,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FKWV01000005",91.722,0,1037,749,686.99778,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FKXF01000023",91.722,0,1037,749,686.99778,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_13963","NZ_FKXL01000017",85.059,0,1031,1024,871.00416,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_13963","NZ_FKWV01000005",85.059,0,1031,1024,871.00416,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_13963","NZ_FKXF01000023",85.059,0,1031,1024,871.00416,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FKXL01000017",86.484,0,1024,947,819.00348,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FKWV01000005",86.484,0,1024,947,819.00348,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FKXF01000023",86.484,0,1024,947,819.00348,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_12669","NZ_FNPJ01000004",90.089,0,1013,787,709.00043,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_135","NZ_FNOE01000002",89.788,0,1011,803,720.99764,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLUB01000021",85.895,0,1005,950,816.0025,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRM01000021",85.895,0,1005,950,816.0025,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLWD01000035",83.23,0,1000,1127,938.0021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLXP01000026",85.789,0,1000,950,814.9955,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLTT01000022",85.789,0,1000,950,814.9955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRF01000022",85.789,0,1000,950,814.9955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_15086","NZ_FKXL01000017",83.574,0,994,1108,925.99992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLWD01000035",85.684,0,994,950,813.998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_135","NZ_FNPJ01000004",90,0,994,780,702,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_23935","NZ_FNOE01000002",85.865,0,989,948,814.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_15086","NZ_FKWV01000005",83.484,0,989,1108,925.00272,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_15086","NZ_FKXF01000023",83.484,0,989,1108,925.00272,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FNOE01000002",91.725,0,981,713,653.99925,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_12669","NZ_FNOE01000002",89.44,0,981,786,702.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FNPJ01000004",92.12,0,979,698,642.9976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_1625","NZ_FKXL01000017",85.066,0,976,991,843.00406,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLUB01000021",85.443,0,976,948,809.99964,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRM01000021",85.443,0,976,948,809.99964,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLWD01000035",83.677,0,974,1066,891.99682,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_2349","NZ_FKXL01000017",85.852,0,974,933,800.99916,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_2349","NZ_FKWV01000005",85.852,0,974,933,800.99916,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_2349","NZ_FKXF01000023",85.852,0,974,933,800.99916,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FNOE01000002",91.989,0,974,699,643.00311,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_1625","NZ_FKWV01000005",84.965,0,970,991,842.00315,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_1625","NZ_FKXF01000023",84.965,0,970,991,842.00315,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_28410","NZ_FNOE01000002",79.902,0,970,1423,1137.00546,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLUB01000021",85.104,0,970,960,816.9984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRM01000021",85.104,0,970,960,816.9984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLWD01000035",85.338,0,970,948,809.00424,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLXP01000026",85.338,0,970,948,809.00424,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLTT01000022",85.338,0,970,948,809.00424,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRF01000022",85.338,0,970,948,809.00424,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FNPJ01000004",82.394,0,968,1153,950.00282,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FNPJ01000004",86.636,0,968,883,764.99588,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLWD01000035",85,0,965,960,816,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLXP01000026",85,0,965,960,816,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLTT01000022",85,0,965,960,816,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRF01000022",85,0,965,960,816,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FNPJ01000004",91.152,0,959,712,649.00224,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FKXL01000017",92.857,0,955,658,610.99906,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FKWV01000005",92.857,0,955,658,610.99906,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FKXF01000023",92.857,0,955,658,610.99906,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_7569","NZ_FKXL01000017",82.799,0,953,1122,929.00478,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FNOE01000002",84.855,0,952,964,818.0022,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FNOE01000002",91.86,0,952,688,631.9968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_7569","NZ_FKWV01000005",82.709,0,948,1122,927.99498,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_7569","NZ_FKXF01000023",82.709,0,948,1122,927.99498,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FNOE01000002",86.297,0,948,883,762.00251,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLXP01000026",86.987,0,946,853,741.99911,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLUB01000021",86.987,0,946,853,741.99911,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLTT01000022",86.987,0,946,853,741.99911,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRM01000021",86.987,0,946,853,741.99911,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRF01000022",86.987,0,946,853,741.99911,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLWD01000035",86.87,0,941,853,741.0011,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_28410","NZ_FNPJ01000004",79.262,0,933,1437,1138.99494,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FKXL01000017",86.041,0,929,874,751.99834,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FKWV01000005",86.041,0,929,874,751.99834,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FKXF01000023",86.041,0,929,874,751.99834,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FNPJ01000004",91.266,0,929,687,626.99742,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_FNOE01000002",89.168,0,929,757,675.00176,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_FNPJ01000004",89.007,0,928,755,672.00285,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3018","NZ_FNPJ01000004",88.333,0,922,780,688.9974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FNOE01000002",91.291,0,909,666,607.99806,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_FNPJ01000004",82.136,0,905,1086,891.99696,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FNPJ01000004",90.262,0,898,688,621.00256,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FKXL01000017",90.379,0,896,686,619.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FKWV01000005",90.379,0,896,686,619.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FKXF01000023",90.379,0,896,686,619.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_23935","NZ_FNPJ01000004",84.122,0,896,951,800.00022,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_10283","NZ_FNOE01000002",90.29,0,896,690,623.001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT_vs_bact_coverage_filtered_hits","k127_7601","NZ_FNPJ01000004",90.855,0,894,678,615.9969,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FNOE01000002",91.692,0,893,650,595.998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT_vs_bact_coverage_filtered_hits","k127_7601","NZ_FNOE01000002",90.842,0,893,677,615.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_FNOE01000002",88.738,0,889,737,653.99906,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12900","NZ_FKXL01000017",80.831,0,889,1179,952.99749,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12900","NZ_FKWV01000005",80.831,0,889,1179,952.99749,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12900","NZ_FKXF01000023",80.831,0,889,1179,952.99749,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3018","NZ_FNOE01000002",87.564,0,887,780,682.9992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FKXL01000017",92.695,0,885,616,571.0012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FKWV01000005",92.695,0,885,616,571.0012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FKXF01000023",92.695,0,885,616,571.0012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FNOE01000002",89.87,0,883,691,621.0017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18589","NZ_FKXL01000017",83.419,0,881,977,815.00363,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18589","NZ_FKWV01000005",83.282,0,876,975,811.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18589","NZ_FKXF01000023",83.282,0,876,975,811.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_10283","NZ_FNPJ01000004",89.769,0,876,694,622.99686,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_FKXL01000017",91.798,0,874,634,581.99932,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_FKWV01000005",91.798,0,874,634,581.99932,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_FKXF01000023",91.798,0,874,634,581.99932,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FNPJ01000004",91.063,0,870,649,590.99887,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FNOE01000002",83.114,0,870,989,821.99746,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FNPJ01000004",90.211,0,867,664,599.00104,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8692","NZ_FNPJ01000004",83.598,0,865,945,790.0011,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8692","NZ_FNOE01000002",83.708,0,863,933,780.99564,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLWD01000035",86.507,0,863,793,686.00051,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLWD01000035",94.159,0,859,565,531.99835,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLXP01000026",94.159,0,859,565,531.99835,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLUB01000021",94.159,0,859,565,531.99835,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLTT01000022",94.159,0,859,565,531.99835,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRM01000021",94.159,0,859,565,531.99835,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRF01000022",94.159,0,859,565,531.99835,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLWD01000035",85.749,0,857,835,716.00415,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_12626","NZ_FKXL01000017",83.299,0,856,964,803.00236,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_FNPJ01000004",87.805,0,854,738,648.0009,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FNPJ01000004",82.892,0,854,982,813.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_12626","NZ_FKWV01000005",83.195,0,850,964,801.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_12626","NZ_FKXF01000023",83.195,0,850,964,801.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_14261","NZ_FNOE01000002",90.184,0,839,652,587.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FNPJ01000004",91.475,0,839,610,557.9975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FKXL01000017",91.612,0,835,608,557.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FKWV01000005",91.612,0,835,608,557.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FKXF01000023",91.612,0,835,608,557.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLXP01000026",88.319,0,835,702,619.99938,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLUB01000021",88.319,0,835,702,619.99938,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLTT01000022",88.319,0,835,702,619.99938,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRM01000021",88.319,0,835,702,619.99938,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRF01000022",88.319,0,835,702,619.99938,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_14261","NZ_FNPJ01000004",90,0,833,650,585,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLWD01000035",84.651,0,833,860,727.9986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_FNOE01000002",89.771,0,832,655,588.00005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_FNPJ01000004",89.124,0,819,662,590.00088,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FNPJ01000004",91.196,0,817,602,548.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_FNPJ01000004",89.313,0,817,655,585.00015,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8069","NZ_FKXL01000017",91.472,0,813,598,547.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8069","NZ_FKWV01000005",91.472,0,813,598,547.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8069","NZ_FKXF01000023",91.472,0,813,598,547.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FNOE01000002",90.701,0,811,613,555.99713,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FNOE01000002",83.945,0,809,872,732.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FNOE01000002",83.541,0,808,881,735.99621,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_33721","NZ_FKXL01000017",83.428,0,808,881,735.00068,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_33721","NZ_FKWV01000005",83.428,0,808,881,735.00068,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_33721","NZ_FKXF01000023",83.428,0,808,881,735.00068,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_10290","NZ_FKXL01000017",83.242,0,808,913,759.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_6646","NZ_FKXL01000017",82.209,0,806,978,804.00402,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_10290","NZ_FKWV01000005",83.133,0,802,913,759.00429,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_10290","NZ_FKXF01000023",83.133,0,802,913,759.00429,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_2384","NZ_FKXL01000017",83.295,0,800,880,732.996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_2384","NZ_FKWV01000005",83.295,0,800,880,732.996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_2384","NZ_FKXF01000023",83.295,0,800,880,732.996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_6646","NZ_FKWV01000005",82.106,0,800,978,802.99668,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_6646","NZ_FKXF01000023",82.106,0,800,978,802.99668,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_FNOE01000002",88.94,0,797,651,578.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLXP01000026",94.423,0,795,520,490.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLUB01000021",94.423,0,795,520,490.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLTT01000022",94.423,0,795,520,490.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRM01000021",94.423,0,795,520,490.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRF01000022",94.423,0,795,520,490.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FNOE01000002",90.563,0,795,604,547.00052,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_16554","NZ_FKXL01000017",80.517,0,795,1083,871.99911,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_16554","NZ_FKWV01000005",80.517,0,795,1083,871.99911,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_16554","NZ_FKXF01000023",80.517,0,795,1083,871.99911,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_FNOE01000002",82.567,0,793,935,772.00145,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FNPJ01000004",93.75,0,791,528,495,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLWD01000035",94.231,0,789,520,490.0012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLWD01000035",79.636,0,787,1154,918.99944,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FNPJ01000004",83.049,0,785,879,730.00071,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_17637","NZ_FKXL01000017",94.821,0,784,502,476.00142,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_17637","NZ_FKWV01000005",94.821,0,784,502,476.00142,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_17637","NZ_FKXF01000023",94.821,0,784,502,476.00142,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FKXL01000017",79.577,0,776,1136,903.99472,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FKWV01000005",79.577,0,776,1136,903.99472,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FKXF01000023",79.577,0,776,1136,903.99472,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLWD01000035",86.906,0,774,695,603.9967,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLXP01000026",86.906,0,774,695,603.9967,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLUB01000021",86.906,0,774,695,603.9967,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLTT01000022",86.906,0,774,695,603.9967,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRM01000021",86.906,0,774,695,603.9967,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRF01000022",86.906,0,774,695,603.9967,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FNPJ01000004",87.725,0,774,668,586.003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_FNPJ01000004",83.471,0,773,847,706.99937,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_7037","NZ_FKXL01000017",93.511,0,771,524,489.99764,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_7037","NZ_FKWV01000005",93.511,0,771,524,489.99764,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_7037","NZ_FKXF01000023",93.511,0,771,524,489.99764,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FNOE01000002",87.706,0,771,667,584.99902,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FNOE01000002",92.435,0,769,542,500.9977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_1501","NZ_FKXL01000017",82.366,0,767,913,752.00158,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3234","NZ_FKXL01000017",93.411,0,765,516,482.00076,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3234","NZ_FKWV01000005",93.411,0,765,516,482.00076,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3234","NZ_FKXF01000023",93.411,0,765,516,482.00076,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLWD01000035",86.969,0,763,683,593.99827,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLXP01000026",86.969,0,763,683,593.99827,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLUB01000021",86.969,0,763,683,593.99827,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLTT01000022",86.969,0,763,683,593.99827,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRM01000021",86.969,0,763,683,593.99827,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRF01000022",86.969,0,763,683,593.99827,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLWD01000035",86.58,0,763,693,599.9994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLUB01000021",86.58,0,763,693,599.9994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRM01000021",86.58,0,763,693,599.9994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_1501","NZ_FKWV01000005",82.217,0,761,911,748.99687,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_1501","NZ_FKXF01000023",82.217,0,761,911,748.99687,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_FNOE01000002",87.982,0,761,649,571.00318,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLUB01000021",84.04,0,760,802,674.0008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRM01000021",84.04,0,760,802,674.0008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLXP01000026",86.436,0,758,693,599.00148,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLTT01000022",86.436,0,758,693,599.00148,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRF01000022",86.436,0,758,693,599.00148,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FKXL01000017",80.585,0,754,1025,825.99625,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FKWV01000005",80.585,0,754,1025,825.99625,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FKXF01000023",80.585,0,754,1025,825.99625,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLWD01000035",83.915,0,754,802,672.9983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLXP01000026",83.915,0,754,802,672.9983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLTT01000022",83.915,0,754,802,672.9983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRF01000022",83.915,0,754,802,672.9983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_FNPJ01000004",87.73,0,754,652,571.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2422","NZ_FNOE01000002",87.538,0,749,658,576.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FNOE01000002",82.864,0,747,852,706.00128,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FNOE01000002",90.827,0,743,556,504.99812,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_FNOE01000002",89.845,0,741,581,521.99945,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLUB01000021",79.406,0,741,1078,855.99668,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRM01000021",79.406,0,741,1078,855.99668,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FNPJ01000004",82.767,0,741,853,706.00251,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_7688","NZ_FKXL01000017",82.609,0,741,874,722.00266,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_14637","NZ_FNPJ01000004",79.849,0,739,1062,847.99638,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_5940","NZ_FNPJ01000004",79.558,0,739,1086,863.99988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FNPJ01000004",85.694,0,737,713,610.99822,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLXP01000026",87.956,0,737,631,555.00236,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLUB01000021",87.956,0,737,631,555.00236,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLTT01000022",87.956,0,737,631,555.00236,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRM01000021",87.956,0,737,631,555.00236,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRF01000022",87.956,0,737,631,555.00236,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_5940","NZ_FNOE01000002",79.596,0,737,1088,866.00448,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_FKXL01000017",88.982,0,736,599,533.00218,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_FKWV01000005",88.982,0,736,599,533.00218,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_FKXF01000023",88.982,0,736,599,533.00218,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLWD01000035",79.314,0,736,1078,855.00492,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLXP01000026",79.314,0,736,1078,855.00492,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLTT01000022",79.314,0,736,1078,855.00492,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRF01000022",79.314,0,736,1078,855.00492,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_726","NZ_FKWV01000005",92.899,0,736,507,470.99793,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_726","NZ_FKXF01000023",92.899,0,736,507,470.99793,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_7688","NZ_FKWV01000005",82.494,0,736,874,720.99756,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_7688","NZ_FKXF01000023",82.494,0,736,874,720.99756,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3173","NZ_FKXL01000017",82.635,0,728,835,690.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3173","NZ_FKWV01000005",82.635,0,728,835,690.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3173","NZ_FKXF01000023",82.635,0,728,835,690.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLXP01000026",89.212,0,726,584,520.99808,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLUB01000021",89.212,0,726,584,520.99808,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLTT01000022",89.212,0,726,584,520.99808,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRM01000021",89.212,0,726,584,520.99808,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRF01000022",89.212,0,726,584,520.99808,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_FNOE01000002",87.678,0,726,633,555.00174,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_726","NZ_FKXL01000017",92.505,0,725,507,469.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLUB01000021",86.405,0,723,662,572.0011,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRM01000021",86.405,0,723,662,572.0011,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLUB01000021",86.05,0,723,681,586.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRM01000021",86.05,0,723,681,586.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLWD01000035",87.5,0,721,632,553,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLWD01000035",86.254,0,717,662,571.00148,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLXP01000026",86.254,0,717,662,571.00148,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLTT01000022",86.254,0,717,662,571.00148,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRF01000022",86.254,0,717,662,571.00148,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLWD01000035",85.903,0,717,681,584.99943,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLXP01000026",85.903,0,717,681,584.99943,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLTT01000022",85.903,0,717,681,584.99943,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRF01000022",85.903,0,717,681,584.99943,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2422","NZ_FNPJ01000004",86.606,0,715,657,569.00142,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_FNOE01000002",90.235,0,715,553,498.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_60251","NZ_FKWV01000005",84.679,0,715,731,619.00349,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_60251","NZ_FKXF01000023",84.679,0,715,731,619.00349,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FNPJ01000004",88.756,0,715,587,520.99772,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FNOE01000002",85.07,0,712,710,603.997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_FNPJ01000004",88.851,0,712,583,518.00133,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FKXL01000017",82.185,0,712,842,691.9977,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FKWV01000005",82.185,0,712,842,691.9977,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FKXF01000023",82.185,0,712,842,691.9977,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLWD01000035",83.25,0,712,800,666,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_60251","NZ_FKXL01000017",84.542,0,710,731,618.00202,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FNOE01000002",78.942,0,708,1078,850.99476,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2135","NZ_FKXL01000017",88.147,0,708,599,528.00053,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2135","NZ_FKWV01000005",88.147,0,708,599,528.00053,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2135","NZ_FKXF01000023",88.147,0,708,599,528.00053,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FNOE01000002",87.809,0,706,607,533.00063,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLWD01000035",86.604,0,704,642,555.99768,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLXP01000026",86.604,0,704,642,555.99768,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLUB01000021",86.604,0,704,642,555.99768,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLTT01000022",86.604,0,704,642,555.99768,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRM01000021",86.604,0,704,642,555.99768,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRF01000022",86.604,0,704,642,555.99768,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FNOE01000002",88.679,0,704,583,516.99857,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FNOE01000002",82.772,0,704,801,663.00372,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FKXL01000017",81.321,0,702,878,713.99838,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FKWV01000005",81.321,0,702,878,713.99838,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FKXF01000023",81.321,0,702,878,713.99838,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FNPJ01000004",78.81,0,702,1076,847.9956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FKXL01000017",81.861,0,702,849,694.99989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FKWV01000005",81.861,0,702,849,694.99989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FKXF01000023",81.861,0,702,849,694.99989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FNOE01000002",91.406,0,702,512,467.99872,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_15247","NZ_FNPJ01000004",90.149,0,701,538,485.00162,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLXP01000026",82.957,0,701,798,661.99686,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLUB01000021",82.957,0,701,798,661.99686,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLTT01000022",82.957,0,701,798,661.99686,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRM01000021",82.957,0,701,798,661.99686,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRF01000022",82.957,0,701,798,661.99686,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_FNPJ01000004",88.64,0,701,581,514.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_14637","NZ_FNOE01000002",79.249,0,699,1065,844.00185,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FNPJ01000004",82.625,0,699,800,661,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FNPJ01000004",90.377,0,697,530,478.9981,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLWD01000035",88.676,0,697,574,509.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLUB01000021",87.479,0,697,607,530.99753,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRM01000021",87.479,0,697,607,530.99753,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLXP01000026",91.12,0,697,518,472.0016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLUB01000021",91.12,0,697,518,472.0016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLTT01000022",91.12,0,697,518,472.0016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRM01000021",91.12,0,697,518,472.0016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRF01000022",91.12,0,697,518,472.0016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_FNOE01000002",88.488,0,695,582,515.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLWD01000035",88.115,0,695,589,518.99735,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_3899","NZ_FNOE01000002",89.165,0,693,563,501.99895,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FNPJ01000004",87.377,0,693,610,532.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FNPJ01000004",84.724,0,693,707,598.99868,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLXP01000026",89.007,0,691,564,501.99948,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLUB01000021",89.007,0,691,564,501.99948,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLTT01000022",89.007,0,691,564,501.99948,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRM01000021",89.007,0,691,564,501.99948,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRF01000022",89.007,0,691,564,501.99948,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLWD01000035",87.315,0,691,607,530.00205,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLXP01000026",87.315,0,691,607,530.00205,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLTT01000022",87.315,0,691,607,530.00205,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRF01000022",87.315,0,691,607,530.00205,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_FNPJ01000004",91.176,0,691,510,464.9976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FNOE01000002",89.907,0,689,535,481.00245,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FNPJ01000004",82.886,0,689,783,648.99738,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FNPJ01000004",80.444,0,688,946,761.00024,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_FNOE01000002",91.287,0,688,505,460.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLWD01000035",83.671,0,686,741,620.00211,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_FNPJ01000004",89.15,0,686,553,492.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_FNPJ01000004",86.457,0,686,635,549.00195,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLWD01000035",78.351,0,686,1104,864.99504,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FNPJ01000004",87.5,0,684,600,525,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLXP01000026",83.598,0,682,756,632.00088,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLUB01000021",83.598,0,682,756,632.00088,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLTT01000022",83.598,0,682,756,632.00088,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRM01000021",83.598,0,682,756,632.00088,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRF01000022",83.598,0,682,756,632.00088,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FKXL01000017",80.844,0,680,877,709.00188,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FKWV01000005",80.844,0,680,877,709.00188,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FKXF01000023",80.844,0,680,877,709.00188,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLWD01000035",80.613,0,680,913,735.99669,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FNOE01000002",89.338,0,680,544,485.99872,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_22570","NZ_FKXL01000017",85.714,0,680,658,563.99812,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_22570","NZ_FKWV01000005",85.714,0,680,658,563.99812,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_22570","NZ_FKXF01000023",85.714,0,680,658,563.99812,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_FNOE01000002",88.124,0,680,581,512.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FNPJ01000004",89.299,0,680,542,484.00058,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FNOE01000002",89.319,0,680,543,485.00217,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLWD01000035",90.522,0,680,517,467.99874,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLXP01000026",78.261,0,680,1104,864.00144,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLUB01000021",78.261,0,680,1104,864.00144,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLTT01000022",78.261,0,680,1104,864.00144,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRM01000021",78.261,0,680,1104,864.00144,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRF01000022",78.261,0,680,1104,864.00144,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FNPJ01000004",89.533,0,678,535,479.00155,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13421","NZ_FKXL01000017",83.18,0,676,761,632.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13421","NZ_FKWV01000005",83.18,0,676,761,632.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13421","NZ_FKXF01000023",83.18,0,676,761,632.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLWD01000035",87.822,0,676,583,512.00226,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FNOE01000002",81.57,0,676,841,686.0037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLWD01000035",83.026,0,676,760,630.9976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FNPJ01000004",85.824,0,676,649,556.99776,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLWD01000035",82.663,0,675,796,657.99748,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLXP01000026",82.663,0,675,796,657.99748,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLUB01000021",82.663,0,675,796,657.99748,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLTT01000022",82.663,0,675,796,657.99748,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRM01000021",82.663,0,675,796,657.99748,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRF01000022",82.663,0,675,796,657.99748,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FNOE01000002",91.481,0,675,493,451.00133,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_FNPJ01000004",87.889,0,675,578,507.99842,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9839","NZ_FNOE01000002",82.614,0,673,788,650.99832,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_5613","NZ_FKWV01000005",90.43,0,673,512,463.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_5613","NZ_FKXF01000023",90.43,0,673,512,463.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9743","NZ_FNOE01000002",86.603,0,673,627,543.00081,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FNOE01000002",82.413,0,673,779,641.99727,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_FNOE01000002",84.582,0,673,694,586.99908,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_15247","NZ_FNOE01000002",89.239,0,671,539,480.99821,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLWD01000035",81.873,0,671,822,672.99606,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLXP01000026",81.873,0,671,822,672.99606,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLTT01000022",81.873,0,671,822,672.99606,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRF01000022",81.873,0,671,822,672.99606,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_3899","NZ_FNPJ01000004",88.414,0,671,561,496.00254,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLWD01000035",80.592,0,671,912,734.99904,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_FNOE01000002",87.737,0,671,579,507.99723,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2037","NZ_FNPJ01000004",90.211,0,671,521,469.99931,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_1474","NZ_FNOE01000002",82.776,0,669,778,643.99728,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLUB01000021",86.656,0,669,607,526.00192,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRM01000021",86.656,0,669,607,526.00192,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FNOE01000002",86.196,0,667,623,537.00108,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLUB01000021",81.752,0,665,822,672.00144,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRM01000021",81.752,0,665,822,672.00144,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_FKXL01000017",87.608,0,665,581,509.00248,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_FKWV01000005",87.608,0,665,581,509.00248,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_FKXF01000023",87.608,0,665,581,509.00248,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLWD01000035",81.183,0,665,845,685.99635,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLXP01000026",81.183,0,665,845,685.99635,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLTT01000022",81.183,0,665,845,685.99635,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRF01000022",81.183,0,665,845,685.99635,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLWD01000035",83.201,0,665,756,628.99956,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLWD01000035",86.491,0,664,607,525.00037,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLXP01000026",86.491,0,664,607,525.00037,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLTT01000022",86.491,0,664,607,525.00037,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRF01000022",86.491,0,664,607,525.00037,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_27066","NZ_FKXL01000017",82.94,0,664,762,632.0028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_27066","NZ_FKWV01000005",82.94,0,664,762,632.0028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_27066","NZ_FKXF01000023",82.94,0,664,762,632.0028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FNPJ01000004",81.775,0,664,834,682.0035,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FNOE01000002",84.097,0,664,698,586.99706,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLXP01000026",84.858,0,662,667,566.00286,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLUB01000021",84.858,0,662,667,566.00286,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLTT01000022",84.858,0,662,667,566.00286,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRM01000021",84.858,0,662,667,566.00286,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRF01000022",84.858,0,662,667,566.00286,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_5613","NZ_FKXL01000017",90.039,0,662,512,460.99968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FKXL01000017",83.966,0,660,711,596.99826,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FKWV01000005",83.966,0,660,711,596.99826,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FKXF01000023",83.966,0,660,711,596.99826,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLUB01000021",81.065,0,660,845,684.99925,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRM01000021",81.065,0,660,845,684.99925,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_646","NZ_FKXL01000017",78.876,0,660,1032,814.00032,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_646","NZ_FKWV01000005",78.896,0,660,1033,814.99568,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_646","NZ_FKXF01000023",78.896,0,660,1033,814.99568,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FNPJ01000004",81.213,0,660,841,683.00133,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FNPJ01000004",87.631,0,660,574,503.00194,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLWD01000035",80.13,0,658,921,737.9973,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLXP01000026",81.28,0,656,844,686.0032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLUB01000021",81.28,0,656,844,686.0032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLTT01000022",81.28,0,656,844,686.0032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRM01000021",81.28,0,656,844,686.0032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRF01000022",81.28,0,656,844,686.0032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLUB01000021",81.154,0,656,849,688.99746,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRM01000021",81.154,0,656,849,688.99746,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXP01000026",81.154,0,656,849,688.99746,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLTT01000022",81.154,0,656,849,688.99746,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRF01000022",81.154,0,656,849,688.99746,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8254","NZ_FNPJ01000004",88.645,0,656,546,484.0017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FNPJ01000004",89.266,0,656,531,474.00246,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FNPJ01000004",91.224,0,656,490,446.9976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FNPJ01000004",81.432,0,654,824,670.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLWD01000035",84.49,0,654,677,571.9973,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLWD01000035",80.796,0,652,854,689.99784,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLXP01000026",80.796,0,652,854,689.99784,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLTT01000022",80.796,0,652,854,689.99784,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRF01000022",80.796,0,652,854,689.99784,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLXP01000026",89.163,0,652,526,468.99738,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLUB01000021",89.163,0,652,526,468.99738,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLTT01000022",89.163,0,652,526,468.99738,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRM01000021",89.163,0,652,526,468.99738,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRF01000022",89.163,0,652,526,468.99738,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FNPJ01000004",89.515,0,652,515,461.00225,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FNPJ01000004",88.641,0,652,537,476.00217,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2037","NZ_FNOE01000002",89.635,0,652,521,466.99835,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FNPJ01000004",83.811,0,652,698,585.00078,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLUB01000021",82.392,0,651,761,627.00312,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRM01000021",82.392,0,651,761,627.00312,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_FNPJ01000004",86.882,0,651,587,509.99734,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLUB01000021",88.419,0,651,544,480.99936,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRM01000021",88.419,0,651,544,480.99936,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLWD01000035",89.122,0,651,524,466.99928,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXP01000026",80.992,0,649,847,686.00224,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLUB01000021",80.992,0,649,847,686.00224,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLTT01000022",80.992,0,649,847,686.00224,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRM01000021",80.992,0,649,847,686.00224,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRF01000022",80.992,0,649,847,686.00224,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLWD01000035",85.42,0,649,631,539.0002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLXP01000026",89.015,0,647,528,469.9992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLUB01000021",89.015,0,647,528,469.9992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLTT01000022",89.015,0,647,528,469.9992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRM01000021",89.015,0,647,528,469.9992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRF01000022",89.015,0,647,528,469.9992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_18381","NZ_FNPJ01000004",85.556,0,647,630,539.0028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLXP01000026",86.712,0,647,587,508.99944,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLUB01000021",86.712,0,647,587,508.99944,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLTT01000022",86.712,0,647,587,508.99944,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRM01000021",86.712,0,647,587,508.99944,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRF01000022",86.712,0,647,587,508.99944,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FNPJ01000004",90.467,0,647,493,446.00231,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FKXL01000017",81.227,0,645,815,662.00005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FKWV01000005",81.227,0,645,815,662.00005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FKXF01000023",81.227,0,645,815,662.00005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLWD01000035",81.026,0,645,838,678.99788,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9743","NZ_FNPJ01000004",85.623,0,645,626,535.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLWD01000035",88.235,0,645,544,479.9984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLXP01000026",88.235,0,645,544,479.9984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLTT01000022",88.235,0,645,544,479.9984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRF01000022",88.235,0,645,544,479.9984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLXP01000026",83.548,0,645,699,584.00052,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLUB01000021",83.548,0,645,699,584.00052,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLTT01000022",83.548,0,645,699,584.00052,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRM01000021",83.548,0,645,699,584.00052,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRF01000022",83.548,0,645,699,584.00052,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_FNPJ01000004",83.885,0,645,695,583.00075,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLXP01000026",88.931,0,645,524,465.99844,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLUB01000021",88.931,0,645,524,465.99844,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLTT01000022",88.931,0,645,524,465.99844,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRM01000021",88.931,0,645,524,465.99844,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRF01000022",88.931,0,645,524,465.99844,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FNOE01000002",81.098,0,643,820,665.0036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_FNPJ01000004",85.6,0,643,625,535,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FNOE01000002",81.273,0,643,833,677.00409,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_FNOE01000002",85.285,0,643,632,539.0012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLWD01000035",87.59,0,640,556,487.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLXP01000026",87.59,0,640,556,487.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLUB01000021",87.59,0,640,556,487.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLTT01000022",87.59,0,640,556,487.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRM01000021",87.59,0,640,556,487.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRF01000022",87.59,0,640,556,487.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_FKXL01000017",82.726,0,640,741,612.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_FKWV01000005",82.726,0,640,741,612.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_FKXF01000023",82.726,0,640,741,612.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FKXL01000017",80.549,0,638,874,703.99826,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT_vs_bact_coverage_filtered_hits","k127_284","NZ_FNOE01000002",85.238,0,638,630,536.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_5380","NZ_FKXL01000017",86.318,1.52e-180,636,592,511.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_5380","NZ_FKWV01000005",86.318,1.52e-180,636,592,511.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_5380","NZ_FKXF01000023",86.318,1.52e-180,636,592,511.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLWD01000035",84.498,1.72e-180,636,658,555.99684,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_10412","NZ_FKXL01000017",81.818,7.32e-180,634,792,647.99856,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_FNOE01000002",88.719,4.81e-180,634,523,464.00037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_18381","NZ_FNOE01000002",85.261,5.91e-180,634,631,537.99691,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FKWV01000005",80.435,3.25e-179,632,874,703.0019,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FKXF01000023",80.435,3.25e-179,632,874,703.0019,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLWD01000035",79.912,3.19e-179,632,906,724.00272,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_FNOE01000002",85.28,2.08e-179,632,625,533,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FNOE01000002",83.121,2.35e-179,632,705,586.00305,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLWD01000035",82.166,3.5e-178,628,757,621.99662,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_10412","NZ_FKWV01000005",81.692,3.4e-178,628,792,647.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_10412","NZ_FKXF01000023",81.692,3.4e-178,628,792,647.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLXP01000026",80.714,4.08e-178,628,840,677.9976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLUB01000021",80.714,4.08e-178,628,840,677.9976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLTT01000022",80.714,4.08e-178,628,840,677.9976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRM01000021",80.714,4.08e-178,628,840,677.9976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRF01000022",80.714,4.08e-178,628,840,677.9976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_10954","NZ_FKXL01000017",80.889,3.58e-178,628,832,672.99648,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FNOE01000002",79.281,4.11e-178,628,946,749.99826,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FNOE01000002",90.02,2.65e-178,628,491,441.9982,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FNOE01000002",81.891,1.35e-177,627,751,615.00141,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLXP01000026",85.366,1.04e-177,627,615,525.0009,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLUB01000021",85.366,1.04e-177,627,615,525.0009,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLTT01000022",85.366,1.04e-177,627,615,525.0009,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRM01000021",85.366,1.04e-177,627,615,525.0009,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRF01000022",85.366,1.04e-177,627,615,525.0009,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLWD01000035",84.043,1.02e-177,627,658,553.00294,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8254","NZ_FNOE01000002",87.706,8.37e-178,627,545,477.9977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FNPJ01000004",84.992,9.7e-178,627,633,537.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_FNOE01000002",88.911,2.83e-177,625,514,457.00254,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLWD01000035",82.917,1.43e-176,623,720,597.0024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_10954","NZ_FKWV01000005",80.723,1.66e-176,623,830,670.0009,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_10954","NZ_FKXF01000023",80.723,1.66e-176,623,830,670.0009,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_2164","NZ_FKXL01000017",83.406,1.45e-176,623,687,572.99922,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_2164","NZ_FKWV01000005",83.406,1.45e-176,623,687,572.99922,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_2164","NZ_FKXF01000023",83.406,1.45e-176,623,687,572.99922,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT_vs_bact_coverage_filtered_hits","k127_284","NZ_FNPJ01000004",84.858,1.25e-176,623,634,537.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLXP01000026",85.246,1.73e-176,623,610,520.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLUB01000021",85.246,1.73e-176,623,610,520.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLTT01000022",85.246,1.73e-176,623,610,520.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRM01000021",85.246,1.73e-176,623,610,520.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRF01000022",85.246,1.73e-176,623,610,520.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_FKXL01000017",81.328,5.99e-176,621,798,648.99744,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_FKWV01000005",81.328,5.99e-176,621,798,648.99744,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_FKXF01000023",81.328,5.99e-176,621,798,648.99744,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLXP01000026",88.023,3.06e-175,619,526,463.00098,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLUB01000021",88.023,3.06e-175,619,526,463.00098,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLTT01000022",88.023,3.06e-175,619,526,463.00098,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRM01000021",88.023,3.06e-175,619,526,463.00098,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRF01000022",88.023,3.06e-175,619,526,463.00098,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FKXL01000017",81.313,2.04e-175,619,792,643.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FKWV01000005",81.313,2.04e-175,619,792,643.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FKXF01000023",81.313,2.04e-175,619,792,643.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_21311","NZ_FKXL01000017",85.786,6.76e-175,617,598,513.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_21311","NZ_FKWV01000005",85.786,6.76e-175,617,598,513.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_21311","NZ_FKXF01000023",85.786,6.76e-175,617,598,513.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLWD01000035",80.755,7.71e-175,617,821,662.99855,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLXP01000026",80.755,7.71e-175,617,821,662.99855,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLTT01000022",80.755,7.71e-175,617,821,662.99855,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRF01000022",80.755,7.71e-175,617,821,662.99855,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11443","NZ_FKXL01000017",83.456,2.28e-174,616,677,564.99712,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FKXL01000017",80.167,4.18e-174,616,837,670.99779,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FKWV01000005",80.167,4.18e-174,616,837,670.99779,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FKXF01000023",80.167,4.18e-174,616,837,670.99779,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_FKXL01000017",87.293,1.81e-174,616,543,474.00099,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_FKWV01000005",87.293,1.81e-174,616,543,474.00099,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_FKXF01000023",87.293,1.81e-174,616,543,474.00099,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_1474","NZ_FNPJ01000004",81.41,1.12e-173,614,780,634.998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FKXL01000017",79.906,1.18e-173,614,851,680.00006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FKWV01000005",79.906,1.18e-173,614,851,680.00006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FKXF01000023",79.906,1.18e-173,614,851,680.00006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_39167","NZ_FKXL01000017",80.803,3.5e-173,612,797,643.99991,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_39167","NZ_FKWV01000005",80.803,3.5e-173,612,797,643.99991,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_39167","NZ_FKXF01000023",80.803,3.5e-173,612,797,643.99991,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLUB01000021",80.68,3.59e-173,612,823,663.9964,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRM01000021",80.68,3.59e-173,612,823,663.9964,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLUB01000021",88.155,2.71e-173,612,515,453.99825,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRM01000021",88.155,2.71e-173,612,515,453.99825,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FNPJ01000004",85.378,2.58e-173,612,595,507.9991,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11443","NZ_FKWV01000005",83.309,1.06e-172,610,677,564.00193,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11443","NZ_FKXF01000023",83.309,1.06e-172,610,677,564.00193,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FNOE01000002",87.643,8.2e-173,610,526,461.00218,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9839","NZ_FNPJ01000004",81.067,4.43e-172,608,787,637.99729,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FNPJ01000004",81.172,4.52e-172,608,802,650.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FNOE01000002",81.196,4.52e-172,608,803,652.00388,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_23928","NZ_FKXL01000017",87.709,2.97e-172,608,537,470.99733,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_23928","NZ_FKWV01000005",87.709,2.97e-172,608,537,470.99733,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_23928","NZ_FKXF01000023",87.709,2.97e-172,608,537,470.99733,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLWD01000035",80.39,5.42e-172,608,821,660.0019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLWD01000035",87.313,1.08e-171,606,536,467.99768,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FNOE01000002",86.511,1.12e-171,606,556,481.00116,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLWD01000035",87.961,1.26e-171,606,515,452.99915,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLXP01000026",87.961,1.26e-171,606,515,452.99915,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLTT01000022",87.961,1.26e-171,606,515,452.99915,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRF01000022",87.961,1.26e-171,606,515,452.99915,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_FNOE01000002",85.593,1.19e-171,606,590,504.9987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLWD01000035",83.483,1.34e-171,606,666,555.99678,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLXP01000026",83.483,1.34e-171,606,666,555.99678,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLUB01000021",83.483,1.34e-171,606,666,555.99678,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLTT01000022",83.483,1.34e-171,606,666,555.99678,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRM01000021",83.483,1.34e-171,606,666,555.99678,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRF01000022",83.483,1.34e-171,606,666,555.99678,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLXP01000026",85.333,4.52e-171,604,600,511.998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLUB01000021",85.333,4.52e-171,604,600,511.998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLTT01000022",85.333,4.52e-171,604,600,511.998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRM01000021",85.333,4.52e-171,604,600,511.998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRF01000022",85.333,4.52e-171,604,600,511.998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_FNOE01000002",85.314,4.37e-171,604,606,517.00284,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLXP01000026",85.279,4.78e-171,604,591,503.99889,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLUB01000021",85.279,4.78e-171,604,591,503.99889,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLTT01000022",85.279,4.78e-171,604,591,503.99889,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRM01000021",85.279,4.78e-171,604,591,503.99889,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRF01000022",85.279,4.78e-171,604,591,503.99889,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLXP01000026",87.313,1.38e-170,603,536,467.99768,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLUB01000021",87.313,1.38e-170,603,536,467.99768,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLTT01000022",87.313,1.38e-170,603,536,467.99768,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRM01000021",87.313,1.38e-170,603,536,467.99768,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRF01000022",87.313,1.38e-170,603,536,467.99768,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_FNPJ01000004",85.124,1.57e-170,603,605,515.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLXP01000026",80.268,2.52e-170,603,821,659.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLTT01000022",80.268,2.52e-170,603,821,659.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRF01000022",80.268,2.52e-170,603,821,659.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLWD01000035",85.544,1.53e-170,603,588,502.99872,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLXP01000026",85.544,1.53e-170,603,588,502.99872,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLUB01000021",85.544,1.53e-170,603,588,502.99872,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLTT01000022",85.544,1.53e-170,603,588,502.99872,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRM01000021",85.544,1.53e-170,603,588,502.99872,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRF01000022",85.544,1.53e-170,603,588,502.99872,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_14193","NZ_FNPJ01000004",78.477,9.37e-170,601,985,772.99845,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FKXL01000017",83.801,6.17e-170,601,642,538.00242,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FKWV01000005",83.801,6.17e-170,601,642,538.00242,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FKXF01000023",83.801,6.17e-170,601,642,538.00242,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLWD01000035",82.411,2.38e-169,599,705,580.99755,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLXP01000026",82.411,2.38e-169,599,705,580.99755,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLUB01000021",82.411,2.38e-169,599,705,580.99755,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLTT01000022",82.411,2.38e-169,599,705,580.99755,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRM01000021",82.411,2.38e-169,599,705,580.99755,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRF01000022",82.411,2.38e-169,599,705,580.99755,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FNPJ01000004",82.386,2.38e-169,599,704,579.99744,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLWD01000035",87.194,6.4e-169,597,531,463.00014,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLXP01000026",87.194,6.4e-169,597,531,463.00014,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLUB01000021",87.194,6.4e-169,597,531,463.00014,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLTT01000022",87.194,6.4e-169,597,531,463.00014,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRM01000021",87.194,6.4e-169,597,531,463.00014,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRF01000022",87.194,6.4e-169,597,531,463.00014,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLUB01000021",80.146,1.17e-168,597,821,657.99866,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRM01000021",80.146,1.17e-168,597,821,657.99866,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_FNOE01000002",82.87,1.04e-168,597,683,566.0021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FKXL01000017",79.484,4.22e-168,595,853,677.99852,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FKWV01000005",79.484,4.22e-168,595,853,677.99852,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FKXF01000023",79.484,4.22e-168,595,853,677.99852,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FNOE01000002",84.899,2.6e-168,595,596,505.99804,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLUB01000021",86.642,3.02e-168,595,539,467.00038,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRM01000021",86.642,3.02e-168,595,539,467.00038,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLWD01000035",84.754,2.7e-168,595,610,516.9994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_14193","NZ_FNOE01000002",78.441,1.57e-167,593,988,774.99708,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FNOE01000002",79.736,1.69e-167,593,834,664.99824,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLWD01000035",87.945,8.06e-168,593,506,445.0017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_FNPJ01000004",87.262,8.16e-168,593,526,458.99812,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLXP01000026",87.921,2.9e-167,592,505,444.00105,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLUB01000021",87.921,2.9e-167,592,505,444.00105,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLTT01000022",87.921,2.9e-167,592,505,444.00105,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRM01000021",87.921,2.9e-167,592,505,444.00105,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRF01000022",87.921,2.9e-167,592,505,444.00105,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FKXL01000017",79.436,6.61e-167,592,851,676.00036,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FKWV01000005",79.436,6.61e-167,592,851,676.00036,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FKXF01000023",79.436,6.61e-167,592,851,676.00036,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLXP01000026",84.925,3.77e-167,592,597,507.00225,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLUB01000021",84.925,3.77e-167,592,597,507.00225,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLTT01000022",84.925,3.77e-167,592,597,507.00225,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRM01000021",84.925,3.77e-167,592,597,507.00225,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRF01000022",84.925,3.77e-167,592,597,507.00225,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17583","NZ_FNOE01000002",84.941,1.2e-166,590,591,502.00131,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLWD01000035",81.234,1.53e-166,590,778,632.00052,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLWD01000035",86.456,1.41e-166,590,539,465.99784,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLXP01000026",86.456,1.41e-166,590,539,465.99784,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLTT01000022",86.456,1.41e-166,590,539,465.99784,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRF01000022",86.456,1.41e-166,590,539,465.99784,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLWD01000035",82.27,1.43e-166,590,705,580.0035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLXP01000026",82.32,1.43e-166,590,707,582.0024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLUB01000021",82.32,1.43e-166,590,707,582.0024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLTT01000022",82.32,1.43e-166,590,707,582.0024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRM01000021",82.32,1.43e-166,590,707,582.0024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRF01000022",82.32,1.43e-166,590,707,582.0024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FNOE01000002",85.814,1.32e-166,590,571,489.99794,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLWD01000035",84.859,4.55e-166,588,601,510.00259,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FNPJ01000004",79.621,7.86e-166,588,844,672.00124,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLWD01000035",86.729,1.39e-165,586,535,464.00015,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_FNOE01000002",85.269,1.52e-165,586,577,492.00213,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_FNPJ01000004",84.89,1.55e-165,586,589,500.0021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLXP01000026",88.525,5.04e-165,584,488,432.002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLUB01000021",88.525,5.04e-165,584,488,432.002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLTT01000022",88.525,5.04e-165,584,488,432.002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRM01000021",88.525,5.04e-165,584,488,432.002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRF01000022",88.525,5.04e-165,584,488,432.002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FNPJ01000004",85.817,5.24e-165,584,557,478.00069,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FNPJ01000004",84.983,5.49e-165,584,586,498.00038,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FNPJ01000004",78.225,1.38e-164,584,969,758.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FNOE01000002",79.363,9.13e-165,584,848,672.99824,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FKXL01000017",83.051,6.54e-165,584,649,539.00099,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FKWV01000005",83.051,6.54e-165,584,649,539.00099,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FKXF01000023",83.051,6.54e-165,584,649,539.00099,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FNOE01000002",86.692,1.79e-164,582,526,455.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLXP01000026",80.715,4.95e-164,582,783,631.99845,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLUB01000021",80.715,4.95e-164,582,783,631.99845,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLTT01000022",80.715,4.95e-164,582,783,631.99845,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRM01000021",80.715,4.95e-164,582,783,631.99845,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRF01000022",80.715,4.95e-164,582,783,631.99845,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FNPJ01000004",81.175,9.95e-164,580,749,608.00075,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_FNPJ01000004",85.069,7.05e-164,580,576,489.99744,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FNOE01000002",83.575,3.42e-163,579,621,519.00075,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLWD01000035",83.005,2.86e-163,579,659,547.00295,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FNOE01000002",86,1.3e-162,577,550,473,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FNOE01000002",81.74,1.12e-162,577,701,572.9974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FNPJ01000004",80.559,4.96e-162,575,751,604.99809,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLXP01000026",84.708,3.29e-162,575,582,493.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLUB01000021",84.708,3.29e-162,575,582,493.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLTT01000022",84.708,3.29e-162,575,582,493.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRM01000021",84.708,3.29e-162,575,582,493.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRF01000022",84.708,3.29e-162,575,582,493.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16892","NZ_FKXL01000017",81.199,1.53e-161,573,734,596.00066,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_8124","NZ_FKXL01000017",84.922,1.21e-161,573,577,489.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_11340","NZ_FNOE01000002",85.818,1.13e-161,573,550,471.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_FNPJ01000004",86.99,1.04e-161,573,515,447.9985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLUB01000021",87.885,3.79e-161,571,487,427.99995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRM01000021",87.885,3.79e-161,571,487,427.99995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLUB01000021",86.564,4.02e-161,571,521,450.99844,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRM01000021",86.564,4.02e-161,571,521,450.99844,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15916","NZ_FKWV01000005",82.655,1.75e-160,569,663,548.00265,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15916","NZ_FKXF01000023",82.655,1.75e-160,569,663,548.00265,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_10112","NZ_FKXL01000017",88.008,1.47e-160,569,492,432.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16892","NZ_FKWV01000005",81.65,7.11e-160,568,703,573.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16892","NZ_FKXF01000023",81.65,7.11e-160,568,703,573.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLWD01000035",84.655,5.5e-160,568,580,490.999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLXP01000026",84.655,5.5e-160,568,580,490.999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLUB01000021",84.655,5.5e-160,568,580,490.999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLTT01000022",84.655,5.5e-160,568,580,490.999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRM01000021",84.655,5.5e-160,568,580,490.999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRF01000022",84.655,5.5e-160,568,580,490.999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLWD01000035",82.164,6.5e-160,568,684,562.00176,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLXP01000026",82.164,6.5e-160,568,684,562.00176,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLUB01000021",82.164,6.5e-160,568,684,562.00176,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLTT01000022",82.164,6.5e-160,568,684,562.00176,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRM01000021",82.164,6.5e-160,568,684,562.00176,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRF01000022",82.164,6.5e-160,568,684,562.00176,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_8124","NZ_FKWV01000005",84.749,5.61e-160,568,577,489.00173,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_8124","NZ_FKXF01000023",84.749,5.61e-160,568,577,489.00173,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLWD01000035",79.731,4.27e-159,566,819,652.99689,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLXP01000026",79.731,4.27e-159,566,819,652.99689,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLTT01000022",79.731,4.27e-159,566,819,652.99689,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRF01000022",79.731,4.27e-159,566,819,652.99689,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLXP01000026",80.92,3.21e-159,566,739,597.9988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLUB01000021",80.92,3.21e-159,566,739,597.9988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLTT01000022",80.92,3.21e-159,566,739,597.9988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRM01000021",80.92,3.21e-159,566,739,597.9988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRF01000022",80.92,3.21e-159,566,739,597.9988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FNOE01000002",83.175,2.14e-159,566,630,524.0025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLWD01000035",87.68,1.76e-159,566,487,427.0016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLXP01000026",87.68,1.76e-159,566,487,427.0016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLTT01000022",87.68,1.76e-159,566,487,427.0016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRF01000022",87.68,1.76e-159,566,487,427.0016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLWD01000035",86.372,1.87e-159,566,521,449.99812,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLXP01000026",86.372,1.87e-159,566,521,449.99812,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLTT01000022",86.372,1.87e-159,566,521,449.99812,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRF01000022",86.372,1.87e-159,566,521,449.99812,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLWD01000035",84.3,7.16e-159,564,586,493.998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_11526","NZ_FKXL01000017",79.641,1.02e-158,564,835,665.00235,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_11526","NZ_FKWV01000005",79.641,1.02e-158,564,835,665.00235,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_11526","NZ_FKXF01000023",79.641,1.02e-158,564,835,665.00235,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15916","NZ_FKXL01000017",82.504,8.14e-159,564,663,547.00152,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_10112","NZ_FKWV01000005",87.805,6.85e-159,564,492,432.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_10112","NZ_FKXF01000023",87.805,6.85e-159,564,492,432.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_16795","NZ_FNPJ01000004",83.253,7.66e-159,564,621,517.00113,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLUB01000021",81.267,1.54e-158,564,726,589.99842,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRM01000021",81.267,1.54e-158,564,726,589.99842,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15758","NZ_FNOE01000002",84.444,7.18e-159,564,585,493.9974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_FNOE01000002",78.141,5.86e-158,562,947,739.99527,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FNPJ01000004",85.958,8.39e-158,560,527,452.99866,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_FNOE01000002",86.654,8.16e-158,560,517,448.00118,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15758","NZ_FNPJ01000004",84.3,9.28e-158,560,586,493.998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_FNOE01000002",89.931,8.11e-158,560,437,392.99847,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_2276","NZ_FKXL01000017",85.375,3.12e-157,558,547,467.00125,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_2276","NZ_FKWV01000005",85.375,3.12e-157,558,547,467.00125,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_2276","NZ_FKXF01000023",85.375,3.12e-157,558,547,467.00125,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_2421","NZ_FNPJ01000004",78.753,5.3e-157,558,866,682.00098,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_2915","NZ_FNPJ01000004",79.551,4.65e-157,558,802,637.99902,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FNPJ01000004",80.466,4.33e-157,558,773,622.00218,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FNPJ01000004",86.408,1.05e-156,556,515,445.0012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLWD01000035",79.634,2.05e-156,556,820,652.9988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_2915","NZ_FNOE01000002",79.728,1.67e-156,556,809,644.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FNPJ01000004",78.947,1.99e-156,556,855,674.99685,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FNOE01000002",76.316,3.47e-156,556,1102,841.00232,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FNPJ01000004",85.165,6.07e-156,555,546,465.0009,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_1286","NZ_FNOE01000002",84.402,4.24e-156,555,577,486.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT_vs_bact_coverage_filtered_hits","k127_3429","NZ_FNOE01000002",85.37,4.37e-156,555,540,460.998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FNPJ01000004",78.409,2.61e-155,553,880,689.9992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FNOE01000002",78.49,2.61e-155,553,874,686.0026,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3927","NZ_FNPJ01000004",79.056,2.26e-155,553,869,686.99664,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLWD01000035",84.048,1.54e-155,553,583,489.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLWD01000035",87.949,1.59e-155,553,473,415.99877,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLXP01000026",87.949,1.59e-155,553,473,415.99877,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLUB01000021",87.949,1.59e-155,553,473,415.99877,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLTT01000022",87.949,1.59e-155,553,473,415.99877,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRM01000021",87.949,1.59e-155,553,473,415.99877,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRF01000022",87.949,1.59e-155,553,473,415.99877,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLWD01000035",78.36,9.37e-155,551,878,688.0008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLXP01000026",78.36,9.37e-155,551,878,688.0008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLUB01000021",78.36,9.37e-155,551,878,688.0008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLTT01000022",78.36,9.37e-155,551,878,688.0008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRM01000021",78.36,9.37e-155,551,878,688.0008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRF01000022",78.36,9.37e-155,551,878,688.0008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_2421","NZ_FNOE01000002",78.687,8.87e-155,551,868,683.00316,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_FNPJ01000004",82.962,5.95e-155,551,628,521.00136,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3927","NZ_FNOE01000002",78.984,8.14e-155,551,866,684.00144,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FNPJ01000004",76.225,1.62e-154,551,1102,839.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLWD01000035",80.541,3.23e-154,549,740,596.0034,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLXP01000026",88.767,3.11e-154,549,454,403.00218,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLUB01000021",88.767,3.11e-154,549,454,403.00218,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLTT01000022",88.767,3.11e-154,549,454,403.00218,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRM01000021",88.767,3.11e-154,549,454,403.00218,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRF01000022",88.767,3.11e-154,549,454,403.00218,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_FNPJ01000004",77.918,1.64e-153,547,951,741.00018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLUB01000021",78.348,1.24e-153,547,896,701.99808,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRM01000021",78.348,1.24e-153,547,896,701.99808,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FKXL01000017",81.97,8.29e-154,547,660,541.002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FKWV01000005",81.97,8.29e-154,547,660,541.002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FKXF01000023",81.97,8.29e-154,547,660,541.002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_FNPJ01000004",86.127,6.35e-154,547,519,446.99913,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLXP01000026",83.932,7.16e-154,547,585,491.0022,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLUB01000021",83.932,7.16e-154,547,585,491.0022,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLTT01000022",83.932,7.16e-154,547,585,491.0022,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRM01000021",83.932,7.16e-154,547,585,491.0022,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRF01000022",83.932,7.16e-154,547,585,491.0022,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLWD01000035",81.422,8.67e-154,547,689,560.99758,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLXP01000026",81.349,8.67e-154,547,697,567.00253,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLUB01000021",81.349,8.67e-154,547,697,567.00253,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLTT01000022",81.349,8.67e-154,547,697,567.00253,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRM01000021",81.349,8.67e-154,547,697,567.00253,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRF01000022",81.349,8.67e-154,547,697,567.00253,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_FKXL01000017",84.854,2.43e-153,545,548,464.99992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_FKWV01000005",84.854,2.43e-153,545,548,464.99992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_FKXF01000023",84.854,2.43e-153,545,548,464.99992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FNOE01000002",81.75,2.97e-153,545,663,542.0025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FNPJ01000004",81.791,1.07e-152,544,659,539.00269,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_FNPJ01000004",89.269,8.16e-153,544,438,390.99822,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLWD01000035",85.255,3.94e-152,542,529,450.99895,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLXP01000026",85.255,3.94e-152,542,529,450.99895,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLTT01000022",85.255,3.94e-152,542,529,450.99895,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRF01000022",85.255,3.94e-152,542,529,450.99895,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLXP01000026",78.237,5.78e-152,542,896,701.00352,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLTT01000022",78.237,5.78e-152,542,896,701.00352,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRF01000022",78.237,5.78e-152,542,896,701.00352,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FNPJ01000004",78.041,5.78e-152,542,888,693.00408,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLWD01000035",74.814,9.08e-152,542,1342,1004.00388,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLWD01000035",82.616,3.59e-152,542,627,518.00232,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLXP01000026",82.616,3.59e-152,542,627,518.00232,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLUB01000021",82.616,3.59e-152,542,627,518.00232,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLTT01000022",82.616,3.59e-152,542,627,518.00232,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRM01000021",82.616,3.59e-152,542,627,518.00232,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRF01000022",82.616,3.59e-152,542,627,518.00232,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLWD01000035",83.733,3.33e-152,542,584,489.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12298","NZ_FKXL01000017",82.555,3.81e-152,542,642,530.0031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12298","NZ_FKWV01000005",82.555,3.81e-152,542,642,530.0031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12298","NZ_FKXF01000023",82.555,3.81e-152,542,642,530.0031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLWD01000035",82.595,4.2e-152,542,632,522.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLXP01000026",88.546,5.71e-152,542,454,401.99884,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLUB01000021",88.546,5.71e-152,542,454,401.99884,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLTT01000022",88.546,5.71e-152,542,454,401.99884,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRM01000021",88.546,5.71e-152,542,454,401.99884,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRF01000022",88.546,5.71e-152,542,454,401.99884,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FKXL01000017",81.406,1.42e-151,540,683,556.00298,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FKWV01000005",81.406,1.42e-151,540,683,556.00298,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FKXF01000023",81.406,1.42e-151,540,683,556.00298,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FNPJ01000004",81.378,1.42e-151,540,682,554.99796,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_FNOE01000002",83.673,1.22e-151,540,588,491.99724,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLWD01000035",85.855,1.14e-151,540,509,437.00195,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLXP01000026",85.855,1.14e-151,540,509,437.00195,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLUB01000021",85.855,1.14e-151,540,509,437.00195,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLTT01000022",85.855,1.14e-151,540,509,437.00195,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRM01000021",85.855,1.14e-151,540,509,437.00195,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRF01000022",85.855,1.14e-151,540,509,437.00195,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FNPJ01000004",80.345,1.6e-151,540,753,604.99785,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLWD01000035",80.33,6.51e-151,538,727,583.9991,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLXP01000026",80.33,6.51e-151,538,727,583.9991,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLTT01000022",80.33,6.51e-151,538,727,583.9991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRF01000022",80.33,6.51e-151,538,727,583.9991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FNOE01000002",77.423,1.09e-150,538,970,751.0031,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_FKXL01000017",85.255,3.91e-151,538,529,450.99895,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_FKWV01000005",85.255,3.91e-151,538,529,450.99895,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_FKXF01000023",85.255,3.91e-151,538,529,450.99895,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLWD01000035",82.198,4.8e-151,538,646,530.99908,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLXP01000026",82.198,4.8e-151,538,646,530.99908,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLUB01000021",82.198,4.8e-151,538,646,530.99908,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLTT01000022",82.198,4.8e-151,538,646,530.99908,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRM01000021",82.198,4.8e-151,538,646,530.99908,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRF01000022",82.198,4.8e-151,538,646,530.99908,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FKXL01000017",79.241,6.04e-151,538,790,626.0039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FKWV01000005",79.241,6.04e-151,538,790,626.0039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FKXF01000023",79.241,6.04e-151,538,790,626.0039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FKXL01000017",84.63,1.83e-150,536,540,457.002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FKWV01000005",84.63,1.83e-150,536,540,457.002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FKXF01000023",84.63,1.83e-150,536,540,457.002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLUB01000021",85.122,1.83e-150,536,531,451.99782,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRM01000021",85.122,1.83e-150,536,531,451.99782,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLWD01000035",78.052,2.69e-150,536,893,697.00436,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_9342","NZ_FNOE01000002",86.228,1.46e-150,536,501,432.00228,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLXP01000026",83.821,6.88e-150,534,581,487.00001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLUB01000021",83.821,6.88e-150,534,581,487.00001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLTT01000022",83.821,6.88e-150,534,581,487.00001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRM01000021",83.821,6.88e-150,534,581,487.00001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRF01000022",83.821,6.88e-150,534,581,487.00001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15803","NZ_FKXL01000017",81.552,6.44e-150,534,683,557.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_FNPJ01000004",85.417,5.01e-150,534,528,451.00176,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLWD01000035",82.82,5.86e-150,534,617,510.9994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FNOE01000002",82.876,7.29e-150,534,619,513.00244,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FNPJ01000004",82.287,7.5e-150,534,621,511.00227,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FKXL01000017",84.116,5.93e-150,534,554,466.00264,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FKWV01000005",84.116,5.93e-150,534,554,466.00264,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FKXF01000023",84.116,5.93e-150,534,554,466.00264,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FKXL01000017",84.375,2.85e-149,532,544,459,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FKWV01000005",84.375,2.85e-149,532,544,459,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FKXF01000023",84.375,2.85e-149,532,544,459,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLUB01000021",80.193,3.03e-149,532,727,583.00311,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRM01000021",80.193,3.03e-149,532,727,583.00311,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FNPJ01000004",80.797,2.45e-149,532,703,568.00291,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_FKXL01000017",81.86,9.34e-149,531,656,537.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_FKWV01000005",81.86,9.34e-149,531,656,537.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_FKXF01000023",81.86,9.34e-149,531,656,537.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FKXL01000017",81.567,8.82e-149,531,651,531.00117,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FKWV01000005",81.567,8.82e-149,531,651,531.00117,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FKXF01000023",81.567,8.82e-149,531,651,531.00117,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_FKXL01000017",84.787,2.39e-148,529,539,457.00193,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_FKWV01000005",84.787,2.39e-148,529,539,457.00193,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_FKXF01000023",84.787,2.39e-148,529,539,457.00193,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15803","NZ_FKWV01000005",81.433,3e-148,529,684,557.00172,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15803","NZ_FKXF01000023",81.433,3e-148,529,684,557.00172,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FKXL01000017",82.968,2.66e-148,529,593,492.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FKWV01000005",82.968,2.66e-148,529,593,492.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FKXF01000023",82.968,2.66e-148,529,593,492.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_77739","NZ_FNPJ01000004",82.448,3.1e-148,529,621,512.00208,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_FNPJ01000004",81.454,3.03e-148,529,674,548.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_11340","NZ_FNPJ01000004",84.144,2.48e-148,529,555,466.9992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FNOE01000002",80.159,3.47e-148,529,756,606.00204,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_FNPJ01000004",83.249,9.47e-148,527,591,492.00159,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_77739","NZ_FNOE01000002",82.362,1.11e-147,527,618,508.99716,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FNOE01000002",85.029,1e-147,527,521,443.00109,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_15068","NZ_FKXL01000017",83.709,3.29e-147,525,577,483.00093,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_15068","NZ_FKWV01000005",83.709,3.29e-147,525,577,483.00093,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_15068","NZ_FKXF01000023",83.709,3.29e-147,525,577,483.00093,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17583","NZ_FNPJ01000004",82.997,3.43e-147,525,594,493.00218,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLWD01000035",79.012,5.91e-147,525,810,639.9972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_6823","NZ_FKXL01000017",82.867,3.48e-147,525,607,503.00269,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FNOE01000002",80.826,1.43e-146,523,678,548.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_1286","NZ_FNPJ01000004",83.362,1.2e-146,523,577,480.99874,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FNOE01000002",83.333,6.12e-146,521,588,489.99804,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FKXL01000017",80.46,5.31e-146,521,696,560.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FKWV01000005",80.46,5.31e-146,521,696,560.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FKXF01000023",80.46,5.31e-146,521,696,560.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_FNOE01000002",84.717,3.98e-146,521,530,449.0001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FNPJ01000004",85.859,3.79e-146,521,495,425.00205,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_MLWD01000035",76.326,1.08e-145,521,1056,806.00256,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_FNOE01000002",84.981,3.9e-146,521,526,447.00006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLWD01000035",78.436,6.46e-146,521,844,661.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FKXL01000017",78.504,7.6e-146,521,842,661.00368,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FKWV01000005",78.504,7.6e-146,521,842,661.00368,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FKXF01000023",78.504,7.6e-146,521,842,661.00368,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FNOE01000002",77.79,2.71e-145,520,887,689.9973,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLWD01000035",78.967,4.49e-145,520,813,642.00171,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_6823","NZ_FKWV01000005",82.645,1.62e-145,520,605,500.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_6823","NZ_FKXF01000023",82.645,1.62e-145,520,605,500.00225,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FKXL01000017",83.217,2.03e-145,520,572,476.00124,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FKWV01000005",83.217,2.03e-145,520,572,476.00124,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FKXF01000023",83.217,2.03e-145,520,572,476.00124,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLWD01000035",78.941,3.31e-145,520,812,641.00092,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLXP01000026",87.336,1.59e-145,520,458,399.99888,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLUB01000021",87.336,1.59e-145,520,458,399.99888,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLTT01000022",87.336,1.59e-145,520,458,399.99888,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRM01000021",87.336,1.59e-145,520,458,399.99888,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRF01000022",87.336,1.59e-145,520,458,399.99888,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_FNPJ01000004",84.848,1.4e-145,520,528,447.99744,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT_vs_bact_coverage_filtered_hits","k127_3429","NZ_FNPJ01000004",84.124,5.73e-145,518,548,460.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLWD01000035",82.063,2.18e-144,516,630,516.9969,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLWD01000035",83.633,1.93e-144,516,556,464.99948,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_285","NZ_FNOE01000002",80.169,2.49e-144,516,711,570.00159,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FNPJ01000004",85.513,8.21e-144,514,497,424.99961,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_FNPJ01000004",83.818,6.87e-144,514,550,460.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_FNPJ01000004",84.99,6.47e-144,514,513,435.9987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_14654","NZ_FKXL01000017",82.881,2.65e-143,512,590,488.9979,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_14654","NZ_FKWV01000005",82.881,2.65e-143,512,590,488.9979,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_14654","NZ_FKXF01000023",82.881,2.65e-143,512,590,488.9979,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FNOE01000002",76.281,6.53e-143,512,1054,804.00174,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_285","NZ_FNPJ01000004",80.028,3.22e-143,512,711,568.99908,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FKXL01000017",78.96,3.91e-143,512,808,637.9968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FKWV01000005",78.96,3.91e-143,512,808,637.9968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FKXF01000023",78.96,3.91e-143,512,808,637.9968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FKXL01000017",83.363,9.96e-143,510,553,460.99739,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FKWV01000005",83.363,9.96e-143,510,553,460.99739,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FKXF01000023",83.363,9.96e-143,510,553,460.99739,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FNOE01000002",80.256,1.15e-142,510,704,565.00224,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_29443","NZ_FNPJ01000004",82.683,1.21e-142,510,589,487.00287,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FKXL01000017",80.233,4.21e-142,508,688,552.00304,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FKWV01000005",80.233,4.21e-142,508,688,552.00304,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FKXF01000023",80.233,4.21e-142,508,688,552.00304,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLWD01000035",80,4.12e-142,508,700,560,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_FNPJ01000004",84.95,3e-142,508,505,428.9975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_FNOE01000002",83.607,3.19e-142,508,549,459.00243,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FKXL01000017",83.577,3.94e-142,508,548,458.00196,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FKWV01000005",83.577,3.94e-142,508,548,458.00196,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FKXF01000023",83.577,3.94e-142,508,548,458.00196,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLWD01000035",79.034,7.27e-142,508,787,621.99758,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLXP01000026",83.948,3.55e-142,508,542,454.99816,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLUB01000021",83.948,3.55e-142,508,542,454.99816,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLTT01000022",83.948,3.55e-142,508,542,454.99816,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRM01000021",83.948,3.55e-142,508,542,454.99816,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRF01000022",83.948,3.55e-142,508,542,454.99816,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_19534","NZ_FNOE01000002",82.353,4.24e-142,508,595,490.00035,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLWD01000035",80.882,3.94e-142,508,680,549.9976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FNOE01000002",83.962,1.12e-141,507,530,444.9986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLWD01000035",81.194,5.03e-141,505,670,543.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_19534","NZ_FNPJ01000004",80.816,5.48e-141,505,662,535.00192,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLWD01000035",81.476,5.05e-141,505,637,519.00212,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_569","NZ_FKXL01000017",80.438,2.07e-140,503,685,551.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_569","NZ_FKWV01000005",80.438,2.07e-140,503,685,551.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_569","NZ_FKXF01000023",80.438,2.07e-140,503,685,551.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLXP01000026",79.857,1.92e-140,503,700,558.999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLUB01000021",79.857,1.92e-140,503,700,558.999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLTT01000022",79.857,1.92e-140,503,700,558.999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRM01000021",79.857,1.92e-140,503,700,558.999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRF01000022",79.857,1.92e-140,503,700,558.999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FNPJ01000004",79.856,1.92e-140,503,695,554.9992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_FNPJ01000004",84.091,1.44e-140,503,528,444.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9398","NZ_FNPJ01000004",85.282,1.48e-140,503,496,422.99872,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FKXL01000017",84.03,1.48e-140,503,526,441.9978,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FKWV01000005",84.03,1.48e-140,503,526,441.9978,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FKXF01000023",84.03,1.48e-140,503,526,441.9978,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FNOE01000002",87.359,1.56e-140,503,443,387.00037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_FNOE01000002",84.25,5.08e-140,501,527,443.9975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLWD01000035",84.333,1.8e-139,499,517,436.00161,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_FKXL01000017",82.245,2.34e-139,499,597,491.00265,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_FKWV01000005",82.245,2.34e-139,499,597,491.00265,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_FKXF01000023",82.245,2.34e-139,499,597,491.00265,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLWD01000035",82.293,7.38e-139,497,593,487.99749,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FKXL01000017",80,8.77e-139,497,685,548,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FKWV01000005",80,8.77e-139,497,685,548,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FKXF01000023",80,8.77e-139,497,685,548,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLXP01000026",82.948,8.45e-139,497,563,466.99724,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLUB01000021",82.948,8.45e-139,497,563,466.99724,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLTT01000022",82.948,8.45e-139,497,563,466.99724,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRM01000021",82.948,8.45e-139,497,563,466.99724,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRF01000022",82.948,8.45e-139,497,563,466.99724,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FNPJ01000004",83.616,6.71e-139,497,531,444.00096,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FKXL01000017",73.958,6.74e-138,496,1463,1082.00554,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FKWV01000005",73.94,6.74e-138,496,1462,1081.0028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FKXF01000023",73.94,6.74e-138,496,1462,1081.0028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLWD01000035",84.479,2.49e-138,496,509,429.99811,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FKXL01000017",80.147,3.11e-138,496,680,544.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FKWV01000005",80.147,3.11e-138,496,680,544.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FKXF01000023",80.147,3.11e-138,496,680,544.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLXP01000026",83.738,2.66e-138,496,535,447.9983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLUB01000021",83.738,2.66e-138,496,535,447.9983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLTT01000022",83.738,2.66e-138,496,535,447.9983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRM01000021",83.738,2.66e-138,496,535,447.9983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRF01000022",83.738,2.66e-138,496,535,447.9983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6199","NZ_FKXL01000017",83.244,2.62e-138,496,561,466.99884,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6199","NZ_FKWV01000005",83.244,2.62e-138,496,561,466.99884,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6199","NZ_FKXF01000023",83.244,2.62e-138,496,561,466.99884,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FNOE01000002",85.041,2.79e-138,496,488,415.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9398","NZ_FNOE01000002",83.932,8.91e-138,494,529,444.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_16695","NZ_FNOE01000002",82.302,9.52e-138,494,582,478.99764,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FKXL01000017",78.819,2.04e-137,494,779,614.00001,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FKWV01000005",78.819,2.04e-137,494,779,614.00001,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FKXF01000023",78.819,2.04e-137,494,779,614.00001,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14743","NZ_FNOE01000002",79.83,1.28e-137,494,704,562.0032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FNPJ01000004",80.93,1.05e-137,494,645,521.9985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLWD01000035",83.06,1.27e-137,494,549,455.9994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLXP01000026",83.06,1.27e-137,494,549,455.9994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLTT01000022",83.06,1.27e-137,494,549,455.9994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRF01000022",83.06,1.27e-137,494,549,455.9994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13189","NZ_FKXL01000017",87.674,9.07e-138,494,430,376.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13189","NZ_FKWV01000005",87.674,9.07e-138,494,430,376.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13189","NZ_FKXF01000023",87.674,9.07e-138,494,430,376.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLXP01000026",82.245,3.5e-137,492,597,491.00265,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLUB01000021",82.245,3.5e-137,492,597,491.00265,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLTT01000022",82.245,3.5e-137,492,597,491.00265,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRM01000021",82.245,3.5e-137,492,597,491.00265,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRF01000022",82.245,3.5e-137,492,597,491.00265,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLXP01000026",79.804,4.15e-137,492,713,569.00252,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLUB01000021",79.804,4.15e-137,492,713,569.00252,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLTT01000022",79.804,4.15e-137,492,713,569.00252,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRM01000021",79.804,4.15e-137,492,713,569.00252,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRF01000022",79.804,4.15e-137,492,713,569.00252,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_FKXL01000017",84.8,3.01e-137,492,500,424,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_FKWV01000005",84.8,3.01e-137,492,500,424,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_FKXF01000023",84.8,3.01e-137,492,500,424,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FNPJ01000004",88.136,1.32e-136,490,413,364.00168,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLXP01000026",84.283,1.16e-136,490,509,429.00047,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLUB01000021",84.283,1.16e-136,490,509,429.00047,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLTT01000022",84.283,1.16e-136,490,509,429.00047,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRM01000021",84.283,1.16e-136,490,509,429.00047,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRF01000022",84.283,1.16e-136,490,509,429.00047,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_FNOE01000002",82.847,1.2e-136,490,548,454.00156,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FKXL01000017",82.5,4.27e-136,488,560,462,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FKWV01000005",82.5,4.27e-136,488,560,462,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FKXF01000023",82.5,4.27e-136,488,560,462,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FKXL01000017",82.79,4.94e-136,488,552,457.0008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FKWV01000005",82.79,4.94e-136,488,552,457.0008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FKXF01000023",82.79,4.94e-136,488,552,457.0008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLWD01000035",81.758,4.59e-136,488,603,493.00074,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLUB01000021",82.878,5.92e-136,488,549,455.00022,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRM01000021",82.878,5.92e-136,488,549,455.00022,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLWD01000035",80.303,1.82e-135,486,660,529.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLWD01000035",82.077,1.63e-135,486,597,489.99969,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FNPJ01000004",77.712,2.79e-135,486,839,652.00368,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLWD01000035",79.663,1.93e-135,486,713,567.99719,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_17354","NZ_FNPJ01000004",82.594,1.8e-135,486,586,484.00084,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_16695","NZ_FNPJ01000004",81.99,5.73e-135,484,583,478.0017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLWD01000035",79.24,1.15e-134,484,737,583.9988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FNPJ01000004",84.631,6.05e-135,484,488,412.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_11486","NZ_FNOE01000002",82.302,2.04e-134,483,582,478.99764,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FNPJ01000004",83.493,2.2e-134,483,521,434.99853,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_45682","NZ_FNOE01000002",81.88,1.12e-133,481,585,478.998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_2599","NZ_FKXL01000017",79.941,8.78e-134,481,683,545.99703,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_2599","NZ_FKWV01000005",79.941,8.78e-134,481,683,545.99703,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_2599","NZ_FKXF01000023",79.941,8.78e-134,481,683,545.99703,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLXP01000026",80.152,8.49e-134,481,660,529.0032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLUB01000021",80.152,8.49e-134,481,660,529.0032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLTT01000022",80.152,8.49e-134,481,660,529.0032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRM01000021",80.152,8.49e-134,481,660,529.0032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRF01000022",80.152,8.49e-134,481,660,529.0032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_9342","NZ_FNPJ01000004",84.337,6.94e-134,481,498,419.99826,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FNPJ01000004",76.89,1.77e-133,481,926,712.0014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_FNPJ01000004",83.493,7.04e-134,481,521,434.99853,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9001","NZ_FNOE01000002",85.652,7.06e-134,481,460,393.9992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_8147","NZ_FNPJ01000004",82.423,1.51e-133,481,586,482.99878,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16421","NZ_FKXL01000017",86.53,2.66e-133,479,438,379.0014,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16421","NZ_FKWV01000005",86.53,2.66e-133,479,438,379.0014,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16421","NZ_FKXF01000023",86.53,2.66e-133,479,438,379.0014,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLXP01000026",81.818,3.05e-133,479,605,494.9989,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLUB01000021",81.818,3.05e-133,479,605,494.9989,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLTT01000022",81.818,3.05e-133,479,605,494.9989,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRM01000021",81.818,3.05e-133,479,605,494.9989,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRF01000022",81.818,3.05e-133,479,605,494.9989,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_5717","NZ_FNOE01000002",85.35,2.54e-133,479,471,401.9985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLWD01000035",81.059,2.84e-133,479,623,504.99757,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_17354","NZ_FNOE01000002",82.253,3e-133,479,586,482.00258,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FNOE01000002",81.313,1.1e-132,477,594,482.99922,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_1592","NZ_FNOE01000002",83.493,8.56e-133,477,521,434.99853,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FNOE01000002",80.343,1.06e-132,477,641,514.99863,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLWD01000035",80,1.45e-132,477,665,532,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXP01000026",80.03,1.45e-132,477,666,532.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLUB01000021",80.03,1.45e-132,477,666,532.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLTT01000022",80.03,1.45e-132,477,666,532.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRM01000021",80.03,1.45e-132,477,666,532.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRF01000022",80.03,1.45e-132,477,666,532.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_11776","NZ_FKXL01000017",78.71,4.75e-132,475,775,610.0025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_11776","NZ_FKWV01000005",78.682,4.75e-132,475,774,608.99868,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_11776","NZ_FKXF01000023",78.682,4.75e-132,475,774,608.99868,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FNOE01000002",79.678,4.05e-132,475,684,544.99752,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FNPJ01000004",87.775,3.15e-132,475,409,358.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_8147","NZ_FNOE01000002",82.082,2.53e-131,473,586,481.00052,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FNPJ01000004",82.162,4.98e-131,472,555,455.9991,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_FNPJ01000004",76.805,7.04e-131,472,914,701.9977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FNPJ01000004",81.081,5.11e-131,472,592,479.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_1592","NZ_FNPJ01000004",83.269,3.98e-131,472,520,432.9988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FNOE01000002",79.023,1.94e-130,470,696,550.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5298","NZ_FKWV01000005",81.633,1.61e-130,470,588,480.00204,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5298","NZ_FKXF01000023",81.633,1.61e-130,470,588,480.00204,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_29443","NZ_FNOE01000002",81.481,2.06e-130,470,594,483.99714,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7507","NZ_FNPJ01000004",77.711,2.25e-130,470,830,645.0013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLWD01000035",82.585,1.53e-130,470,557,459.99845,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FNPJ01000004",78.955,2.01e-130,470,727,574.00285,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FNOE01000002",81.138,2.01e-130,470,615,498.9987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_FNPJ01000004",78.408,9.3e-130,468,741,581.00328,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_FNPJ01000004",81.738,5.63e-130,468,564,461.00232,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FNOE01000002",77.076,8.74e-130,468,903,695.99628,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FKXL01000017",80.696,6.22e-130,468,632,509.99872,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FKWV01000005",80.696,6.22e-130,468,632,509.99872,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FKXF01000023",80.696,6.22e-130,468,632,509.99872,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLWD01000035",81.818,6.46e-130,468,572,467.99896,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_FNOE01000002",82.746,1.9e-129,466,539,446.00094,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FNOE01000002",82.084,2.32e-129,466,547,448.99948,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6179","NZ_FKXL01000017",86.854,1.84e-129,466,426,369.99804,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6179","NZ_FKWV01000005",86.854,1.84e-129,466,426,369.99804,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6179","NZ_FKXF01000023",86.854,1.84e-129,466,426,369.99804,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FNOE01000002",84.946,1.9e-129,466,465,394.9989,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_12406","NZ_FNPJ01000004",81.095,2.87e-129,466,603,489.00285,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FKXL01000017",84.454,1.84e-129,466,476,402.00104,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FKWV01000005",84.454,1.84e-129,466,476,402.00104,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FKXF01000023",84.454,1.84e-129,466,476,402.00104,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FNOE01000002",87.019,8.02e-129,464,416,361.99904,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLXP01000026",79.476,8.76e-129,464,687,546.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLUB01000021",79.476,8.76e-129,464,687,546.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLTT01000022",79.476,8.76e-129,464,687,546.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRM01000021",79.476,8.76e-129,464,687,546.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRF01000022",79.476,8.76e-129,464,687,546.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FKXL01000017",78.324,1.78e-128,464,752,588.99648,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FKWV01000005",78.324,1.78e-128,464,752,588.99648,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FKXF01000023",78.324,1.78e-128,464,752,588.99648,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5298","NZ_FKXL01000017",81.463,7.47e-129,464,588,479.00244,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLWD01000035",81.169,9.27e-129,464,616,500.00104,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLXP01000026",81.661,7.33e-129,464,578,472.00058,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLUB01000021",81.661,7.33e-129,464,578,472.00058,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLTT01000022",81.661,7.33e-129,464,578,472.00058,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRM01000021",81.661,7.33e-129,464,578,472.00058,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRF01000022",81.661,7.33e-129,464,578,472.00058,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_FNOE01000002",85.129,7.98e-129,464,464,394.99856,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLXP01000026",82.406,7.14e-129,464,557,459.00142,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLUB01000021",82.406,7.14e-129,464,557,459.00142,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLTT01000022",82.406,7.14e-129,464,557,459.00142,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRM01000021",82.406,7.14e-129,464,557,459.00142,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRF01000022",82.406,7.14e-129,464,557,459.00142,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_FNPJ01000004",81.379,2.67e-128,462,580,471.9982,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_11311","NZ_FNPJ01000004",78.677,3.33e-128,462,741,582.99657,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_49540","NZ_FNPJ01000004",78.061,4.64e-128,462,825,644.00325,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7507","NZ_FNOE01000002",77.644,3.76e-128,462,832,645.99808,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLXP01000026",82.44,2.86e-128,462,541,446.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLUB01000021",82.44,2.86e-128,462,541,446.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLTT01000022",82.44,2.86e-128,462,541,446.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRM01000021",82.44,2.86e-128,462,541,446.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRF01000022",82.44,2.86e-128,462,541,446.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_8465","NZ_FNPJ01000004",84.265,2.38e-128,462,483,406.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FKXL01000017",81.655,1.66e-127,460,556,454.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FKWV01000005",81.655,1.66e-127,460,556,454.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FKXF01000023",81.655,1.66e-127,460,556,454.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3333","NZ_FNPJ01000004",78.426,1.58e-127,460,788,617.99688,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FNPJ01000004",76.471,4e-127,460,918,702.00378,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_6458","NZ_FNOE01000002",85.366,8.6e-128,460,451,385.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLWD01000035",82.987,8.83e-128,460,529,439.00123,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLXP01000026",82.987,8.83e-128,460,529,439.00123,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLUB01000021",82.987,8.83e-128,460,529,439.00123,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLTT01000022",82.987,8.83e-128,460,529,439.00123,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRM01000021",82.987,8.83e-128,460,529,439.00123,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRF01000022",82.987,8.83e-128,460,529,439.00123,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_5717","NZ_FNPJ01000004",84.567,9.2e-128,460,473,400.00191,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_FNPJ01000004",82.472,3.19e-127,459,542,446.99824,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_45682","NZ_FNPJ01000004",81.142,5.27e-127,459,578,469.00076,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLWD01000035",79.33,4.08e-127,459,687,544.9971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FNPJ01000004",79.209,4.08e-127,459,683,540.99747,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLWD01000035",81.25,3.59e-127,459,592,481,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLXP01000026",81.25,3.59e-127,459,592,481,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLUB01000021",81.25,3.59e-127,459,592,481,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLTT01000022",81.25,3.59e-127,459,592,481,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRM01000021",81.25,3.59e-127,459,592,481,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRF01000022",81.25,3.59e-127,459,592,481,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLWD01000035",81.488,3.41e-127,459,578,471.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLWD01000035",82.682,3.14e-127,459,537,444.00234,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLXP01000026",82.682,3.14e-127,459,537,444.00234,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLUB01000021",82.682,3.14e-127,459,537,444.00234,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLTT01000022",82.682,3.14e-127,459,537,444.00234,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRM01000021",82.682,3.14e-127,459,537,444.00234,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRF01000022",82.682,3.14e-127,459,537,444.00234,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FKXL01000017",83.884,3.26e-127,459,484,405.99856,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FKWV01000005",83.884,3.26e-127,459,484,405.99856,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FKXF01000023",83.884,3.26e-127,459,484,405.99856,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2751","NZ_FNOE01000002",85.301,3.28e-127,459,449,383.00149,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLWD01000035",81.04,1.28e-126,457,596,482.9984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLWD01000035",84.681,1.36e-126,457,470,398.0007,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14743","NZ_FNPJ01000004",78.822,1.68e-126,457,713,562.00086,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLXP01000026",82.576,4.6e-126,455,528,436.00128,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLUB01000021",82.576,4.6e-126,455,528,436.00128,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLTT01000022",82.576,4.6e-126,455,528,436.00128,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRM01000021",82.576,4.6e-126,455,528,436.00128,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRF01000022",82.576,4.6e-126,455,528,436.00128,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_FNPJ01000004",77.078,7.33e-126,455,842,648.99676,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1041","NZ_FKXL01000017",80.705,4.59e-126,455,596,481.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1041","NZ_FKWV01000005",80.705,4.59e-126,455,596,481.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1041","NZ_FKXF01000023",80.705,4.59e-126,455,596,481.0018,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9001","NZ_FNPJ01000004",84.783,4.28e-126,455,460,390.0018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_FKXL01000017",82.576,4.03e-126,455,528,436.00128,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_FKWV01000005",82.576,4.03e-126,455,528,436.00128,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_FKXF01000023",82.576,4.03e-126,455,528,436.00128,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15963","NZ_FNOE01000002",82.476,1.82e-125,453,525,432.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FKXL01000017",82.264,1.65e-125,453,530,435.9992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FKWV01000005",82.264,1.65e-125,453,530,435.9992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FKXF01000023",82.264,1.65e-125,453,530,435.9992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLWD01000035",83.466,1.41e-125,453,502,418.99932,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18390","NZ_FNPJ01000004",81.57,2.16e-125,453,586,478.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6834","NZ_FNPJ01000004",81.338,8.16e-125,451,568,461.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLXP01000026",82.331,9.58e-125,451,532,438.00092,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLUB01000021",82.331,9.58e-125,451,532,438.00092,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLTT01000022",82.331,9.58e-125,451,532,438.00092,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRM01000021",82.331,9.58e-125,451,532,438.00092,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRF01000022",82.331,9.58e-125,451,532,438.00092,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_11311","NZ_FNOE01000002",80.743,7.2e-125,451,592,477.99856,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLWD01000035",83.333,6.21e-125,451,492,409.99836,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXP01000026",83.333,6.21e-125,451,492,409.99836,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLTT01000022",83.333,6.21e-125,451,492,409.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRF01000022",83.333,6.21e-125,451,492,409.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12289","NZ_FKXL01000017",80.587,2.17e-124,449,613,493.99831,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FNPJ01000004",75.071,5.19e-124,449,1051,788.99621,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1072","NZ_FNPJ01000004",79.056,8.89e-124,448,678,535.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_20031","NZ_FNPJ01000004",82.028,9.33e-124,448,562,460.99736,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_FNOE01000002",80.895,2.69e-123,446,581,469.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_20031","NZ_FNOE01000002",81.851,3.36e-123,446,562,460.00262,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3333","NZ_FNOE01000002",77.987,4.42e-123,446,795,619.99665,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLXP01000026",84.322,2.93e-123,446,472,397.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLUB01000021",84.322,2.93e-123,446,472,397.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLTT01000022",84.322,2.93e-123,446,472,397.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRM01000021",84.322,2.93e-123,446,472,397.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRF01000022",84.322,2.93e-123,446,472,397.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_FNPJ01000004",82.07,2.47e-123,446,541,443.9987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLUB01000021",83.13,2.89e-123,446,492,408.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRM01000021",83.13,2.89e-123,446,492,408.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12289","NZ_FKWV01000005",80.392,1.01e-122,444,612,491.99904,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12289","NZ_FKXF01000023",80.392,1.01e-122,444,612,491.99904,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLXP01000026",84.396,9.74e-123,444,455,384.0018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLUB01000021",84.396,9.74e-123,444,455,384.0018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLTT01000022",84.396,9.74e-123,444,455,384.0018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRM01000021",84.396,9.74e-123,444,455,384.0018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRF01000022",84.396,9.74e-123,444,455,384.0018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_46217","NZ_FNOE01000002",78.099,1.22e-122,444,726,566.99874,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_14523","NZ_FNPJ01000004",81.441,9.24e-123,444,555,451.99755,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_12406","NZ_FNOE01000002",80.464,1.34e-122,444,604,486.00256,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_1548","NZ_FNOE01000002",81.934,9.03e-123,444,548,448.99832,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLWD01000035",83.367,1.03e-122,444,499,416.00133,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLXP01000026",83.367,1.03e-122,444,499,416.00133,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLUB01000021",83.367,1.03e-122,444,499,416.00133,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLTT01000022",83.367,1.03e-122,444,499,416.00133,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRM01000021",83.367,1.03e-122,444,499,416.00133,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRF01000022",83.367,1.03e-122,444,499,416.00133,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLWD01000035",82.524,8.5e-123,444,515,424.9986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLXP01000026",82.745,1.09e-122,444,510,421.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLUB01000021",82.745,1.09e-122,444,510,421.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLTT01000022",82.745,1.09e-122,444,510,421.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRM01000021",82.745,1.09e-122,444,510,421.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRF01000022",82.745,1.09e-122,444,510,421.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5148","NZ_FNPJ01000004",87.032,3.09e-122,442,401,348.99832,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_FNPJ01000004",81.574,3.31e-122,442,559,455.99866,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_FNOE01000002",82.15,3.32e-122,442,521,428.0015,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLXP01000026",82.319,3.62e-122,442,526,432.99794,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLUB01000021",82.319,3.62e-122,442,526,432.99794,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLTT01000022",82.319,3.62e-122,442,526,432.99794,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRM01000021",82.319,3.62e-122,442,526,432.99794,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRF01000022",82.319,3.62e-122,442,526,432.99794,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FNOE01000002",85.011,3.5e-122,442,447,379.99917,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_14433","NZ_FNOE01000002",80.731,5.01e-122,442,602,486.00062,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLXP01000026",80.519,4.34e-122,442,616,495.99704,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLUB01000021",80.519,4.34e-122,442,616,495.99704,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLTT01000022",80.519,4.34e-122,442,616,495.99704,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRM01000021",80.519,4.34e-122,442,616,495.99704,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRF01000022",80.519,4.34e-122,442,616,495.99704,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLXP01000026",83.101,3.06e-122,442,503,417.99803,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLUB01000021",83.101,3.06e-122,442,503,417.99803,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLTT01000022",83.101,3.06e-122,442,503,417.99803,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRM01000021",83.101,3.06e-122,442,503,417.99803,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRF01000022",83.101,3.06e-122,442,503,417.99803,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_11556","NZ_FNPJ01000004",81.818,1.55e-121,440,561,458.99898,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_FNOE01000002",75.12,3.59e-121,440,1045,785.004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLUB01000021",81.387,1.52e-121,440,548,446.00076,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRM01000021",81.387,1.52e-121,440,548,446.00076,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18390","NZ_FNOE01000002",81.058,1.68e-121,440,586,474.99988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_FNOE01000002",82.42,1.46e-121,440,529,436.0018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_987","NZ_FKXL01000017",80.743,1.33e-121,440,592,477.99856,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FKXL01000017",78.947,1.44e-121,440,665,524.99755,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FKWV01000005",78.947,1.44e-121,440,665,524.99755,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FKXF01000023",78.947,1.44e-121,440,665,524.99755,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_11556","NZ_FNOE01000002",81.72,5.57e-121,438,558,455.9976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_2059","NZ_FKXL01000017",81.784,4.14e-121,438,538,439.99792,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_2059","NZ_FKWV01000005",81.784,4.14e-121,438,538,439.99792,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_2059","NZ_FKXF01000023",81.784,4.14e-121,438,538,439.99792,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FNOE01000002",77.278,7.93e-121,438,801,618.99678,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FKXL01000017",79.43,5.08e-121,438,632,501.9976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FKWV01000005",79.43,5.08e-121,438,632,501.9976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FKXF01000023",79.43,5.08e-121,438,632,501.9976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_1548","NZ_FNPJ01000004",81.784,4.2e-121,438,538,439.99792,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FKXL01000017",83.761,4.28e-121,438,468,392.00148,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FKWV01000005",83.761,4.28e-121,438,468,392.00148,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FKXF01000023",83.761,4.28e-121,438,468,392.00148,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15963","NZ_FNPJ01000004",81.905,1.84e-120,436,525,430.00125,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FKXL01000017",82.205,1.49e-120,436,517,424.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FKWV01000005",82.205,1.49e-120,436,517,424.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FKXF01000023",82.205,1.49e-120,436,517,424.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_197","NZ_FNOE01000002",87.5,1.45e-120,436,384,336,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_10170","NZ_FNPJ01000004",85.48,7.13e-120,435,427,364.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLWD01000035",81.204,7.07e-120,435,548,444.99792,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLXP01000026",81.204,7.07e-120,435,548,444.99792,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLTT01000022",81.204,7.07e-120,435,548,444.99792,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRF01000022",81.204,7.07e-120,435,548,444.99792,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FNPJ01000004",81.421,5.63e-120,435,549,447.00129,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLWD01000035",81.853,5.23e-120,435,529,433.00237,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLWD01000035",81.973,5.22e-120,435,527,431.99771,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLXP01000026",81.973,5.22e-120,435,527,431.99771,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLUB01000021",81.973,5.22e-120,435,527,431.99771,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLTT01000022",81.973,5.22e-120,435,527,431.99771,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRM01000021",81.973,5.22e-120,435,527,431.99771,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRF01000022",81.973,5.22e-120,435,527,431.99771,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_49540","NZ_FNOE01000002",77.345,1.01e-119,435,821,635.00245,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9184","NZ_FNOE01000002",81.307,8.05e-120,435,551,448.00157,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLXP01000026",83.991,5.56e-120,435,456,382.99896,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLUB01000021",83.991,5.56e-120,435,456,382.99896,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLTT01000022",83.991,5.56e-120,435,456,382.99896,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRM01000021",83.991,5.56e-120,435,456,382.99896,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRF01000022",83.991,5.56e-120,435,456,382.99896,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_FNOE01000002",82.095,5.21e-120,435,525,430.99875,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_987","NZ_FKWV01000005",80.574,6.19e-120,435,592,476.99808,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_987","NZ_FKXF01000023",80.574,6.19e-120,435,592,476.99808,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLXP01000026",84.106,5.12e-120,435,453,381.00018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLUB01000021",84.106,5.12e-120,435,453,381.00018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLTT01000022",84.106,5.12e-120,435,453,381.00018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRM01000021",84.106,5.12e-120,435,453,381.00018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRF01000022",84.106,5.12e-120,435,453,381.00018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_197","NZ_FNPJ01000004",87.599,5.21e-120,435,379,332.00021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLWD01000035",81.992,2.97e-119,433,522,427.99824,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLXP01000026",81.992,2.97e-119,433,522,427.99824,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLTT01000022",81.992,2.97e-119,433,522,427.99824,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRF01000022",81.992,2.97e-119,433,522,427.99824,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_11486","NZ_FNPJ01000004",80.789,2.09e-119,433,583,470.99987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLWD01000035",81.216,2.01e-119,433,559,453.99744,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_FNOE01000002",77.261,4.44e-119,433,796,614.99756,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLUB01000021",85.082,1.07e-118,431,429,365.00178,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRM01000021",85.082,1.07e-118,431,429,365.00178,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_FNPJ01000004",84.424,8.19e-119,431,443,373.99832,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FNPJ01000004",80.033,7.83e-119,431,606,484.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLXP01000026",82.892,7.22e-119,431,491,406.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLUB01000021",82.892,7.22e-119,431,491,406.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLTT01000022",82.892,7.22e-119,431,491,406.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRM01000021",82.892,7.22e-119,431,491,406.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRF01000022",82.892,7.22e-119,431,491,406.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLXP01000026",83.956,6.67e-119,431,455,381.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLUB01000021",83.956,6.67e-119,431,455,381.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLTT01000022",83.956,6.67e-119,431,455,381.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRM01000021",83.956,6.67e-119,431,455,381.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRF01000022",83.956,6.67e-119,431,455,381.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_19333","NZ_FNOE01000002",80.372,7.62e-119,431,591,474.99852,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5148","NZ_FNOE01000002",86.207,2.41e-118,429,406,350.00042,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLWD01000035",80.919,2.62e-118,429,566,458.00154,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLXP01000026",80.919,2.62e-118,429,566,458.00154,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLUB01000021",80.919,2.62e-118,429,566,458.00154,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLTT01000022",80.919,2.62e-118,429,566,458.00154,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRM01000021",80.919,2.62e-118,429,566,458.00154,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRF01000022",80.919,2.62e-118,429,566,458.00154,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_FNPJ01000004",80.944,2.62e-118,429,572,462.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2029","NZ_FNPJ01000004",88.219,2.37e-118,429,365,321.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FNOE01000002",81.835,2.9e-118,429,534,436.9989,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLXP01000026",81.071,2.58e-118,429,560,453.9976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLUB01000021",81.071,2.58e-118,429,560,453.9976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLTT01000022",81.071,2.58e-118,429,560,453.9976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRM01000021",81.071,2.58e-118,429,560,453.9976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRF01000022",81.071,2.58e-118,429,560,453.9976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_8641","NZ_FNPJ01000004",83.093,8.63e-118,427,485,403.00105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLUB01000021",81.923,9.31e-118,427,520,425.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRM01000021",81.923,9.31e-118,427,520,425.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_FNOE01000002",77.39,2.09e-117,427,774,598.9986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLWD01000035",81.749,8.72e-118,427,526,429.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLXP01000026",81.749,8.72e-118,427,526,429.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLUB01000021",81.749,8.72e-118,427,526,429.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLTT01000022",81.749,8.72e-118,427,526,429.99974,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRM01000021",81.749,8.72e-118,427,526,429.99974,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRF01000022",81.749,8.72e-118,427,526,429.99974,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_17773","NZ_FKXL01000017",79.084,3.9e-117,425,655,518.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_17773","NZ_FKWV01000005",79.084,3.9e-117,425,655,518.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_17773","NZ_FKXF01000023",79.084,3.9e-117,425,655,518.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLXP01000026",78.701,4.05e-117,425,662,521.00062,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLUB01000021",78.701,4.05e-117,425,662,521.00062,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLTT01000022",78.701,4.05e-117,425,662,521.00062,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRM01000021",78.701,4.05e-117,425,662,521.00062,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRF01000022",78.701,4.05e-117,425,662,521.00062,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_46217","NZ_FNPJ01000004",77.517,1.59e-116,424,725,561.99825,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_10935","NZ_FNPJ01000004",79.967,1.32e-116,424,599,479.00233,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_10935","NZ_FNOE01000002",80.342,1.32e-116,424,585,470.0007,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6834","NZ_FNOE01000002",80.526,1.78e-116,424,570,458.9982,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLWD01000035",80.405,1.25e-116,424,592,475.9976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_519","NZ_FNOE01000002",87.772,1.17e-116,424,368,323.00096,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLWD01000035",81.731,4.33e-116,422,520,425.0012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLXP01000026",81.731,4.33e-116,422,520,425.0012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLTT01000022",81.731,4.33e-116,422,520,425.0012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRF01000022",81.731,4.33e-116,422,520,425.0012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLWD01000035",78.55,1.89e-115,420,662,520.001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FNPJ01000004",78.701,1.89e-115,420,662,521.00062,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FNPJ01000004",80.212,1.68e-115,420,566,453.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FNPJ01000004",80.372,1.62e-115,420,591,474.99852,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLXP01000026",78.099,1.99e-115,420,726,566.99874,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLUB01000021",78.099,1.99e-115,420,726,566.99874,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLTT01000022",78.099,1.99e-115,420,726,566.99874,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRM01000021",78.099,1.99e-115,420,726,566.99874,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRF01000022",78.099,1.99e-115,420,726,566.99874,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_779","NZ_FNOE01000002",81.139,3.07e-115,420,562,456.00118,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_22919","NZ_FNPJ01000004",81.625,1.86e-115,420,517,422.00125,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLWD01000035",84.34,1.5e-115,420,447,376.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLUB01000021",85.468,6.33e-115,418,406,347.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRM01000021",85.468,6.33e-115,418,406,347.00008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_15020","NZ_FNOE01000002",79.582,6.07e-115,418,622,495.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_519","NZ_FNPJ01000004",87.738,5.42e-115,418,367,321.99846,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_4819","NZ_FNOE01000002",84.455,5.89e-115,418,431,364.00105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_31841","NZ_FNPJ01000004",79.167,2.58e-114,416,624,494.00208,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1072","NZ_FNOE01000002",78.203,2.51e-114,416,679,530.99837,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLWD01000035",80.556,2.04e-114,416,576,464.00256,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXP01000026",78.914,2.4e-114,416,626,494.00164,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLUB01000021",78.914,2.4e-114,416,626,494.00164,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLTT01000022",78.914,2.4e-114,416,626,494.00164,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRM01000021",78.914,2.4e-114,416,626,494.00164,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRF01000022",78.914,2.4e-114,416,626,494.00164,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_19333","NZ_FNPJ01000004",79.693,2.13e-114,416,586,467.00098,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLWD01000035",80.556,2.04e-114,416,576,464.00256,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_11223","NZ_FNPJ01000004",79.167,2.7e-114,416,624,494.00208,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_7961","NZ_FNPJ01000004",77.356,2.72e-114,416,764,590.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FKXL01000017",78.717,2.35e-114,416,639,503.00163,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FKWV01000005",78.717,2.35e-114,416,639,503.00163,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FKXF01000023",78.717,2.35e-114,416,639,503.00163,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_13072","NZ_FNOE01000002",87.062,1.88e-114,416,371,323.00002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLWD01000035",81.495,1.89e-114,416,535,435.99825,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_16624","NZ_FNOE01000002",79.967,2.64e-114,416,609,486.99903,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FNOE01000002",80.106,7.8e-114,414,568,455.00208,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_1988","NZ_FKXL01000017",84.055,7.57e-114,414,439,369.00145,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_1988","NZ_FKWV01000005",84.055,7.57e-114,414,439,369.00145,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_1988","NZ_FKXF01000023",84.055,7.57e-114,414,439,369.00145,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FKXL01000017",85.642,8.19e-114,414,397,339.99874,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FKWV01000005",85.642,8.19e-114,414,397,339.99874,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FKXF01000023",85.642,8.19e-114,414,397,339.99874,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_14639","NZ_FNPJ01000004",78.681,9.12e-114,414,652,513.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLWD01000035",77.961,9.27e-114,414,726,565.99686,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_4210","NZ_FNOE01000002",82.341,6.86e-114,414,487,401.00067,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLWD01000035",85.222,2.95e-113,412,406,346.00132,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLXP01000026",85.222,2.95e-113,412,406,346.00132,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLTT01000022",85.222,2.95e-113,412,406,346.00132,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRF01000022",85.222,2.95e-113,412,406,346.00132,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FNPJ01000004",80.522,2.64e-113,412,575,463.0015,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19182","NZ_FKXL01000017",80.033,2.83e-113,412,606,484.99998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FNOE01000002",80.55,2.64e-113,412,545,438.9975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLXP01000026",82.258,2.55e-113,412,496,407.99968,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLUB01000021",82.258,2.55e-113,412,496,407.99968,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLTT01000022",82.258,2.55e-113,412,496,407.99968,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRM01000021",82.258,2.55e-113,412,496,407.99968,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRF01000022",82.258,2.55e-113,412,496,407.99968,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLWD01000035",80.531,2.64e-113,412,565,455.00015,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLWD01000035",80.763,2.58e-113,412,577,466.00251,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_FNPJ01000004",80.586,2.6e-113,412,546,439.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_943","NZ_FNPJ01000004",80.454,2.83e-113,412,573,461.00142,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_10170","NZ_FNOE01000002",84.259,1.2e-112,411,432,363.99888,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLWD01000035",78.754,1.12e-112,411,626,493.00004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLXP01000026",83.077,8.82e-113,411,455,378.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLUB01000021",83.077,8.82e-113,411,455,378.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLTT01000022",83.077,8.82e-113,411,455,378.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRM01000021",83.077,8.82e-113,411,455,378.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRF01000022",83.077,8.82e-113,411,455,378.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_18076","NZ_FNOE01000002",80.354,9.79e-113,411,565,454.0001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLUB01000021",82.452,1.04e-112,411,473,389.99796,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRM01000021",82.452,1.04e-112,411,473,389.99796,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RT_vs_bact_coverage_filtered_hits","k127_5523","NZ_FNPJ01000004",81.46,9.7e-113,411,507,413.0022,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLXP01000026",81.006,3.63e-112,409,537,435.00222,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLUB01000021",81.006,3.63e-112,409,537,435.00222,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLTT01000022",81.006,3.63e-112,409,537,435.00222,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRM01000021",81.006,3.63e-112,409,537,435.00222,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRF01000022",81.006,3.63e-112,409,537,435.00222,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_10169","NZ_FKXL01000017",81.31,3.13e-112,409,519,421.9989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_10169","NZ_FKWV01000005",81.31,3.13e-112,409,519,421.9989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_10169","NZ_FKXF01000023",81.31,3.13e-112,409,519,421.9989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19182","NZ_FKWV01000005",79.835,1.32e-111,407,605,483.00175,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19182","NZ_FKXF01000023",79.835,1.32e-111,407,605,483.00175,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLWD01000035",82.056,1.19e-111,407,496,406.99776,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_FNOE01000002",74.974,2.56e-111,407,979,733.99546,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_MLWD01000035",78.956,1.4e-111,407,632,499.00192,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2029","NZ_FNOE01000002",86.957,1.11e-111,407,368,320.00176,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_4819","NZ_FNPJ01000004",83.991,1.28e-111,407,431,362.00121,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLWD01000035",80.427,1.21e-111,407,562,451.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4378","NZ_FNPJ01000004",79.734,7.33e-111,405,602,479.99868,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4378","NZ_FNOE01000002",79.736,7.33e-111,405,607,483.99752,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLXP01000026",81.418,3.99e-111,405,522,425.00196,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLUB01000021",81.418,3.99e-111,405,522,425.00196,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLTT01000022",81.418,3.99e-111,405,522,425.00196,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRM01000021",81.418,3.99e-111,405,522,425.00196,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRF01000022",81.418,3.99e-111,405,522,425.00196,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FNPJ01000004",78.594,5.2e-111,405,626,491.99844,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_6458","NZ_FNPJ01000004",83.149,4.09e-111,405,451,375.00199,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_10958","NZ_FNPJ01000004",77.135,5.85e-111,405,761,586.99735,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLWD01000035",82.241,4.85e-111,405,473,388.99993,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLXP01000026",82.241,4.85e-111,405,473,388.99993,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLTT01000022",82.241,4.85e-111,405,473,388.99993,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRF01000022",82.241,4.85e-111,405,473,388.99993,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RT_vs_bact_coverage_filtered_hits","k127_5523","NZ_FNOE01000002",81.323,4.51e-111,405,514,418.00022,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FNOE01000002",79.07,1.71e-110,403,602,476.0014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLWD01000035",80.819,1.69e-110,403,537,433.99803,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLXP01000026",81.928,1.59e-110,403,498,408.00144,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLUB01000021",81.928,1.59e-110,403,498,408.00144,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLTT01000022",81.928,1.59e-110,403,498,408.00144,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRM01000021",81.928,1.59e-110,403,498,408.00144,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRF01000022",81.928,1.59e-110,403,498,408.00144,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_7961","NZ_FNOE01000002",77.124,2.11e-110,403,765,589.9986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FNPJ01000004",79.288,1.76e-110,403,618,489.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9184","NZ_FNPJ01000004",80.147,8.17e-110,401,544,435.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_4210","NZ_FNPJ01000004",81.837,5.34e-110,401,490,401.0013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FNOE01000002",86.096,1.87e-109,399,374,321.99904,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1531","NZ_FNOE01000002",80.645,1.92e-109,399,527,424.99915,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FNPJ01000004",81.287,2.3e-109,399,513,417.00231,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FNOE01000002",78.03,8.83e-109,398,660,514.998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_8920","NZ_FNOE01000002",79.655,7.55e-109,398,580,461.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2751","NZ_FNPJ01000004",82.927,7.24e-109,398,451,374.00077,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_11223","NZ_FNOE01000002",77.004,3.52e-108,396,761,586.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_MLWD01000035",80.177,2.6e-108,396,565,453.00005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_15624","NZ_FNOE01000002",80.784,1.38e-107,394,510,411.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8906","NZ_FNPJ01000004",78.491,1.08e-107,394,623,488.99893,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLXP01000026",82.789,8.86e-108,394,459,380.00151,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLUB01000021",82.789,8.86e-108,394,459,380.00151,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLTT01000022",82.789,8.86e-108,394,459,380.00151,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRM01000021",82.789,8.86e-108,394,459,380.00151,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRF01000022",82.789,8.86e-108,394,459,380.00151,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FNPJ01000004",78.012,1.5e-107,394,664,517.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FNPJ01000004",80.705,9.06e-108,394,539,434.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FNPJ01000004",80.142,3.36e-107,392,564,452.00088,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FNOE01000002",79.035,1.3e-106,390,601,475.00035,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLWD01000035",85.6,1.14e-106,390,375,321,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_6413","NZ_FKWV01000005",81.055,4.03e-106,388,512,415.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_6413","NZ_FKXF01000023",81.055,4.03e-106,388,512,415.0016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8634","NZ_FNOE01000002",80.113,4.69e-106,388,533,427.00229,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_FNPJ01000004",80.418,4.12e-106,388,526,422.99868,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_31841","NZ_FNOE01000002",78.435,2.02e-105,387,626,491.0031,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_15020","NZ_FNPJ01000004",78.72,1.71e-105,387,625,492,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_5648","NZ_FNOE01000002",83.863,1.65e-105,387,409,342.99967,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_779","NZ_FNPJ01000004",80.036,3.11e-105,387,561,449.00196,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_10958","NZ_FNOE01000002",76.802,2.12e-105,387,763,585.99926,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_22919","NZ_FNOE01000002",80.651,1.88e-105,387,522,420.99822,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_3074","NZ_FNOE01000002",81.048,1.47e-105,387,496,401.99808,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1504","NZ_FNOE01000002",80.55,1.47e-105,387,545,438.9975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FKXL01000017",79.707,5.75e-105,385,547,435.99729,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FKWV01000005",79.707,5.75e-105,385,547,435.99729,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FKXF01000023",79.707,5.75e-105,385,547,435.99729,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_47615","NZ_FKXL01000017",80.295,5.5e-105,385,543,436.00185,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_16006","NZ_FNPJ01000004",76.841,7.47e-105,385,747,574.00227,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_FNPJ01000004",84.108,5.3e-105,385,409,344.00172,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_6413","NZ_FKXL01000017",80.859,1.88e-104,383,512,413.99808,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FNOE01000002",78.06,2.43e-104,383,629,490.9974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLXP01000026",75.406,4.52e-104,383,862,649.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLUB01000021",75.406,4.52e-104,383,862,649.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLTT01000022",75.406,4.52e-104,383,862,649.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRM01000021",75.406,4.52e-104,383,862,649.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRF01000022",75.406,4.52e-104,383,862,649.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9323","NZ_FNOE01000002",81.857,1.96e-104,383,463,378.99791,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_13072","NZ_FNPJ01000004",85.146,1.91e-104,383,377,321.00042,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_8920","NZ_FNPJ01000004",78.957,2.11e-104,383,575,454.00275,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FKXL01000017",77.151,9.49e-104,381,709,547.00059,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FKWV01000005",77.151,9.49e-104,381,709,547.00059,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FKXF01000023",77.151,9.49e-104,381,709,547.00059,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FKXL01000017",78.405,8e-104,381,602,471.9981,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FKWV01000005",78.405,8e-104,381,602,471.9981,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FKXF01000023",78.405,8e-104,381,602,471.9981,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_MLWD01000035",79.894,7.14e-104,381,567,452.99898,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_3074","NZ_FNPJ01000004",80.885,6.83e-104,381,497,401.99845,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1504","NZ_FNPJ01000004",80.297,6.84e-104,381,538,431.99786,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLXP01000026",82.648,6.77e-104,381,438,361.99824,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLUB01000021",82.648,6.77e-104,381,438,361.99824,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLTT01000022",82.648,6.77e-104,381,438,361.99824,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRM01000021",82.648,6.77e-104,381,438,361.99824,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRF01000022",82.648,6.77e-104,381,438,361.99824,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FNPJ01000004",78.738,2.81e-103,379,602,474.00276,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLWD01000035",79.181,2.78e-103,379,586,464.00066,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_47615","NZ_FKWV01000005",80.074,2.56e-103,379,542,434.00108,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_47615","NZ_FKXF01000023",80.074,2.56e-103,379,542,434.00108,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_14639","NZ_FNOE01000002",77.846,3.33e-103,379,650,505.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLWD01000035",80.497,8.71e-103,377,523,420.99931,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_13506","NZ_FKXL01000017",80.388,1.07e-102,377,515,413.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_13506","NZ_FKWV01000005",80.388,1.07e-102,377,515,413.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_13506","NZ_FKXF01000023",80.388,1.07e-102,377,515,413.9982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FNOE01000002",80.116,8.87e-103,377,518,415.00088,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLXP01000026",75.347,2.43e-102,377,864,650.99808,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLUB01000021",75.347,2.43e-102,377,864,650.99808,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLTT01000022",75.347,2.43e-102,377,864,650.99808,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRM01000021",75.347,2.43e-102,377,864,650.99808,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRF01000022",75.347,2.43e-102,377,864,650.99808,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8906","NZ_FNOE01000002",77.778,1.08e-102,377,630,490.0014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1531","NZ_FNPJ01000004",79.924,9e-103,377,528,421.99872,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLXP01000026",75.29,2e-102,377,862,648.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLUB01000021",75.29,2e-102,377,862,648.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLTT01000022",75.29,2e-102,377,862,648.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRM01000021",75.29,2e-102,377,862,648.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRF01000022",75.29,2e-102,377,862,648.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FNOE01000002",83.491,9.13e-103,377,424,354.00184,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_5525","NZ_FNPJ01000004",76.676,4.49e-102,375,746,572.00296,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLWD01000035",79.249,4.01e-102,375,559,443.00191,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLXP01000026",79.249,4.01e-102,375,559,443.00191,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLUB01000021",79.249,4.01e-102,375,559,443.00191,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLTT01000022",79.249,4.01e-102,375,559,443.00191,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRM01000021",79.249,4.01e-102,375,559,443.00191,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRF01000022",79.249,4.01e-102,375,559,443.00191,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLXP01000026",82.287,6.17e-102,375,446,367.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLUB01000021",82.287,6.17e-102,375,446,367.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLTT01000022",82.287,6.17e-102,375,446,367.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRM01000021",82.287,6.17e-102,375,446,367.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRF01000022",82.287,6.17e-102,375,446,367.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLXP01000026",78.317,6.3e-102,375,618,483.99906,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLUB01000021",78.317,6.3e-102,375,618,483.99906,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLTT01000022",78.317,6.3e-102,375,618,483.99906,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRM01000021",78.317,6.3e-102,375,618,483.99906,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRF01000022",78.317,6.3e-102,375,618,483.99906,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FNOE01000002",80.115,3.2e-102,375,523,419.00145,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_FNPJ01000004",78.003,4.13e-102,375,641,499.99923,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLWD01000035",82.42,3.15e-102,375,438,360.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14686","NZ_FNOE01000002",80.118,2.05e-101,374,508,406.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_15624","NZ_FNPJ01000004",80.078,1.8e-101,374,512,409.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLXP01000026",82.327,1.39e-101,374,447,368.00169,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLUB01000021",82.327,1.39e-101,374,447,368.00169,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLTT01000022",82.327,1.39e-101,374,447,368.00169,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRM01000021",82.327,1.39e-101,374,447,368.00169,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRF01000022",82.327,1.39e-101,374,447,368.00169,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_5648","NZ_FNPJ01000004",83.498,1.28e-101,374,406,339.00188,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_FNOE01000002",83.493,1.18e-101,374,418,349.00074,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13865","NZ_FNPJ01000004",79.11,1.25e-101,374,584,462.0024,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_33551","NZ_FNOE01000002",80.684,4.25e-101,372,497,400.99948,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_2753","NZ_FNOE01000002",84.987,4.09e-101,372,373,317.00151,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLXP01000026",75.203,1.33e-100,372,863,649.00189,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLUB01000021",75.203,1.33e-100,372,863,649.00189,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLTT01000022",75.203,1.33e-100,372,863,649.00189,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRM01000021",75.203,1.33e-100,372,863,649.00189,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRF01000022",75.203,1.33e-100,372,863,649.00189,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_1476","NZ_FNOE01000002",79.643,4.58e-101,372,560,446.0008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_FKXL01000017",80.306,4.75e-101,372,523,420.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_FKWV01000005",80.306,4.75e-101,372,523,420.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_FKXF01000023",80.306,4.75e-101,372,523,420.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_16006","NZ_FNOE01000002",76.604,5.82e-101,372,748,572.99792,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FNOE01000002",80.196,5.02e-101,372,510,408.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FNPJ01000004",79.693,1.49e-100,370,522,415.99746,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FNOE01000002",74.143,4.53e-100,370,1021,757.00003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLXP01000026",78.155,3.53e-100,370,618,482.9979,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLUB01000021",78.155,3.53e-100,370,618,482.9979,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLTT01000022",78.155,3.53e-100,370,618,482.9979,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRM01000021",78.155,3.53e-100,370,618,482.9979,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRF01000022",78.155,3.53e-100,370,618,482.9979,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_18076","NZ_FNPJ01000004",79.07,5.97e-100,368,559,442.0013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8634","NZ_FNPJ01000004",79.401,2.2e-99,366,534,424.00134,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_FNPJ01000004",77.92,2.31e-99,366,625,487,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLWD01000035",79.623,1.94e-99,366,530,422.0019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLXP01000026",79.623,1.94e-99,366,530,422.0019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLUB01000021",79.623,1.94e-99,366,530,422.0019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLTT01000022",79.623,1.94e-99,366,530,422.0019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRM01000021",79.623,1.94e-99,366,530,422.0019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRF01000022",79.623,1.94e-99,366,530,422.0019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLWD01000035",77.994,1.64e-98,364,618,482.00292,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLWD01000035",78.029,1.89e-98,364,619,482.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FNPJ01000004",78.856,7.9e-99,364,577,454.99912,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLWD01000035",78.632,7.7e-99,364,585,459.9972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_5525","NZ_FNOE01000002",76.439,3.49e-98,363,747,570.99933,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_FNPJ01000004",77.259,3.2e-98,363,664,512.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLWD01000035",78.025,2.99e-98,363,628,489.997,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FKXL01000017",77.449,4.34e-98,363,643,497.99707,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FKWV01000005",77.449,4.34e-98,363,643,497.99707,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FKXF01000023",77.449,4.34e-98,363,643,497.99707,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_2195","NZ_FNPJ01000004",79.771,9.36e-98,361,524,418.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_8827","NZ_FNPJ01000004",80.202,9.32e-98,361,495,396.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_8827","NZ_FNOE01000002",80.361,9.32e-98,361,499,401.00139,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLXP01000026",75.533,2.28e-97,361,797,601.99801,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLUB01000021",75.533,2.28e-97,361,797,601.99801,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLTT01000022",75.533,2.28e-97,361,797,601.99801,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRM01000021",75.533,2.28e-97,361,797,601.99801,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRF01000022",75.533,2.28e-97,361,797,601.99801,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9323","NZ_FNPJ01000004",80.952,9.17e-98,361,462,373.99824,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FNOE01000002",81.33,1.03e-97,361,466,378.9978,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FKXL01000017",76.741,4.2e-97,359,675,518.00175,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FKWV01000005",76.741,4.2e-97,359,675,518.00175,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FKXF01000023",76.741,4.2e-97,359,675,518.00175,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FNPJ01000004",78.125,3.58e-97,359,576,450,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLWD01000035",82.38,3.91e-97,359,437,360.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLXP01000026",82.38,3.91e-97,359,437,360.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLUB01000021",82.38,3.91e-97,359,437,360.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLTT01000022",82.38,3.91e-97,359,437,360.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRM01000021",82.38,3.91e-97,359,437,360.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRF01000022",82.38,3.91e-97,359,437,360.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13865","NZ_FNOE01000002",78.596,3.5e-97,359,584,459.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_FNOE01000002",83.293,3.21e-97,359,413,344.00009,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_2195","NZ_FNOE01000002",79.58,1.21e-96,357,524,416.9992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FKXL01000017",78,1.32e-96,357,600,468,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FKWV01000005",78,1.32e-96,357,600,468,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FKXF01000023",78,1.32e-96,357,600,468,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_4996","NZ_FNOE01000002",75.995,1.69e-96,357,779,592.00105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FKXL01000017",77.833,1.34e-96,357,600,466.998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FKWV01000005",77.833,1.34e-96,357,600,466.998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FKXF01000023",77.833,1.34e-96,357,600,466.998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FNPJ01000004",79.231,4.16e-96,355,520,412.0012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_FNOE01000002",86.28,5.82e-96,355,328,282.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_FNPJ01000004",80.08,4.1e-96,355,502,402.0016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLWD01000035",82.464,4.28e-96,355,422,347.99808,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RB_vs_bact_coverage_filtered_hits","k127_1674","NZ_FNOE01000002",78.893,4.46e-96,355,578,456.00154,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FKXL01000017",81.567,1.61e-95,353,434,354.00078,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FKWV01000005",81.567,1.61e-95,353,434,354.00078,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FKXF01000023",81.567,1.61e-95,353,434,354.00078,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14686","NZ_FNPJ01000004",79.412,2.67e-95,353,510,405.0012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLXP01000026",78.078,3.61e-95,353,593,463.00254,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLUB01000021",78.078,3.61e-95,353,593,463.00254,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLTT01000022",78.078,3.61e-95,353,593,463.00254,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRM01000021",78.078,3.61e-95,353,593,463.00254,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRF01000022",78.078,3.61e-95,353,593,463.00254,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLWD01000035",79.842,1.62e-95,353,506,404.00052,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FNOE01000002",78.066,1.67e-95,353,579,452.00214,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLWD01000035",78.843,3.81e-95,353,553,436.00179,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLXP01000026",79.323,1.82e-95,353,532,421.99836,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLUB01000021",79.323,1.82e-95,353,532,421.99836,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLTT01000022",79.323,1.82e-95,353,532,421.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRM01000021",79.323,1.82e-95,353,532,421.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRF01000022",79.323,1.82e-95,353,532,421.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLXP01000026",77.944,6.13e-95,351,603,470.00232,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLUB01000021",77.944,6.13e-95,351,603,470.00232,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLTT01000022",77.944,6.13e-95,351,603,470.00232,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRM01000021",77.944,6.13e-95,351,603,470.00232,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRF01000022",77.944,6.13e-95,351,603,470.00232,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_FNPJ01000004",77.889,8.01e-94,348,597,464.99733,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLWD01000035",79.135,8.45e-94,348,532,420.9982,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLWD01000035",77.778,2.85e-93,346,603,469.00134,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FNPJ01000004",80.467,2.89e-93,346,471,378.99957,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_33551","NZ_FNPJ01000004",79.596,9.28e-93,344,495,394.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_656","NZ_FNOE01000002",80.786,8.91e-93,344,458,369.99988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_2081","NZ_FNPJ01000004",80.533,8.8e-93,344,488,393.00104,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_MLWD01000035",78.739,9.61e-93,344,555,437.00145,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_2703","NZ_FNPJ01000004",87.748,1.02e-92,344,302,264.99896,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RB_vs_bact_coverage_filtered_hits","k127_1674","NZ_FNPJ01000004",78.388,9.66e-93,344,583,457.00204,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_2753","NZ_FNPJ01000004",83.467,3.2e-92,342,375,313.00125,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLXP01000026",75.632,5.74e-92,342,751,567.99632,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLUB01000021",75.632,5.74e-92,342,751,567.99632,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLTT01000022",75.632,5.74e-92,342,751,567.99632,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRM01000021",75.632,5.74e-92,342,751,567.99632,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRF01000022",75.632,5.74e-92,342,751,567.99632,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_9029","NZ_FNOE01000002",78.909,3.59e-92,342,550,433.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_4996","NZ_FNPJ01000004",75.796,4.72e-92,342,785,594.9986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLXP01000026",79.447,3.5e-92,342,506,402.00182,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLUB01000021",79.447,3.5e-92,342,506,402.00182,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLTT01000022",79.447,3.5e-92,342,506,402.00182,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRM01000021",79.447,3.5e-92,342,506,402.00182,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRF01000022",79.447,3.5e-92,342,506,402.00182,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_1670","NZ_FNPJ01000004",79.837,3.16e-92,342,491,391.99967,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_FNOE01000002",78.508,3.51e-92,342,563,442.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_FNPJ01000004",77.954,3.53e-92,342,567,441.99918,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_10572","NZ_FNPJ01000004",86.207,3.22e-92,342,319,275.00033,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9969","NZ_FNOE01000002",78.61,2.42e-91,340,561,441.0021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15774","NZ_FKXL01000017",79.07,1.15e-91,340,516,408.0012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_FNOE01000002",81.507,4.54e-91,339,438,357.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLWD01000035",77.835,1.68e-90,337,582,452.9997,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLXP01000026",77.835,1.68e-90,337,582,452.9997,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLUB01000021",77.835,1.68e-90,337,582,452.9997,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLTT01000022",77.835,1.68e-90,337,582,452.9997,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRM01000021",77.835,1.68e-90,337,582,452.9997,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRF01000022",77.835,1.68e-90,337,582,452.9997,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11600","NZ_FNPJ01000004",77.11,1.79e-90,337,616,474.9976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLWD01000035",77.509,1.68e-90,337,578,448.00202,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLXP01000026",77.509,1.68e-90,337,578,448.00202,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLUB01000021",77.509,1.68e-90,337,578,448.00202,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLTT01000022",77.509,1.68e-90,337,578,448.00202,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRM01000021",77.509,1.68e-90,337,578,448.00202,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRF01000022",77.509,1.68e-90,337,578,448.00202,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_10572","NZ_FNOE01000002",85.714,1.5e-90,337,322,275.99908,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLWD01000035",77.601,7.6e-90,335,567,439.99767,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLXP01000026",77.601,7.6e-90,335,567,439.99767,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLUB01000021",77.601,7.6e-90,335,567,439.99767,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLTT01000022",77.601,7.6e-90,335,567,439.99767,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRM01000021",77.601,7.6e-90,335,567,439.99767,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRF01000022",77.601,7.6e-90,335,567,439.99767,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_2514","NZ_FNOE01000002",78.159,5.69e-90,335,554,433.00086,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14193","NZ_FNPJ01000004",76.898,6.77e-90,335,619,475.99862,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1396","NZ_FKXL01000017",89.179,5.48e-90,335,268,238.99972,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1396","NZ_FKWV01000005",89.179,5.48e-90,335,268,238.99972,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1396","NZ_FKXF01000023",89.179,5.48e-90,335,268,238.99972,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLWD01000035",79.29,9.6e-90,335,507,402.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FKXL01000017",77.738,5.83e-90,335,557,433.00066,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FKWV01000005",77.738,5.83e-90,335,557,433.00066,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FKXF01000023",77.738,5.83e-90,335,557,433.00066,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLWD01000035",81.132,6.94e-90,335,424,343.99968,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLXP01000026",81.132,6.94e-90,335,424,343.99968,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLUB01000021",81.132,6.94e-90,335,424,343.99968,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLTT01000022",81.132,6.94e-90,335,424,343.99968,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRM01000021",81.132,6.94e-90,335,424,343.99968,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRF01000022",81.132,6.94e-90,335,424,343.99968,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FKXL01000017",87.805,4.38e-89,333,287,252.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FKWV01000005",87.805,4.38e-89,333,287,252.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FKXF01000023",87.805,4.38e-89,333,287,252.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15774","NZ_FKWV01000005",88.256,1.92e-89,333,281,247.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15774","NZ_FKXF01000023",88.256,1.92e-89,333,281,247.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_FNOE01000002",78.571,7.35e-89,331,546,428.99766,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FKXL01000017",75.297,1.98e-88,331,757,569.99829,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FKWV01000005",75.297,1.98e-88,331,757,569.99829,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FKXF01000023",75.297,1.98e-88,331,757,569.99829,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_30343","NZ_FNOE01000002",78.417,7.61e-89,331,556,435.99852,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FKXL01000017",76.418,3.27e-88,329,670,512.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FNPJ01000004",76.897,2.9e-88,329,593,455.99921,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FNOE01000002",80.931,2.81e-88,329,451,364.99881,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_FNOE01000002",76.656,3.11e-88,329,634,485.99904,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14193","NZ_FNOE01000002",76.737,1.13e-87,327,619,475.00203,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FKXL01000017",78.072,9.27e-88,327,529,413.00088,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FKWV01000005",78.072,9.27e-88,327,529,413.00088,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FKXF01000023",78.072,9.27e-88,327,529,413.00088,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLWD01000035",78.352,9.06e-88,327,522,408.99744,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FNOE01000002",84.348,8.88e-88,327,345,291.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_1670","NZ_FNOE01000002",79.268,3.18e-87,326,492,389.99856,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLWD01000035",78.119,3.27e-87,326,521,406.99999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLXP01000026",78.119,3.27e-87,326,521,406.99999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLUB01000021",78.119,3.27e-87,326,521,406.99999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLTT01000022",78.119,3.27e-87,326,521,406.99999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRM01000021",78.119,3.27e-87,326,521,406.99999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRF01000022",78.119,3.27e-87,326,521,406.99999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_FNPJ01000004",77.837,3.54e-87,326,564,439.00068,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8843","NZ_FNPJ01000004",78.09,1.29e-86,324,534,417.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_FNOE01000002",82.071,1.25e-86,324,396,325.00116,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_985","NZ_FNPJ01000004",77.258,2.09e-86,324,598,462.00284,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_FNPJ01000004",78.165,1.23e-86,324,545,425.99925,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLWD01000035",77.329,1.62e-86,324,569,440.00201,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLXP01000026",77.329,1.62e-86,324,569,440.00201,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLUB01000021",77.329,1.62e-86,324,569,440.00201,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLTT01000022",77.329,1.62e-86,324,569,440.00201,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRM01000021",77.329,1.62e-86,324,569,440.00201,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRF01000022",77.329,1.62e-86,324,569,440.00201,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_19532","NZ_FNPJ01000004",76.911,1.38e-86,324,628,483.00108,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FKWV01000005",82,5.48e-86,322,400,328,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FKXF01000023",82,5.48e-86,322,400,328,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_424","NZ_FNOE01000002",77.645,6.77e-86,322,586,454.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FNOE01000002",80.952,4.57e-86,322,441,356.99832,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLXP01000026",78.161,4.22e-86,322,522,408.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLUB01000021",78.161,4.22e-86,322,522,408.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLTT01000022",78.161,4.22e-86,322,522,408.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRM01000021",78.161,4.22e-86,322,522,408.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRF01000022",78.161,4.22e-86,322,522,408.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_484","NZ_FNOE01000002",77.645,6.73e-86,322,586,454.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_12445","NZ_FNPJ01000004",82.368,1.52e-85,320,380,312.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_985","NZ_FNOE01000002",77.28,2.7e-85,320,603,465.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_2514","NZ_FNPJ01000004",77.596,2.06e-84,316,549,426.00204,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FNPJ01000004",77.329,2.13e-84,316,569,440.00201,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11591","NZ_FNPJ01000004",79.15,2.12e-84,316,494,391.001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3519","NZ_FNPJ01000004",77.917,2.23e-84,316,557,433.99769,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FKXL01000017",76.378,3.77e-84,316,635,485.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FKWV01000005",76.378,3.77e-84,316,635,485.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FKXF01000023",76.378,3.77e-84,316,635,485.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FNOE01000002",83.573,8.93e-84,315,347,289.99831,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_14433","NZ_FNPJ01000004",82.451,1.14e-83,315,359,295.99909,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_5651","NZ_FNOE01000002",82.105,7.04e-84,315,380,311.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_424","NZ_FNPJ01000004",77.327,4.08e-83,313,591,457.00257,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_484","NZ_FNPJ01000004",77.327,4.05e-83,313,591,457.00257,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLWD01000035",82.289,9.82e-83,311,367,302.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLXP01000026",82.289,9.82e-83,311,367,302.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLUB01000021",82.289,9.82e-83,311,367,302.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLTT01000022",82.289,9.82e-83,311,367,302.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRM01000021",82.289,9.82e-83,311,367,302.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRF01000022",82.289,9.82e-83,311,367,302.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_12445","NZ_FNOE01000002",81.771,9.15e-83,311,384,314.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_656","NZ_FNPJ01000004",79.476,9.03e-83,311,458,364.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FNOE01000002",80.137,1.04e-82,311,438,351.00006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLXP01000026",75.103,1.63e-82,311,731,549.00293,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLUB01000021",75.103,1.63e-82,311,731,549.00293,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLTT01000022",75.103,1.63e-82,311,731,549.00293,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRM01000021",75.103,1.63e-82,311,731,549.00293,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRF01000022",75.103,1.63e-82,311,731,549.00293,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_19532","NZ_FNOE01000002",76.592,1.07e-82,311,628,480.99776,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_32548","NZ_FNPJ01000004",75.645,4.59e-82,309,698,528.0021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLWD01000035",78.85,5.86e-82,309,487,383.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_32548","NZ_FNOE01000002",75.731,1.65e-81,307,684,518.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_11977","NZ_FNOE01000002",77.158,1.3e-81,307,556,428.99848,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RB_vs_bact_coverage_filtered_hits","k127_5496","NZ_FNPJ01000004",78.384,1.37e-81,307,495,388.0008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FKXL01000017",76.531,1.35e-81,307,588,450.00228,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FKWV01000005",76.531,1.35e-81,307,588,450.00228,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FKXF01000023",76.531,1.35e-81,307,588,450.00228,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_2703","NZ_FNOE01000002",85.43,4.83e-81,305,302,257.9986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLWD01000035",82.065,1.61e-80,303,368,301.9992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLWD01000035",80.096,1.04e-79,302,417,334.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLXP01000026",80.096,1.04e-79,302,417,334.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLUB01000021",80.096,1.04e-79,302,417,334.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLTT01000022",80.096,1.04e-79,302,417,334.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRM01000021",80.096,1.04e-79,302,417,334.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRF01000022",80.096,1.04e-79,302,417,334.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLXP01000026",76.094,6.31e-80,302,594,451.99836,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLUB01000021",76.094,6.31e-80,302,594,451.99836,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLTT01000022",76.094,6.31e-80,302,594,451.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRM01000021",76.094,6.31e-80,302,594,451.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRF01000022",76.094,6.31e-80,302,594,451.99836,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FNOE01000002",80.465,5.83e-80,302,430,345.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11600","NZ_FNOE01000002",76.175,2.34e-79,300,617,469.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FNPJ01000004",77.265,2.06e-79,300,563,435.00195,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_10294","NZ_FNPJ01000004",86.331,1.92e-79,300,278,240.00018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8843","NZ_FNOE01000002",79.039,7.82e-79,298,458,361.99862,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FKXL01000017",76.013,8.37e-79,298,617,469.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FKWV01000005",76.013,8.37e-79,298,617,469.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FKXF01000023",76.013,8.37e-79,298,617,469.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FNPJ01000004",77.098,7.54e-79,298,572,441.00056,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_5651","NZ_FNPJ01000004",81.316,7.09e-79,298,380,309.0008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLWD01000035",75.926,2.94e-78,296,594,451.00044,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLWD01000035",78.557,8.1e-78,296,485,381.00145,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLXP01000026",78.557,8.1e-78,296,485,381.00145,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLUB01000021",78.557,8.1e-78,296,485,381.00145,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLTT01000022",78.557,8.1e-78,296,485,381.00145,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRM01000021",78.557,8.1e-78,296,485,381.00145,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRF01000022",78.557,8.1e-78,296,485,381.00145,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_MLWD01000035",78.603,1.32e-77,294,458,360.00174,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_MLWD01000035",76.382,1.04e-77,294,597,456.00054,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLWD01000035",78.298,9.1e-78,294,470,368.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLXP01000026",78.298,9.1e-78,294,470,368.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLUB01000021",78.298,9.1e-78,294,470,368.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLTT01000022",78.298,9.1e-78,294,470,368.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRM01000021",78.298,9.1e-78,294,470,368.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRF01000022",78.298,9.1e-78,294,470,368.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_MLWD01000035",77.606,3.27e-77,292,518,401.99908,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FKXL01000017",80.622,9.73e-77,292,418,336.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FKWV01000005",80.622,9.73e-77,292,418,336.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FKXF01000023",80.622,9.73e-77,292,418,336.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_30343","NZ_FNPJ01000004",81.389,3.59e-77,292,360,293.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4078","NZ_FKXL01000017",78.226,3.41e-77,292,496,388.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4078","NZ_FKWV01000005",78.226,3.41e-77,292,496,388.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4078","NZ_FKXF01000023",78.226,3.41e-77,292,496,388.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLWD01000035",76.735,3.47e-77,292,533,408.99755,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FNOE01000002",75.798,1.37e-76,291,595,450.9981,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_11977","NZ_FNPJ01000004",76.786,1.31e-76,291,560,430.0016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_943","NZ_FNOE01000002",92.574,1.38e-76,291,202,186.99948,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_2081","NZ_FNOE01000002",81.792,1.5e-75,287,346,283.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLXP01000026",81.301,1.62e-75,287,369,300.00069,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLUB01000021",81.301,1.62e-75,287,369,300.00069,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLTT01000022",81.301,1.62e-75,287,369,300.00069,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRM01000021",81.301,1.62e-75,287,369,300.00069,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRF01000022",81.301,1.62e-75,287,369,300.00069,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLXP01000026",76.548,1.61e-75,287,533,408.00084,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLUB01000021",76.548,1.61e-75,287,533,408.00084,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLTT01000022",76.548,1.61e-75,287,533,408.00084,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRM01000021",76.548,1.61e-75,287,533,408.00084,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRF01000022",76.548,1.61e-75,287,533,408.00084,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FKXL01000017",76.895,1.58e-75,287,541,416.00195,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FKWV01000005",76.895,1.58e-75,287,541,416.00195,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FKXF01000023",76.895,1.58e-75,287,541,416.00195,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_FKXL01000017",74.553,1.03e-74,285,727,542.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_FKWV01000005",74.553,1.03e-74,285,727,542.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_FKXF01000023",74.553,1.03e-74,285,727,542.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_FKXL01000017",77.154,1.99e-74,283,499,384.99846,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_FKWV01000005",77.154,1.99e-74,283,499,384.99846,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_FKXF01000023",77.154,1.99e-74,283,499,384.99846,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_9221","NZ_FNPJ01000004",80.051,2.75e-74,283,396,317.00196,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_11955","NZ_FNPJ01000004",79.582,9.06e-74,281,431,342.99842,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_1476","NZ_FNPJ01000004",81.449,7.93e-74,281,345,280.99905,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FKXL01000017",81.924,9.03e-74,281,343,280.99932,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FKWV01000005",81.924,9.03e-74,281,343,280.99932,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FKXF01000023",81.924,9.03e-74,281,343,280.99932,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FNPJ01000004",79.803,2.77e-73,279,406,324.00018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FKXL01000017",79.506,3.63e-73,279,405,321.9993,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FKWV01000005",79.506,3.63e-73,279,405,321.9993,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FKXF01000023",79.506,3.63e-73,279,405,321.9993,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FKXL01000017",75.952,3.52e-73,279,578,439.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FKWV01000005",75.952,3.52e-73,279,578,439.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FKXF01000023",75.952,3.52e-73,279,578,439.00256,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_11955","NZ_FNOE01000002",79.405,1.17e-72,278,437,346.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FKXL01000017",83.729,1.12e-72,278,295,247.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FKWV01000005",83.729,1.12e-72,278,295,247.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FKXF01000023",83.729,1.12e-72,278,295,247.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_MLWD01000035",76.619,9.81e-73,278,556,426.00164,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_13054","NZ_FKXL01000017",85.091,1.36e-72,278,275,234.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_13054","NZ_FKWV01000005",85.091,1.36e-72,278,275,234.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_13054","NZ_FKXF01000023",85.091,1.36e-72,278,275,234.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7015","NZ_FNOE01000002",76.786,1.25e-72,278,560,430.0016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_MLWD01000035",80.429,1.49e-72,278,373,300.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_FNPJ01000004",76.049,1.02e-72,278,572,435.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RB_vs_bact_coverage_filtered_hits","k127_5496","NZ_FNOE01000002",75.767,1.07e-72,278,619,468.99773,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_10294","NZ_FNOE01000002",78.753,9.01e-73,278,433,341.00049,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FNOE01000002",79.567,3.53e-72,276,416,330.99872,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_3012","NZ_FNOE01000002",78.604,3.27e-72,276,444,349.00176,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_14433","NZ_FNPJ01000004",79.157,1.93e-71,274,427,338.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2998","NZ_FNOE01000002",80.481,1.21e-71,274,374,300.99894,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FNOE01000002",75.923,4.69e-71,272,569,432.00187,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_MLWD01000035",80.214,5.56e-71,272,374,300.00036,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_3012","NZ_FNPJ01000004",78.555,4.23e-71,272,429,337.00095,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FNPJ01000004",80.645,2.41e-70,270,372,299.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLWD01000035",76.25,1.89e-70,270,560,427,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FKXL01000017",80.108,8.8e-70,268,372,298.00176,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FKWV01000005",80.108,8.8e-70,268,372,298.00176,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FKXF01000023",80.108,8.8e-70,268,372,298.00176,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLWD01000035",86.722,7.08e-70,268,241,209.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_FNOE01000002",87.19,7.08e-70,268,242,210.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_16624","NZ_FNPJ01000004",81.194,7.81e-70,268,335,271.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FKXL01000017",85.502,7.32e-70,268,269,230.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FKWV01000005",85.502,7.32e-70,268,269,230.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FKXF01000023",85.502,7.32e-70,268,269,230.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FKXL01000017",78.998,2.32e-69,267,419,331.00162,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FKWV01000005",78.998,2.32e-69,267,419,331.00162,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FKXF01000023",78.998,2.32e-69,267,419,331.00162,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FNOE01000002",78.522,2.63e-69,267,433,340.00026,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLXP01000026",87.446,2e-69,267,231,202.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLUB01000021",87.446,2e-69,267,231,202.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLTT01000022",87.446,2e-69,267,231,202.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRM01000021",87.446,2e-69,267,231,202.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRF01000022",87.446,2e-69,267,231,202.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FNOE01000002",80.376,1.12e-68,265,372,298.99872,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLXP01000026",92.432,1.14e-68,265,185,170.9992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLUB01000021",92.432,1.14e-68,265,185,170.9992,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLTT01000022",92.432,1.14e-68,265,185,170.9992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRM01000021",92.432,1.14e-68,265,185,170.9992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRF01000022",92.432,1.14e-68,265,185,170.9992,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLXP01000026",76.114,8.8e-69,265,561,426.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLUB01000021",76.114,8.8e-69,265,561,426.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLTT01000022",76.114,8.8e-69,265,561,426.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRM01000021",76.114,8.8e-69,265,561,426.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRF01000022",76.114,8.8e-69,265,561,426.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_FNPJ01000004",86.777,9.16e-69,265,242,210.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FKXL01000017",77.729,8.42e-69,265,458,355.99882,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FKWV01000005",77.729,8.42e-69,265,458,355.99882,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FKXF01000023",77.729,8.42e-69,265,458,355.99882,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FNPJ01000004",78.883,4.91e-68,263,412,324.99796,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLWD01000035",93.296,4.42e-68,263,179,166.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXP01000026",93.296,4.42e-68,263,179,166.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLUB01000021",93.296,4.42e-68,263,179,166.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLTT01000022",93.296,4.42e-68,263,179,166.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRM01000021",93.296,4.42e-68,263,179,166.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRF01000022",93.296,4.42e-68,263,179,166.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLWD01000035",75.485,1.01e-67,261,567,427.99995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FKXL01000017",78.469,1.37e-67,261,418,328.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FKWV01000005",78.469,1.37e-67,261,418,328.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FKXF01000023",78.469,1.37e-67,261,418,328.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_19633","NZ_FNPJ01000004",82.724,9.25e-68,261,301,248.99924,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_16624","NZ_FNPJ01000004",89.048,1.31e-67,261,210,187.0008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FKXL01000017",81.515,1.12e-67,261,330,268.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FKWV01000005",81.515,1.12e-67,261,330,268.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FKXF01000023",81.515,1.12e-67,261,330,268.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FNPJ01000004",84.942,1.22e-67,261,259,219.99978,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FNOE01000002",79.024,3.49e-67,259,410,323.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11591","NZ_FNOE01000002",78.043,3.62e-67,259,419,327.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FKXL01000017",79.434,2.3e-66,257,389,308.99826,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FKWV01000005",79.434,2.3e-66,257,389,308.99826,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FKXF01000023",79.434,2.3e-66,257,389,308.99826,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_9221","NZ_FNOE01000002",78.14,1.67e-66,257,430,336.002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2998","NZ_FNPJ01000004",79.679,1.22e-66,257,374,297.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLXP01000026",75.352,4.72e-66,255,568,427.99936,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLUB01000021",75.352,4.72e-66,255,568,427.99936,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLTT01000022",75.352,4.72e-66,255,568,427.99936,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRM01000021",75.352,4.72e-66,255,568,427.99936,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRF01000022",75.352,4.72e-66,255,568,427.99936,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLWD01000035",79.845,6.75e-66,255,387,309.00015,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXP01000026",79.845,6.75e-66,255,387,309.00015,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLUB01000021",79.845,6.75e-66,255,387,309.00015,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLTT01000022",79.845,6.75e-66,255,387,309.00015,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRM01000021",79.845,6.75e-66,255,387,309.00015,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRF01000022",79.845,6.75e-66,255,387,309.00015,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FKXL01000017",80.337,4.52e-65,254,356,285.99972,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FKWV01000005",80.337,4.52e-65,254,356,285.99972,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FKXF01000023",80.337,4.52e-65,254,356,285.99972,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7015","NZ_FNPJ01000004",75.986,2.11e-65,254,558,424.00188,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLXP01000026",85.537,2.29e-65,254,242,206.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLUB01000021",85.537,2.29e-65,254,242,206.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLTT01000022",85.537,2.29e-65,254,242,206.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRM01000021",85.537,2.29e-65,254,242,206.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRF01000022",85.537,2.29e-65,254,242,206.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_9029","NZ_FNPJ01000004",90.155,6.23e-65,252,193,173.99915,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FKXL01000017",79.521,3.16e-64,250,376,298.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FKWV01000005",79.521,3.16e-64,250,376,298.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FKXF01000023",79.521,3.16e-64,250,376,298.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FNOE01000002",79.778,1.37e-63,248,361,287.99858,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_3026","NZ_FNPJ01000004",75.524,7.75e-64,248,572,431.99728,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLXP01000026",85.897,1.02e-63,248,234,200.99898,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLUB01000021",85.897,1.02e-63,248,234,200.99898,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLTT01000022",85.897,1.02e-63,248,234,200.99898,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRM01000021",85.897,1.02e-63,248,234,200.99898,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRF01000022",85.897,1.02e-63,248,234,200.99898,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FKXL01000017",73.919,1.09e-63,248,694,512.99786,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLWD01000035",80.793,4.06e-63,246,328,265.00104,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_943","NZ_FNOE01000002",80.564,3.03e-63,246,319,256.99916,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9969","NZ_FNPJ01000004",80.435,1.95e-62,244,322,259.0007,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FNOE01000002",80.299,1.01e-62,244,335,269.00165,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FKXL01000017",79.552,1.63e-62,244,357,284.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FKWV01000005",79.552,1.63e-62,244,357,284.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FKXF01000023",79.552,1.63e-62,244,357,284.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_FNPJ01000004",87.85,9.18e-63,244,214,187.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_19633","NZ_FNOE01000002",81.788,9.31e-63,244,302,246.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FKWV01000005",72.687,5.76e-62,243,897,652.00239,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FKXF01000023",72.687,5.76e-62,243,897,652.00239,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FKWV01000005",73.775,5.06e-62,243,694,511.9985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FKXF01000023",73.775,5.06e-62,243,694,511.9985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_FNOE01000002",76.754,1.74e-61,241,456,349.99824,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FKXL01000017",79.112,5.31e-61,239,383,302.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FKWV01000005",79.112,5.31e-61,239,383,302.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FKXF01000023",79.112,5.31e-61,239,383,302.99896,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLWD01000035",77.578,5.74e-61,239,446,345.99788,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXP01000026",77.578,5.74e-61,239,446,345.99788,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLUB01000021",77.578,5.74e-61,239,446,345.99788,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLTT01000022",77.578,5.74e-61,239,446,345.99788,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRM01000021",77.578,5.74e-61,239,446,345.99788,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRF01000022",77.578,5.74e-61,239,446,345.99788,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9969","NZ_FNPJ01000004",89.005,3.27e-60,237,191,169.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FKXL01000017",72.575,2.68e-60,237,897,650.99775,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FNPJ01000004",78.68,7.34e-60,235,394,309.9992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXP01000026",80.183,8.79e-60,235,328,263.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLUB01000021",80.183,8.79e-60,235,328,263.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLTT01000022",80.183,8.79e-60,235,328,263.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRM01000021",80.183,8.79e-60,235,328,263.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRF01000022",80.183,8.79e-60,235,328,263.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_92432","NZ_FNPJ01000004",77.404,5.66e-60,235,416,322.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLXP01000026",81.915,9.43e-60,235,282,231.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLUB01000021",81.915,9.43e-60,235,282,231.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLTT01000022",81.915,9.43e-60,235,282,231.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRM01000021",81.915,9.43e-60,235,282,231.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRF01000022",81.915,9.43e-60,235,282,231.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FKXL01000017",78.962,5.77e-60,235,366,289.00092,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FKWV01000005",78.962,5.77e-60,235,366,289.00092,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FKXF01000023",78.962,5.77e-60,235,366,289.00092,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLXP01000026",93.631,6.79e-60,235,157,147.00067,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLUB01000021",93.631,6.79e-60,235,157,147.00067,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLTT01000022",93.631,6.79e-60,235,157,147.00067,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRM01000021",93.631,6.79e-60,235,157,147.00067,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRF01000022",93.631,6.79e-60,235,157,147.00067,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_17735","NZ_FNPJ01000004",88.205,2.23e-59,233,195,171.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_18931","NZ_FNPJ01000004",88.205,2.34e-59,233,195,171.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FKXL01000017",76.562,8.84e-59,231,448,342.99776,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FKWV01000005",76.562,8.84e-59,231,448,342.99776,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FKXF01000023",76.562,8.84e-59,231,448,342.99776,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_FNOE01000002",81.695,8.91e-59,231,295,241.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_MLWD01000035",79.36,1.01e-58,231,344,272.9984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_FKXL01000017",74.062,1.41e-58,231,640,473.9968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_FKWV01000005",74.062,1.41e-58,231,640,473.9968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_FKXF01000023",74.062,1.41e-58,231,640,473.9968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FNPJ01000004",76.278,2.32e-58,231,489,372.99942,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_FNOE01000002",79.758,3.64e-58,230,331,263.99898,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_MLWD01000035",75.556,9.26e-58,228,495,374.0022,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_MLWD01000035",75.453,4.31e-57,226,497,375.00141,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_40515","NZ_FNPJ01000004",77.778,4.61e-57,226,387,301.00086,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FKXL01000017",79.032,6.47e-57,226,372,293.99904,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FKWV01000005",79.032,6.47e-57,226,372,293.99904,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FKXF01000023",79.032,6.47e-57,226,372,293.99904,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_FKXL01000017",74.873,5.69e-57,226,589,441.00197,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_FKWV01000005",74.915,5.69e-57,226,590,441.9985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_FKXF01000023",74.915,5.69e-57,226,590,441.9985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FNPJ01000004",79.3,9.16e-57,226,343,271.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_1476","NZ_FNPJ01000004",91.018,3.77e-57,226,167,152.00006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_3026","NZ_FNOE01000002",74.825,1.31e-56,224,572,427.999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10376","NZ_FNOE01000002",76.538,1.28e-56,224,439,336.00182,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLWD01000035",85.78,5.72e-56,222,218,187.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLXP01000026",85.78,5.72e-56,222,218,187.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLUB01000021",85.78,5.72e-56,222,218,187.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLTT01000022",85.78,5.72e-56,222,218,187.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRM01000021",85.78,5.72e-56,222,218,187.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRF01000022",85.78,5.72e-56,222,218,187.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FKXL01000017",87.192,6.84e-56,222,203,176.99976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FKWV01000005",87.192,6.84e-56,222,203,176.99976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FKXF01000023",87.192,6.84e-56,222,203,176.99976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FNOE01000002",79.07,4.26e-55,220,344,272.0008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_FNOE01000002",84.513,1.55e-55,220,226,190.99938,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_FNOE01000002",93.836,2.64e-55,220,146,137.00056,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FNPJ01000004",79.167,5.77e-55,219,336,266.00112,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_FNOE01000002",78.016,9.19e-55,219,373,290.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLWD01000035",75.941,6.65e-55,219,478,362.99798,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXP01000026",75.941,6.65e-55,219,478,362.99798,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLUB01000021",75.941,6.65e-55,219,478,362.99798,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLTT01000022",75.941,6.65e-55,219,478,362.99798,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRM01000021",75.941,6.65e-55,219,478,362.99798,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRF01000022",75.941,6.65e-55,219,478,362.99798,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_17735","NZ_FNOE01000002",86.667,2.24e-54,217,195,169.00065,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_18931","NZ_FNOE01000002",86.667,2.35e-54,217,195,169.00065,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_FNOE01000002",77.344,7.8e-54,215,384,297.00096,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_13054","NZ_FNPJ01000004",82.329,1.08e-53,215,249,204.99921,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_13054","NZ_FNOE01000002",82.143,1.08e-53,215,252,207.00036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_13464","NZ_FNOE01000002",75,8.19e-54,215,540,405,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FNOE01000002",78.932,2.69e-53,213,337,266.00084,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FKXL01000017",85.577,2.98e-53,213,208,178.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FKWV01000005",85.577,2.98e-53,213,208,178.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FKXF01000023",85.577,2.98e-53,213,208,178.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FNOE01000002",94.853,2.59e-53,213,136,129.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FKXL01000017",78.393,3.63e-53,213,361,282.99873,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FKWV01000005",78.393,3.63e-53,213,361,282.99873,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FKXF01000023",78.393,3.63e-53,213,361,282.99873,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_FNOE01000002",77.628,3.42e-53,213,371,287.99988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10376","NZ_FNPJ01000004",76.027,3.57e-52,209,438,332.99826,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FNOE01000002",75.46,1.08e-51,209,489,368.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FNOE01000002",94.118,1.56e-51,207,136,128.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_FNOE01000002",94.118,1.5e-51,207,136,128.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FKXL01000017",85.167,1.28e-51,207,209,177.99903,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FKWV01000005",85.167,1.28e-51,207,209,177.99903,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FKXF01000023",85.167,1.28e-51,207,209,177.99903,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_MLWD01000035",80.277,1.64e-51,207,289,232.00053,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLXP01000026",75.368,1.25e-51,207,475,357.998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLUB01000021",75.368,1.25e-51,207,475,357.998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLTT01000022",75.368,1.25e-51,207,475,357.998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRM01000021",75.368,1.25e-51,207,475,357.998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRF01000022",75.368,1.25e-51,207,475,357.998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FKWV01000005",71.933,2.28e-51,207,962,691.99546,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FKXF01000023",71.933,2.28e-51,207,962,691.99546,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FKXL01000017",75.519,1.47e-51,207,482,364.00158,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FKWV01000005",75.519,1.47e-51,207,482,364.00158,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FKXF01000023",75.519,1.47e-51,207,482,364.00158,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FNPJ01000004",77.027,1.3e-50,206,370,284.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_MLWD01000035",75.938,4.49e-51,206,453,343.99914,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FNOE01000002",91.837,1.19e-50,206,147,135.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_92432","NZ_FNOE01000002",74.632,4.44e-51,206,544,405.99808,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_15723","NZ_FNOE01000002",76.009,4.32e-51,206,446,339.00014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLWD01000035",76.235,4.5e-51,206,425,323.99875,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FKXL01000017",85.93,4.94e-51,206,199,171.0007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FKWV01000005",85.93,4.94e-51,206,199,171.0007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FKXF01000023",85.93,4.94e-51,206,199,171.0007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FNPJ01000004",85.784,7.56e-51,206,204,174.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLWD01000035",77.867,2.76e-50,204,375,292.00125,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLXP01000026",77.867,2.76e-50,204,375,292.00125,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLUB01000021",77.867,2.76e-50,204,375,292.00125,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLTT01000022",77.867,2.76e-50,204,375,292.00125,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRM01000021",77.867,2.76e-50,204,375,292.00125,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRF01000022",77.867,2.76e-50,204,375,292.00125,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6750","NZ_FKXL01000017",80.741,2.46e-50,204,270,218.0007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6750","NZ_FKWV01000005",80.741,2.46e-50,204,270,218.0007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6750","NZ_FKXF01000023",80.741,2.46e-50,204,270,218.0007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FNOE01000002",76.982,7.45e-50,202,391,300.99962,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_MLWD01000035",76.555,6.22e-50,202,418,319.9999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_15723","NZ_FNPJ01000004",83.886,5.59e-50,202,211,176.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLWD01000035",83.796,1.33e-49,202,216,180.99936,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLXP01000026",83.796,1.33e-49,202,216,180.99936,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLUB01000021",83.796,1.33e-49,202,216,180.99936,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLTT01000022",83.796,1.33e-49,202,216,180.99936,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRM01000021",83.796,1.33e-49,202,216,180.99936,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRF01000022",83.796,1.33e-49,202,216,180.99936,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FNPJ01000004",76.457,6.69e-50,202,429,328.00053,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_FNOE01000002",80.435,2.74e-49,200,276,222.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FKXL01000017",84.286,8.04e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FKWV01000005",84.286,8.04e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FKXF01000023",84.286,8.04e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FNOE01000002",76.64,2.18e-48,198,381,291.9984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_FKXL01000017",73.928,8.13e-49,198,583,431.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_FKWV01000005",73.928,8.13e-49,198,583,431.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_FKXF01000023",73.928,8.13e-49,198,583,431.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FKXL01000017",84.286,8.28e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FKWV01000005",84.286,8.28e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FKXF01000023",84.286,8.28e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FKXL01000017",84.286,7.87e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FKWV01000005",84.286,7.87e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FKXF01000023",84.286,7.87e-49,198,210,177.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FNOE01000002",71.861,1.3e-48,198,924,663.99564,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FNPJ01000004",84.434,1.73e-48,198,212,179.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FKXL01000017",86.932,5.18e-48,196,176,153.00032,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FKWV01000005",86.932,5.18e-48,196,176,153.00032,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FKXF01000023",86.932,5.18e-48,196,176,153.00032,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_315","NZ_FNPJ01000004",80.597,3.47e-48,196,268,215.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FKXL01000017",71.755,4.94e-48,196,963,691.00065,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FKXL01000017",83.886,1.1e-47,195,211,176.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FKWV01000005",83.886,1.1e-47,195,211,176.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FKXF01000023",83.886,1.1e-47,195,211,176.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLWD01000035",84.772,1e-46,193,197,167.00084,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLXP01000026",84.772,1e-46,193,197,167.00084,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLUB01000021",84.772,1e-46,193,197,167.00084,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLTT01000022",84.772,1e-46,193,197,167.00084,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRM01000021",84.772,1e-46,193,197,167.00084,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRF01000022",84.772,1e-46,193,197,167.00084,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_MLWD01000035",81.405,5e-47,193,242,197.0001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_15351","NZ_FNPJ01000004",84.08,3.6e-47,193,201,169.0008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8653","NZ_FNPJ01000004",84.08,3.85e-47,193,201,169.0008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FNOE01000002",83.721,8.03e-47,193,215,180.00015,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_13464","NZ_FNPJ01000004",84.184,4.96e-46,189,196,165.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3519","NZ_FNOE01000002",86.55,5.07e-46,189,171,148.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLWD01000035",82.174,4.36e-46,189,230,189.0002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FNPJ01000004",77.591,7.83e-46,189,357,276.99987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLXP01000026",75.414,2.93e-45,187,423,319.00122,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLUB01000021",75.414,2.93e-45,187,423,319.00122,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLTT01000022",75.414,2.93e-45,187,423,319.00122,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRM01000021",75.414,2.93e-45,187,423,319.00122,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRF01000022",75.414,2.93e-45,187,423,319.00122,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLXP01000026",75.355,6.98e-45,185,422,317.9981,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLUB01000021",75.355,6.98e-45,185,422,317.9981,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLTT01000022",75.355,6.98e-45,185,422,317.9981,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRM01000021",75.355,6.98e-45,185,422,317.9981,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRF01000022",75.355,6.98e-45,185,422,317.9981,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLWD01000035",75.711,3.95e-44,183,387,293.00157,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLXP01000026",75.711,3.95e-44,183,387,293.00157,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLUB01000021",75.711,3.95e-44,183,387,293.00157,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLTT01000022",75.711,3.95e-44,183,387,293.00157,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRM01000021",75.711,3.95e-44,183,387,293.00157,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRF01000022",75.711,3.95e-44,183,387,293.00157,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLWD01000035",77.348,5.59e-44,183,362,279.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXP01000026",77.348,5.59e-44,183,362,279.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLUB01000021",77.348,5.59e-44,183,362,279.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLTT01000022",77.348,5.59e-44,183,362,279.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRM01000021",77.348,5.59e-44,183,362,279.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRF01000022",77.348,5.59e-44,183,362,279.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FKXL01000017",86.364,5.59e-44,183,176,152.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FKWV01000005",86.364,5.59e-44,183,176,152.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FKXF01000023",86.364,5.59e-44,183,176,152.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLWD01000035",74.569,4.67e-44,183,464,346.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLXP01000026",74.569,4.67e-44,183,464,346.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLUB01000021",74.569,4.67e-44,183,464,346.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLTT01000022",74.569,4.67e-44,183,464,346.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRM01000021",74.569,4.67e-44,183,464,346.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRF01000022",74.569,4.67e-44,183,464,346.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_30343","NZ_FNPJ01000004",89.116,2.25e-44,183,147,131.00052,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLWD01000035",84.783,6.34e-44,183,184,156.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLXP01000026",84.783,6.34e-44,183,184,156.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLUB01000021",84.783,6.34e-44,183,184,156.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLTT01000022",84.783,6.34e-44,183,184,156.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRM01000021",84.783,6.34e-44,183,184,156.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRF01000022",84.783,6.34e-44,183,184,156.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLWD01000035",83.575,2.2e-43,182,207,173.00025,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLXP01000026",83.575,2.2e-43,182,207,173.00025,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLUB01000021",83.575,2.2e-43,182,207,173.00025,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLTT01000022",83.575,2.2e-43,182,207,173.00025,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRM01000021",83.575,2.2e-43,182,207,173.00025,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRF01000022",83.575,2.2e-43,182,207,173.00025,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLXP01000026",75.118,1.07e-43,182,422,316.99796,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLUB01000021",75.118,1.07e-43,182,422,316.99796,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLTT01000022",75.118,1.07e-43,182,422,316.99796,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRM01000021",75.118,1.07e-43,182,422,316.99796,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRF01000022",75.118,1.07e-43,182,422,316.99796,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FKXL01000017",82.938,7.93e-44,182,211,174.99918,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FKWV01000005",82.938,7.93e-44,182,211,174.99918,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FKXF01000023",82.938,7.93e-44,182,211,174.99918,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLWD01000035",76.031,1.31e-43,182,388,295.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXP01000026",76.031,1.31e-43,182,388,295.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLUB01000021",76.031,1.31e-43,182,388,295.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLTT01000022",76.031,1.31e-43,182,388,295.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRM01000021",76.031,1.31e-43,182,388,295.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRF01000022",76.031,1.31e-43,182,388,295.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_15027","NZ_FKXL01000017",83.019,3.33e-43,180,212,176.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_15027","NZ_FKWV01000005",83.019,3.33e-43,180,212,176.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_15027","NZ_FKXF01000023",83.019,3.33e-43,180,212,176.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FKXL01000017",88.667,9.56e-43,178,150,133.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FKWV01000005",88.667,9.56e-43,178,150,133.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FKXF01000023",88.667,9.56e-43,178,150,133.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_MLWD01000035",82.464,1.17e-42,178,211,173.99904,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FNOE01000002",75.41,1.13e-42,178,427,322.0007,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLWD01000035",77.183,3.52e-42,176,355,273.99965,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXP01000026",77.183,3.52e-42,176,355,273.99965,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FKXL01000017",86.391,3.52e-42,176,169,146.00079,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FKWV01000005",86.391,3.52e-42,176,169,146.00079,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FKXF01000023",86.391,3.52e-42,176,169,146.00079,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLUB01000021",77.183,3.52e-42,176,355,273.99965,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLTT01000022",77.183,3.52e-42,176,355,273.99965,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRM01000021",77.183,3.52e-42,176,355,273.99965,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRF01000022",77.183,3.52e-42,176,355,273.99965,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLWD01000035",84.916,6.34e-42,176,179,151.99964,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FNOE01000002",82.843,2.16e-41,174,204,168.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLWD01000035",84.831,1.51e-41,174,178,150.99918,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FNOE01000002",93.22,1.41e-41,174,118,109.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FKXL01000017",82.212,1.29e-41,174,208,171.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FKWV01000005",82.212,1.29e-41,174,208,171.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FKXF01000023",82.212,1.29e-41,174,208,171.00096,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FNPJ01000004",84.021,1.3e-40,172,194,163.00074,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4541","NZ_FKXL01000017",80,4.46e-40,171,250,200,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4541","NZ_FKWV01000005",80,4.46e-40,171,250,200,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4541","NZ_FKXF01000023",80,4.46e-40,171,250,200,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_FNOE01000002",81.951,2.34e-40,171,205,167.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_26507","NZ_FNOE01000002",89.209,5.25e-40,171,139,124.00051,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLXP01000026",85.03,2.04e-40,171,167,142.0001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLUB01000021",85.03,2.04e-40,171,167,142.0001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLTT01000022",85.03,2.04e-40,171,167,142.0001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRM01000021",85.03,2.04e-40,171,167,142.0001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRF01000022",85.03,2.04e-40,171,167,142.0001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FNPJ01000004",82.353,1.01e-39,169,204,168.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLWD01000035",84.27,8.36e-40,169,178,150.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_FNOE01000002",92.373,7e-40,169,118,109.00014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FNOE01000002",83.249,6.06e-39,167,197,164.00053,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_MLWD01000035",84.524,2.29e-39,167,168,142.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FNOE01000002",75.13,1.43e-38,165,386,290.0018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_FNOE01000002",82.323,9.14e-39,165,198,162.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_FKXL01000017",73.895,9.2e-39,165,475,351.00125,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_FKWV01000005",73.895,9.2e-39,165,475,351.00125,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_FKXF01000023",73.895,9.2e-39,165,475,351.00125,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FNPJ01000004",83.889,8.26e-38,163,180,151.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FNPJ01000004",77.17,3.04e-38,163,311,239.9987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FNPJ01000004",76.292,1.51e-37,161,329,251.00068,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_MLWD01000035",84.524,1.06e-37,161,168,142.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FNPJ01000004",74.674,6.66e-37,159,383,286.00142,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_MLWD01000035",85.906,1.3e-36,158,149,127.99994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_MLWD01000035",85.714,1.3e-36,158,154,131.99956,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FNOE01000002",83.06,3.84e-36,158,183,151.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_20945","NZ_FNPJ01000004",79.399,1.36e-36,158,233,184.99967,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLWD01000035",83.051,1.41e-36,158,177,147.00027,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FNOE01000002",76.849,1.41e-36,158,311,239.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_5075","NZ_FNPJ01000004",82.011,1.53e-36,158,189,155.00079,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_19981","NZ_FNPJ01000004",84.713,4.42e-36,156,157,132.99941,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FNOE01000002",90.598,4.48e-36,156,117,105.99966,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_26507","NZ_FNPJ01000004",88.636,1.47e-35,156,132,116.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_FNOE01000002",85.906,1.68e-35,154,149,127.99994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_MLWD01000035",73.649,1.98e-35,154,444,327.00156,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXP01000026",84.967,1.83e-35,154,153,129.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLUB01000021",84.967,1.83e-35,154,153,129.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLTT01000022",84.967,1.83e-35,154,153,129.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRM01000021",84.967,1.83e-35,154,153,129.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRF01000022",84.967,1.83e-35,154,153,129.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_FKXL01000017",80.829,5.75e-35,152,193,155.99997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_FKWV01000005",80.829,5.75e-35,152,193,155.99997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_FKXF01000023",80.829,5.75e-35,152,193,155.99997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLXP01000026",87.692,7.65e-35,152,130,113.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLUB01000021",87.692,7.65e-35,152,130,113.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLTT01000022",87.692,7.65e-35,152,130,113.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRM01000021",87.692,7.65e-35,152,130,113.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRF01000022",87.692,7.65e-35,152,130,113.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FNOE01000002",76.527,5.7e-35,152,311,237.99897,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLWD01000035",83.436,2.12e-34,150,163,136.00068,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FNOE01000002",91.667,2.35e-34,150,108,99.00036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_5878","NZ_FNPJ01000004",88,7.37e-34,148,125,110,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXP01000026",84.314,7.62e-34,148,153,129.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLUB01000021",84.314,7.62e-34,148,153,129.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLTT01000022",84.314,7.62e-34,148,153,129.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRM01000021",84.314,7.62e-34,148,153,129.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRF01000022",84.314,7.62e-34,148,153,129.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_FNOE01000002",84.868,8.29e-34,148,152,128.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_FKXL01000017",75.633,8.16e-34,148,316,239.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_FKWV01000005",75.633,8.16e-34,148,316,239.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_FKXF01000023",75.633,8.16e-34,148,316,239.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLWD01000035",76.38,8.5e-34,148,326,248.9988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXP01000026",76.38,8.5e-34,148,326,248.9988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLUB01000021",76.38,8.5e-34,148,326,248.9988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLTT01000022",76.38,8.5e-34,148,326,248.9988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRM01000021",76.38,8.5e-34,148,326,248.9988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRF01000022",76.38,8.5e-34,148,326,248.9988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_7569","NZ_FNPJ01000004",86.567,5.89e-33,147,134,115.99978,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_20945","NZ_FNOE01000002",79.091,2.94e-33,147,220,174.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_FKXL01000017",76.115,1.08e-32,145,314,239.0011,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_FKWV01000005",76.115,1.08e-32,145,314,239.0011,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_FKXF01000023",76.115,1.08e-32,145,314,239.0011,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_36658","NZ_FNPJ01000004",81.215,3.41e-32,143,181,146.99915,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_2901","NZ_FNPJ01000004",81.215,3.75e-32,143,181,146.99915,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_36658","NZ_FNOE01000002",81.25,1.23e-31,141,176,143,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_5878","NZ_FNOE01000002",86.614,1.23e-31,141,127,109.99978,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_2901","NZ_FNOE01000002",81.25,1.35e-31,141,176,143,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_7569","NZ_FNOE01000002",85.401,2.74e-31,141,137,116.99937,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLWD01000035",89.474,1.3e-31,141,114,102.00036,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLXP01000026",89.474,1.3e-31,141,114,102.00036,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLUB01000021",89.474,1.3e-31,141,114,102.00036,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLTT01000022",89.474,1.3e-31,141,114,102.00036,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRM01000021",89.474,1.3e-31,141,114,102.00036,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRF01000022",89.474,1.3e-31,141,114,102.00036,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLWD01000035",83.784,1.66e-31,141,148,124.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXP01000026",83.784,1.66e-31,141,148,124.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLUB01000021",83.784,1.66e-31,141,148,124.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLTT01000022",83.784,1.66e-31,141,148,124.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRM01000021",83.784,1.66e-31,141,148,124.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRF01000022",83.784,1.66e-31,141,148,124.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FNPJ01000004",85.401,1.23e-31,141,137,116.99937,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_FNOE01000002",85.106,4.73e-31,139,141,119.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_19981","NZ_FNOE01000002",82.803,4.45e-31,139,157,130.00071,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_28059","NZ_FNPJ01000004",88.136,5.44e-31,139,118,104.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FNPJ01000004",75.908,1.63e-30,137,303,230.00124,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FNOE01000002",75.987,1.63e-30,137,304,231.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLXP01000026",74.438,1.81e-30,137,356,264.99928,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLUB01000021",74.438,1.81e-30,137,356,264.99928,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLTT01000022",74.438,1.81e-30,137,356,264.99928,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRM01000021",74.438,1.81e-30,137,356,264.99928,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRF01000022",74.438,1.81e-30,137,356,264.99928,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXP01000026",74.51,2.88e-30,137,357,266.0007,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLUB01000021",74.51,2.88e-30,137,357,266.0007,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLTT01000022",74.51,2.88e-30,137,357,266.0007,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRM01000021",74.51,2.88e-30,137,357,266.0007,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRF01000022",74.51,2.88e-30,137,357,266.0007,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLWD01000035",77.108,2.07e-29,134,249,191.99892,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLXP01000026",77.108,2.07e-29,134,249,191.99892,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLUB01000021",77.108,2.07e-29,134,249,191.99892,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLTT01000022",77.108,2.07e-29,134,249,191.99892,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRM01000021",77.108,2.07e-29,134,249,191.99892,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRF01000022",77.108,2.07e-29,134,249,191.99892,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FNPJ01000004",90.722,6.17e-28,130,97,88.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FNOE01000002",90.722,6.17e-28,130,97,88.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLWD01000035",87.5,3.91e-27,126,112,98,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLWD01000035",88.571,3.63e-27,126,105,92.99955,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLXP01000026",88.571,3.63e-27,126,105,92.99955,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLUB01000021",88.571,3.63e-27,126,105,92.99955,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLTT01000022",88.571,3.63e-27,126,105,92.99955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRM01000021",88.571,3.63e-27,126,105,92.99955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRF01000022",88.571,3.63e-27,126,105,92.99955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLWD01000035",87.5,6.22e-27,126,112,98,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLWD01000035",87.85,3.45e-27,126,107,93.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXP01000026",87.85,3.45e-27,126,107,93.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLUB01000021",87.85,3.45e-27,126,107,93.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLTT01000022",87.85,3.45e-27,126,107,93.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRM01000021",87.85,3.45e-27,126,107,93.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRF01000022",87.85,3.45e-27,126,107,93.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLXP01000026",73.926,1.25e-26,124,349,258.00174,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLUB01000021",73.926,1.25e-26,124,349,258.00174,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLTT01000022",73.926,1.25e-26,124,349,258.00174,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRM01000021",73.926,1.25e-26,124,349,258.00174,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRF01000022",73.926,1.25e-26,124,349,258.00174,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8815","NZ_FKXL01000017",87.736,1.48e-26,124,106,93.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8815","NZ_FKWV01000005",87.736,1.48e-26,124,106,93.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8815","NZ_FKXF01000023",87.736,1.48e-26,124,106,93.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLWD01000035",75.155,1.24e-26,124,322,241.9991,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXP01000026",75.155,1.24e-26,124,322,241.9991,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLUB01000021",75.155,1.24e-26,124,322,241.9991,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLTT01000022",75.155,1.24e-26,124,322,241.9991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRM01000021",75.155,1.24e-26,124,322,241.9991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRF01000022",75.155,1.24e-26,124,322,241.9991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FKXL01000017",86.726,2.09e-25,121,113,98.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FKWV01000005",86.726,2.09e-25,121,113,98.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FKXF01000023",86.726,2.09e-25,121,113,98.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLWD01000035",85.841,1.64e-25,121,113,97.00033,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXP01000026",85.841,1.64e-25,121,113,97.00033,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLUB01000021",85.841,1.64e-25,121,113,97.00033,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLTT01000022",85.841,1.64e-25,121,113,97.00033,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRM01000021",85.841,1.64e-25,121,113,97.00033,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRF01000022",85.841,1.64e-25,121,113,97.00033,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLWD01000035",89.474,1.83e-25,121,95,85.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLXP01000026",89.474,1.83e-25,121,95,85.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLUB01000021",89.474,1.83e-25,121,95,85.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLTT01000022",89.474,1.83e-25,121,95,85.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRM01000021",89.474,1.83e-25,121,95,85.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRF01000022",89.474,1.83e-25,121,95,85.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLWD01000035",85.841,1.66e-25,121,113,97.00033,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXP01000026",85.841,1.66e-25,121,113,97.00033,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLUB01000021",85.841,1.66e-25,121,113,97.00033,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLTT01000022",85.841,1.66e-25,121,113,97.00033,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRM01000021",85.841,1.66e-25,121,113,97.00033,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRF01000022",85.841,1.66e-25,121,113,97.00033,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLXP01000026",91.86,1.99e-25,121,86,78.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLUB01000021",91.86,1.99e-25,121,86,78.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLTT01000022",91.86,1.99e-25,121,86,78.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRM01000021",91.86,1.99e-25,121,86,78.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRF01000022",91.86,1.99e-25,121,86,78.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_FNOE01000002",93.671,6.12e-25,119,79,74.00009,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_MLWD01000035",86.667,2.46e-24,117,105,91.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FKXL01000017",86.486,2.09e-24,117,111,95.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FKWV01000005",86.486,2.09e-24,117,111,95.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FKXF01000023",86.486,2.09e-24,117,111,95.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLWD01000035",87.879,1.16e-23,115,99,87.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLXP01000026",87.879,1.16e-23,115,99,87.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLUB01000021",87.879,1.16e-23,115,99,87.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLTT01000022",87.879,1.16e-23,115,99,87.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRM01000021",87.879,1.16e-23,115,99,87.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRF01000022",87.879,1.16e-23,115,99,87.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLWD01000035",86.538,1.97e-23,115,104,89.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLXP01000026",86.538,1.97e-23,115,104,89.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLUB01000021",86.538,1.97e-23,115,104,89.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLTT01000022",86.538,1.97e-23,115,104,89.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRM01000021",86.538,1.97e-23,115,104,89.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRF01000022",86.538,1.97e-23,115,104,89.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15963","NZ_FNPJ01000004",88.421,9.77e-24,115,95,83.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_FNOE01000002",71.882,1.43e-23,115,441,316.99962,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLWD01000035",86.538,9.95e-24,115,104,89.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLXP01000026",86.538,9.95e-24,115,104,89.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLUB01000021",86.538,9.95e-24,115,104,89.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLTT01000022",86.538,9.95e-24,115,104,89.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRM01000021",86.538,9.95e-24,115,104,89.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRF01000022",86.538,9.95e-24,115,104,89.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_FNPJ01000004",75.655,7.1e-23,113,267,201.99885,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLWD01000035",86.667,2.71e-23,113,105,91.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_35451","NZ_FNPJ01000004",81.618,9.75e-23,111,136,111.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FNPJ01000004",75.194,1.29e-21,108,258,194.00052,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_16426","NZ_FKXL01000017",81.481,1.41e-21,108,135,109.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_16426","NZ_FKWV01000005",81.481,1.41e-21,108,135,109.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_16426","NZ_FKXF01000023",81.481,1.41e-21,108,135,109.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_FNOE01000002",72.527,6.99e-21,106,364,263.99828,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_6886","NZ_FNPJ01000004",83.333,4.7e-21,106,120,99.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_MLWD01000035",85.047,4.51e-21,106,107,91.00029,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15963","NZ_FNOE01000002",86.316,2.12e-20,104,95,82.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_15183","NZ_FKXL01000017",87.64,8.17e-20,102,89,77.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_15183","NZ_FKWV01000005",87.64,8.17e-20,102,89,77.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_15183","NZ_FKXF01000023",87.64,8.17e-20,102,89,77.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLWD01000035",86.813,6.07e-20,102,91,78.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXP01000026",86.813,6.07e-20,102,91,78.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLUB01000021",86.813,6.07e-20,102,91,78.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLTT01000022",86.813,6.07e-20,102,91,78.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRM01000021",86.813,6.07e-20,102,91,78.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRF01000022",86.813,6.07e-20,102,91,78.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FNOE01000002",74.903,6.02e-20,102,259,193.99877,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_1474","NZ_FKXL01000017",93.939,3.88e-19,100,66,61.99974,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_2753","NZ_FKXL01000017",93.939,2.13e-19,100,66,61.99974,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9743","NZ_FKXL01000017",93.939,2.96e-19,100,66,61.99974,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4290","NZ_FNPJ01000004",90.667,2.24e-19,100,75,68.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4290","NZ_FNOE01000002",83.784,2.24e-19,100,111,93.00024,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_14187","NZ_FNPJ01000004",89.744,1.02e-18,99,78,70.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_18974","NZ_FKXL01000017",81.301,1.14e-18,99,123,100.00023,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_18974","NZ_FKWV01000005",81.301,1.14e-18,99,123,100.00023,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_18974","NZ_FKXF01000023",81.301,1.14e-18,99,123,100.00023,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLWD01000035",85.714,2.76e-18,97.1,91,77.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXP01000026",85.714,2.76e-18,97.1,91,77.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLUB01000021",85.714,2.76e-18,97.1,91,77.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLTT01000022",85.714,2.76e-18,97.1,91,77.99974,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRM01000021",85.714,2.76e-18,97.1,91,77.99974,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRF01000022",85.714,2.76e-18,97.1,91,77.99974,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLWD01000035",84.694,3.05e-18,97.1,98,83.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLXP01000026",84.694,3.05e-18,97.1,98,83.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLUB01000021",84.694,3.05e-18,97.1,98,83.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLTT01000022",84.694,3.05e-18,97.1,98,83.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRM01000021",84.694,3.05e-18,97.1,98,83.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRF01000022",84.694,3.05e-18,97.1,98,83.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_10058","NZ_FNOE01000002",75.362,1.07e-17,95.3,207,155.99934,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_6386","NZ_FKXL01000017",85.263,1.1e-17,95.3,95,80.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_6386","NZ_FKWV01000005",85.263,1.1e-17,95.3,95,80.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_6386","NZ_FKXF01000023",85.263,1.1e-17,95.3,95,80.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLXP01000026",92.424,1.27e-17,95.3,66,60.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLUB01000021",92.424,1.27e-17,95.3,66,60.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLTT01000022",92.424,1.27e-17,95.3,66,60.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRM01000021",92.424,1.27e-17,95.3,66,60.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRF01000022",92.424,1.27e-17,95.3,66,60.99984,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_FNPJ01000004",74.427,1.3e-17,95.3,262,194.99874,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_5717","NZ_FKXL01000017",92.424,1.07e-17,95.3,66,60.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_FNOE01000002",82.692,1.49e-16,91.6,104,85.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_FNOE01000002",85.393,1.2e-15,89.8,89,75.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FNOE01000002",94.737,5.88e-16,89.8,57,54.00009,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_FNOE01000002",83.505,5.87e-15,86.1,97,80.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_FNOE01000002",78.333,4.69e-12,76.8,120,93.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_9342","NZ_FKXL01000017",92.308,1.38e-11,75,52,48.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLXP01000026",92.308,1.46e-11,75,52,48.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLUB01000021",92.308,1.46e-11,75,52,48.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLTT01000022",92.308,1.46e-11,75,52,48.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRM01000021",92.308,1.46e-11,75,52,48.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRF01000022",92.308,1.46e-11,75,52,48.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLXP01000026",93.478,5.93e-10,69.4,46,42.99988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLUB01000021",93.478,5.93e-10,69.4,46,42.99988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLTT01000022",93.478,5.93e-10,69.4,46,42.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRM01000021",93.478,5.93e-10,69.4,46,42.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRF01000022",93.478,5.93e-10,69.4,46,42.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15774","NZ_FKWV01000005",83.099,2.79e-08,63.9,71,59.00029,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15774","NZ_FKXF01000023",83.099,2.79e-08,63.9,71,59.00029,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_FKXL01000017",85.965,1.35e-06,58.4,57,49.00005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_FKWV01000005",85.965,1.35e-06,58.4,57,49.00005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_FKXF01000023",85.965,1.35e-06,58.4,57,49.00005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_JBGJJV010000032",97.332,0,1587,937,912.00084,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FLCN01000004",96.692,0,1552,937,906.00404,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FLBN01000099",96.585,0,1546,937,905.00145,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_FLBI01000046",96.371,0,1535,937,902.99627,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRC01000027",95.309,0,1482,938,893.99842,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRI01000021",95.203,0,1476,938,893.00414,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRO01000021",95.203,0,1476,938,893.00414,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLXR01000021",95.203,0,1476,938,893.00414,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRG01000021",95.203,0,1476,938,893.00414,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLYG01000019",95.203,0,1476,938,893.00414,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRJ01000019",95.203,0,1476,938,893.00414,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLSM01000018",95.203,0,1476,938,893.00414,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLSQ01000022",95.203,0,1476,938,893.00414,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLXY01000024",95.203,0,1476,938,893.00414,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLXS01000025",95.203,0,1476,938,893.00414,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLUD01000021",95.203,0,1476,938,893.00414,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLYZ01000021",95.203,0,1476,938,893.00414,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLSP01000022",95.203,0,1476,938,893.00414,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLSH01000020",95.203,0,1476,938,893.00414,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLYY01000023",95.203,0,1476,938,893.00414,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLYC01000020",95.203,0,1476,938,893.00414,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLXZ01000020",95.203,0,1476,938,893.00414,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_JBGJJV010000032",99.317,0,1059,586,581.99762,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRI01000021",98.311,0,1038,592,582.00112,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRO01000021",98.311,0,1038,592,582.00112,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLXR01000021",98.311,0,1038,592,582.00112,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRG01000021",98.311,0,1038,592,582.00112,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLYG01000019",98.311,0,1038,592,582.00112,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRJ01000019",98.311,0,1038,592,582.00112,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLSM01000018",98.311,0,1038,592,582.00112,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLSQ01000022",98.311,0,1038,592,582.00112,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLXY01000024",98.311,0,1038,592,582.00112,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLXS01000025",98.311,0,1038,592,582.00112,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLUD01000021",98.311,0,1038,592,582.00112,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRC01000027",98.311,0,1038,592,582.00112,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLYZ01000021",98.311,0,1038,592,582.00112,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLSP01000022",98.311,0,1038,592,582.00112,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLSH01000020",98.311,0,1038,592,582.00112,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLYY01000023",98.311,0,1038,592,582.00112,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLYC01000020",98.311,0,1038,592,582.00112,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLXZ01000020",98.311,0,1038,592,582.00112,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRZ01000037",98.142,0,1033,592,581.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLWB01000035",98.142,0,1033,592,581.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLZF01000029",98.142,0,1033,592,581.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLRE01000049",97.973,0,1027,592,580.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_JBGJJV010000032",97.466,0,1011,592,576.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FLBI01000046",96.959,0,994,592,573.99728,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLWB01000035",97.27,0,994,586,570.0022,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLZF01000029",97.27,0,994,586,570.0022,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_JBGJJV010000032",98.571,0,990,560,551.9976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FLBN01000099",96.791,0,989,592,573.00272,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_FLCN01000004",96.791,0,989,592,573.00272,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_JBGJJV010000032",100,0,979,530,530,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRZ01000037",96.758,0,977,586,567.00188,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_FLCN01000004",97.679,0,963,560,547.0024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_FLBI01000046",97.5,0,957,560,546,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_FLBN01000099",97.5,0,957,560,546,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRI01000021",98.868,0,946,530,524.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRZ01000037",98.868,0,946,530,524.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRO01000021",98.868,0,946,530,524.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLXR01000021",98.868,0,946,530,524.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRG01000021",98.868,0,946,530,524.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLYG01000019",98.868,0,946,530,524.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRJ01000019",98.868,0,946,530,524.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLSM01000018",98.868,0,946,530,524.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLSQ01000022",98.868,0,946,530,524.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLXY01000024",98.868,0,946,530,524.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLXS01000025",98.868,0,946,530,524.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLWB01000035",98.868,0,946,530,524.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLUD01000021",98.868,0,946,530,524.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRC01000027",98.868,0,946,530,524.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLYZ01000021",98.868,0,946,530,524.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLSP01000022",98.868,0,946,530,524.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLZF01000029",98.868,0,946,530,524.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLSH01000020",98.868,0,946,530,524.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLYY01000023",98.868,0,946,530,524.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLYC01000020",98.868,0,946,530,524.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLXZ01000020",98.868,0,946,530,524.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FLBI01000046",98.679,0,941,530,522.9987,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FLBN01000099",98.491,0,935,530,522.0023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_FLCN01000004",98.491,0,935,530,522.0023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRI01000021",95.745,0,904,564,540.0018,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRO01000021",95.745,0,904,564,540.0018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLXR01000021",95.745,0,904,564,540.0018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRG01000021",95.745,0,904,564,540.0018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLYG01000019",95.745,0,904,564,540.0018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRJ01000019",95.745,0,904,564,540.0018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLSM01000018",95.745,0,904,564,540.0018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLSQ01000022",95.745,0,904,564,540.0018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLXY01000024",95.745,0,904,564,540.0018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLXS01000025",95.745,0,904,564,540.0018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLUD01000021",95.745,0,904,564,540.0018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRC01000027",95.745,0,904,564,540.0018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLYZ01000021",95.745,0,904,564,540.0018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLSP01000022",95.745,0,904,564,540.0018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLSH01000020",95.745,0,904,564,540.0018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLYY01000023",95.745,0,904,564,540.0018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLYC01000020",95.745,0,904,564,540.0018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLXZ01000020",95.745,0,904,564,540.0018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRE01000049",95.567,0,898,564,538.99788,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLRZ01000037",95.567,0,898,564,538.99788,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLWB01000035",95.567,0,898,564,538.99788,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLZF01000029",95.567,0,898,564,538.99788,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLRE01000049",98.869,0,789,442,437.00098,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_JAUEGY010000142",98.408,1.59e-155,553,314,309.00112,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FLBI01000046",98.824,1.11e-34,152,85,84.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FLBN01000099",98.824,1.11e-34,152,85,84.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRI01000021",98.824,1.11e-34,152,85,84.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRE01000049",98.824,1.11e-34,152,85,84.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_FLCN01000004",98.824,1.11e-34,152,85,84.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRZ01000037",98.824,1.11e-34,152,85,84.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRO01000021",98.824,1.11e-34,152,85,84.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLXR01000021",98.824,1.11e-34,152,85,84.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRG01000021",98.824,1.11e-34,152,85,84.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLYG01000019",98.824,1.11e-34,152,85,84.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRJ01000019",98.824,1.11e-34,152,85,84.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLSM01000018",98.824,1.11e-34,152,85,84.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLSQ01000022",98.824,1.11e-34,152,85,84.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLXY01000024",98.824,1.11e-34,152,85,84.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLXS01000025",98.824,1.11e-34,152,85,84.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLWB01000035",98.824,1.11e-34,152,85,84.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLUD01000021",98.824,1.11e-34,152,85,84.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLRC01000027",98.824,1.11e-34,152,85,84.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLYZ01000021",98.824,1.11e-34,152,85,84.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLSP01000022",98.824,1.11e-34,152,85,84.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLZF01000029",98.824,1.11e-34,152,85,84.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLSH01000020",98.824,1.11e-34,152,85,84.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLYY01000023",98.824,1.11e-34,152,85,84.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLYC01000020",98.824,1.11e-34,152,85,84.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLXZ01000020",98.824,1.11e-34,152,85,84.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_JBGJJV010000032",98.824,1.11e-34,152,85,84.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FLBI01000046",98.148,1.17e-17,95.3,54,52.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FLBN01000099",98.148,1.17e-17,95.3,54,52.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FLCN01000004",98.148,1.17e-17,95.3,54,52.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_JBGJJV010000032",98.148,1.17e-17,95.3,54,52.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRI01000021",96.154,7.03e-15,86.1,52,50.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRE01000049",96.154,7.03e-15,86.1,52,50.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRZ01000037",96.154,7.03e-15,86.1,52,50.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRO01000021",96.154,7.03e-15,86.1,52,50.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXR01000021",96.154,7.03e-15,86.1,52,50.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRG01000021",96.154,7.03e-15,86.1,52,50.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYG01000019",96.154,7.03e-15,86.1,52,50.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRJ01000019",96.154,7.03e-15,86.1,52,50.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSM01000018",96.154,7.03e-15,86.1,52,50.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSQ01000022",96.154,7.03e-15,86.1,52,50.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXY01000024",96.154,7.03e-15,86.1,52,50.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXS01000025",96.154,7.03e-15,86.1,52,50.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLWB01000035",96.154,7.03e-15,86.1,52,50.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLUD01000021",96.154,7.03e-15,86.1,52,50.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRC01000027",96.154,7.03e-15,86.1,52,50.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYZ01000021",96.154,7.03e-15,86.1,52,50.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSP01000022",96.154,7.03e-15,86.1,52,50.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLZF01000029",96.154,7.03e-15,86.1,52,50.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSH01000020",96.154,7.03e-15,86.1,52,50.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYY01000023",96.154,7.03e-15,86.1,52,50.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYC01000020",96.154,7.03e-15,86.1,52,50.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXZ01000020",96.154,7.03e-15,86.1,52,50.00008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRI01000021",95.652,1.47e-11,75,46,43.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRO01000021",95.652,1.47e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLXR01000021",95.652,1.47e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRG01000021",95.652,1.47e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLYG01000019",95.652,1.47e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRJ01000019",95.652,1.47e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLSM01000018",95.652,1.47e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLSQ01000022",95.652,1.47e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLXY01000024",95.652,1.47e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLXS01000025",95.652,1.47e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLUD01000021",95.652,1.47e-11,75,46,43.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRC01000027",95.652,1.47e-11,75,46,43.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLYZ01000021",95.652,1.47e-11,75,46,43.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLSP01000022",95.652,1.47e-11,75,46,43.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLSH01000020",95.652,1.47e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLYY01000023",95.652,1.47e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLYC01000020",95.652,1.47e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLXZ01000020",95.652,1.47e-11,75,46,43.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRI01000021",95.652,1.45e-11,75,46,43.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRO01000021",95.652,1.45e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLXR01000021",95.652,1.45e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRG01000021",95.652,1.45e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLYG01000019",95.652,1.45e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRJ01000019",95.652,1.45e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLSM01000018",95.652,1.45e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLSQ01000022",95.652,1.45e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLXY01000024",95.652,1.45e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLXS01000025",95.652,1.45e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLUD01000021",95.652,1.45e-11,75,46,43.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRC01000027",95.652,1.45e-11,75,46,43.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLYZ01000021",95.652,1.45e-11,75,46,43.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLSP01000022",95.652,1.45e-11,75,46,43.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLSH01000020",95.652,1.45e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLYY01000023",95.652,1.45e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLYC01000020",95.652,1.45e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLXZ01000020",95.652,1.45e-11,75,46,43.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRI01000021",95.652,1.34e-11,75,46,43.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRO01000021",95.652,1.34e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLXR01000021",95.652,1.34e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRG01000021",95.652,1.34e-11,75,46,43.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLYG01000019",95.652,1.34e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRJ01000019",95.652,1.34e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLSM01000018",95.652,1.34e-11,75,46,43.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLSQ01000022",95.652,1.34e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLXY01000024",95.652,1.34e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLXS01000025",95.652,1.34e-11,75,46,43.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLUD01000021",95.652,1.34e-11,75,46,43.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRC01000027",95.652,1.34e-11,75,46,43.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLYZ01000021",95.652,1.34e-11,75,46,43.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLSP01000022",95.652,1.34e-11,75,46,43.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLSH01000020",95.652,1.34e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLYY01000023",95.652,1.34e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLYC01000020",95.652,1.34e-11,75,46,43.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLXZ01000020",95.652,1.34e-11,75,46,43.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRI01000021",100,6.44e-10,69.4,37,37,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRO01000021",100,6.44e-10,69.4,37,37,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLXR01000021",100,6.44e-10,69.4,37,37,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRG01000021",100,6.44e-10,69.4,37,37,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLYG01000019",100,6.44e-10,69.4,37,37,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRJ01000019",100,6.44e-10,69.4,37,37,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLSM01000018",100,6.44e-10,69.4,37,37,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLSQ01000022",100,6.44e-10,69.4,37,37,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLXY01000024",100,6.44e-10,69.4,37,37,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLXS01000025",100,6.44e-10,69.4,37,37,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLUD01000021",100,6.44e-10,69.4,37,37,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRC01000027",100,6.44e-10,69.4,37,37,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLYZ01000021",100,6.44e-10,69.4,37,37,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLSP01000022",100,6.44e-10,69.4,37,37,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLSH01000020",100,6.44e-10,69.4,37,37,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLYY01000023",100,6.44e-10,69.4,37,37,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLYC01000020",100,6.44e-10,69.4,37,37,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLXZ01000020",100,6.44e-10,69.4,37,37,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRI01000021",100,2.36e-09,67.6,36,36,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRO01000021",100,2.36e-09,67.6,36,36,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLXR01000021",100,2.36e-09,67.6,36,36,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRG01000021",100,2.36e-09,67.6,36,36,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLYG01000019",100,2.36e-09,67.6,36,36,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRJ01000019",100,2.36e-09,67.6,36,36,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLSM01000018",100,2.36e-09,67.6,36,36,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLSQ01000022",100,2.36e-09,67.6,36,36,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLXY01000024",100,2.36e-09,67.6,36,36,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLXS01000025",100,2.36e-09,67.6,36,36,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLUD01000021",100,2.36e-09,67.6,36,36,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRC01000027",100,2.36e-09,67.6,36,36,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLYZ01000021",100,2.36e-09,67.6,36,36,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLSP01000022",100,2.36e-09,67.6,36,36,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLSH01000020",100,2.36e-09,67.6,36,36,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLYY01000023",100,2.36e-09,67.6,36,36,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLYC01000020",100,2.36e-09,67.6,36,36,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLXZ01000020",100,2.36e-09,67.6,36,36,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRI01000021",100,2.36e-09,67.6,36,36,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRO01000021",100,2.36e-09,67.6,36,36,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLXR01000021",100,2.36e-09,67.6,36,36,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRG01000021",100,2.36e-09,67.6,36,36,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLYG01000019",100,2.36e-09,67.6,36,36,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRJ01000019",100,2.36e-09,67.6,36,36,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLSM01000018",100,2.36e-09,67.6,36,36,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLSQ01000022",100,2.36e-09,67.6,36,36,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLXY01000024",100,2.36e-09,67.6,36,36,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLXS01000025",100,2.36e-09,67.6,36,36,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLUD01000021",100,2.36e-09,67.6,36,36,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRC01000027",100,2.36e-09,67.6,36,36,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLYZ01000021",100,2.36e-09,67.6,36,36,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLSP01000022",100,2.36e-09,67.6,36,36,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLSH01000020",100,2.36e-09,67.6,36,36,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLYY01000023",100,2.36e-09,67.6,36,36,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLYC01000020",100,2.36e-09,67.6,36,36,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLXZ01000020",100,2.36e-09,67.6,36,36,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_FLBI01000046",97.436,4.06e-09,67.6,39,38.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_FLBN01000099",97.436,4.06e-09,67.6,39,38.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRI01000021",97.436,4.06e-09,67.6,39,38.00004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRE01000049",97.436,4.06e-09,67.6,39,38.00004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_FLCN01000004",97.436,4.06e-09,67.6,39,38.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRZ01000037",97.436,4.06e-09,67.6,39,38.00004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRO01000021",97.436,4.06e-09,67.6,39,38.00004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLXR01000021",97.436,4.06e-09,67.6,39,38.00004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRG01000021",97.436,4.06e-09,67.6,39,38.00004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLYG01000019",97.436,4.06e-09,67.6,39,38.00004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRJ01000019",97.436,4.06e-09,67.6,39,38.00004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLSM01000018",97.436,4.06e-09,67.6,39,38.00004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLSQ01000022",97.436,4.06e-09,67.6,39,38.00004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLXY01000024",97.436,4.06e-09,67.6,39,38.00004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLXS01000025",97.436,4.06e-09,67.6,39,38.00004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLWB01000035",97.436,4.06e-09,67.6,39,38.00004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLUD01000021",97.436,4.06e-09,67.6,39,38.00004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLRC01000027",97.436,4.06e-09,67.6,39,38.00004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLYZ01000021",97.436,4.06e-09,67.6,39,38.00004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLSP01000022",97.436,4.06e-09,67.6,39,38.00004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLZF01000029",97.436,4.06e-09,67.6,39,38.00004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLSH01000020",97.436,4.06e-09,67.6,39,38.00004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLYY01000023",97.436,4.06e-09,67.6,39,38.00004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLYC01000020",97.436,4.06e-09,67.6,39,38.00004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLXZ01000020",97.436,4.06e-09,67.6,39,38.00004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_JBGJJV010000032",97.436,4.06e-09,67.6,39,38.00004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRI01000021",100,8.09e-09,65.8,35,35,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRO01000021",100,8.09e-09,65.8,35,35,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLXR01000021",100,8.09e-09,65.8,35,35,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRG01000021",100,8.09e-09,65.8,35,35,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLYG01000019",100,8.09e-09,65.8,35,35,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRJ01000019",100,8.09e-09,65.8,35,35,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLSM01000018",100,8.09e-09,65.8,35,35,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLSQ01000022",100,8.09e-09,65.8,35,35,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLXY01000024",100,8.09e-09,65.8,35,35,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLXS01000025",100,8.09e-09,65.8,35,35,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLUD01000021",100,8.09e-09,65.8,35,35,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRC01000027",100,8.09e-09,65.8,35,35,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLYZ01000021",100,8.09e-09,65.8,35,35,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLSP01000022",100,8.09e-09,65.8,35,35,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLSH01000020",100,8.09e-09,65.8,35,35,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLYY01000023",100,8.09e-09,65.8,35,35,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLYC01000020",100,8.09e-09,65.8,35,35,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLXZ01000020",100,8.09e-09,65.8,35,35,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRI01000021",100,3.23e-08,63.9,34,34,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRO01000021",100,3.23e-08,63.9,34,34,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLXR01000021",100,3.23e-08,63.9,34,34,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRG01000021",100,3.23e-08,63.9,34,34,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLYG01000019",100,3.23e-08,63.9,34,34,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRJ01000019",100,3.23e-08,63.9,34,34,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLSM01000018",100,3.23e-08,63.9,34,34,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLSQ01000022",100,3.23e-08,63.9,34,34,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLXY01000024",100,3.23e-08,63.9,34,34,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLXS01000025",100,3.23e-08,63.9,34,34,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLUD01000021",100,3.23e-08,63.9,34,34,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLRC01000027",100,3.23e-08,63.9,34,34,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLYZ01000021",100,3.23e-08,63.9,34,34,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLSP01000022",100,3.23e-08,63.9,34,34,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLSH01000020",100,3.23e-08,63.9,34,34,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLYY01000023",100,3.23e-08,63.9,34,34,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLYC01000020",100,3.23e-08,63.9,34,34,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLXZ01000020",100,3.23e-08,63.9,34,34,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_FLBI01000046",97.222,1.13e-07,62.1,36,34.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_FLBN01000099",97.222,1.13e-07,62.1,36,34.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRI01000021",97.222,1.13e-07,62.1,36,34.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRE01000049",97.222,1.13e-07,62.1,36,34.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_FLCN01000004",97.222,1.13e-07,62.1,36,34.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRZ01000037",97.222,1.13e-07,62.1,36,34.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRO01000021",97.222,1.13e-07,62.1,36,34.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLXR01000021",97.222,1.13e-07,62.1,36,34.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRG01000021",97.222,1.13e-07,62.1,36,34.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLYG01000019",97.222,1.13e-07,62.1,36,34.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRJ01000019",97.222,1.13e-07,62.1,36,34.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLSM01000018",97.222,1.13e-07,62.1,36,34.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLSQ01000022",97.222,1.13e-07,62.1,36,34.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLXY01000024",97.222,1.13e-07,62.1,36,34.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLXS01000025",97.222,1.13e-07,62.1,36,34.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLWB01000035",97.222,1.13e-07,62.1,36,34.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLUD01000021",97.222,1.13e-07,62.1,36,34.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLRC01000027",97.222,1.13e-07,62.1,36,34.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLYZ01000021",97.222,1.13e-07,62.1,36,34.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLSP01000022",97.222,1.13e-07,62.1,36,34.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLZF01000029",97.222,1.13e-07,62.1,36,34.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLSH01000020",97.222,1.13e-07,62.1,36,34.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLYY01000023",97.222,1.13e-07,62.1,36,34.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLYC01000020",97.222,1.13e-07,62.1,36,34.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLXZ01000020",97.222,1.13e-07,62.1,36,34.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_JBGJJV010000032",97.222,1.13e-07,62.1,36,34.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_FLBI01000046",97.222,1.33e-07,62.1,36,34.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_FLBN01000099",97.222,1.33e-07,62.1,36,34.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRI01000021",97.222,1.33e-07,62.1,36,34.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRE01000049",97.222,1.33e-07,62.1,36,34.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_FLCN01000004",97.222,1.33e-07,62.1,36,34.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRZ01000037",97.222,1.33e-07,62.1,36,34.99992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRO01000021",97.222,1.33e-07,62.1,36,34.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLXR01000021",97.222,1.33e-07,62.1,36,34.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRG01000021",97.222,1.33e-07,62.1,36,34.99992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLYG01000019",97.222,1.33e-07,62.1,36,34.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRJ01000019",97.222,1.33e-07,62.1,36,34.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLSM01000018",97.222,1.33e-07,62.1,36,34.99992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLSQ01000022",97.222,1.33e-07,62.1,36,34.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLXY01000024",97.222,1.33e-07,62.1,36,34.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLXS01000025",97.222,1.33e-07,62.1,36,34.99992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLWB01000035",97.222,1.33e-07,62.1,36,34.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLUD01000021",97.222,1.33e-07,62.1,36,34.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLRC01000027",97.222,1.33e-07,62.1,36,34.99992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLYZ01000021",97.222,1.33e-07,62.1,36,34.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLSP01000022",97.222,1.33e-07,62.1,36,34.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLZF01000029",97.222,1.33e-07,62.1,36,34.99992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLSH01000020",97.222,1.33e-07,62.1,36,34.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLYY01000023",97.222,1.33e-07,62.1,36,34.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLYC01000020",97.222,1.33e-07,62.1,36,34.99992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLXZ01000020",97.222,1.33e-07,62.1,36,34.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_JBGJJV010000032",97.222,1.33e-07,62.1,36,34.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_JBGJJV010000032",86.561,0,1565,1451,1256.00011,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FLBI01000046",86.492,0,1557,1451,1254.99892,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FLBN01000099",86.511,0,1557,1453,1257.00483,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_FLCN01000004",86.511,0,1557,1453,1257.00483,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRZ01000037",86.029,0,1522,1453,1250.00137,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLWB01000035",86.029,0,1522,1453,1250.00137,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLZF01000029",86.029,0,1522,1453,1250.00137,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRZ01000037",94.67,0,1448,938,888.0046,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLWB01000035",94.67,0,1448,938,888.0046,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLZF01000029",94.67,0,1448,938,888.0046,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRI01000021",85.994,0,1445,1378,1184.99732,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRO01000021",85.994,0,1445,1378,1184.99732,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLXR01000021",85.994,0,1445,1378,1184.99732,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRG01000021",85.994,0,1445,1378,1184.99732,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLYG01000019",85.994,0,1445,1378,1184.99732,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRJ01000019",85.994,0,1445,1378,1184.99732,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLSM01000018",85.994,0,1445,1378,1184.99732,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLSQ01000022",85.994,0,1445,1378,1184.99732,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLXY01000024",85.994,0,1445,1378,1184.99732,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLXS01000025",85.994,0,1445,1378,1184.99732,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLUD01000021",85.994,0,1445,1378,1184.99732,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLYZ01000021",85.994,0,1445,1378,1184.99732,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLSP01000022",85.994,0,1445,1378,1184.99732,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLSH01000020",85.994,0,1445,1378,1184.99732,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLYY01000023",85.994,0,1445,1378,1184.99732,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLYC01000020",85.994,0,1445,1378,1184.99732,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLXZ01000020",85.994,0,1445,1378,1184.99732,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRC01000027",85.922,0,1439,1378,1184.00516,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLRE01000049",94.456,0,1437,938,885.99728,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLRE01000049",85.737,0,1315,1276,1094.00412,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JBGJJV010000032",83.547,0,1205,1325,1106.99775,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FLBI01000046",83.396,0,1194,1325,1104.997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRC01000027",83.371,0,1192,1323,1102.99833,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FLCN01000004",83.245,0,1182,1325,1102.99625,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRI01000021",83.233,0,1181,1324,1102.00492,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRZ01000037",83.233,0,1181,1324,1102.00492,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRO01000021",83.233,0,1181,1324,1102.00492,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRG01000021",83.233,0,1181,1324,1102.00492,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYG01000019",83.233,0,1181,1324,1102.00492,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSM01000018",83.233,0,1181,1324,1102.00492,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSQ01000022",83.233,0,1181,1324,1102.00492,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXY01000024",83.233,0,1181,1324,1102.00492,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXS01000025",83.233,0,1181,1324,1102.00492,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLUD01000021",83.233,0,1181,1324,1102.00492,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYZ01000021",83.233,0,1181,1324,1102.00492,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSP01000022",83.233,0,1181,1324,1102.00492,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSH01000020",83.233,0,1181,1324,1102.00492,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYY01000023",83.233,0,1181,1324,1102.00492,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYC01000020",83.233,0,1181,1324,1102.00492,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRI01000021",87.948,0,1179,1004,882.99792,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRO01000021",87.948,0,1179,1004,882.99792,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRG01000021",87.948,0,1179,1004,882.99792,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLYG01000019",87.948,0,1179,1004,882.99792,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLSM01000018",87.948,0,1179,1004,882.99792,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLSQ01000022",87.948,0,1179,1004,882.99792,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLXY01000024",87.948,0,1179,1004,882.99792,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLXS01000025",87.948,0,1179,1004,882.99792,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLUD01000021",87.948,0,1179,1004,882.99792,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRC01000027",87.948,0,1179,1004,882.99792,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLYZ01000021",87.948,0,1179,1004,882.99792,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLSP01000022",87.948,0,1179,1004,882.99792,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLSH01000020",87.948,0,1179,1004,882.99792,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLYY01000023",87.948,0,1179,1004,882.99792,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLYC01000020",87.948,0,1179,1004,882.99792,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FLBN01000099",83.17,0,1177,1325,1102.0025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXR01000021",83.157,0,1175,1324,1100.99868,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRJ01000019",83.157,0,1175,1324,1100.99868,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLWB01000035",83.157,0,1175,1324,1100.99868,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLZF01000029",83.157,0,1175,1324,1100.99868,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXZ01000020",83.157,0,1175,1324,1100.99868,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLXR01000021",87.849,0,1173,1004,882.00396,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRJ01000019",87.849,0,1173,1004,882.00396,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLXZ01000020",87.849,0,1173,1004,882.00396,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRE01000049",83.082,0,1170,1324,1100.00568,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRZ01000037",87.749,0,1168,1004,880.99996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLWB01000035",87.761,0,1168,1005,881.99805,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLZF01000029",87.761,0,1168,1005,881.99805,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FLBI01000046",87.55,0,1157,1004,879.002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLRE01000049",87.55,0,1157,1004,879.002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_JBGJJV010000032",87.562,0,1157,1005,879.9981,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FLBN01000099",87.45,0,1151,1004,877.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_FLCN01000004",87.45,0,1151,1004,877.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FLBI01000046",87.68,0,1118,974,854.0032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_JBGJJV010000032",87.681,0,1109,966,846.99846,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FLBN01000099",87.474,0,1107,974,851.99676,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_FLCN01000004",87.474,0,1107,974,851.99676,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_JBGJJV010000032",84.31,0,1101,1160,977.996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRZ01000037",87.384,0,1094,967,845.00328,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLWB01000035",87.384,0,1094,967,845.00328,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLZF01000029",87.384,0,1094,967,845.00328,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLWB01000035",84.038,0,1085,1159,974.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLZF01000029",84.038,0,1085,1159,974.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRZ01000037",83.865,0,1074,1159,971.99535,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FLBI01000046",86.585,0,1066,984,851.9964,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FLBN01000099",86.585,0,1066,984,851.9964,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_FLCN01000004",86.585,0,1066,984,851.9964,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FLBI01000046",86.211,0,1022,950,819.0045,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FLBN01000099",86.105,0,1016,950,817.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_FLCN01000004",86.105,0,1016,950,817.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRC01000027",86,0,1011,950,817,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_JBGJJV010000032",83.407,0,1009,1127,939.99689,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FLBI01000046",85.714,0,1007,973,833.99722,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FLBN01000099",85.744,0,1007,975,836.004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_FLCN01000004",85.744,0,1007,975,836.004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_FLBN01000099",88.263,0,1005,852,752.00076,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_FLCN01000004",88.263,0,1005,852,752.00076,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRI01000021",85.895,0,1005,950,816.0025,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRE01000049",85.895,0,1005,950,816.0025,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRO01000021",85.895,0,1005,950,816.0025,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRG01000021",85.895,0,1005,950,816.0025,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLYG01000019",85.895,0,1005,950,816.0025,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLSM01000018",85.895,0,1005,950,816.0025,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLSQ01000022",85.895,0,1005,950,816.0025,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLXY01000024",85.895,0,1005,950,816.0025,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLXS01000025",85.895,0,1005,950,816.0025,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLUD01000021",85.895,0,1005,950,816.0025,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLYZ01000021",85.895,0,1005,950,816.0025,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLSP01000022",85.895,0,1005,950,816.0025,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLSH01000020",85.895,0,1005,950,816.0025,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLYY01000023",85.895,0,1005,950,816.0025,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLYC01000020",85.895,0,1005,950,816.0025,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLWB01000035",83.23,0,1000,1127,938.0021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLZF01000029",83.23,0,1000,1127,938.0021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRZ01000037",85.789,0,1000,950,814.9955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLXR01000021",85.789,0,1000,950,814.9955,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLRJ01000019",85.789,0,1000,950,814.9955,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLXZ01000020",85.789,0,1000,950,814.9955,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_FLBI01000046",88.042,0,994,853,750.99826,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLWB01000035",85.684,0,994,950,813.998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLZF01000029",85.684,0,994,950,813.998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRZ01000037",82.964,0,983,1127,935.00428,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_FLBI01000046",86.162,0,981,925,796.9985,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_FLBN01000099",86.162,0,981,925,796.9985,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_FLCN01000004",86.162,0,981,925,796.9985,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRE01000049",85.533,0,981,947,809.99751,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRC01000027",85.549,0,981,948,811.00452,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_JBGJJV010000032",85.368,0,977,950,810.996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRE01000049",85.193,0,976,959,817.00087,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRC01000027",85.208,0,976,960,817.9968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FLBI01000046",85.428,0,976,947,809.00316,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FLBN01000099",85.428,0,976,947,809.00316,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRI01000021",85.443,0,976,948,809.99964,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_FLCN01000004",85.428,0,976,947,809.00316,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRZ01000037",85.443,0,976,948,809.99964,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRO01000021",85.443,0,976,948,809.99964,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRG01000021",85.443,0,976,948,809.99964,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLYG01000019",85.443,0,976,948,809.99964,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLSM01000018",85.443,0,976,948,809.99964,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLSQ01000022",85.443,0,976,948,809.99964,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLXY01000024",85.443,0,976,948,809.99964,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLXS01000025",85.443,0,976,948,809.99964,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLUD01000021",85.443,0,976,948,809.99964,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLYZ01000021",85.443,0,976,948,809.99964,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLSP01000022",85.443,0,976,948,809.99964,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLSH01000020",85.443,0,976,948,809.99964,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLYY01000023",85.443,0,976,948,809.99964,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLYC01000020",85.443,0,976,948,809.99964,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLWB01000035",83.677,0,974,1066,891.99682,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLZF01000029",83.677,0,974,1066,891.99682,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FLBI01000046",85.089,0,970,959,816.00351,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FLBN01000099",85.089,0,970,959,816.00351,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRI01000021",85.104,0,970,960,816.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_FLCN01000004",85.089,0,970,959,816.00351,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRZ01000037",85.104,0,970,960,816.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRO01000021",85.104,0,970,960,816.9984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRG01000021",85.104,0,970,960,816.9984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLYG01000019",85.104,0,970,960,816.9984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLSM01000018",85.104,0,970,960,816.9984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLSQ01000022",85.104,0,970,960,816.9984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLXY01000024",85.104,0,970,960,816.9984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLXS01000025",85.104,0,970,960,816.9984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLUD01000021",85.104,0,970,960,816.9984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLYZ01000021",85.104,0,970,960,816.9984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLSP01000022",85.104,0,970,960,816.9984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLSH01000020",85.104,0,970,960,816.9984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLYY01000023",85.104,0,970,960,816.9984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLYC01000020",85.104,0,970,960,816.9984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLXR01000021",85.338,0,970,948,809.00424,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLRJ01000019",85.338,0,970,948,809.00424,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLWB01000035",85.338,0,970,948,809.00424,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLZF01000029",85.338,0,970,948,809.00424,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLXZ01000020",85.338,0,970,948,809.00424,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRE01000049",87.441,0,968,852,744.99732,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLXR01000021",85,0,965,960,816,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLRJ01000019",85,0,965,960,816,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLWB01000035",85,0,965,960,816,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLZF01000029",85,0,965,960,816,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLXZ01000020",85,0,965,960,816,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRZ01000037",83.49,0,963,1066,890.0034,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_JBGJJV010000032",83.49,0,963,1066,890.0034,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_JBGJJV010000032",87.309,0,961,851,742.99959,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRI01000021",86.987,0,946,853,741.99911,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRO01000021",86.987,0,946,853,741.99911,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLXR01000021",86.987,0,946,853,741.99911,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRG01000021",86.987,0,946,853,741.99911,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLYG01000019",86.987,0,946,853,741.99911,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRJ01000019",86.987,0,946,853,741.99911,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLSM01000018",86.987,0,946,853,741.99911,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLSQ01000022",86.987,0,946,853,741.99911,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLXY01000024",86.987,0,946,853,741.99911,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLXS01000025",86.987,0,946,853,741.99911,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLUD01000021",86.987,0,946,853,741.99911,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRC01000027",86.987,0,946,853,741.99911,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLYZ01000021",86.987,0,946,853,741.99911,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLSP01000022",86.987,0,946,853,741.99911,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLSH01000020",86.987,0,946,853,741.99911,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLYY01000023",86.987,0,946,853,741.99911,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLYC01000020",86.987,0,946,853,741.99911,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLXZ01000020",86.987,0,946,853,741.99911,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLRZ01000037",86.87,0,941,853,741.0011,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLWB01000035",86.87,0,941,853,741.0011,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLZF01000029",86.87,0,941,853,741.0011,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_JBGJJV010000032",84.688,0,937,947,801.99536,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_JBGJJV010000032",84.359,0,931,959,809.00281,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FLBN01000099",86.158,0,889,838,722.00404,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FLCN01000004",86.158,0,889,838,722.00404,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_FLBI01000046",86.038,0,883,838,720.99844,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_JBGJJV010000032",94.69,0,876,565,534.9985,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_JBGJJV010000032",85.8,0,874,838,719.004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_JBGJJV010000032",85.971,0,869,834,716.99814,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FLBI01000046",85.783,0,865,837,718.00371,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FLBN01000099",85.816,0,865,839,719.99624,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_FLCN01000004",85.816,0,865,839,719.99624,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRZ01000037",86.507,0,863,793,686.00051,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLWB01000035",86.507,0,863,793,686.00051,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLZF01000029",86.507,0,863,793,686.00051,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRI01000021",94.159,0,859,565,531.99835,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRZ01000037",94.159,0,859,565,531.99835,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRO01000021",94.159,0,859,565,531.99835,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLXR01000021",94.159,0,859,565,531.99835,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRG01000021",94.159,0,859,565,531.99835,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLYG01000019",94.159,0,859,565,531.99835,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRJ01000019",94.159,0,859,565,531.99835,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLSM01000018",94.159,0,859,565,531.99835,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLSQ01000022",94.159,0,859,565,531.99835,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLXY01000024",94.159,0,859,565,531.99835,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLXS01000025",94.159,0,859,565,531.99835,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLWB01000035",94.159,0,859,565,531.99835,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLUD01000021",94.159,0,859,565,531.99835,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRC01000027",94.159,0,859,565,531.99835,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLYZ01000021",94.159,0,859,565,531.99835,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLSP01000022",94.159,0,859,565,531.99835,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLZF01000029",94.159,0,859,565,531.99835,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLSH01000020",94.159,0,859,565,531.99835,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLYY01000023",94.159,0,859,565,531.99835,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLYC01000020",94.159,0,859,565,531.99835,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLXZ01000020",94.159,0,859,565,531.99835,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRZ01000037",85.749,0,857,835,716.00415,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLWB01000035",85.749,0,857,835,716.00415,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLZF01000029",85.749,0,857,835,716.00415,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_FLBI01000046",93.982,0,854,565,530.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_FLBN01000099",93.805,0,848,565,529.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_FLCN01000004",93.805,0,848,565,529.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_JBGJJV010000032",84.884,0,843,860,730.0024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FLBI01000046",84.785,0,837,861,729.99885,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FLBN01000099",84.82,0,837,863,731.9966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_FLCN01000004",84.82,0,837,863,731.9966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRI01000021",88.319,0,835,702,619.99938,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRO01000021",88.319,0,835,702,619.99938,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLXR01000021",88.319,0,835,702,619.99938,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRG01000021",88.319,0,835,702,619.99938,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLYG01000019",88.319,0,835,702,619.99938,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRJ01000019",88.319,0,835,702,619.99938,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLSM01000018",88.319,0,835,702,619.99938,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLSQ01000022",88.319,0,835,702,619.99938,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLXY01000024",88.319,0,835,702,619.99938,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLXS01000025",88.319,0,835,702,619.99938,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLUD01000021",88.319,0,835,702,619.99938,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRC01000027",88.319,0,835,702,619.99938,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLYZ01000021",88.319,0,835,702,619.99938,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLSP01000022",88.319,0,835,702,619.99938,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLSH01000020",88.319,0,835,702,619.99938,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLYY01000023",88.319,0,835,702,619.99938,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLYC01000020",88.319,0,835,702,619.99938,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLXZ01000020",88.319,0,835,702,619.99938,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRZ01000037",84.651,0,833,860,727.9986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLWB01000035",84.651,0,833,860,727.9986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLZF01000029",84.651,0,833,860,727.9986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_FLBI01000046",94.615,0,800,520,491.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_FLBN01000099",94.615,0,800,520,491.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_FLCN01000004",94.615,0,800,520,491.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRI01000021",94.423,0,795,520,490.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRO01000021",94.423,0,795,520,490.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLXR01000021",94.423,0,795,520,490.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRG01000021",94.423,0,795,520,490.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLYG01000019",94.423,0,795,520,490.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRJ01000019",94.423,0,795,520,490.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLSM01000018",94.423,0,795,520,490.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLSQ01000022",94.423,0,795,520,490.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLXY01000024",94.423,0,795,520,490.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLXS01000025",94.423,0,795,520,490.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLUD01000021",94.423,0,795,520,490.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRC01000027",94.423,0,795,520,490.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLYZ01000021",94.423,0,795,520,490.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLSP01000022",94.423,0,795,520,490.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLSH01000020",94.423,0,795,520,490.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLYY01000023",94.423,0,795,520,490.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLYC01000020",94.423,0,795,520,490.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLXZ01000020",94.423,0,795,520,490.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRZ01000037",94.231,0,789,520,490.0012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLWB01000035",94.231,0,789,520,490.0012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLZF01000029",94.231,0,789,520,490.0012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRZ01000037",79.636,0,787,1154,918.99944,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLWB01000035",79.636,0,787,1154,918.99944,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLZF01000029",79.636,0,787,1154,918.99944,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLRE01000049",94.685,0,787,508,480.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FLBI01000046",87.194,0,785,695,605.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FLBN01000099",87.194,0,785,695,605.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRE01000049",87.194,0,785,695,605.9983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_FLCN01000004",87.194,0,785,695,605.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_JBGJJV010000032",94.038,0,784,520,488.9976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FLBI01000046",87.013,0,780,693,603.00009,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FLBN01000099",87.013,0,780,693,603.00009,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_FLCN01000004",87.013,0,780,693,603.00009,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRE01000049",84.414,0,776,802,677.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRI01000021",86.906,0,774,695,603.9967,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRZ01000037",86.906,0,774,695,603.9967,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRO01000021",86.906,0,774,695,603.9967,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLXR01000021",86.906,0,774,695,603.9967,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRG01000021",86.906,0,774,695,603.9967,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLYG01000019",86.906,0,774,695,603.9967,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRJ01000019",86.906,0,774,695,603.9967,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLSM01000018",86.906,0,774,695,603.9967,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLSQ01000022",86.906,0,774,695,603.9967,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLXY01000024",86.906,0,774,695,603.9967,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLXS01000025",86.906,0,774,695,603.9967,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLWB01000035",86.906,0,774,695,603.9967,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLUD01000021",86.906,0,774,695,603.9967,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLRC01000027",86.906,0,774,695,603.9967,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLYZ01000021",86.906,0,774,695,603.9967,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLSP01000022",86.906,0,774,695,603.9967,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLZF01000029",86.906,0,774,695,603.9967,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLSH01000020",86.906,0,774,695,603.9967,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLYY01000023",86.906,0,774,695,603.9967,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLYC01000020",86.906,0,774,695,603.9967,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLXZ01000020",86.906,0,774,695,603.9967,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_JBGJJV010000032",79.417,0,774,1166,926.00222,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRE01000049",87.262,0,774,683,595.99946,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_JBGJJV010000032",86.763,0,769,695,603.00285,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FLBI01000046",87.026,0,769,686,596.99836,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FLBN01000099",87.026,0,769,686,596.99836,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_FLCN01000004",87.026,0,769,686,596.99836,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRE01000049",86.724,0,769,693,600.99732,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FLBI01000046",79.04,0,763,1188,938.9952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FLBN01000099",79.076,0,763,1190,941.0044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_FLCN01000004",79.076,0,763,1190,941.0044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRI01000021",86.969,0,763,683,593.99827,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRZ01000037",86.969,0,763,683,593.99827,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRO01000021",86.969,0,763,683,593.99827,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLXR01000021",86.969,0,763,683,593.99827,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRG01000021",86.969,0,763,683,593.99827,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLYG01000019",86.969,0,763,683,593.99827,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRJ01000019",86.969,0,763,683,593.99827,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLSM01000018",86.969,0,763,683,593.99827,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLSQ01000022",86.969,0,763,683,593.99827,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLXY01000024",86.969,0,763,683,593.99827,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLXS01000025",86.969,0,763,683,593.99827,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLWB01000035",86.969,0,763,683,593.99827,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLUD01000021",86.969,0,763,683,593.99827,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLRC01000027",86.969,0,763,683,593.99827,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLYZ01000021",86.969,0,763,683,593.99827,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLSP01000022",86.969,0,763,683,593.99827,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLZF01000029",86.969,0,763,683,593.99827,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLSH01000020",86.969,0,763,683,593.99827,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLYY01000023",86.969,0,763,683,593.99827,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLYC01000020",86.969,0,763,683,593.99827,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLXZ01000020",86.969,0,763,683,593.99827,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRI01000021",86.58,0,763,693,599.9994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRZ01000037",86.58,0,763,693,599.9994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRO01000021",86.58,0,763,693,599.9994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRG01000021",86.58,0,763,693,599.9994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLYG01000019",86.58,0,763,693,599.9994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLSM01000018",86.58,0,763,693,599.9994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLSQ01000022",86.58,0,763,693,599.9994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLXY01000024",86.58,0,763,693,599.9994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLXS01000025",86.58,0,763,693,599.9994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLWB01000035",86.58,0,763,693,599.9994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLUD01000021",86.58,0,763,693,599.9994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRC01000027",86.58,0,763,693,599.9994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLYZ01000021",86.58,0,763,693,599.9994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLSP01000022",86.58,0,763,693,599.9994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLZF01000029",86.58,0,763,693,599.9994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLSH01000020",86.58,0,763,693,599.9994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLYY01000023",86.58,0,763,693,599.9994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLYC01000020",86.58,0,763,693,599.9994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FLBI01000046",84.02,0,760,801,673.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRI01000021",84.04,0,760,802,674.0008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRO01000021",84.04,0,760,802,674.0008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRG01000021",84.04,0,760,802,674.0008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLYG01000019",84.04,0,760,802,674.0008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLSM01000018",84.04,0,760,802,674.0008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLSQ01000022",84.04,0,760,802,674.0008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLXY01000024",84.04,0,760,802,674.0008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLXS01000025",84.04,0,760,802,674.0008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLUD01000021",84.04,0,760,802,674.0008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRC01000027",84.04,0,760,802,674.0008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLYZ01000021",84.04,0,760,802,674.0008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLSP01000022",84.04,0,760,802,674.0008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLSH01000020",84.04,0,760,802,674.0008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLYY01000023",84.04,0,760,802,674.0008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLYC01000020",84.04,0,760,802,674.0008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLXR01000021",86.436,0,758,693,599.00148,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLRJ01000019",86.436,0,758,693,599.00148,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLXZ01000020",86.436,0,758,693,599.00148,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_FLBI01000046",88.328,0,754,634,559.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_FLBN01000099",88.328,0,754,634,559.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_FLCN01000004",88.328,0,754,634,559.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRZ01000037",83.915,0,754,802,672.9983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLXR01000021",83.915,0,754,802,672.9983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLRJ01000019",83.915,0,754,802,672.9983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLWB01000035",83.915,0,754,802,672.9983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLZF01000029",83.915,0,754,802,672.9983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLXZ01000020",83.915,0,754,802,672.9983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_JBGJJV010000032",86.589,0,752,686,594.00054,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_JBGJJV010000032",86.291,0,752,693,597.99663,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FLBN01000099",83.77,0,749,801,670.9977,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_FLCN01000004",83.77,0,749,801,670.9977,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_JBGJJV010000032",83.77,0,749,801,670.9977,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_JBGJJV010000032",87.994,0,743,633,557.00202,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FLBI01000046",78.369,0,741,1202,941.99538,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRI01000021",79.406,0,741,1078,855.99668,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRO01000021",79.406,0,741,1078,855.99668,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRG01000021",79.406,0,741,1078,855.99668,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLYG01000019",79.406,0,741,1078,855.99668,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLSM01000018",79.406,0,741,1078,855.99668,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLSQ01000022",79.406,0,741,1078,855.99668,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLXY01000024",79.406,0,741,1078,855.99668,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLXS01000025",79.406,0,741,1078,855.99668,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLUD01000021",79.406,0,741,1078,855.99668,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRC01000027",79.406,0,741,1078,855.99668,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLYZ01000021",79.406,0,741,1078,855.99668,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLSP01000022",79.406,0,741,1078,855.99668,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLSH01000020",79.406,0,741,1078,855.99668,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLYY01000023",79.406,0,741,1078,855.99668,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLYC01000020",79.406,0,741,1078,855.99668,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRI01000021",87.956,0,737,631,555.00236,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRO01000021",87.956,0,737,631,555.00236,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLXR01000021",87.956,0,737,631,555.00236,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRG01000021",87.956,0,737,631,555.00236,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLYG01000019",87.956,0,737,631,555.00236,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRJ01000019",87.956,0,737,631,555.00236,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLSM01000018",87.956,0,737,631,555.00236,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLSQ01000022",87.956,0,737,631,555.00236,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLXY01000024",87.956,0,737,631,555.00236,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLXS01000025",87.956,0,737,631,555.00236,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLUD01000021",87.956,0,737,631,555.00236,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRC01000027",87.956,0,737,631,555.00236,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLYZ01000021",87.956,0,737,631,555.00236,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLSP01000022",87.956,0,737,631,555.00236,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLSH01000020",87.956,0,737,631,555.00236,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLYY01000023",87.956,0,737,631,555.00236,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLYC01000020",87.956,0,737,631,555.00236,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLXZ01000020",87.956,0,737,631,555.00236,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FLBN01000099",78.286,0,736,1202,940.99772,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRE01000049",79.314,0,736,1078,855.00492,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_FLCN01000004",78.286,0,736,1202,940.99772,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRZ01000037",79.314,0,736,1078,855.00492,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLXR01000021",79.314,0,736,1078,855.00492,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLRJ01000019",79.314,0,736,1078,855.00492,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLWB01000035",79.314,0,736,1078,855.00492,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLZF01000029",79.314,0,736,1078,855.00492,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLXZ01000020",79.314,0,736,1078,855.00492,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FLBI01000046",86.707,0,734,662,574.00034,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FLBN01000099",86.707,0,734,662,574.00034,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_FLCN01000004",86.707,0,734,662,574.00034,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_JBGJJV010000032",79.224,0,732,1083,857.99592,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_JAUEGY010000142",89.078,0,728,586,521.99708,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRC01000027",86.556,0,728,662,573.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRC01000027",86.197,0,728,681,587.00157,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRI01000021",89.212,0,726,584,520.99808,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRO01000021",89.212,0,726,584,520.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLXR01000021",89.212,0,726,584,520.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRG01000021",89.212,0,726,584,520.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLYG01000019",89.212,0,726,584,520.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRJ01000019",89.212,0,726,584,520.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLSM01000018",89.212,0,726,584,520.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLSQ01000022",89.212,0,726,584,520.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLXY01000024",89.212,0,726,584,520.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLXS01000025",89.212,0,726,584,520.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLUD01000021",89.212,0,726,584,520.99808,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRC01000027",89.212,0,726,584,520.99808,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLYZ01000021",89.212,0,726,584,520.99808,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLSP01000022",89.212,0,726,584,520.99808,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLSH01000020",89.212,0,726,584,520.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLYY01000023",89.212,0,726,584,520.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLYC01000020",89.212,0,726,584,520.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLXZ01000020",89.212,0,726,584,520.99808,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRI01000021",86.405,0,723,662,572.0011,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRZ01000037",86.405,0,723,662,572.0011,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRO01000021",86.405,0,723,662,572.0011,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRG01000021",86.405,0,723,662,572.0011,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLYG01000019",86.405,0,723,662,572.0011,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLSM01000018",86.405,0,723,662,572.0011,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLSQ01000022",86.405,0,723,662,572.0011,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLXY01000024",86.405,0,723,662,572.0011,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLXS01000025",86.405,0,723,662,572.0011,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLUD01000021",86.405,0,723,662,572.0011,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLYZ01000021",86.405,0,723,662,572.0011,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLSP01000022",86.405,0,723,662,572.0011,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLSH01000020",86.405,0,723,662,572.0011,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLYY01000023",86.405,0,723,662,572.0011,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLYC01000020",86.405,0,723,662,572.0011,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FLBI01000046",86.029,0,723,680,584.9972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FLBN01000099",86.029,0,723,680,584.9972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRI01000021",86.05,0,723,681,586.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_FLCN01000004",86.029,0,723,680,584.9972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRZ01000037",86.05,0,723,681,586.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRO01000021",86.05,0,723,681,586.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRG01000021",86.05,0,723,681,586.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLYG01000019",86.05,0,723,681,586.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLSM01000018",86.05,0,723,681,586.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLSQ01000022",86.05,0,723,681,586.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLXY01000024",86.05,0,723,681,586.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLXS01000025",86.05,0,723,681,586.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLUD01000021",86.05,0,723,681,586.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLYZ01000021",86.05,0,723,681,586.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLSP01000022",86.05,0,723,681,586.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLSH01000020",86.05,0,723,681,586.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLYY01000023",86.05,0,723,681,586.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLYC01000020",86.05,0,723,681,586.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRE01000049",87.48,0,721,631,551.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLRZ01000037",87.5,0,721,632,553,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLWB01000035",87.5,0,721,632,553,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLZF01000029",87.5,0,721,632,553,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_JBGJJV010000032",83.333,0,717,798,664.99734,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLXR01000021",86.254,0,717,662,571.00148,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRJ01000019",86.254,0,717,662,571.00148,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLWB01000035",86.254,0,717,662,571.00148,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLZF01000029",86.254,0,717,662,571.00148,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLXZ01000020",86.254,0,717,662,571.00148,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRE01000049",85.882,0,717,680,583.9976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLXR01000021",85.903,0,717,681,584.99943,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLRJ01000019",85.903,0,717,681,584.99943,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLWB01000035",85.903,0,717,681,584.99943,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLZF01000029",85.903,0,717,681,584.99943,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLXZ01000020",85.903,0,717,681,584.99943,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FLBI01000046",86.916,0,715,642,558.00072,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FLBN01000099",86.916,0,715,642,558.00072,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRE01000049",86.916,0,715,642,558.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_FLCN01000004",86.916,0,715,642,558.00072,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_FLBN01000099",91.731,0,713,520,477.0012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRE01000049",91.683,0,713,517,474.00111,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_FLCN01000004",91.731,0,713,520,477.0012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRZ01000037",83.25,0,712,800,666,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLWB01000035",83.25,0,712,800,666,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLZF01000029",83.25,0,712,800,666,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLRE01000049",86.103,0,712,662,570.00186,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_JBGJJV010000032",86.103,0,712,662,570.00186,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLRE01000049",87.993,0,712,608,534.99744,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_JBGJJV010000032",91.506,0,708,518,474.00108,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FLBI01000046",78.913,0,708,1086,856.99518,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FLBN01000099",78.913,0,708,1086,856.99518,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_FLCN01000004",78.913,0,708,1086,856.99518,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FLBI01000046",83.083,0,706,798,663.00234,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRI01000021",86.604,0,704,642,555.99768,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRZ01000037",86.604,0,704,642,555.99768,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRO01000021",86.604,0,704,642,555.99768,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLXR01000021",86.604,0,704,642,555.99768,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRG01000021",86.604,0,704,642,555.99768,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLYG01000019",86.604,0,704,642,555.99768,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRJ01000019",86.604,0,704,642,555.99768,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLSM01000018",86.604,0,704,642,555.99768,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLSQ01000022",86.604,0,704,642,555.99768,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLXY01000024",86.604,0,704,642,555.99768,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLXS01000025",86.604,0,704,642,555.99768,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLWB01000035",86.604,0,704,642,555.99768,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLUD01000021",86.604,0,704,642,555.99768,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLRC01000027",86.604,0,704,642,555.99768,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLYZ01000021",86.604,0,704,642,555.99768,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLSP01000022",86.604,0,704,642,555.99768,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLZF01000029",86.604,0,704,642,555.99768,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLSH01000020",86.604,0,704,642,555.99768,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLYY01000023",86.604,0,704,642,555.99768,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLYC01000020",86.604,0,704,642,555.99768,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLXZ01000020",86.604,0,704,642,555.99768,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FLBI01000046",87.644,0,702,607,531.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FLBN01000099",87.644,0,702,607,531.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_FLCN01000004",87.644,0,702,607,531.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRC01000027",87.644,0,702,607,531.99908,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_FLBI01000046",91.346,0,702,520,474.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_FLBN01000099",84.076,0,701,741,623.00316,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_FLCN01000004",84.076,0,701,741,623.00316,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_JBGJJV010000032",84.076,0,701,741,623.00316,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRI01000021",82.957,0,701,798,661.99686,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FLCN01000004",82.915,0,701,796,660.0034,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRO01000021",82.957,0,701,798,661.99686,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLXR01000021",82.957,0,701,798,661.99686,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRG01000021",82.957,0,701,798,661.99686,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLYG01000019",82.957,0,701,798,661.99686,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRJ01000019",82.957,0,701,798,661.99686,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLSM01000018",82.957,0,701,798,661.99686,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLSQ01000022",82.957,0,701,798,661.99686,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLXY01000024",82.957,0,701,798,661.99686,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLXS01000025",82.957,0,701,798,661.99686,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLUD01000021",82.957,0,701,798,661.99686,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLYZ01000021",82.957,0,701,798,661.99686,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLSP01000022",82.957,0,701,798,661.99686,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLSH01000020",82.957,0,701,798,661.99686,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLYY01000023",82.957,0,701,798,661.99686,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLYC01000020",82.957,0,701,798,661.99686,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLXZ01000020",82.957,0,701,798,661.99686,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_JBGJJV010000032",86.449,0,699,642,555.00258,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FLBI01000046",83.952,0,699,754,632.99808,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FLBN01000099",83.952,0,699,754,632.99808,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_FLCN01000004",83.952,0,699,754,632.99808,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRZ01000037",88.676,0,697,574,509.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLWB01000035",88.676,0,697,574,509.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLZF01000029",88.676,0,697,574,509.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_FLBI01000046",88.448,0,697,580,512.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_FLBN01000099",88.488,0,697,582,515.00016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_FLCN01000004",88.488,0,697,582,515.00016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRI01000021",87.479,0,697,607,530.99753,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRE01000049",87.479,0,697,607,530.99753,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRZ01000037",87.479,0,697,607,530.99753,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRO01000021",87.479,0,697,607,530.99753,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRG01000021",87.479,0,697,607,530.99753,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLYG01000019",87.479,0,697,607,530.99753,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLSM01000018",87.479,0,697,607,530.99753,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLSQ01000022",87.479,0,697,607,530.99753,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLXY01000024",87.479,0,697,607,530.99753,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLXS01000025",87.479,0,697,607,530.99753,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLUD01000021",87.479,0,697,607,530.99753,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLYZ01000021",87.479,0,697,607,530.99753,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLSP01000022",87.479,0,697,607,530.99753,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLSH01000020",87.479,0,697,607,530.99753,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLYY01000023",87.479,0,697,607,530.99753,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLYC01000020",87.479,0,697,607,530.99753,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRI01000021",91.12,0,697,518,472.0016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRO01000021",91.12,0,697,518,472.0016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLXR01000021",91.12,0,697,518,472.0016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRG01000021",91.12,0,697,518,472.0016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLYG01000019",91.12,0,697,518,472.0016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRJ01000019",91.12,0,697,518,472.0016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLSM01000018",91.12,0,697,518,472.0016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLSQ01000022",91.12,0,697,518,472.0016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLXY01000024",91.12,0,697,518,472.0016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLXS01000025",91.12,0,697,518,472.0016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLUD01000021",91.12,0,697,518,472.0016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRC01000027",91.12,0,697,518,472.0016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLYZ01000021",91.12,0,697,518,472.0016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLSP01000022",91.12,0,697,518,472.0016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLSH01000020",91.12,0,697,518,472.0016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLYY01000023",91.12,0,697,518,472.0016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLYC01000020",91.12,0,697,518,472.0016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLXZ01000020",91.12,0,697,518,472.0016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRE01000049",78.533,0,697,1104,867.00432,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_FLBI01000046",83.941,0,695,741,622.00281,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_FLBN01000099",82.789,0,695,796,659.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRC01000027",82.811,0,695,797,660.00367,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_FLBI01000046",88.676,0,695,574,509.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_FLBN01000099",88.676,0,695,574,509.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_FLCN01000004",88.676,0,695,574,509.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_JBGJJV010000032",88.676,0,695,574,509.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_JBGJJV010000032",85.294,0,695,680,579.9992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRZ01000037",88.115,0,695,589,518.99735,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLWB01000035",88.115,0,695,589,518.99735,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLZF01000029",88.115,0,695,589,518.99735,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_FLBI01000046",83.487,0,695,757,631.99659,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRE01000049",82.36,0,693,822,676.9992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_JBGJJV010000032",88.115,0,693,589,518.99735,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRI01000021",89.007,0,691,564,501.99948,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRO01000021",89.007,0,691,564,501.99948,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLXR01000021",89.007,0,691,564,501.99948,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRG01000021",89.007,0,691,564,501.99948,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLYG01000019",89.007,0,691,564,501.99948,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRJ01000019",89.007,0,691,564,501.99948,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLSM01000018",89.007,0,691,564,501.99948,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLSQ01000022",89.007,0,691,564,501.99948,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLXY01000024",89.007,0,691,564,501.99948,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLXS01000025",89.007,0,691,564,501.99948,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLUD01000021",89.007,0,691,564,501.99948,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRC01000027",89.007,0,691,564,501.99948,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLYZ01000021",89.007,0,691,564,501.99948,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLSP01000022",89.007,0,691,564,501.99948,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLSH01000020",89.007,0,691,564,501.99948,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLYY01000023",89.007,0,691,564,501.99948,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLYC01000020",89.007,0,691,564,501.99948,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLXZ01000020",89.007,0,691,564,501.99948,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLXR01000021",87.315,0,691,607,530.00205,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLRJ01000019",87.315,0,691,607,530.00205,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLWB01000035",87.315,0,691,607,530.00205,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLZF01000029",87.315,0,691,607,530.00205,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLXZ01000020",87.315,0,691,607,530.00205,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_FLBN01000099",83.355,0,689,757,630.99735,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_FLCN01000004",83.355,0,689,757,630.99735,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_FLBI01000046",87.925,0,688,588,516.999,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_FLBN01000099",87.925,0,688,588,516.999,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_FLCN01000004",87.925,0,688,588,516.999,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_JBGJJV010000032",83.709,0,688,755,632.00295,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_JBGJJV010000032",78.565,0,688,1087,854.00155,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRZ01000037",83.671,0,686,741,620.00211,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLWB01000035",83.671,0,686,741,620.00211,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLZF01000029",83.671,0,686,741,620.00211,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRE01000049",82.915,0,686,796,660.0034,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_JBGJJV010000032",87.15,0,686,607,529.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRZ01000037",78.351,0,686,1104,864.99504,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLWB01000035",78.351,0,686,1104,864.99504,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRC01000027",78.391,0,686,1106,867.00446,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLZF01000029",78.351,0,686,1104,864.99504,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLRE01000049",82.625,0,684,800,661,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_JAUEGY010000142",88.401,0,684,569,503.00169,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRI01000021",83.598,0,682,756,632.00088,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRO01000021",83.598,0,682,756,632.00088,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLXR01000021",83.598,0,682,756,632.00088,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRG01000021",83.598,0,682,756,632.00088,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLYG01000019",83.598,0,682,756,632.00088,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRJ01000019",83.598,0,682,756,632.00088,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLSM01000018",83.598,0,682,756,632.00088,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLSQ01000022",83.598,0,682,756,632.00088,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLXY01000024",83.598,0,682,756,632.00088,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLXS01000025",83.598,0,682,756,632.00088,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLUD01000021",83.598,0,682,756,632.00088,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRC01000027",83.598,0,682,756,632.00088,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLYZ01000021",83.598,0,682,756,632.00088,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLSP01000022",83.598,0,682,756,632.00088,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLSH01000020",83.598,0,682,756,632.00088,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLYY01000023",83.598,0,682,756,632.00088,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLYC01000020",83.598,0,682,756,632.00088,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLXZ01000020",83.598,0,682,756,632.00088,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FLBI01000046",80.496,0,680,928,747.00288,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRZ01000037",80.613,0,680,913,735.99669,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLWB01000035",80.613,0,680,913,735.99669,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLZF01000029",80.613,0,680,913,735.99669,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_JBGJJV010000032",87.993,0,680,583,512.99919,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_JBGJJV010000032",83.467,0,680,750,626.0025,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLRZ01000037",90.522,0,680,517,467.99874,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLWB01000035",90.522,0,680,517,467.99874,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLZF01000029",90.522,0,680,517,467.99874,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRI01000021",78.261,0,680,1104,864.00144,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRO01000021",78.261,0,680,1104,864.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLXR01000021",78.261,0,680,1104,864.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRG01000021",78.261,0,680,1104,864.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLYG01000019",78.261,0,680,1104,864.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLRJ01000019",78.261,0,680,1104,864.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLSM01000018",78.261,0,680,1104,864.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLSQ01000022",78.261,0,680,1104,864.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLXY01000024",78.261,0,680,1104,864.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLXS01000025",78.261,0,680,1104,864.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLUD01000021",78.261,0,680,1104,864.00144,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLYZ01000021",78.261,0,680,1104,864.00144,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLSP01000022",78.261,0,680,1104,864.00144,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLSH01000020",78.261,0,680,1104,864.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLYY01000023",78.261,0,680,1104,864.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLYC01000020",78.261,0,680,1104,864.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLXZ01000020",78.261,0,680,1104,864.00144,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_JAUEGY010000142",88.204,0,678,568,500.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FLBI01000046",81.995,0,676,822,673.9989,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_JBGJJV010000032",81.995,0,676,822,673.9989,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLRE01000049",94,0,676,450,423,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRE01000049",81.42,0,676,845,687.999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRZ01000037",87.822,0,676,583,512.00226,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLWB01000035",87.822,0,676,583,512.00226,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLZF01000029",87.822,0,676,583,512.00226,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRZ01000037",83.026,0,676,760,630.9976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLWB01000035",83.026,0,676,760,630.9976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLZF01000029",83.026,0,676,760,630.9976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FLBI01000046",85.037,0,675,675,573.99975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FLBI01000046",86.721,0,675,610,528.9981,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FLBN01000099",86.721,0,675,610,528.9981,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_FLCN01000004",86.721,0,675,610,528.9981,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRC01000027",86.82,0,675,607,526.9974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FLBI01000046",83.333,0,675,750,624.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRI01000021",82.663,0,675,796,657.99748,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRZ01000037",82.663,0,675,796,657.99748,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRO01000021",82.663,0,675,796,657.99748,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLXR01000021",82.663,0,675,796,657.99748,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRG01000021",82.663,0,675,796,657.99748,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLYG01000019",82.663,0,675,796,657.99748,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRJ01000019",82.663,0,675,796,657.99748,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLSM01000018",82.663,0,675,796,657.99748,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLSQ01000022",82.663,0,675,796,657.99748,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLXY01000024",82.663,0,675,796,657.99748,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLXS01000025",82.663,0,675,796,657.99748,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLWB01000035",82.663,0,675,796,657.99748,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLUD01000021",82.663,0,675,796,657.99748,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLRC01000027",82.663,0,675,796,657.99748,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLYZ01000021",82.663,0,675,796,657.99748,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLSP01000022",82.663,0,675,796,657.99748,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLZF01000029",82.663,0,675,796,657.99748,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLSH01000020",82.663,0,675,796,657.99748,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLYY01000023",82.663,0,675,796,657.99748,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLYC01000020",82.663,0,675,796,657.99748,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLXZ01000020",82.663,0,675,796,657.99748,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_JBGJJV010000032",82.982,0,675,758,629.00356,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_JAUEGY010000142",89.011,0,675,546,486.00006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_FLBI01000046",80.702,0,673,912,736.00224,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FLBN01000099",81.873,0,671,822,672.99606,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_FLCN01000004",81.873,0,671,822,672.99606,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRZ01000037",81.873,0,671,822,672.99606,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLXR01000021",81.873,0,671,822,672.99606,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRJ01000019",81.873,0,671,822,672.99606,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLWB01000035",81.873,0,671,822,672.99606,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLZF01000029",81.873,0,671,822,672.99606,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLXZ01000020",81.873,0,671,822,672.99606,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRZ01000037",80.592,0,671,912,734.99904,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLWB01000035",80.592,0,671,912,734.99904,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLZF01000029",80.592,0,671,912,734.99904,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JAUEGY010000142",88.256,0,671,562,495.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FLBI01000046",94.131,0,671,443,417.00033,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FLBN01000099",94.131,0,671,443,417.00033,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_FLCN01000004",94.131,0,671,443,417.00033,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FLBN01000099",84.889,0,669,675,573.00075,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_FLCN01000004",84.889,0,669,675,573.00075,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRI01000021",86.656,0,669,607,526.00192,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRE01000049",86.656,0,669,607,526.00192,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRZ01000037",86.656,0,669,607,526.00192,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRO01000021",86.656,0,669,607,526.00192,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRG01000021",86.656,0,669,607,526.00192,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLYG01000019",86.656,0,669,607,526.00192,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLSM01000018",86.656,0,669,607,526.00192,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLSQ01000022",86.656,0,669,607,526.00192,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLXY01000024",86.656,0,669,607,526.00192,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLXS01000025",86.656,0,669,607,526.00192,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLUD01000021",86.656,0,669,607,526.00192,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLYZ01000021",86.656,0,669,607,526.00192,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLSP01000022",86.656,0,669,607,526.00192,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLSH01000020",86.656,0,669,607,526.00192,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLYY01000023",86.656,0,669,607,526.00192,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLYC01000020",86.656,0,669,607,526.00192,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_FLBI01000046",85.962,0,669,634,544.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_FLBN01000099",85.962,0,669,634,544.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_FLCN01000004",85.962,0,669,634,544.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FLBN01000099",83.2,0,669,750,624,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_FLCN01000004",83.2,0,669,750,624,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRE01000049",82.786,0,667,761,630.00146,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRI01000021",81.752,0,665,822,672.00144,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRO01000021",81.752,0,665,822,672.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRG01000021",81.752,0,665,822,672.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLYG01000019",81.752,0,665,822,672.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLSM01000018",81.752,0,665,822,672.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLSQ01000022",81.752,0,665,822,672.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLXY01000024",81.752,0,665,822,672.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLXS01000025",81.752,0,665,822,672.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLUD01000021",81.752,0,665,822,672.00144,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLRC01000027",81.752,0,665,822,672.00144,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLYZ01000021",81.752,0,665,822,672.00144,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLSP01000022",81.752,0,665,822,672.00144,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLSH01000020",81.752,0,665,822,672.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLYY01000023",81.752,0,665,822,672.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLYC01000020",81.752,0,665,822,672.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JBGJJV010000032",80.236,0,665,931,746.99716,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRZ01000037",81.183,0,665,845,685.99635,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLXR01000021",81.183,0,665,845,685.99635,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRJ01000019",81.183,0,665,845,685.99635,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLWB01000035",81.183,0,665,845,685.99635,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLZF01000029",81.183,0,665,845,685.99635,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLXZ01000020",81.183,0,665,845,685.99635,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_JBGJJV010000032",81.213,0,665,841,683.00133,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRZ01000037",83.201,0,665,756,628.99956,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLWB01000035",83.201,0,665,756,628.99956,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLZF01000029",83.201,0,665,756,628.99956,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_JBGJJV010000032",80.504,0,664,913,735.00152,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FLBI01000046",80.192,0,664,939,753.00288,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLXR01000021",86.491,0,664,607,525.00037,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLRJ01000019",86.491,0,664,607,525.00037,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLWB01000035",86.491,0,664,607,525.00037,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLZF01000029",86.491,0,664,607,525.00037,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLXZ01000020",86.491,0,664,607,525.00037,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FLBI01000046",74.954,0,664,1621,1215.00434,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRI01000021",84.858,0,662,667,566.00286,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRO01000021",84.858,0,662,667,566.00286,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLXR01000021",84.858,0,662,667,566.00286,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRG01000021",84.858,0,662,667,566.00286,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLYG01000019",84.858,0,662,667,566.00286,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRJ01000019",84.858,0,662,667,566.00286,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLSM01000018",84.858,0,662,667,566.00286,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLSQ01000022",84.858,0,662,667,566.00286,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLXY01000024",84.858,0,662,667,566.00286,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLXS01000025",84.858,0,662,667,566.00286,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLUD01000021",84.858,0,662,667,566.00286,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRC01000027",84.858,0,662,667,566.00286,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLYZ01000021",84.858,0,662,667,566.00286,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLSP01000022",84.858,0,662,667,566.00286,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLSH01000020",84.858,0,662,667,566.00286,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLYY01000023",84.858,0,662,667,566.00286,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLYC01000020",84.858,0,662,667,566.00286,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLXZ01000020",84.858,0,662,667,566.00286,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FLBI01000046",81.094,0,660,841,682.00054,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRI01000021",81.065,0,660,845,684.99925,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRO01000021",81.065,0,660,845,684.99925,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRG01000021",81.065,0,660,845,684.99925,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLYG01000019",81.065,0,660,845,684.99925,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLSM01000018",81.065,0,660,845,684.99925,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLSQ01000022",81.065,0,660,845,684.99925,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLXY01000024",81.065,0,660,845,684.99925,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLXS01000025",81.065,0,660,845,684.99925,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLUD01000021",81.065,0,660,845,684.99925,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLRC01000027",81.065,0,660,845,684.99925,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLYZ01000021",81.065,0,660,845,684.99925,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLSP01000022",81.065,0,660,845,684.99925,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLSH01000020",81.065,0,660,845,684.99925,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLYY01000023",81.065,0,660,845,684.99925,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLYC01000020",81.065,0,660,845,684.99925,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRZ01000037",80.13,0,658,921,737.9973,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLWB01000035",80.13,0,658,921,737.9973,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLZF01000029",80.13,0,658,921,737.9973,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_JBGJJV010000032",84.615,0,658,676,571.9974,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FLCN01000004",80.086,0,658,929,743.99894,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_FLBN01000099",80.086,0,658,929,743.99894,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_JBGJJV010000032",85.624,0,658,633,541.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FLBN01000099",74.877,0,658,1620,1213.0074,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_FLCN01000004",74.877,0,658,1620,1213.0074,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FLBI01000046",88.827,0,658,537,477.00099,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FLBN01000099",88.827,0,658,537,477.00099,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_FLCN01000004",88.827,0,658,537,477.00099,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRI01000021",81.28,0,656,844,686.0032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRO01000021",81.28,0,656,844,686.0032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLXR01000021",81.28,0,656,844,686.0032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRG01000021",81.28,0,656,844,686.0032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLYG01000019",81.28,0,656,844,686.0032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRJ01000019",81.28,0,656,844,686.0032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLSM01000018",81.28,0,656,844,686.0032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLSQ01000022",81.28,0,656,844,686.0032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLXY01000024",81.28,0,656,844,686.0032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLXS01000025",81.28,0,656,844,686.0032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLUD01000021",81.28,0,656,844,686.0032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRC01000027",81.28,0,656,844,686.0032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLYZ01000021",81.28,0,656,844,686.0032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLSP01000022",81.28,0,656,844,686.0032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLSH01000020",81.28,0,656,844,686.0032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLYY01000023",81.28,0,656,844,686.0032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLYC01000020",81.28,0,656,844,686.0032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLXZ01000020",81.28,0,656,844,686.0032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRC01000027",81.154,0,656,849,688.99746,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRI01000021",81.154,0,656,849,688.99746,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRO01000021",81.154,0,656,849,688.99746,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRG01000021",81.154,0,656,849,688.99746,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYG01000019",81.154,0,656,849,688.99746,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSM01000018",81.154,0,656,849,688.99746,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSQ01000022",81.154,0,656,849,688.99746,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXY01000024",81.154,0,656,849,688.99746,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXS01000025",81.154,0,656,849,688.99746,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLUD01000021",81.154,0,656,849,688.99746,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYZ01000021",81.154,0,656,849,688.99746,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSP01000022",81.154,0,656,849,688.99746,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSH01000020",81.154,0,656,849,688.99746,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYY01000023",81.154,0,656,849,688.99746,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLYC01000020",81.154,0,656,849,688.99746,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXR01000021",81.154,0,656,849,688.99746,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRJ01000019",81.154,0,656,849,688.99746,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLXZ01000020",81.154,0,656,849,688.99746,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRZ01000037",84.49,0,654,677,571.9973,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLWB01000035",84.49,0,654,677,571.9973,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLZF01000029",84.49,0,654,677,571.9973,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRZ01000037",80.796,0,652,854,689.99784,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLXR01000021",80.796,0,652,854,689.99784,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRJ01000019",80.796,0,652,854,689.99784,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLWB01000035",80.796,0,652,854,689.99784,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLZF01000029",80.796,0,652,854,689.99784,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLXZ01000020",80.796,0,652,854,689.99784,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_JBGJJV010000032",80.774,0,652,853,689.00222,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_JAUEGY010000142",88.022,0,652,551,485.00122,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRI01000021",89.163,0,652,526,468.99738,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRO01000021",89.163,0,652,526,468.99738,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLXR01000021",89.163,0,652,526,468.99738,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRG01000021",89.163,0,652,526,468.99738,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLYG01000019",89.163,0,652,526,468.99738,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRJ01000019",89.163,0,652,526,468.99738,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLSM01000018",89.163,0,652,526,468.99738,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLSQ01000022",89.163,0,652,526,468.99738,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLXY01000024",89.163,0,652,526,468.99738,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLXS01000025",89.163,0,652,526,468.99738,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLUD01000021",89.163,0,652,526,468.99738,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRC01000027",89.163,0,652,526,468.99738,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLYZ01000021",89.163,0,652,526,468.99738,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLSP01000022",89.163,0,652,526,468.99738,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLSH01000020",89.163,0,652,526,468.99738,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLYY01000023",89.163,0,652,526,468.99738,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLYC01000020",89.163,0,652,526,468.99738,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLXZ01000020",89.163,0,652,526,468.99738,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_JBGJJV010000032",84.932,0,652,657,558.00324,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRE01000049",89.143,0,652,525,468.00075,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRI01000021",82.392,0,651,761,627.00312,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRO01000021",82.392,0,651,761,627.00312,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRG01000021",82.392,0,651,761,627.00312,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLYG01000019",82.392,0,651,761,627.00312,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLSM01000018",82.392,0,651,761,627.00312,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLSQ01000022",82.392,0,651,761,627.00312,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLXY01000024",82.392,0,651,761,627.00312,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLXS01000025",82.392,0,651,761,627.00312,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLUD01000021",82.392,0,651,761,627.00312,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLRC01000027",82.392,0,651,761,627.00312,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLYZ01000021",82.392,0,651,761,627.00312,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLSP01000022",82.392,0,651,761,627.00312,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLSH01000020",82.392,0,651,761,627.00312,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLYY01000023",82.392,0,651,761,627.00312,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLYC01000020",82.392,0,651,761,627.00312,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_FLBN01000099",80.285,0,651,913,733.00205,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_FLCN01000004",80.285,0,651,913,733.00205,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRI01000021",88.419,0,651,544,480.99936,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRO01000021",88.419,0,651,544,480.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRG01000021",88.419,0,651,544,480.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLYG01000019",88.419,0,651,544,480.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLSM01000018",88.419,0,651,544,480.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLSQ01000022",88.419,0,651,544,480.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLXY01000024",88.419,0,651,544,480.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLXS01000025",88.419,0,651,544,480.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLUD01000021",88.419,0,651,544,480.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRC01000027",88.419,0,651,544,480.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLYZ01000021",88.419,0,651,544,480.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLSP01000022",88.419,0,651,544,480.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLSH01000020",88.419,0,651,544,480.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLYY01000023",88.419,0,651,544,480.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLYC01000020",88.419,0,651,544,480.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRZ01000037",89.122,0,651,524,466.99928,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLWB01000035",89.122,0,651,524,466.99928,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLZF01000029",89.122,0,651,524,466.99928,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRI01000021",80.992,0,649,847,686.00224,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRO01000021",80.992,0,649,847,686.00224,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXR01000021",80.992,0,649,847,686.00224,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRG01000021",80.992,0,649,847,686.00224,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYG01000019",80.992,0,649,847,686.00224,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRJ01000019",80.992,0,649,847,686.00224,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSM01000018",80.992,0,649,847,686.00224,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSQ01000022",80.992,0,649,847,686.00224,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXY01000024",80.992,0,649,847,686.00224,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXS01000025",80.992,0,649,847,686.00224,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLUD01000021",80.992,0,649,847,686.00224,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRC01000027",80.992,0,649,847,686.00224,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYZ01000021",80.992,0,649,847,686.00224,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSP01000022",80.992,0,649,847,686.00224,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSH01000020",80.992,0,649,847,686.00224,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYY01000023",80.992,0,649,847,686.00224,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYC01000020",80.992,0,649,847,686.00224,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXZ01000020",80.992,0,649,847,686.00224,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_JBGJJV010000032",79.829,0,649,937,747.99773,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FLBN01000099",80.856,0,649,841,679.99896,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_FLCN01000004",80.856,0,649,841,679.99896,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_JAUEGY010000142",87.346,0,649,569,496.99874,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRZ01000037",85.42,0,649,631,539.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLWB01000035",85.42,0,649,631,539.0002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLZF01000029",85.42,0,649,631,539.0002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_JAUEGY010000142",89.272,0,649,522,465.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FLBI01000046",80.657,0,647,853,688.00421,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FLBN01000099",79.894,0,647,940,751.0036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FLCN01000004",79.894,0,647,940,751.0036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRI01000021",89.015,0,647,528,469.9992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRO01000021",89.015,0,647,528,469.9992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLXR01000021",89.015,0,647,528,469.9992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRG01000021",89.015,0,647,528,469.9992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLYG01000019",89.015,0,647,528,469.9992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRJ01000019",89.015,0,647,528,469.9992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLSM01000018",89.015,0,647,528,469.9992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLSQ01000022",89.015,0,647,528,469.9992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLXY01000024",89.015,0,647,528,469.9992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLXS01000025",89.015,0,647,528,469.9992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLUD01000021",89.015,0,647,528,469.9992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRC01000027",89.015,0,647,528,469.9992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLYZ01000021",89.015,0,647,528,469.9992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLSP01000022",89.015,0,647,528,469.9992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLSH01000020",89.015,0,647,528,469.9992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLYY01000023",89.015,0,647,528,469.9992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLYC01000020",89.015,0,647,528,469.9992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLXZ01000020",89.015,0,647,528,469.9992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRI01000021",86.712,0,647,587,508.99944,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRO01000021",86.712,0,647,587,508.99944,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLXR01000021",86.712,0,647,587,508.99944,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRG01000021",86.712,0,647,587,508.99944,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLYG01000019",86.712,0,647,587,508.99944,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRJ01000019",86.712,0,647,587,508.99944,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLSM01000018",86.712,0,647,587,508.99944,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLSQ01000022",86.712,0,647,587,508.99944,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLXY01000024",86.712,0,647,587,508.99944,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLXS01000025",86.712,0,647,587,508.99944,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLUD01000021",86.712,0,647,587,508.99944,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRC01000027",86.712,0,647,587,508.99944,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLYZ01000021",86.712,0,647,587,508.99944,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLSP01000022",86.712,0,647,587,508.99944,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLSH01000020",86.712,0,647,587,508.99944,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLYY01000023",86.712,0,647,587,508.99944,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLYC01000020",86.712,0,647,587,508.99944,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLXZ01000020",86.712,0,647,587,508.99944,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRZ01000037",81.026,0,645,838,678.99788,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLWB01000035",81.026,0,645,838,678.99788,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLZF01000029",81.026,0,645,838,678.99788,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRE01000049",88.235,0,645,544,479.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRZ01000037",88.235,0,645,544,479.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLXR01000021",88.235,0,645,544,479.9984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLRJ01000019",88.235,0,645,544,479.9984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLWB01000035",88.235,0,645,544,479.9984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLZF01000029",88.235,0,645,544,479.9984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLXZ01000020",88.235,0,645,544,479.9984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRI01000021",83.548,0,645,699,584.00052,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRO01000021",83.548,0,645,699,584.00052,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLXR01000021",83.548,0,645,699,584.00052,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRG01000021",83.548,0,645,699,584.00052,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLYG01000019",83.548,0,645,699,584.00052,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRJ01000019",83.548,0,645,699,584.00052,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLSM01000018",83.548,0,645,699,584.00052,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLSQ01000022",83.548,0,645,699,584.00052,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLXY01000024",83.548,0,645,699,584.00052,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLXS01000025",83.548,0,645,699,584.00052,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLUD01000021",83.548,0,645,699,584.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRC01000027",83.548,0,645,699,584.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLYZ01000021",83.548,0,645,699,584.00052,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLSP01000022",83.548,0,645,699,584.00052,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLSH01000020",83.548,0,645,699,584.00052,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLYY01000023",83.548,0,645,699,584.00052,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLYC01000020",83.548,0,645,699,584.00052,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLXZ01000020",83.548,0,645,699,584.00052,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRI01000021",88.931,0,645,524,465.99844,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRO01000021",88.931,0,645,524,465.99844,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLXR01000021",88.931,0,645,524,465.99844,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRG01000021",88.931,0,645,524,465.99844,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLYG01000019",88.931,0,645,524,465.99844,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRJ01000019",88.931,0,645,524,465.99844,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLSM01000018",88.931,0,645,524,465.99844,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLSQ01000022",88.931,0,645,524,465.99844,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLXY01000024",88.931,0,645,524,465.99844,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLXS01000025",88.931,0,645,524,465.99844,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLUD01000021",88.931,0,645,524,465.99844,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLRC01000027",88.931,0,645,524,465.99844,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLYZ01000021",88.931,0,645,524,465.99844,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLSP01000022",88.931,0,645,524,465.99844,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLSH01000020",88.931,0,645,524,465.99844,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLYY01000023",88.931,0,645,524,465.99844,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLYC01000020",88.931,0,645,524,465.99844,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLXZ01000020",88.931,0,645,524,465.99844,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_JAUEGY010000142",87.17,0,643,569,495.9973,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLRE01000049",82.672,0,643,756,625.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_JBGJJV010000032",85.714,0,641,609,521.99826,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_JAUEGY010000142",87.89,0,641,545,479.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_JAUEGY010000142",87.367,0,641,562,491.00254,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRI01000021",87.59,0,640,556,487.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRZ01000037",87.59,0,640,556,487.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRO01000021",87.59,0,640,556,487.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLXR01000021",87.59,0,640,556,487.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRG01000021",87.59,0,640,556,487.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLYG01000019",87.59,0,640,556,487.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRJ01000019",87.59,0,640,556,487.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLSM01000018",87.59,0,640,556,487.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLSQ01000022",87.59,0,640,556,487.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLXY01000024",87.59,0,640,556,487.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLXS01000025",87.59,0,640,556,487.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLWB01000035",87.59,0,640,556,487.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLUD01000021",87.59,0,640,556,487.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRC01000027",87.59,0,640,556,487.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLYZ01000021",87.59,0,640,556,487.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLSP01000022",87.59,0,640,556,487.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLZF01000029",87.59,0,640,556,487.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLSH01000020",87.59,0,640,556,487.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLYY01000023",87.59,0,640,556,487.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLYC01000020",87.59,0,640,556,487.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLXZ01000020",87.59,0,640,556,487.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_JBGJJV010000032",88.17,0,640,541,476.9997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_JBGJJV010000032",88.74,0,640,524,464.9976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FLBI01000046",83.264,0,638,717,597.00288,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_FLBI01000046",80.907,0,638,838,678.00066,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FLBN01000099",80.422,2.59e-180,636,853,685.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_FLCN01000004",80.422,2.59e-180,636,853,685.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRZ01000037",84.498,1.72e-180,636,658,555.99684,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLWB01000035",84.498,1.72e-180,636,658,555.99684,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLZF01000029",84.498,1.72e-180,636,658,555.99684,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_JBGJJV010000032",83.171,6.6e-180,634,719,597.99949,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_JBGJJV010000032",87.387,5.13e-180,634,555,484.99785,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FLBI01000046",87.985,5.04e-180,634,541,475.99885,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FLBN01000099",83.171,2.37e-179,632,719,597.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_FLCN01000004",83.171,2.37e-179,632,719,597.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRZ01000037",79.912,3.19e-179,632,906,724.00272,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLWB01000035",79.912,3.19e-179,632,906,724.00272,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLZF01000029",79.912,3.19e-179,632,906,724.00272,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_JBGJJV010000032",80.81,3.16e-179,632,839,677.9959,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FLBN01000099",88.697,1.81e-179,632,522,462.99834,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_FLCN01000004",88.697,1.81e-179,632,522,462.99834,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_FLBN01000099",84.195,7.89e-179,630,658,554.0031,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_FLCN01000004",84.195,7.89e-179,630,658,554.0031,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_JBGJJV010000032",84.195,7.89e-179,630,658,554.0031,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRE01000049",80.999,3.56e-178,628,821,665.00179,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLWB01000035",82.166,3.5e-178,628,757,621.99662,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLZF01000029",82.166,3.5e-178,628,757,621.99662,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLRE01000049",87.23,2.39e-178,628,556,484.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_FLBN01000099",88.224,2.28e-178,628,535,471.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_FLCN01000004",88.224,2.28e-178,628,535,471.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRI01000021",80.714,4.08e-178,628,840,677.9976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRO01000021",80.714,4.08e-178,628,840,677.9976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLXR01000021",80.714,4.08e-178,628,840,677.9976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRG01000021",80.714,4.08e-178,628,840,677.9976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLYG01000019",80.714,4.08e-178,628,840,677.9976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRJ01000019",80.714,4.08e-178,628,840,677.9976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLSM01000018",80.714,4.08e-178,628,840,677.9976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLSQ01000022",80.714,4.08e-178,628,840,677.9976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLXY01000024",80.714,4.08e-178,628,840,677.9976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLXS01000025",80.714,4.08e-178,628,840,677.9976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLUD01000021",80.714,4.08e-178,628,840,677.9976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRC01000027",80.714,4.08e-178,628,840,677.9976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLYZ01000021",80.714,4.08e-178,628,840,677.9976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLSP01000022",80.714,4.08e-178,628,840,677.9976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLSH01000020",80.714,4.08e-178,628,840,677.9976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLYY01000023",80.714,4.08e-178,628,840,677.9976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLYC01000020",80.714,4.08e-178,628,840,677.9976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLXZ01000020",80.714,4.08e-178,628,840,677.9976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRI01000021",85.366,1.04e-177,627,615,525.0009,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRO01000021",85.366,1.04e-177,627,615,525.0009,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLXR01000021",85.366,1.04e-177,627,615,525.0009,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRG01000021",85.366,1.04e-177,627,615,525.0009,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLYG01000019",85.366,1.04e-177,627,615,525.0009,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRJ01000019",85.366,1.04e-177,627,615,525.0009,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLSM01000018",85.366,1.04e-177,627,615,525.0009,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLSQ01000022",85.366,1.04e-177,627,615,525.0009,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLXY01000024",85.366,1.04e-177,627,615,525.0009,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLXS01000025",85.366,1.04e-177,627,615,525.0009,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLUD01000021",85.366,1.04e-177,627,615,525.0009,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRC01000027",85.366,1.04e-177,627,615,525.0009,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLYZ01000021",85.366,1.04e-177,627,615,525.0009,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLSP01000022",85.366,1.04e-177,627,615,525.0009,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLSH01000020",85.366,1.04e-177,627,615,525.0009,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLYY01000023",85.366,1.04e-177,627,615,525.0009,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLYC01000020",85.366,1.04e-177,627,615,525.0009,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLXZ01000020",85.366,1.04e-177,627,615,525.0009,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_JBGJJV010000032",79.65,1.48e-177,627,914,728.001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRZ01000037",84.043,1.02e-177,627,658,553.00294,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLWB01000035",84.043,1.02e-177,627,658,553.00294,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLZF01000029",84.043,1.02e-177,627,658,553.00294,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_FLBI01000046",84.043,3.67e-177,625,658,553.00294,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRZ01000037",82.917,1.43e-176,623,720,597.0024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLWB01000035",82.917,1.43e-176,623,720,597.0024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLZF01000029",82.917,1.43e-176,623,720,597.0024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FLBI01000046",80.877,1.66e-176,623,821,664.00017,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_JBGJJV010000032",80.877,1.66e-176,623,821,664.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FLBI01000046",87.027,1.11e-176,623,555,482.99985,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_FLBI01000046",84.195,1.34e-176,623,658,554.0031,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRI01000021",85.246,1.73e-176,623,610,520.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRO01000021",85.246,1.73e-176,623,610,520.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLXR01000021",85.246,1.73e-176,623,610,520.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRG01000021",85.246,1.73e-176,623,610,520.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLYG01000019",85.246,1.73e-176,623,610,520.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRJ01000019",85.246,1.73e-176,623,610,520.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLSM01000018",85.246,1.73e-176,623,610,520.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLSQ01000022",85.246,1.73e-176,623,610,520.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLXY01000024",85.246,1.73e-176,623,610,520.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLXS01000025",85.246,1.73e-176,623,610,520.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLUD01000021",85.246,1.73e-176,623,610,520.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRC01000027",85.246,1.73e-176,623,610,520.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLYZ01000021",85.246,1.73e-176,623,610,520.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLSP01000022",85.246,1.73e-176,623,610,520.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLSH01000020",85.246,1.73e-176,623,610,520.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLYY01000023",85.246,1.73e-176,623,610,520.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLYC01000020",85.246,1.73e-176,623,610,520.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLXZ01000020",85.246,1.73e-176,623,610,520.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_FLBI01000046",87.805,3.84e-176,621,533,468.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_FLBN01000099",87.85,3.84e-176,621,535,469.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_FLCN01000004",87.85,3.84e-176,621,535,469.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_JBGJJV010000032",82.011,5.86e-176,621,756,620.00316,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_FLBN01000099",80.572,6.83e-176,621,839,675.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_FLCN01000004",80.572,6.83e-176,621,839,675.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_JBGJJV010000032",74.444,1.18e-175,621,1620,1205.9928,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRI01000021",88.023,3.06e-175,619,526,463.00098,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRO01000021",88.023,3.06e-175,619,526,463.00098,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLXR01000021",88.023,3.06e-175,619,526,463.00098,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRG01000021",88.023,3.06e-175,619,526,463.00098,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLYG01000019",88.023,3.06e-175,619,526,463.00098,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRJ01000019",88.023,3.06e-175,619,526,463.00098,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLSM01000018",88.023,3.06e-175,619,526,463.00098,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLSQ01000022",88.023,3.06e-175,619,526,463.00098,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLXY01000024",88.023,3.06e-175,619,526,463.00098,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLXS01000025",88.023,3.06e-175,619,526,463.00098,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLUD01000021",88.023,3.06e-175,619,526,463.00098,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRC01000027",88.023,3.06e-175,619,526,463.00098,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLYZ01000021",88.023,3.06e-175,619,526,463.00098,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLSP01000022",88.023,3.06e-175,619,526,463.00098,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLSH01000020",88.023,3.06e-175,619,526,463.00098,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLYY01000023",88.023,3.06e-175,619,526,463.00098,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLYC01000020",88.023,3.06e-175,619,526,463.00098,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLXZ01000020",88.023,3.06e-175,619,526,463.00098,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLRE01000049",81.675,2.46e-175,619,764,623.997,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FLBN01000099",80.755,7.71e-175,617,821,662.99855,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_FLCN01000004",80.755,7.71e-175,617,821,662.99855,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRZ01000037",80.755,7.71e-175,617,821,662.99855,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLXR01000021",80.755,7.71e-175,617,821,662.99855,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRJ01000019",80.755,7.71e-175,617,821,662.99855,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLWB01000035",80.755,7.71e-175,617,821,662.99855,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLZF01000029",80.755,7.71e-175,617,821,662.99855,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLXZ01000020",80.755,7.71e-175,617,821,662.99855,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRZ01000037",81.902,7.59e-175,617,757,619.99814,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_FLBI01000046",87.85,4.93e-175,617,535,469.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRC01000027",88.35,5.82e-175,617,515,455.0025,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_FLBN01000099",84.043,6.22e-175,617,658,553.00294,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_FLCN01000004",84.043,6.22e-175,617,658,553.00294,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRE01000049",83.784,6.2e-175,617,666,558.00144,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FLBI01000046",82.979,6.57e-175,617,705,585.00195,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_FLBN01000099",88.735,1.72e-174,616,506,448.9991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_FLCN01000004",88.735,1.72e-174,616,506,448.9991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRE01000049",87.687,6.38e-174,614,536,470.00232,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_FLBI01000046",79.431,1.15e-173,614,914,725.99934,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_FLBN01000099",79.431,1.15e-173,614,914,725.99934,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_FLCN01000004",79.431,1.15e-173,614,914,725.99934,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRE01000049",80.512,1.16e-173,614,821,661.00352,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FLBI01000046",74.779,1.9e-173,614,1586,1185.99494,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FLCN01000004",74.779,1.9e-173,614,1586,1185.99494,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRI01000021",80.68,3.59e-173,612,823,663.9964,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRO01000021",80.68,3.59e-173,612,823,663.9964,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRG01000021",80.68,3.59e-173,612,823,663.9964,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLYG01000019",80.68,3.59e-173,612,823,663.9964,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLSM01000018",80.68,3.59e-173,612,823,663.9964,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLSQ01000022",80.68,3.59e-173,612,823,663.9964,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLXY01000024",80.68,3.59e-173,612,823,663.9964,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLXS01000025",80.68,3.59e-173,612,823,663.9964,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLUD01000021",80.68,3.59e-173,612,823,663.9964,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLRC01000027",80.68,3.59e-173,612,823,663.9964,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLYZ01000021",80.68,3.59e-173,612,823,663.9964,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLSP01000022",80.68,3.59e-173,612,823,663.9964,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLSH01000020",80.68,3.59e-173,612,823,663.9964,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLYY01000023",80.68,3.59e-173,612,823,663.9964,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLYC01000020",80.68,3.59e-173,612,823,663.9964,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FLBN01000099",86.667,2.4e-173,612,555,481.00185,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_FLCN01000004",86.667,2.4e-173,612,555,481.00185,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_JBGJJV010000032",87.687,2.29e-173,612,536,470.00232,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FLBI01000046",88.155,2.71e-173,612,515,453.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FLBN01000099",88.155,2.71e-173,612,515,453.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRI01000021",88.155,2.71e-173,612,515,453.99825,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_FLCN01000004",88.155,2.71e-173,612,515,453.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRZ01000037",88.155,2.71e-173,612,515,453.99825,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRO01000021",88.155,2.71e-173,612,515,453.99825,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRG01000021",88.155,2.71e-173,612,515,453.99825,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLYG01000019",88.155,2.71e-173,612,515,453.99825,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLSM01000018",88.155,2.71e-173,612,515,453.99825,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLSQ01000022",88.155,2.71e-173,612,515,453.99825,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLXY01000024",88.155,2.71e-173,612,515,453.99825,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLXS01000025",88.155,2.71e-173,612,515,453.99825,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLUD01000021",88.155,2.71e-173,612,515,453.99825,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLYZ01000021",88.155,2.71e-173,612,515,453.99825,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLSP01000022",88.155,2.71e-173,612,515,453.99825,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLSH01000020",88.155,2.71e-173,612,515,453.99825,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLYY01000023",88.155,2.71e-173,612,515,453.99825,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLYC01000020",88.155,2.71e-173,612,515,453.99825,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_JBGJJV010000032",87.5,8.32e-173,610,536,469,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FLBI01000046",85.959,1.27e-172,610,584,502.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FLBN01000099",85.959,1.27e-172,610,584,502.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_FLCN01000004",85.959,1.27e-172,610,584,502.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_FLBI01000046",88.538,8e-173,610,506,448.00228,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRE01000049",82.695,1.1e-172,610,705,582.99975,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_JBGJJV010000032",85.338,9.65e-173,610,607,518.00166,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRZ01000037",80.39,5.42e-172,608,821,660.0019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLWB01000035",80.39,5.42e-172,608,821,660.0019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLZF01000029",80.39,5.42e-172,608,821,660.0019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLRE01000049",89.184,6.99e-172,608,490,437.0016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_FLBN01000099",74.716,8.82e-172,608,1586,1184.99576,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FLBI01000046",86.631,3.47e-172,608,561,485.99991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FLBN01000099",86.631,3.47e-172,608,561,485.99991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_FLCN01000004",86.631,3.47e-172,608,561,485.99991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRZ01000037",87.313,1.08e-171,606,536,467.99768,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLWB01000035",87.313,1.08e-171,606,536,467.99768,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLZF01000029",87.313,1.08e-171,606,536,467.99768,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLXR01000021",87.961,1.26e-171,606,515,452.99915,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRJ01000019",87.961,1.26e-171,606,515,452.99915,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLWB01000035",87.961,1.26e-171,606,515,452.99915,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLZF01000029",87.961,1.26e-171,606,515,452.99915,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLXZ01000020",87.961,1.26e-171,606,515,452.99915,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FLBI01000046",83.459,1.34e-171,606,665,555.00235,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRI01000021",83.483,1.34e-171,606,666,555.99678,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRZ01000037",83.483,1.34e-171,606,666,555.99678,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRO01000021",83.483,1.34e-171,606,666,555.99678,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLXR01000021",83.483,1.34e-171,606,666,555.99678,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRG01000021",83.483,1.34e-171,606,666,555.99678,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLYG01000019",83.483,1.34e-171,606,666,555.99678,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRJ01000019",83.483,1.34e-171,606,666,555.99678,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLSM01000018",83.483,1.34e-171,606,666,555.99678,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLSQ01000022",83.483,1.34e-171,606,666,555.99678,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLXY01000024",83.483,1.34e-171,606,666,555.99678,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLXS01000025",83.483,1.34e-171,606,666,555.99678,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLWB01000035",83.483,1.34e-171,606,666,555.99678,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLUD01000021",83.483,1.34e-171,606,666,555.99678,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLRC01000027",83.483,1.34e-171,606,666,555.99678,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLYZ01000021",83.483,1.34e-171,606,666,555.99678,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLSP01000022",83.483,1.34e-171,606,666,555.99678,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLZF01000029",83.483,1.34e-171,606,666,555.99678,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLSH01000020",83.483,1.34e-171,606,666,555.99678,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLYY01000023",83.483,1.34e-171,606,666,555.99678,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLYC01000020",83.483,1.34e-171,606,666,555.99678,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLXZ01000020",83.483,1.34e-171,606,666,555.99678,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRI01000021",85.333,4.52e-171,604,600,511.998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRO01000021",85.333,4.52e-171,604,600,511.998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLXR01000021",85.333,4.52e-171,604,600,511.998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRG01000021",85.333,4.52e-171,604,600,511.998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLYG01000019",85.333,4.52e-171,604,600,511.998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRJ01000019",85.333,4.52e-171,604,600,511.998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLSM01000018",85.333,4.52e-171,604,600,511.998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLSQ01000022",85.333,4.52e-171,604,600,511.998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLXY01000024",85.333,4.52e-171,604,600,511.998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLXS01000025",85.333,4.52e-171,604,600,511.998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLUD01000021",85.333,4.52e-171,604,600,511.998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRC01000027",85.333,4.52e-171,604,600,511.998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLYZ01000021",85.333,4.52e-171,604,600,511.998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLSP01000022",85.333,4.52e-171,604,600,511.998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLSH01000020",85.333,4.52e-171,604,600,511.998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLYY01000023",85.333,4.52e-171,604,600,511.998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLYC01000020",85.333,4.52e-171,604,600,511.998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLXZ01000020",85.333,4.52e-171,604,600,511.998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRI01000021",85.279,4.78e-171,604,591,503.99889,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRO01000021",85.279,4.78e-171,604,591,503.99889,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLXR01000021",85.279,4.78e-171,604,591,503.99889,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRG01000021",85.279,4.78e-171,604,591,503.99889,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLYG01000019",85.279,4.78e-171,604,591,503.99889,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRJ01000019",85.279,4.78e-171,604,591,503.99889,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLSM01000018",85.279,4.78e-171,604,591,503.99889,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLSQ01000022",85.279,4.78e-171,604,591,503.99889,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLXY01000024",85.279,4.78e-171,604,591,503.99889,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLXS01000025",85.279,4.78e-171,604,591,503.99889,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLUD01000021",85.279,4.78e-171,604,591,503.99889,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRC01000027",85.279,4.78e-171,604,591,503.99889,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLYZ01000021",85.279,4.78e-171,604,591,503.99889,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLSP01000022",85.279,4.78e-171,604,591,503.99889,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLSH01000020",85.279,4.78e-171,604,591,503.99889,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLYY01000023",85.279,4.78e-171,604,591,503.99889,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLYC01000020",85.279,4.78e-171,604,591,503.99889,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLXZ01000020",85.279,4.78e-171,604,591,503.99889,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_JBGJJV010000032",87.382,1.37e-170,603,531,463.99842,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRI01000021",87.313,1.38e-170,603,536,467.99768,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRO01000021",87.313,1.38e-170,603,536,467.99768,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLXR01000021",87.313,1.38e-170,603,536,467.99768,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRG01000021",87.313,1.38e-170,603,536,467.99768,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLYG01000019",87.313,1.38e-170,603,536,467.99768,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRJ01000019",87.313,1.38e-170,603,536,467.99768,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLSM01000018",87.313,1.38e-170,603,536,467.99768,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLSQ01000022",87.313,1.38e-170,603,536,467.99768,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLXY01000024",87.313,1.38e-170,603,536,467.99768,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLXS01000025",87.313,1.38e-170,603,536,467.99768,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLUD01000021",87.313,1.38e-170,603,536,467.99768,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRC01000027",87.313,1.38e-170,603,536,467.99768,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLYZ01000021",87.313,1.38e-170,603,536,467.99768,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLSP01000022",87.313,1.38e-170,603,536,467.99768,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLSH01000020",87.313,1.38e-170,603,536,467.99768,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLYY01000023",87.313,1.38e-170,603,536,467.99768,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLYC01000020",87.313,1.38e-170,603,536,467.99768,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLXZ01000020",87.313,1.38e-170,603,536,467.99768,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLXR01000021",80.268,2.52e-170,603,821,659.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRJ01000019",80.268,2.52e-170,603,821,659.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLXZ01000020",80.268,2.52e-170,603,821,659.00028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FLBI01000046",85.544,1.53e-170,603,588,502.99872,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRI01000021",85.544,1.53e-170,603,588,502.99872,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRZ01000037",85.544,1.53e-170,603,588,502.99872,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRO01000021",85.544,1.53e-170,603,588,502.99872,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLXR01000021",85.544,1.53e-170,603,588,502.99872,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRG01000021",85.544,1.53e-170,603,588,502.99872,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLYG01000019",85.544,1.53e-170,603,588,502.99872,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRJ01000019",85.544,1.53e-170,603,588,502.99872,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLSM01000018",85.544,1.53e-170,603,588,502.99872,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLSQ01000022",85.544,1.53e-170,603,588,502.99872,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLXY01000024",85.544,1.53e-170,603,588,502.99872,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLXS01000025",85.544,1.53e-170,603,588,502.99872,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLWB01000035",85.544,1.53e-170,603,588,502.99872,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLUD01000021",85.544,1.53e-170,603,588,502.99872,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRC01000027",85.544,1.53e-170,603,588,502.99872,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLYZ01000021",85.544,1.53e-170,603,588,502.99872,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLSP01000022",85.544,1.53e-170,603,588,502.99872,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLZF01000029",85.544,1.53e-170,603,588,502.99872,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLSH01000020",85.544,1.53e-170,603,588,502.99872,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLYY01000023",85.544,1.53e-170,603,588,502.99872,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLYC01000020",85.544,1.53e-170,603,588,502.99872,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLXZ01000020",85.544,1.53e-170,603,588,502.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLRE01000049",87.767,5.86e-170,601,515,452.00005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_JBGJJV010000032",87.767,5.86e-170,601,515,452.00005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FLBI01000046",86.827,6.49e-170,601,539,467.99753,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FLBN01000099",86.827,6.49e-170,601,539,467.99753,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_FLCN01000004",86.827,6.49e-170,601,539,467.99753,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_JAUEGY010000142",86.827,6.49e-170,601,539,467.99753,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_JBGJJV010000032",83.308,6.24e-170,601,665,553.9982,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRI01000021",82.411,2.38e-169,599,705,580.99755,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRZ01000037",82.411,2.38e-169,599,705,580.99755,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRO01000021",82.411,2.38e-169,599,705,580.99755,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLXR01000021",82.411,2.38e-169,599,705,580.99755,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRG01000021",82.411,2.38e-169,599,705,580.99755,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLYG01000019",82.411,2.38e-169,599,705,580.99755,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRJ01000019",82.411,2.38e-169,599,705,580.99755,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLSM01000018",82.411,2.38e-169,599,705,580.99755,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLSQ01000022",82.411,2.38e-169,599,705,580.99755,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLXY01000024",82.411,2.38e-169,599,705,580.99755,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLXS01000025",82.411,2.38e-169,599,705,580.99755,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLWB01000035",82.411,2.38e-169,599,705,580.99755,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLUD01000021",82.411,2.38e-169,599,705,580.99755,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLRC01000027",82.411,2.38e-169,599,705,580.99755,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLYZ01000021",82.411,2.38e-169,599,705,580.99755,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLSP01000022",82.411,2.38e-169,599,705,580.99755,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLZF01000029",82.411,2.38e-169,599,705,580.99755,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLSH01000020",82.411,2.38e-169,599,705,580.99755,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLYY01000023",82.411,2.38e-169,599,705,580.99755,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLYC01000020",82.411,2.38e-169,599,705,580.99755,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLXZ01000020",82.411,2.38e-169,599,705,580.99755,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRI01000021",87.194,6.4e-169,597,531,463.00014,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRZ01000037",87.194,6.4e-169,597,531,463.00014,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRO01000021",87.194,6.4e-169,597,531,463.00014,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLXR01000021",87.194,6.4e-169,597,531,463.00014,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRG01000021",87.194,6.4e-169,597,531,463.00014,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLYG01000019",87.194,6.4e-169,597,531,463.00014,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRJ01000019",87.194,6.4e-169,597,531,463.00014,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLSM01000018",87.194,6.4e-169,597,531,463.00014,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLSQ01000022",87.194,6.4e-169,597,531,463.00014,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLXY01000024",87.194,6.4e-169,597,531,463.00014,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLXS01000025",87.194,6.4e-169,597,531,463.00014,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLWB01000035",87.194,6.4e-169,597,531,463.00014,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLUD01000021",87.194,6.4e-169,597,531,463.00014,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRC01000027",87.194,6.4e-169,597,531,463.00014,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLYZ01000021",87.194,6.4e-169,597,531,463.00014,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLSP01000022",87.194,6.4e-169,597,531,463.00014,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLZF01000029",87.194,6.4e-169,597,531,463.00014,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLSH01000020",87.194,6.4e-169,597,531,463.00014,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLYY01000023",87.194,6.4e-169,597,531,463.00014,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLYC01000020",87.194,6.4e-169,597,531,463.00014,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLXZ01000020",87.194,6.4e-169,597,531,463.00014,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_JBGJJV010000032",88.119,6.23e-169,597,505,445.00095,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRI01000021",80.146,1.17e-168,597,821,657.99866,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRO01000021",80.146,1.17e-168,597,821,657.99866,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRG01000021",80.146,1.17e-168,597,821,657.99866,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLYG01000019",80.146,1.17e-168,597,821,657.99866,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLSM01000018",80.146,1.17e-168,597,821,657.99866,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLSQ01000022",80.146,1.17e-168,597,821,657.99866,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLXY01000024",80.146,1.17e-168,597,821,657.99866,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLXS01000025",80.146,1.17e-168,597,821,657.99866,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLUD01000021",80.146,1.17e-168,597,821,657.99866,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLRC01000027",80.146,1.17e-168,597,821,657.99866,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLYZ01000021",80.146,1.17e-168,597,821,657.99866,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLSP01000022",80.146,1.17e-168,597,821,657.99866,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLSH01000020",80.146,1.17e-168,597,821,657.99866,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLYY01000023",80.146,1.17e-168,597,821,657.99866,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLYC01000020",80.146,1.17e-168,597,821,657.99866,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FLBN01000099",85.374,7.14e-169,597,588,501.99912,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_FLCN01000004",85.374,7.14e-169,597,588,501.99912,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_JBGJJV010000032",85.374,7.14e-169,597,588,501.99912,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRI01000021",86.642,3.02e-168,595,539,467.00038,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRO01000021",86.642,3.02e-168,595,539,467.00038,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRG01000021",86.642,3.02e-168,595,539,467.00038,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLYG01000019",86.642,3.02e-168,595,539,467.00038,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLSM01000018",86.642,3.02e-168,595,539,467.00038,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLSQ01000022",86.642,3.02e-168,595,539,467.00038,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLXY01000024",86.642,3.02e-168,595,539,467.00038,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLXS01000025",86.642,3.02e-168,595,539,467.00038,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLUD01000021",86.642,3.02e-168,595,539,467.00038,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRC01000027",86.642,3.02e-168,595,539,467.00038,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLYZ01000021",86.642,3.02e-168,595,539,467.00038,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLSP01000022",86.642,3.02e-168,595,539,467.00038,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLSH01000020",86.642,3.02e-168,595,539,467.00038,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLYY01000023",86.642,3.02e-168,595,539,467.00038,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLYC01000020",86.642,3.02e-168,595,539,467.00038,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FLBN01000099",83.158,2.9e-168,595,665,553.0007,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_FLCN01000004",83.158,2.9e-168,595,665,553.0007,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLWB01000035",84.754,2.7e-168,595,610,516.9994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLZF01000029",84.754,2.7e-168,595,610,516.9994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FLBN01000099",82.436,3.08e-168,595,706,581.99816,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_FLCN01000004",82.436,3.08e-168,595,706,581.99816,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRZ01000037",87.945,8.06e-168,593,506,445.0017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLWB01000035",87.945,8.06e-168,593,506,445.0017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLZF01000029",87.945,8.06e-168,593,506,445.0017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_FLBI01000046",83.409,1.02e-167,593,657,547.99713,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_JAUEGY010000142",89.849,8.64e-168,593,463,416.00087,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FLBN01000099",84.95,3.52e-167,592,598,508.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FLCN01000004",84.95,3.52e-167,592,598,508.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FLBI01000046",87.006,2.98e-167,592,531,462.00186,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRI01000021",87.921,2.9e-167,592,505,444.00105,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRO01000021",87.921,2.9e-167,592,505,444.00105,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLXR01000021",87.921,2.9e-167,592,505,444.00105,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRG01000021",87.921,2.9e-167,592,505,444.00105,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLYG01000019",87.921,2.9e-167,592,505,444.00105,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRJ01000019",87.921,2.9e-167,592,505,444.00105,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLSM01000018",87.921,2.9e-167,592,505,444.00105,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLSQ01000022",87.921,2.9e-167,592,505,444.00105,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLXY01000024",87.921,2.9e-167,592,505,444.00105,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLXS01000025",87.921,2.9e-167,592,505,444.00105,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLUD01000021",87.921,2.9e-167,592,505,444.00105,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRC01000027",87.921,2.9e-167,592,505,444.00105,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLYZ01000021",87.921,2.9e-167,592,505,444.00105,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLSP01000022",87.921,2.9e-167,592,505,444.00105,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLSH01000020",87.921,2.9e-167,592,505,444.00105,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLYY01000023",87.921,2.9e-167,592,505,444.00105,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLYC01000020",87.921,2.9e-167,592,505,444.00105,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLXZ01000020",87.921,2.9e-167,592,505,444.00105,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FLBI01000046",80,5.46e-167,592,820,656,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FLBN01000099",80,5.46e-167,592,820,656,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_FLCN01000004",80,5.46e-167,592,820,656,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRI01000021",84.925,3.77e-167,592,597,507.00225,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRO01000021",84.925,3.77e-167,592,597,507.00225,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLXR01000021",84.925,3.77e-167,592,597,507.00225,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRG01000021",84.925,3.77e-167,592,597,507.00225,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLYG01000019",84.925,3.77e-167,592,597,507.00225,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRJ01000019",84.925,3.77e-167,592,597,507.00225,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLSM01000018",84.925,3.77e-167,592,597,507.00225,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLSQ01000022",84.925,3.77e-167,592,597,507.00225,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLXY01000024",84.925,3.77e-167,592,597,507.00225,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLXS01000025",84.925,3.77e-167,592,597,507.00225,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLUD01000021",84.925,3.77e-167,592,597,507.00225,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRC01000027",84.925,3.77e-167,592,597,507.00225,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLYZ01000021",84.925,3.77e-167,592,597,507.00225,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLSP01000022",84.925,3.77e-167,592,597,507.00225,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLSH01000020",84.925,3.77e-167,592,597,507.00225,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLYY01000023",84.925,3.77e-167,592,597,507.00225,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLYC01000020",84.925,3.77e-167,592,597,507.00225,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLXZ01000020",84.925,3.77e-167,592,597,507.00225,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLWB01000035",81.234,1.53e-166,590,778,632.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLZF01000029",81.234,1.53e-166,590,778,632.00052,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRE01000049",86.456,1.41e-166,590,539,465.99784,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRZ01000037",86.456,1.41e-166,590,539,465.99784,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLXR01000021",86.456,1.41e-166,590,539,465.99784,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLRJ01000019",86.456,1.41e-166,590,539,465.99784,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLWB01000035",86.456,1.41e-166,590,539,465.99784,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLZF01000029",86.456,1.41e-166,590,539,465.99784,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLXZ01000020",86.456,1.41e-166,590,539,465.99784,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_JBGJJV010000032",86.456,1.41e-166,590,539,465.99784,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRI01000021",82.32,1.43e-166,590,707,582.0024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRZ01000037",82.27,1.43e-166,590,705,580.0035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRO01000021",82.32,1.43e-166,590,707,582.0024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLXR01000021",82.32,1.43e-166,590,707,582.0024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRG01000021",82.32,1.43e-166,590,707,582.0024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLYG01000019",82.32,1.43e-166,590,707,582.0024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRJ01000019",82.32,1.43e-166,590,707,582.0024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLSM01000018",82.32,1.43e-166,590,707,582.0024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLSQ01000022",82.32,1.43e-166,590,707,582.0024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLXY01000024",82.32,1.43e-166,590,707,582.0024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLXS01000025",82.32,1.43e-166,590,707,582.0024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLWB01000035",82.27,1.43e-166,590,705,580.0035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLUD01000021",82.32,1.43e-166,590,707,582.0024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRC01000027",82.32,1.43e-166,590,707,582.0024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLYZ01000021",82.32,1.43e-166,590,707,582.0024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLSP01000022",82.32,1.43e-166,590,707,582.0024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLZF01000029",82.27,1.43e-166,590,705,580.0035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLSH01000020",82.32,1.43e-166,590,707,582.0024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLYY01000023",82.32,1.43e-166,590,707,582.0024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLYC01000020",82.32,1.43e-166,590,707,582.0024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLXZ01000020",82.32,1.43e-166,590,707,582.0024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_JBGJJV010000032",83.283,1.32e-166,590,658,548.00214,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_FLBI01000046",82.378,1.42e-166,590,698,574.99844,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRZ01000037",84.859,4.55e-166,588,601,510.00259,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLWB01000035",84.859,4.55e-166,588,601,510.00259,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLZF01000029",84.859,4.55e-166,588,601,510.00259,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FLBI01000046",82.153,5.16e-166,588,706,580.00018,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_JBGJJV010000032",82.153,5.16e-166,588,706,580.00018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLRE01000049",81.175,1.76e-165,588,749,608.00075,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_FLBN01000099",83.257,4.76e-166,588,657,546.99849,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_FLCN01000004",83.257,4.76e-166,588,657,546.99849,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_FLBI01000046",84.783,1.64e-165,586,598,507.00234,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_JBGJJV010000032",84.783,1.64e-165,586,598,507.00234,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLRE01000049",86.817,1.38e-165,586,531,460.99827,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLRZ01000037",86.729,1.39e-165,586,535,464.00015,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLWB01000035",86.729,1.39e-165,586,535,464.00015,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLZF01000029",86.729,1.39e-165,586,535,464.00015,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_JBGJJV010000032",79.903,2.54e-165,586,821,656.00363,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRZ01000037",86.126,1.63e-165,586,555,477.9993,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRI01000021",88.525,5.04e-165,584,488,432.002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRO01000021",88.525,5.04e-165,584,488,432.002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLXR01000021",88.525,5.04e-165,584,488,432.002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRG01000021",88.525,5.04e-165,584,488,432.002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLYG01000019",88.525,5.04e-165,584,488,432.002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRJ01000019",88.525,5.04e-165,584,488,432.002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLSM01000018",88.525,5.04e-165,584,488,432.002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLSQ01000022",88.525,5.04e-165,584,488,432.002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLXY01000024",88.525,5.04e-165,584,488,432.002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLXS01000025",88.525,5.04e-165,584,488,432.002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLUD01000021",88.525,5.04e-165,584,488,432.002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRC01000027",88.525,5.04e-165,584,488,432.002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLYZ01000021",88.525,5.04e-165,584,488,432.002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLSP01000022",88.525,5.04e-165,584,488,432.002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLSH01000020",88.525,5.04e-165,584,488,432.002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLYY01000023",88.525,5.04e-165,584,488,432.002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLYC01000020",88.525,5.04e-165,584,488,432.002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLXZ01000020",88.525,5.04e-165,584,488,432.002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_FLBN01000099",84.957,5.5e-165,584,585,496.99845,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_FLCN01000004",84.957,5.5e-165,584,585,496.99845,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_FLBI01000046",81.283,8.85e-165,584,748,607.99684,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRZ01000037",81.105,7.14e-165,584,778,630.9969,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_FLBN01000099",85.077,5.47e-165,584,583,495.99891,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_FLCN01000004",85.077,5.47e-165,584,583,495.99891,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_JBGJJV010000032",88.797,5.63e-165,584,482,428.00154,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FLBN01000099",82.037,2.4e-164,582,707,580.00159,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_FLCN01000004",82.037,2.4e-164,582,707,580.00159,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRI01000021",80.715,4.95e-164,582,783,631.99845,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRO01000021",80.715,4.95e-164,582,783,631.99845,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLXR01000021",80.715,4.95e-164,582,783,631.99845,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRG01000021",80.715,4.95e-164,582,783,631.99845,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLYG01000019",80.715,4.95e-164,582,783,631.99845,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRJ01000019",80.715,4.95e-164,582,783,631.99845,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLSM01000018",80.715,4.95e-164,582,783,631.99845,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLSQ01000022",80.715,4.95e-164,582,783,631.99845,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLXY01000024",80.715,4.95e-164,582,783,631.99845,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLXS01000025",80.715,4.95e-164,582,783,631.99845,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLUD01000021",80.715,4.95e-164,582,783,631.99845,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRC01000027",80.715,4.95e-164,582,783,631.99845,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLYZ01000021",80.715,4.95e-164,582,783,631.99845,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLSP01000022",80.715,4.95e-164,582,783,631.99845,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLSH01000020",80.715,4.95e-164,582,783,631.99845,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLYY01000023",80.715,4.95e-164,582,783,631.99845,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLYC01000020",80.715,4.95e-164,582,783,631.99845,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLXZ01000020",80.715,4.95e-164,582,783,631.99845,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FLBN01000099",86.629,6.44e-164,580,531,459.99999,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_FLCN01000004",86.629,6.44e-164,580,531,459.99999,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRE01000049",81.68,1.52e-163,580,726,592.9968,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_FLBI01000046",84.786,2.56e-163,579,585,495.9981,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRE01000049",82.456,3e-163,579,684,563.99904,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_FLBN01000099",81.15,4.12e-163,579,748,607.002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_FLCN01000004",81.15,4.12e-163,579,748,607.002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_JBGJJV010000032",82.011,3.1e-163,579,706,578.99766,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRZ01000037",83.005,2.86e-163,579,659,547.00295,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLWB01000035",83.005,2.86e-163,579,659,547.00295,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLZF01000029",83.005,2.86e-163,579,659,547.00295,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_FLBN01000099",82.117,3.07e-163,579,699,573.99783,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_FLCN01000004",82.117,3.07e-163,579,699,573.99783,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLRE01000049",81.175,1.45e-162,577,749,608.00075,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_JAUEGY010000142",88.09,8.15e-163,577,487,428.9983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRC01000027",86.756,8.63e-163,577,521,451.99876,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRI01000021",84.708,3.29e-162,575,582,493.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRO01000021",84.708,3.29e-162,575,582,493.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLXR01000021",84.708,3.29e-162,575,582,493.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRG01000021",84.708,3.29e-162,575,582,493.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLYG01000019",84.708,3.29e-162,575,582,493.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRJ01000019",84.708,3.29e-162,575,582,493.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLSM01000018",84.708,3.29e-162,575,582,493.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLSQ01000022",84.708,3.29e-162,575,582,493.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLXY01000024",84.708,3.29e-162,575,582,493.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLXS01000025",84.708,3.29e-162,575,582,493.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLUD01000021",84.708,3.29e-162,575,582,493.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRC01000027",84.708,3.29e-162,575,582,493.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLYZ01000021",84.708,3.29e-162,575,582,493.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLSP01000022",84.708,3.29e-162,575,582,493.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLSH01000020",84.708,3.29e-162,575,582,493.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLYY01000023",84.708,3.29e-162,575,582,493.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLYC01000020",84.708,3.29e-162,575,582,493.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLXZ01000020",84.708,3.29e-162,575,582,493.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_JBGJJV010000032",82.31,1.4e-161,573,684,563.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FLBI01000046",75.128,2.95e-161,573,1367,1026.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_FLBI01000046",84.708,1.18e-161,573,582,493.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FLBI01000046",79.853,9.18e-161,571,819,653.99607,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_JBGJJV010000032",79.853,9.18e-161,571,819,653.99607,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FLBI01000046",87.885,3.79e-161,571,487,427.99995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FLBN01000099",87.885,3.79e-161,571,487,427.99995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRI01000021",87.885,3.79e-161,571,487,427.99995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_FLCN01000004",87.885,3.79e-161,571,487,427.99995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRO01000021",87.885,3.79e-161,571,487,427.99995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRG01000021",87.885,3.79e-161,571,487,427.99995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLYG01000019",87.885,3.79e-161,571,487,427.99995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLSM01000018",87.885,3.79e-161,571,487,427.99995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLSQ01000022",87.885,3.79e-161,571,487,427.99995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLXY01000024",87.885,3.79e-161,571,487,427.99995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLXS01000025",87.885,3.79e-161,571,487,427.99995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLUD01000021",87.885,3.79e-161,571,487,427.99995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRC01000027",87.885,3.79e-161,571,487,427.99995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLYZ01000021",87.885,3.79e-161,571,487,427.99995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLSP01000022",87.885,3.79e-161,571,487,427.99995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLSH01000020",87.885,3.79e-161,571,487,427.99995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLYY01000023",87.885,3.79e-161,571,487,427.99995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLYC01000020",87.885,3.79e-161,571,487,427.99995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FLBI01000046",85.9,4.02e-161,571,539,463.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FLBN01000099",85.9,4.02e-161,571,539,463.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRI01000021",86.564,4.02e-161,571,521,450.99844,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRE01000049",86.564,4.02e-161,571,521,450.99844,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_FLCN01000004",85.9,4.02e-161,571,539,463.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRZ01000037",86.564,4.02e-161,571,521,450.99844,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRO01000021",86.564,4.02e-161,571,521,450.99844,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRG01000021",86.564,4.02e-161,571,521,450.99844,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLYG01000019",86.564,4.02e-161,571,521,450.99844,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLSM01000018",86.564,4.02e-161,571,521,450.99844,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLSQ01000022",86.564,4.02e-161,571,521,450.99844,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLXY01000024",86.564,4.02e-161,571,521,450.99844,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLXS01000025",86.564,4.02e-161,571,521,450.99844,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLUD01000021",86.564,4.02e-161,571,521,450.99844,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLYZ01000021",86.564,4.02e-161,571,521,450.99844,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLSP01000022",86.564,4.02e-161,571,521,450.99844,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLSH01000020",86.564,4.02e-161,571,521,450.99844,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLYY01000023",86.564,4.02e-161,571,521,450.99844,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLYC01000020",86.564,4.02e-161,571,521,450.99844,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRE01000049",80.8,3.67e-160,569,750,606,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRI01000021",84.655,5.5e-160,568,580,490.999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRZ01000037",84.655,5.5e-160,568,580,490.999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRO01000021",84.655,5.5e-160,568,580,490.999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLXR01000021",84.655,5.5e-160,568,580,490.999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRG01000021",84.655,5.5e-160,568,580,490.999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLYG01000019",84.655,5.5e-160,568,580,490.999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRJ01000019",84.655,5.5e-160,568,580,490.999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLSM01000018",84.655,5.5e-160,568,580,490.999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLSQ01000022",84.655,5.5e-160,568,580,490.999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLXY01000024",84.655,5.5e-160,568,580,490.999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLXS01000025",84.655,5.5e-160,568,580,490.999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLWB01000035",84.655,5.5e-160,568,580,490.999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLUD01000021",84.655,5.5e-160,568,580,490.999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRC01000027",84.655,5.5e-160,568,580,490.999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLYZ01000021",84.655,5.5e-160,568,580,490.999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLSP01000022",84.655,5.5e-160,568,580,490.999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLZF01000029",84.655,5.5e-160,568,580,490.999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLSH01000020",84.655,5.5e-160,568,580,490.999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLYY01000023",84.655,5.5e-160,568,580,490.999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLYC01000020",84.655,5.5e-160,568,580,490.999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLXZ01000020",84.655,5.5e-160,568,580,490.999,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FLBI01000046",82.164,6.5e-160,568,684,562.00176,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRI01000021",82.164,6.5e-160,568,684,562.00176,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRZ01000037",82.164,6.5e-160,568,684,562.00176,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRO01000021",82.164,6.5e-160,568,684,562.00176,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLXR01000021",82.164,6.5e-160,568,684,562.00176,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRG01000021",82.164,6.5e-160,568,684,562.00176,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLYG01000019",82.164,6.5e-160,568,684,562.00176,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRJ01000019",82.164,6.5e-160,568,684,562.00176,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLSM01000018",82.164,6.5e-160,568,684,562.00176,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLSQ01000022",82.164,6.5e-160,568,684,562.00176,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLXY01000024",82.164,6.5e-160,568,684,562.00176,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLXS01000025",82.164,6.5e-160,568,684,562.00176,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLWB01000035",82.164,6.5e-160,568,684,562.00176,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLUD01000021",82.164,6.5e-160,568,684,562.00176,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLRC01000027",82.164,6.5e-160,568,684,562.00176,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLYZ01000021",82.164,6.5e-160,568,684,562.00176,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLSP01000022",82.164,6.5e-160,568,684,562.00176,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLZF01000029",82.164,6.5e-160,568,684,562.00176,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLSH01000020",82.164,6.5e-160,568,684,562.00176,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLYY01000023",82.164,6.5e-160,568,684,562.00176,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLYC01000020",82.164,6.5e-160,568,684,562.00176,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLXZ01000020",82.164,6.5e-160,568,684,562.00176,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FLBN01000099",75.018,1.37e-159,568,1365,1023.9957,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_FLCN01000004",75.018,1.37e-159,568,1365,1023.9957,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_JBGJJV010000032",80.882,8.92e-160,568,748,604.99736,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLRE01000049",84.817,2.54e-159,566,573,486.00141,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLRE01000049",84.167,2.13e-159,566,600,505.002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FLBN01000099",79.731,4.27e-159,566,819,652.99689,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_FLCN01000004",79.731,4.27e-159,566,819,652.99689,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRZ01000037",79.731,4.27e-159,566,819,652.99689,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLXR01000021",79.731,4.27e-159,566,819,652.99689,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRJ01000019",79.731,4.27e-159,566,819,652.99689,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLWB01000035",79.731,4.27e-159,566,819,652.99689,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLZF01000029",79.731,4.27e-159,566,819,652.99689,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLXZ01000020",79.731,4.27e-159,566,819,652.99689,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRI01000021",80.92,3.21e-159,566,739,597.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRO01000021",80.92,3.21e-159,566,739,597.9988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLXR01000021",80.92,3.21e-159,566,739,597.9988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRG01000021",80.92,3.21e-159,566,739,597.9988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLYG01000019",80.92,3.21e-159,566,739,597.9988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRJ01000019",80.92,3.21e-159,566,739,597.9988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLSM01000018",80.92,3.21e-159,566,739,597.9988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLSQ01000022",80.92,3.21e-159,566,739,597.9988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLXY01000024",80.92,3.21e-159,566,739,597.9988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLXS01000025",80.92,3.21e-159,566,739,597.9988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLUD01000021",80.92,3.21e-159,566,739,597.9988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRC01000027",80.92,3.21e-159,566,739,597.9988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLYZ01000021",80.92,3.21e-159,566,739,597.9988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLSP01000022",80.92,3.21e-159,566,739,597.9988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLSH01000020",80.92,3.21e-159,566,739,597.9988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLYY01000023",80.92,3.21e-159,566,739,597.9988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLYC01000020",80.92,3.21e-159,566,739,597.9988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLXZ01000020",80.92,3.21e-159,566,739,597.9988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_JBGJJV010000032",80.67,2.58e-159,566,776,625.9992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRE01000049",87.68,1.76e-159,566,487,427.0016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRZ01000037",87.68,1.76e-159,566,487,427.0016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLXR01000021",87.68,1.76e-159,566,487,427.0016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLRJ01000019",87.68,1.76e-159,566,487,427.0016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLWB01000035",87.68,1.76e-159,566,487,427.0016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLZF01000029",87.68,1.76e-159,566,487,427.0016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLXZ01000020",87.68,1.76e-159,566,487,427.0016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_JBGJJV010000032",87.68,1.76e-159,566,487,427.0016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLXR01000021",86.372,1.87e-159,566,521,449.99812,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLRJ01000019",86.372,1.87e-159,566,521,449.99812,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLWB01000035",86.372,1.87e-159,566,521,449.99812,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLZF01000029",86.372,1.87e-159,566,521,449.99812,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLXZ01000020",86.372,1.87e-159,566,521,449.99812,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRZ01000037",84.3,7.16e-159,564,586,493.998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLWB01000035",84.3,7.16e-159,564,586,493.998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLZF01000029",84.3,7.16e-159,564,586,493.998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_JBGJJV010000032",84.3,7.16e-159,564,586,493.998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRI01000021",81.267,1.54e-158,564,726,589.99842,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRO01000021",81.267,1.54e-158,564,726,589.99842,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRG01000021",81.267,1.54e-158,564,726,589.99842,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLYG01000019",81.267,1.54e-158,564,726,589.99842,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLSM01000018",81.267,1.54e-158,564,726,589.99842,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLSQ01000022",81.267,1.54e-158,564,726,589.99842,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLXY01000024",81.267,1.54e-158,564,726,589.99842,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLXS01000025",81.267,1.54e-158,564,726,589.99842,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLUD01000021",81.267,1.54e-158,564,726,589.99842,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLRC01000027",81.267,1.54e-158,564,726,589.99842,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLYZ01000021",81.267,1.54e-158,564,726,589.99842,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLSP01000022",81.267,1.54e-158,564,726,589.99842,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLSH01000020",81.267,1.54e-158,564,726,589.99842,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLYY01000023",81.267,1.54e-158,564,726,589.99842,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLYC01000020",81.267,1.54e-158,564,726,589.99842,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_FLBN01000099",84.444,7.11e-159,564,585,493.9974,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_FLCN01000004",84.444,7.11e-159,564,585,493.9974,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FLBI01000046",82.995,8.96e-159,564,641,531.99795,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FLBN01000099",82.995,8.96e-159,564,641,531.99795,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_FLCN01000004",82.995,8.96e-159,564,641,531.99795,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_JBGJJV010000032",84.483,2.56e-158,562,580,490.0014,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FLBN01000099",82.018,3.03e-158,562,684,561.00312,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_FLCN01000004",82.018,3.03e-158,562,684,561.00312,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_JAUEGY010000142",88.437,2.42e-158,562,467,413.00079,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FLBI01000046",80.854,1.39e-157,560,726,587.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_JBGJJV010000032",85.529,8.7e-158,560,539,461.00131,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_FLBI01000046",84.274,3.31e-157,558,585,493.0029,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRC01000027",88.161,3.41e-157,558,473,417.00153,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRE01000049",78.498,2.01e-156,556,879,689.99742,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_FLBI01000046",84.31,1.19e-156,556,580,488.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRZ01000037",79.634,2.05e-156,556,820,652.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLWB01000035",79.634,2.05e-156,556,820,652.9988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLZF01000029",79.634,2.05e-156,556,820,652.9988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_FLBI01000046",86.328,1.14e-156,556,512,441.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_FLBN01000099",86.328,1.14e-156,556,512,441.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_FLCN01000004",86.328,1.14e-156,556,512,441.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_JBGJJV010000032",83.043,1.5e-156,556,631,524.00133,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_JBGJJV010000032",84.22,1.19e-156,556,583,491.0026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRE01000049",82.462,1.44e-156,556,650,536.003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FLBN01000099",80.716,6.46e-156,555,726,585.99816,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_FLCN01000004",80.716,6.46e-156,555,726,585.99816,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRE01000049",80.623,6.94e-156,555,738,594.99774,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FLBI01000046",87.759,4.41e-156,555,482,422.99838,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FLBN01000099",87.759,4.41e-156,555,482,422.99838,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_FLCN01000004",87.759,4.41e-156,555,482,422.99838,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FLBI01000046",85.526,1.82e-155,553,532,454.99832,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FLBN01000099",85.526,1.82e-155,553,532,454.99832,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_FLCN01000004",85.526,1.82e-155,553,532,454.99832,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRE01000049",84.075,1.54e-155,553,584,490.998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRZ01000037",84.048,1.54e-155,553,583,489.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLWB01000035",84.048,1.54e-155,553,583,489.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLZF01000029",84.048,1.54e-155,553,583,489.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRI01000021",87.949,1.59e-155,553,473,415.99877,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRE01000049",87.949,1.59e-155,553,473,415.99877,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRZ01000037",87.949,1.59e-155,553,473,415.99877,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRO01000021",87.949,1.59e-155,553,473,415.99877,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLXR01000021",87.949,1.59e-155,553,473,415.99877,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRG01000021",87.949,1.59e-155,553,473,415.99877,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLYG01000019",87.949,1.59e-155,553,473,415.99877,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLRJ01000019",87.949,1.59e-155,553,473,415.99877,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLSM01000018",87.949,1.59e-155,553,473,415.99877,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLSQ01000022",87.949,1.59e-155,553,473,415.99877,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLXY01000024",87.949,1.59e-155,553,473,415.99877,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLXS01000025",87.949,1.59e-155,553,473,415.99877,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLWB01000035",87.949,1.59e-155,553,473,415.99877,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLUD01000021",87.949,1.59e-155,553,473,415.99877,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLYZ01000021",87.949,1.59e-155,553,473,415.99877,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLSP01000022",87.949,1.59e-155,553,473,415.99877,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLZF01000029",87.949,1.59e-155,553,473,415.99877,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLSH01000020",87.949,1.59e-155,553,473,415.99877,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLYY01000023",87.949,1.59e-155,553,473,415.99877,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLYC01000020",87.949,1.59e-155,553,473,415.99877,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLXZ01000020",87.949,1.59e-155,553,473,415.99877,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRI01000021",78.36,9.37e-155,551,878,688.0008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRZ01000037",78.36,9.37e-155,551,878,688.0008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRO01000021",78.36,9.37e-155,551,878,688.0008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLXR01000021",78.36,9.37e-155,551,878,688.0008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRG01000021",78.36,9.37e-155,551,878,688.0008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLYG01000019",78.36,9.37e-155,551,878,688.0008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRJ01000019",78.36,9.37e-155,551,878,688.0008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLSM01000018",78.36,9.37e-155,551,878,688.0008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLSQ01000022",78.36,9.37e-155,551,878,688.0008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLXY01000024",78.36,9.37e-155,551,878,688.0008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLXS01000025",78.36,9.37e-155,551,878,688.0008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLWB01000035",78.36,9.37e-155,551,878,688.0008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLUD01000021",78.36,9.37e-155,551,878,688.0008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLRC01000027",78.36,9.37e-155,551,878,688.0008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLYZ01000021",78.36,9.37e-155,551,878,688.0008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLSP01000022",78.36,9.37e-155,551,878,688.0008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLZF01000029",78.36,9.37e-155,551,878,688.0008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLSH01000020",78.36,9.37e-155,551,878,688.0008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLYY01000023",78.36,9.37e-155,551,878,688.0008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLYC01000020",78.36,9.37e-155,551,878,688.0008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLXZ01000020",78.36,9.37e-155,551,878,688.0008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_FLBN01000099",84.138,5.54e-155,551,580,488.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_FLCN01000004",84.138,5.54e-155,551,580,488.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_JBGJJV010000032",79.348,9.56e-155,551,828,657.00144,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_JAUEGY010000142",86.328,7.75e-155,551,512,441.99936,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRE01000049",80.605,3.01e-154,549,727,585.99835,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_JBGJJV010000032",80.579,3.01e-154,549,726,585.00354,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLRZ01000037",80.541,3.23e-154,549,740,596.0034,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLWB01000035",80.541,3.23e-154,549,740,596.0034,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLZF01000029",80.541,3.23e-154,549,740,596.0034,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRI01000021",88.767,3.11e-154,549,454,403.00218,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRO01000021",88.767,3.11e-154,549,454,403.00218,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLXR01000021",88.767,3.11e-154,549,454,403.00218,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRG01000021",88.767,3.11e-154,549,454,403.00218,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLYG01000019",88.767,3.11e-154,549,454,403.00218,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRJ01000019",88.767,3.11e-154,549,454,403.00218,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLSM01000018",88.767,3.11e-154,549,454,403.00218,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLSQ01000022",88.767,3.11e-154,549,454,403.00218,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLXY01000024",88.767,3.11e-154,549,454,403.00218,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLXS01000025",88.767,3.11e-154,549,454,403.00218,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLUD01000021",88.767,3.11e-154,549,454,403.00218,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRC01000027",88.767,3.11e-154,549,454,403.00218,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLYZ01000021",88.767,3.11e-154,549,454,403.00218,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLSP01000022",88.767,3.11e-154,549,454,403.00218,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLSH01000020",88.767,3.11e-154,549,454,403.00218,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLYY01000023",88.767,3.11e-154,549,454,403.00218,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLYC01000020",88.767,3.11e-154,549,454,403.00218,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLXZ01000020",88.767,3.11e-154,549,454,403.00218,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRE01000049",82.508,2.22e-154,549,646,533.00168,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRI01000021",78.348,1.24e-153,547,896,701.99808,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRO01000021",78.348,1.24e-153,547,896,701.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRG01000021",78.348,1.24e-153,547,896,701.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLYG01000019",78.348,1.24e-153,547,896,701.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLSM01000018",78.348,1.24e-153,547,896,701.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLSQ01000022",78.348,1.24e-153,547,896,701.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLXY01000024",78.348,1.24e-153,547,896,701.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLXS01000025",78.348,1.24e-153,547,896,701.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLUD01000021",78.348,1.24e-153,547,896,701.99808,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRC01000027",78.348,1.24e-153,547,896,701.99808,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLYZ01000021",78.348,1.24e-153,547,896,701.99808,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLSP01000022",78.348,1.24e-153,547,896,701.99808,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLSH01000020",78.348,1.24e-153,547,896,701.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLYY01000023",78.348,1.24e-153,547,896,701.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLYC01000020",78.348,1.24e-153,547,896,701.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRE01000049",82.775,7.71e-154,547,627,518.99925,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRI01000021",83.932,7.16e-154,547,585,491.0022,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRO01000021",83.932,7.16e-154,547,585,491.0022,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLXR01000021",83.932,7.16e-154,547,585,491.0022,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRG01000021",83.932,7.16e-154,547,585,491.0022,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLYG01000019",83.932,7.16e-154,547,585,491.0022,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRJ01000019",83.932,7.16e-154,547,585,491.0022,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLSM01000018",83.932,7.16e-154,547,585,491.0022,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLSQ01000022",83.932,7.16e-154,547,585,491.0022,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLXY01000024",83.932,7.16e-154,547,585,491.0022,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLXS01000025",83.932,7.16e-154,547,585,491.0022,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLUD01000021",83.932,7.16e-154,547,585,491.0022,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRC01000027",83.932,7.16e-154,547,585,491.0022,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLYZ01000021",83.932,7.16e-154,547,585,491.0022,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLSP01000022",83.932,7.16e-154,547,585,491.0022,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLSH01000020",83.932,7.16e-154,547,585,491.0022,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLYY01000023",83.932,7.16e-154,547,585,491.0022,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLYC01000020",83.932,7.16e-154,547,585,491.0022,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLXZ01000020",83.932,7.16e-154,547,585,491.0022,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLRE01000049",83.877,7.18e-154,547,583,489.00291,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRI01000021",81.349,8.67e-154,547,697,567.00253,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRZ01000037",81.422,8.67e-154,547,689,560.99758,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRO01000021",81.349,8.67e-154,547,697,567.00253,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLXR01000021",81.349,8.67e-154,547,697,567.00253,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRG01000021",81.349,8.67e-154,547,697,567.00253,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLYG01000019",81.349,8.67e-154,547,697,567.00253,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRJ01000019",81.349,8.67e-154,547,697,567.00253,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLSM01000018",81.349,8.67e-154,547,697,567.00253,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLSQ01000022",81.349,8.67e-154,547,697,567.00253,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLXY01000024",81.349,8.67e-154,547,697,567.00253,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLXS01000025",81.349,8.67e-154,547,697,567.00253,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLWB01000035",81.422,8.67e-154,547,689,560.99758,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLUD01000021",81.349,8.67e-154,547,697,567.00253,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLRC01000027",81.349,8.67e-154,547,697,567.00253,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLYZ01000021",81.349,8.67e-154,547,697,567.00253,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLSP01000022",81.349,8.67e-154,547,697,567.00253,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLZF01000029",81.422,8.67e-154,547,689,560.99758,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLSH01000020",81.349,8.67e-154,547,697,567.00253,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLYY01000023",81.349,8.67e-154,547,697,567.00253,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLYC01000020",81.349,8.67e-154,547,697,567.00253,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLXZ01000020",81.349,8.67e-154,547,697,567.00253,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_FLBI01000046",78.991,4.45e-153,545,852,673.00332,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_FLBN01000099",78.991,4.45e-153,545,852,673.00332,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_FLCN01000004",78.991,4.45e-153,545,852,673.00332,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_JBGJJV010000032",81.259,3.12e-153,545,699,568.00041,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_JBGJJV010000032",82.353,1.03e-152,544,646,532.00038,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLRE01000049",83.168,1.22e-152,544,606,503.99808,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRZ01000037",85.255,3.94e-152,542,529,450.99895,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLXR01000021",85.255,3.94e-152,542,529,450.99895,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRJ01000019",85.255,3.94e-152,542,529,450.99895,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLWB01000035",85.255,3.94e-152,542,529,450.99895,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLZF01000029",85.255,3.94e-152,542,529,450.99895,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLXZ01000020",85.255,3.94e-152,542,529,450.99895,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_JBGJJV010000032",85.15,3.94e-152,542,532,452.998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLXR01000021",78.237,5.78e-152,542,896,701.00352,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRJ01000019",78.237,5.78e-152,542,896,701.00352,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLXZ01000020",78.237,5.78e-152,542,896,701.00352,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRZ01000037",74.814,9.08e-152,542,1342,1004.00388,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLWB01000035",74.814,9.08e-152,542,1342,1004.00388,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLZF01000029",74.814,9.08e-152,542,1342,1004.00388,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRI01000021",82.616,3.59e-152,542,627,518.00232,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRZ01000037",82.616,3.59e-152,542,627,518.00232,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRO01000021",82.616,3.59e-152,542,627,518.00232,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLXR01000021",82.616,3.59e-152,542,627,518.00232,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRG01000021",82.616,3.59e-152,542,627,518.00232,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLYG01000019",82.616,3.59e-152,542,627,518.00232,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRJ01000019",82.616,3.59e-152,542,627,518.00232,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLSM01000018",82.616,3.59e-152,542,627,518.00232,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLSQ01000022",82.616,3.59e-152,542,627,518.00232,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLXY01000024",82.616,3.59e-152,542,627,518.00232,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLXS01000025",82.616,3.59e-152,542,627,518.00232,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLWB01000035",82.616,3.59e-152,542,627,518.00232,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLUD01000021",82.616,3.59e-152,542,627,518.00232,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLYZ01000021",82.616,3.59e-152,542,627,518.00232,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLSP01000022",82.616,3.59e-152,542,627,518.00232,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLZF01000029",82.616,3.59e-152,542,627,518.00232,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLSH01000020",82.616,3.59e-152,542,627,518.00232,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLYY01000023",82.616,3.59e-152,542,627,518.00232,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLYC01000020",82.616,3.59e-152,542,627,518.00232,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLXZ01000020",82.616,3.59e-152,542,627,518.00232,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLRZ01000037",83.733,3.33e-152,542,584,489.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLWB01000035",83.733,3.33e-152,542,584,489.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLZF01000029",83.733,3.33e-152,542,584,489.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_JBGJJV010000032",83.733,3.33e-152,542,584,489.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRZ01000037",82.595,4.2e-152,542,632,522.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLWB01000035",82.595,4.2e-152,542,632,522.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLZF01000029",82.595,4.2e-152,542,632,522.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRI01000021",88.546,5.71e-152,542,454,401.99884,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRO01000021",88.546,5.71e-152,542,454,401.99884,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLXR01000021",88.546,5.71e-152,542,454,401.99884,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRG01000021",88.546,5.71e-152,542,454,401.99884,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLYG01000019",88.546,5.71e-152,542,454,401.99884,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRJ01000019",88.546,5.71e-152,542,454,401.99884,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLSM01000018",88.546,5.71e-152,542,454,401.99884,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLSQ01000022",88.546,5.71e-152,542,454,401.99884,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLXY01000024",88.546,5.71e-152,542,454,401.99884,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLXS01000025",88.546,5.71e-152,542,454,401.99884,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLUD01000021",88.546,5.71e-152,542,454,401.99884,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRC01000027",88.546,5.71e-152,542,454,401.99884,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLYZ01000021",88.546,5.71e-152,542,454,401.99884,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLSP01000022",88.546,5.71e-152,542,454,401.99884,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLSH01000020",88.546,5.71e-152,542,454,401.99884,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLYY01000023",88.546,5.71e-152,542,454,401.99884,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLYC01000020",88.546,5.71e-152,542,454,401.99884,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLXZ01000020",88.546,5.71e-152,542,454,401.99884,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLRE01000049",87.66,2.87e-151,540,470,412.002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_JBGJJV010000032",82.955,1.26e-151,540,616,511.0028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FLBI01000046",82.775,1.57e-151,540,627,518.99925,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FLBN01000099",82.775,1.57e-151,540,627,518.99925,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_FLCN01000004",82.775,1.57e-151,540,627,518.99925,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLRE01000049",87.5,1.32e-151,540,472,413,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRI01000021",85.855,1.14e-151,540,509,437.00195,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRE01000049",85.855,1.14e-151,540,509,437.00195,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRZ01000037",85.855,1.14e-151,540,509,437.00195,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRO01000021",85.855,1.14e-151,540,509,437.00195,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLXR01000021",85.855,1.14e-151,540,509,437.00195,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRG01000021",85.855,1.14e-151,540,509,437.00195,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLYG01000019",85.855,1.14e-151,540,509,437.00195,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRJ01000019",85.855,1.14e-151,540,509,437.00195,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLSM01000018",85.855,1.14e-151,540,509,437.00195,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLSQ01000022",85.855,1.14e-151,540,509,437.00195,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLXY01000024",85.855,1.14e-151,540,509,437.00195,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLXS01000025",85.855,1.14e-151,540,509,437.00195,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLWB01000035",85.855,1.14e-151,540,509,437.00195,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLUD01000021",85.855,1.14e-151,540,509,437.00195,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLRC01000027",85.855,1.14e-151,540,509,437.00195,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLYZ01000021",85.855,1.14e-151,540,509,437.00195,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLSP01000022",85.855,1.14e-151,540,509,437.00195,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLZF01000029",85.855,1.14e-151,540,509,437.00195,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLSH01000020",85.855,1.14e-151,540,509,437.00195,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLYY01000023",85.855,1.14e-151,540,509,437.00195,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLYC01000020",85.855,1.14e-151,540,509,437.00195,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLXZ01000020",85.855,1.14e-151,540,509,437.00195,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_JBGJJV010000032",85.742,1.14e-151,540,512,438.99904,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRZ01000037",80.33,6.51e-151,538,727,583.9991,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLXR01000021",80.33,6.51e-151,538,727,583.9991,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRJ01000019",80.33,6.51e-151,538,727,583.9991,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLWB01000035",80.33,6.51e-151,538,727,583.9991,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLZF01000029",80.33,6.51e-151,538,727,583.9991,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLXZ01000020",80.33,6.51e-151,538,727,583.9991,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FLBI01000046",82.927,4.53e-151,538,615,510.00105,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FLBI01000046",82.198,4.8e-151,538,646,530.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRI01000021",82.198,4.8e-151,538,646,530.99908,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRZ01000037",82.198,4.8e-151,538,646,530.99908,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRO01000021",82.198,4.8e-151,538,646,530.99908,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLXR01000021",82.198,4.8e-151,538,646,530.99908,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRG01000021",82.198,4.8e-151,538,646,530.99908,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLYG01000019",82.198,4.8e-151,538,646,530.99908,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRJ01000019",82.198,4.8e-151,538,646,530.99908,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLSM01000018",82.198,4.8e-151,538,646,530.99908,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLSQ01000022",82.198,4.8e-151,538,646,530.99908,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLXY01000024",82.198,4.8e-151,538,646,530.99908,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLXS01000025",82.198,4.8e-151,538,646,530.99908,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLWB01000035",82.198,4.8e-151,538,646,530.99908,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLUD01000021",82.198,4.8e-151,538,646,530.99908,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLRC01000027",82.198,4.8e-151,538,646,530.99908,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLYZ01000021",82.198,4.8e-151,538,646,530.99908,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLSP01000022",82.198,4.8e-151,538,646,530.99908,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLZF01000029",82.198,4.8e-151,538,646,530.99908,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLSH01000020",82.198,4.8e-151,538,646,530.99908,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLYY01000023",82.198,4.8e-151,538,646,530.99908,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLYC01000020",82.198,4.8e-151,538,646,530.99908,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLXZ01000020",82.198,4.8e-151,538,646,530.99908,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRI01000021",85.122,1.83e-150,536,531,451.99782,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRE01000049",85.066,1.83e-150,536,529,449.99914,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRO01000021",85.122,1.83e-150,536,531,451.99782,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRG01000021",85.122,1.83e-150,536,531,451.99782,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLYG01000019",85.122,1.83e-150,536,531,451.99782,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLSM01000018",85.122,1.83e-150,536,531,451.99782,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLSQ01000022",85.122,1.83e-150,536,531,451.99782,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLXY01000024",85.122,1.83e-150,536,531,451.99782,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLXS01000025",85.122,1.83e-150,536,531,451.99782,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLUD01000021",85.122,1.83e-150,536,531,451.99782,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLRC01000027",85.122,1.83e-150,536,531,451.99782,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLYZ01000021",85.122,1.83e-150,536,531,451.99782,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLSP01000022",85.122,1.83e-150,536,531,451.99782,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLSH01000020",85.122,1.83e-150,536,531,451.99782,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLYY01000023",85.122,1.83e-150,536,531,451.99782,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLYC01000020",85.122,1.83e-150,536,531,451.99782,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_JAUEGY010000142",85.019,1.83e-150,536,534,454.00146,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRZ01000037",78.052,2.69e-150,536,893,697.00436,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLWB01000035",78.052,2.69e-150,536,893,697.00436,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLZF01000029",78.052,2.69e-150,536,893,697.00436,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_JBGJJV010000032",78.052,2.69e-150,536,893,697.00436,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_JBGJJV010000032",76.588,3.87e-150,536,1055,808.0034,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLRC01000027",82.428,1.67e-150,536,626,515.99928,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRI01000021",83.821,6.88e-150,534,581,487.00001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRO01000021",83.821,6.88e-150,534,581,487.00001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLXR01000021",83.821,6.88e-150,534,581,487.00001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRG01000021",83.821,6.88e-150,534,581,487.00001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLYG01000019",83.821,6.88e-150,534,581,487.00001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRJ01000019",83.821,6.88e-150,534,581,487.00001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLSM01000018",83.821,6.88e-150,534,581,487.00001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLSQ01000022",83.821,6.88e-150,534,581,487.00001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLXY01000024",83.821,6.88e-150,534,581,487.00001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLXS01000025",83.821,6.88e-150,534,581,487.00001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLUD01000021",83.821,6.88e-150,534,581,487.00001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRC01000027",83.821,6.88e-150,534,581,487.00001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLYZ01000021",83.821,6.88e-150,534,581,487.00001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLSP01000022",83.821,6.88e-150,534,581,487.00001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLSH01000020",83.821,6.88e-150,534,581,487.00001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLYY01000023",83.821,6.88e-150,534,581,487.00001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLYC01000020",83.821,6.88e-150,534,581,487.00001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLXZ01000020",83.821,6.88e-150,534,581,487.00001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_JBGJJV010000032",78.118,9.44e-150,534,882,689.00076,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRZ01000037",82.82,5.86e-150,534,617,510.9994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLWB01000035",82.82,5.86e-150,534,617,510.9994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLZF01000029",82.82,5.86e-150,534,617,510.9994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRI01000021",80.193,3.03e-149,532,727,583.00311,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRO01000021",80.193,3.03e-149,532,727,583.00311,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRG01000021",80.193,3.03e-149,532,727,583.00311,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLYG01000019",80.193,3.03e-149,532,727,583.00311,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLSM01000018",80.193,3.03e-149,532,727,583.00311,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLSQ01000022",80.193,3.03e-149,532,727,583.00311,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLXY01000024",80.193,3.03e-149,532,727,583.00311,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLXS01000025",80.193,3.03e-149,532,727,583.00311,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLUD01000021",80.193,3.03e-149,532,727,583.00311,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLRC01000027",80.193,3.03e-149,532,727,583.00311,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLYZ01000021",80.193,3.03e-149,532,727,583.00311,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLSP01000022",80.193,3.03e-149,532,727,583.00311,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLSH01000020",80.193,3.03e-149,532,727,583.00311,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLYY01000023",80.193,3.03e-149,532,727,583.00311,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLYC01000020",80.193,3.03e-149,532,727,583.00311,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FLBN01000099",82.764,2.11e-149,532,615,508.9986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_FLCN01000004",82.764,2.11e-149,532,615,508.9986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_JAUEGY010000142",90.909,2.17e-149,532,396,359.99964,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_JBGJJV010000032",76.515,5.46e-149,532,1056,807.9984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FLBN01000099",82.043,2.23e-149,532,646,529.99778,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_FLCN01000004",82.043,2.23e-149,532,646,529.99778,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLRE01000049",85.465,3e-149,532,516,440.9994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLRE01000049",77.989,1.25e-148,531,895,698.00155,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_FLBI01000046",82.484,7.79e-149,531,628,517.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FLBI01000046",77.955,4.39e-148,529,880,686.004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLRE01000049",88.889,2.59e-148,529,432,384.00048,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_JBGJJV010000032",82.278,1.01e-147,527,632,519.99696,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLRE01000049",82.205,1.14e-147,527,635,522.00175,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FLBI01000046",77.877,5.82e-147,525,895,696.99915,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FLBN01000099",77.877,5.82e-147,525,895,696.99915,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_FLCN01000004",77.877,5.82e-147,525,895,696.99915,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRZ01000037",79.012,5.91e-147,525,810,639.9972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLWB01000035",79.012,5.91e-147,525,810,639.9972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLZF01000029",79.012,5.91e-147,525,810,639.9972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_FLBN01000099",82.381,3.63e-147,525,630,519.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_FLCN01000004",82.381,3.63e-147,525,630,519.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_JBGJJV010000032",82.166,1.3e-146,523,628,516.00248,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_MLRZ01000037",76.326,1.08e-145,521,1056,806.00256,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_MLWB01000035",76.326,1.08e-145,521,1056,806.00256,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_MLZF01000029",76.326,1.08e-145,521,1056,806.00256,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_JBGJJV010000032",83.813,4.15e-146,521,556,466.00028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLWB01000035",78.436,6.46e-146,521,844,661.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLZF01000029",78.436,6.46e-146,521,844,661.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRZ01000037",78.967,4.49e-145,520,813,642.00171,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLWB01000035",78.967,4.49e-145,520,813,642.00171,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLZF01000029",78.967,4.49e-145,520,813,642.00171,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_FLBN01000099",83.813,1.49e-145,520,556,466.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_FLCN01000004",83.813,1.49e-145,520,556,466.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRZ01000037",78.941,3.31e-145,520,812,641.00092,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLWB01000035",78.941,3.31e-145,520,812,641.00092,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLZF01000029",78.941,3.31e-145,520,812,641.00092,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRI01000021",87.336,1.59e-145,520,458,399.99888,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRO01000021",87.336,1.59e-145,520,458,399.99888,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLXR01000021",87.336,1.59e-145,520,458,399.99888,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRG01000021",87.336,1.59e-145,520,458,399.99888,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLYG01000019",87.336,1.59e-145,520,458,399.99888,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRJ01000019",87.336,1.59e-145,520,458,399.99888,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLSM01000018",87.336,1.59e-145,520,458,399.99888,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLSQ01000022",87.336,1.59e-145,520,458,399.99888,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLXY01000024",87.336,1.59e-145,520,458,399.99888,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLXS01000025",87.336,1.59e-145,520,458,399.99888,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLUD01000021",87.336,1.59e-145,520,458,399.99888,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRC01000027",87.336,1.59e-145,520,458,399.99888,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLYZ01000021",87.336,1.59e-145,520,458,399.99888,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLSP01000022",87.336,1.59e-145,520,458,399.99888,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLSH01000020",87.336,1.59e-145,520,458,399.99888,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLYY01000023",87.336,1.59e-145,520,458,399.99888,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLYC01000020",87.336,1.59e-145,520,458,399.99888,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLXZ01000020",87.336,1.59e-145,520,458,399.99888,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FLBN01000099",77.727,9.51e-145,518,880,683.9976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_FLCN01000004",77.727,9.51e-145,518,880,683.9976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_JBGJJV010000032",76.303,1.61e-144,518,1055,804.99665,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_JAUEGY010000142",83.912,3.76e-144,516,547,458.99864,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRZ01000037",82.063,2.18e-144,516,630,516.9969,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLWB01000035",82.063,2.18e-144,516,630,516.9969,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLZF01000029",82.063,2.18e-144,516,630,516.9969,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRZ01000037",83.633,1.93e-144,516,556,464.99948,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLWB01000035",83.633,1.93e-144,516,556,464.99948,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLZF01000029",83.633,1.93e-144,516,556,464.99948,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FLBI01000046",83.483,2.72e-144,516,557,465.00031,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRZ01000037",78.318,3.01e-144,516,844,661.00392,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLRE01000049",84.837,8.47e-144,514,521,442.00077,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLRE01000049",85.513,8.29e-144,514,497,424.99961,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_FLBI01000046",83.633,6.95e-144,514,556,464.99948,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_JBGJJV010000032",78.292,1.08e-143,514,843,660.00156,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_JBGJJV010000032",78.784,4.6e-143,512,806,634.99904,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_JBGJJV010000032",81.633,1.09e-142,510,637,520.00221,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FLBN01000099",83.303,1.26e-142,510,557,463.99771,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_FLCN01000004",83.303,1.26e-142,510,557,463.99771,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRE01000049",80.057,4.12e-142,508,702,562.00014,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRZ01000037",80,4.12e-142,508,700,560,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLWB01000035",80,4.12e-142,508,700,560,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLZF01000029",80,4.12e-142,508,700,560,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRZ01000037",79.034,7.27e-142,508,787,621.99758,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLWB01000035",79.034,7.27e-142,508,787,621.99758,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLZF01000029",79.034,7.27e-142,508,787,621.99758,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_FLBN01000099",82.343,3.52e-142,508,606,498.99858,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_FLCN01000004",82.343,3.52e-142,508,606,498.99858,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLRE01000049",80.527,8.51e-142,508,683,549.99941,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRI01000021",83.948,3.55e-142,508,542,454.99816,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRO01000021",83.948,3.55e-142,508,542,454.99816,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLXR01000021",83.948,3.55e-142,508,542,454.99816,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRG01000021",83.948,3.55e-142,508,542,454.99816,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLYG01000019",83.948,3.55e-142,508,542,454.99816,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRJ01000019",83.948,3.55e-142,508,542,454.99816,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLSM01000018",83.948,3.55e-142,508,542,454.99816,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLSQ01000022",83.948,3.55e-142,508,542,454.99816,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLXY01000024",83.948,3.55e-142,508,542,454.99816,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLXS01000025",83.948,3.55e-142,508,542,454.99816,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLUD01000021",83.948,3.55e-142,508,542,454.99816,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRC01000027",83.948,3.55e-142,508,542,454.99816,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLYZ01000021",83.948,3.55e-142,508,542,454.99816,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLSP01000022",83.948,3.55e-142,508,542,454.99816,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLSH01000020",83.948,3.55e-142,508,542,454.99816,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLYY01000023",83.948,3.55e-142,508,542,454.99816,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLYC01000020",83.948,3.55e-142,508,542,454.99816,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLXZ01000020",83.948,3.55e-142,508,542,454.99816,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLWB01000035",80.882,3.94e-142,508,680,549.9976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLZF01000029",80.882,3.94e-142,508,680,549.9976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_JBGJJV010000032",78.713,2.58e-141,507,808,636.00104,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRZ01000037",81.194,5.03e-141,505,670,543.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLWB01000035",81.194,5.03e-141,505,670,543.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLZF01000029",81.194,5.03e-141,505,670,543.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FLBI01000046",78.607,7.71e-141,505,804,632.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FLBN01000099",78.554,7.71e-141,505,802,630.00308,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_FLCN01000004",78.554,7.71e-141,505,802,630.00308,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_FLBN01000099",76,1.26e-140,505,1050,798,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_FLCN01000004",76,1.26e-140,505,1050,798,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FLBI01000046",80.084,5.33e-141,505,713,570.99892,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRZ01000037",81.476,5.05e-141,505,637,519.00212,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLWB01000035",81.476,5.05e-141,505,637,519.00212,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLZF01000029",81.476,5.05e-141,505,637,519.00212,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_JBGJJV010000032",83.124,5.88e-141,505,557,463.00068,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRI01000021",79.857,1.92e-140,503,700,558.999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRO01000021",79.857,1.92e-140,503,700,558.999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLXR01000021",79.857,1.92e-140,503,700,558.999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRG01000021",79.857,1.92e-140,503,700,558.999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLYG01000019",79.857,1.92e-140,503,700,558.999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRJ01000019",79.857,1.92e-140,503,700,558.999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLSM01000018",79.857,1.92e-140,503,700,558.999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLSQ01000022",79.857,1.92e-140,503,700,558.999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLXY01000024",79.857,1.92e-140,503,700,558.999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLXS01000025",79.857,1.92e-140,503,700,558.999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLUD01000021",79.857,1.92e-140,503,700,558.999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLRC01000027",79.857,1.92e-140,503,700,558.999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLYZ01000021",79.857,1.92e-140,503,700,558.999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLSP01000022",79.857,1.92e-140,503,700,558.999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLSH01000020",79.857,1.92e-140,503,700,558.999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLYY01000023",79.857,1.92e-140,503,700,558.999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLYC01000020",79.857,1.92e-140,503,700,558.999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLXZ01000020",79.857,1.92e-140,503,700,558.999,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_FLBI01000046",82.178,1.64e-140,503,606,497.99868,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRE01000049",80.084,1.92e-140,503,713,570.99892,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_FLBI01000046",81.476,1.82e-140,503,637,519.00212,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_JBGJJV010000032",80.798,1.83e-140,503,677,547.00246,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLRE01000049",87.731,1.16e-139,501,432,378.99792,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRE01000049",84.676,5.35e-140,501,509,431.00084,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_FLBI01000046",82.403,5.71e-140,501,591,487.00173,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_JBGJJV010000032",82.432,5.71e-140,501,592,487.99744,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_JBGJJV010000032",80.924,2.34e-139,499,671,543.00004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_FLBI01000046",75.951,5.85e-139,499,1052,799.00452,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRZ01000037",84.333,1.8e-139,499,517,436.00161,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLWB01000035",84.333,1.8e-139,499,517,436.00161,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLZF01000029",84.333,1.8e-139,499,517,436.00161,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FLBN01000099",79.944,2.48e-139,499,713,570.00072,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_FLCN01000004",79.944,2.48e-139,499,713,570.00072,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_FLBI01000046",80.952,8.41e-139,497,672,543.99744,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_FLBI01000046",84.333,6.49e-139,497,517,436.00161,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_FLBN01000099",84.333,6.49e-139,497,517,436.00161,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_FLCN01000004",84.333,6.49e-139,497,517,436.00161,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRZ01000037",82.293,7.38e-139,497,593,487.99749,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLWB01000035",82.293,7.38e-139,497,593,487.99749,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLZF01000029",82.293,7.38e-139,497,593,487.99749,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_JBGJJV010000032",82.788,7.22e-139,497,581,480.99828,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_FLBN01000099",81.319,8.45e-139,497,637,518.00203,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRI01000021",82.948,8.45e-139,497,563,466.99724,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_FLCN01000004",81.319,8.45e-139,497,637,518.00203,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRO01000021",82.948,8.45e-139,497,563,466.99724,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLXR01000021",82.948,8.45e-139,497,563,466.99724,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRG01000021",82.948,8.45e-139,497,563,466.99724,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLYG01000019",82.948,8.45e-139,497,563,466.99724,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRJ01000019",82.948,8.45e-139,497,563,466.99724,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLSM01000018",82.948,8.45e-139,497,563,466.99724,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLSQ01000022",82.948,8.45e-139,497,563,466.99724,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLXY01000024",82.948,8.45e-139,497,563,466.99724,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLXS01000025",82.948,8.45e-139,497,563,466.99724,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLUD01000021",82.948,8.45e-139,497,563,466.99724,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRC01000027",82.948,8.45e-139,497,563,466.99724,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLYZ01000021",82.948,8.45e-139,497,563,466.99724,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLSP01000022",82.948,8.45e-139,497,563,466.99724,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLSH01000020",82.948,8.45e-139,497,563,466.99724,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLYY01000023",82.948,8.45e-139,497,563,466.99724,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLYC01000020",82.948,8.45e-139,497,563,466.99724,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLXZ01000020",82.948,8.45e-139,497,563,466.99724,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRZ01000037",80.588,8.53e-139,497,680,547.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_FLBI01000046",84.479,2.49e-138,496,509,429.99811,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_FLBN01000099",84.479,2.49e-138,496,509,429.99811,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_FLCN01000004",84.479,2.49e-138,496,509,429.99811,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRZ01000037",84.479,2.49e-138,496,509,429.99811,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLWB01000035",84.479,2.49e-138,496,509,429.99811,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLZF01000029",84.479,2.49e-138,496,509,429.99811,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_JBGJJV010000032",78.753,5.66e-138,496,786,618.99858,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_FLBN01000099",82.234,2.66e-138,496,591,486.00294,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRI01000021",83.738,2.66e-138,496,535,447.9983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_FLCN01000004",82.234,2.66e-138,496,591,486.00294,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRO01000021",83.738,2.66e-138,496,535,447.9983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLXR01000021",83.738,2.66e-138,496,535,447.9983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRG01000021",83.738,2.66e-138,496,535,447.9983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLYG01000019",83.738,2.66e-138,496,535,447.9983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRJ01000019",83.738,2.66e-138,496,535,447.9983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLSM01000018",83.738,2.66e-138,496,535,447.9983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLSQ01000022",83.738,2.66e-138,496,535,447.9983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLXY01000024",83.738,2.66e-138,496,535,447.9983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLXS01000025",83.738,2.66e-138,496,535,447.9983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLUD01000021",83.738,2.66e-138,496,535,447.9983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRC01000027",83.738,2.66e-138,496,535,447.9983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLYZ01000021",83.738,2.66e-138,496,535,447.9983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLSP01000022",83.738,2.66e-138,496,535,447.9983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLSH01000020",83.738,2.66e-138,496,535,447.9983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLYY01000023",83.738,2.66e-138,496,535,447.9983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLYC01000020",83.738,2.66e-138,496,535,447.9983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLXZ01000020",83.738,2.66e-138,496,535,447.9983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLRE01000049",87.558,2.67e-138,496,434,380.00172,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_FLBI01000046",81.399,2.83e-138,496,629,511.99971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRE01000049",81.073,3.54e-138,496,634,514.00282,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLRE01000049",84.891,2.68e-138,496,503,427.00173,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_JBGJJV010000032",79.804,1.15e-137,494,713,569.00252,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRZ01000037",83.06,1.27e-137,494,549,455.9994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLXR01000021",83.06,1.27e-137,494,549,455.9994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRJ01000019",83.06,1.27e-137,494,549,455.9994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLWB01000035",83.06,1.27e-137,494,549,455.9994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLZF01000029",83.06,1.27e-137,494,549,455.9994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLXZ01000020",83.06,1.27e-137,494,549,455.9994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_FLBI01000046",80.088,1.41e-137,494,683,547.00104,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_FLBN01000099",80.088,1.41e-137,494,683,547.00104,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_FLCN01000004",80.088,1.41e-137,494,683,547.00104,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FLBI01000046",80.455,3.92e-137,492,660,531.003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FLBN01000099",80.455,3.92e-137,492,660,531.003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRE01000049",80.455,3.92e-137,492,660,531.003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_FLCN01000004",80.455,3.92e-137,492,660,531.003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRI01000021",82.245,3.5e-137,492,597,491.00265,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRO01000021",82.245,3.5e-137,492,597,491.00265,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLXR01000021",82.245,3.5e-137,492,597,491.00265,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRG01000021",82.245,3.5e-137,492,597,491.00265,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLYG01000019",82.245,3.5e-137,492,597,491.00265,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRJ01000019",82.245,3.5e-137,492,597,491.00265,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLSM01000018",82.245,3.5e-137,492,597,491.00265,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLSQ01000022",82.245,3.5e-137,492,597,491.00265,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLXY01000024",82.245,3.5e-137,492,597,491.00265,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLXS01000025",82.245,3.5e-137,492,597,491.00265,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLUD01000021",82.245,3.5e-137,492,597,491.00265,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRC01000027",82.245,3.5e-137,492,597,491.00265,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLYZ01000021",82.245,3.5e-137,492,597,491.00265,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLSP01000022",82.245,3.5e-137,492,597,491.00265,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLSH01000020",82.245,3.5e-137,492,597,491.00265,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLYY01000023",82.245,3.5e-137,492,597,491.00265,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLYC01000020",82.245,3.5e-137,492,597,491.00265,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLXZ01000020",82.245,3.5e-137,492,597,491.00265,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_FLBN01000099",80.804,3.91e-137,492,672,543.00288,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_FLCN01000004",80.804,3.91e-137,492,672,543.00288,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRI01000021",79.804,4.15e-137,492,713,569.00252,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRO01000021",79.804,4.15e-137,492,713,569.00252,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLXR01000021",79.804,4.15e-137,492,713,569.00252,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRG01000021",79.804,4.15e-137,492,713,569.00252,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLYG01000019",79.804,4.15e-137,492,713,569.00252,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRJ01000019",79.804,4.15e-137,492,713,569.00252,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLSM01000018",79.804,4.15e-137,492,713,569.00252,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLSQ01000022",79.804,4.15e-137,492,713,569.00252,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLXY01000024",79.804,4.15e-137,492,713,569.00252,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLXS01000025",79.804,4.15e-137,492,713,569.00252,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLUD01000021",79.804,4.15e-137,492,713,569.00252,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRC01000027",79.804,4.15e-137,492,713,569.00252,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLYZ01000021",79.804,4.15e-137,492,713,569.00252,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLSP01000022",79.804,4.15e-137,492,713,569.00252,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLSH01000020",79.804,4.15e-137,492,713,569.00252,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLYY01000023",79.804,4.15e-137,492,713,569.00252,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLYC01000020",79.804,4.15e-137,492,713,569.00252,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLXZ01000020",79.804,4.15e-137,492,713,569.00252,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRI01000021",84.283,1.16e-136,490,509,429.00047,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRO01000021",84.283,1.16e-136,490,509,429.00047,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLXR01000021",84.283,1.16e-136,490,509,429.00047,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRG01000021",84.283,1.16e-136,490,509,429.00047,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLYG01000019",84.283,1.16e-136,490,509,429.00047,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRJ01000019",84.283,1.16e-136,490,509,429.00047,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLSM01000018",84.283,1.16e-136,490,509,429.00047,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLSQ01000022",84.283,1.16e-136,490,509,429.00047,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLXY01000024",84.283,1.16e-136,490,509,429.00047,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLXS01000025",84.283,1.16e-136,490,509,429.00047,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLUD01000021",84.283,1.16e-136,490,509,429.00047,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLRC01000027",84.283,1.16e-136,490,509,429.00047,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLYZ01000021",84.283,1.16e-136,490,509,429.00047,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLSP01000022",84.283,1.16e-136,490,509,429.00047,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLSH01000020",84.283,1.16e-136,490,509,429.00047,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLYY01000023",84.283,1.16e-136,490,509,429.00047,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLYC01000020",84.283,1.16e-136,490,509,429.00047,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLXZ01000020",84.283,1.16e-136,490,509,429.00047,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_JBGJJV010000032",84.283,1.16e-136,490,509,429.00047,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_JAUEGY010000142",82.909,2.06e-136,490,550,455.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_FLCN01000004",81.24,1.32e-136,490,629,510.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_FLBI01000046",83.273,1.18e-136,490,556,462.99788,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FLBI01000046",80.51,1.86e-136,490,667,537.0017,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FLBN01000099",80.48,1.86e-136,490,666,535.9968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FLCN01000004",80.48,1.86e-136,490,666,535.9968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_JAUEGY010000142",83.117,6.65e-136,488,539,448.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_FLBI01000046",78.571,9.47e-136,488,784,615.99664,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_FLBN01000099",78.517,9.47e-136,488,782,614.00294,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_FLCN01000004",78.517,9.47e-136,488,782,614.00294,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRZ01000037",81.758,4.59e-136,488,603,493.00074,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLWB01000035",81.758,4.59e-136,488,603,493.00074,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLZF01000029",81.758,4.59e-136,488,603,493.00074,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_FLBI01000046",78.288,9.34e-136,488,806,631.00128,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_FLBN01000099",78.234,9.34e-136,488,804,629.00136,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_FLCN01000004",78.234,9.34e-136,488,804,629.00136,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRI01000021",82.878,5.92e-136,488,549,455.00022,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRO01000021",82.878,5.92e-136,488,549,455.00022,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRG01000021",82.878,5.92e-136,488,549,455.00022,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLYG01000019",82.878,5.92e-136,488,549,455.00022,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLSM01000018",82.878,5.92e-136,488,549,455.00022,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLSQ01000022",82.878,5.92e-136,488,549,455.00022,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLXY01000024",82.878,5.92e-136,488,549,455.00022,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLXS01000025",82.878,5.92e-136,488,549,455.00022,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLUD01000021",82.878,5.92e-136,488,549,455.00022,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLRC01000027",82.878,5.92e-136,488,549,455.00022,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLYZ01000021",82.878,5.92e-136,488,549,455.00022,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLSP01000022",82.878,5.92e-136,488,549,455.00022,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLSH01000020",82.878,5.92e-136,488,549,455.00022,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLYY01000023",82.878,5.92e-136,488,549,455.00022,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLYC01000020",82.878,5.92e-136,488,549,455.00022,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_FLBI01000046",83.804,5.14e-136,488,531,444.99924,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_FLBN01000099",83.804,5.14e-136,488,531,444.99924,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_FLCN01000004",83.804,5.14e-136,488,531,444.99924,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_JBGJJV010000032",79.603,1.93e-135,486,706,561.99718,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRZ01000037",80.303,1.82e-135,486,660,529.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLWB01000035",80.303,1.82e-135,486,660,529.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLZF01000029",80.303,1.82e-135,486,660,529.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_JBGJJV010000032",80.303,1.82e-135,486,660,529.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRZ01000037",82.077,1.63e-135,486,597,489.99969,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLWB01000035",82.077,1.63e-135,486,597,489.99969,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLZF01000029",82.077,1.63e-135,486,597,489.99969,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLRZ01000037",79.663,1.93e-135,486,713,567.99719,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLWB01000035",79.663,1.93e-135,486,713,567.99719,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLZF01000029",79.663,1.93e-135,486,713,567.99719,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_FLBI01000046",84.661,1.39e-135,486,502,424.99822,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_FLBN01000099",81.081,6.13e-135,484,629,509.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRZ01000037",79.24,1.15e-134,484,737,583.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLWB01000035",79.24,1.15e-134,484,737,583.9988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLZF01000029",79.24,1.15e-134,484,737,583.9988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_JBGJJV010000032",81.22,6.11e-135,484,623,506.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_JBGJJV010000032",80.36,8.67e-135,484,667,536.0012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_FLBI01000046",84.6,2.24e-134,483,500,423,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_JBGJJV010000032",76.302,4.13e-134,483,979,746.99658,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_JAUEGY010000142",82.931,2.76e-134,483,539,446.99809,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRI01000021",80.152,8.49e-134,481,660,529.0032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRO01000021",80.152,8.49e-134,481,660,529.0032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLXR01000021",80.152,8.49e-134,481,660,529.0032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRG01000021",80.152,8.49e-134,481,660,529.0032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLYG01000019",80.152,8.49e-134,481,660,529.0032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRJ01000019",80.152,8.49e-134,481,660,529.0032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLSM01000018",80.152,8.49e-134,481,660,529.0032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLSQ01000022",80.152,8.49e-134,481,660,529.0032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLXY01000024",80.152,8.49e-134,481,660,529.0032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLXS01000025",80.152,8.49e-134,481,660,529.0032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLUD01000021",80.152,8.49e-134,481,660,529.0032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLRC01000027",80.152,8.49e-134,481,660,529.0032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLYZ01000021",80.152,8.49e-134,481,660,529.0032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLSP01000022",80.152,8.49e-134,481,660,529.0032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLSH01000020",80.152,8.49e-134,481,660,529.0032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLYY01000023",80.152,8.49e-134,481,660,529.0032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLYC01000020",80.152,8.49e-134,481,660,529.0032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLXZ01000020",80.152,8.49e-134,481,660,529.0032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_FLBI01000046",81.91,7.57e-134,481,597,489.0027,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLRE01000049",87.835,2.35e-133,479,411,361.00185,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRI01000021",81.818,3.05e-133,479,605,494.9989,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRO01000021",81.818,3.05e-133,479,605,494.9989,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLXR01000021",81.818,3.05e-133,479,605,494.9989,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRG01000021",81.818,3.05e-133,479,605,494.9989,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLYG01000019",81.818,3.05e-133,479,605,494.9989,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRJ01000019",81.818,3.05e-133,479,605,494.9989,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLSM01000018",81.818,3.05e-133,479,605,494.9989,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLSQ01000022",81.818,3.05e-133,479,605,494.9989,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLXY01000024",81.818,3.05e-133,479,605,494.9989,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLXS01000025",81.818,3.05e-133,479,605,494.9989,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLUD01000021",81.818,3.05e-133,479,605,494.9989,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRC01000027",81.818,3.05e-133,479,605,494.9989,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLYZ01000021",81.818,3.05e-133,479,605,494.9989,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLSP01000022",81.818,3.05e-133,479,605,494.9989,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLSH01000020",81.818,3.05e-133,479,605,494.9989,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLYY01000023",81.818,3.05e-133,479,605,494.9989,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLYC01000020",81.818,3.05e-133,479,605,494.9989,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLXZ01000020",81.818,3.05e-133,479,605,494.9989,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_JAUEGY010000142",82.746,4.43e-133,479,539,446.00094,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_FLBI01000046",82.272,2.62e-133,479,581,478.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_FLBN01000099",82.914,2.55e-133,479,556,461.00184,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_FLCN01000004",82.914,2.55e-133,479,556,461.00184,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRZ01000037",81.059,2.84e-133,479,623,504.99757,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLWB01000035",81.059,2.84e-133,479,623,504.99757,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLZF01000029",81.059,2.84e-133,479,623,504.99757,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FLBI01000046",79.286,1.16e-132,477,700,555.002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FLBN01000099",79.286,1.16e-132,477,700,555.002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_FLCN01000004",79.286,1.16e-132,477,700,555.002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_JBGJJV010000032",81.353,9.93e-133,477,606,492.99918,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_FLBI01000046",81.059,1.02e-132,477,623,504.99757,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_FLBN01000099",81.059,1.02e-132,477,623,504.99757,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_FLCN01000004",81.059,1.02e-132,477,623,504.99757,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRI01000021",80.03,1.45e-132,477,666,532.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRZ01000037",80,1.45e-132,477,665,532,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRO01000021",80.03,1.45e-132,477,666,532.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXR01000021",80.03,1.45e-132,477,666,532.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRG01000021",80.03,1.45e-132,477,666,532.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYG01000019",80.03,1.45e-132,477,666,532.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRJ01000019",80.03,1.45e-132,477,666,532.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSM01000018",80.03,1.45e-132,477,666,532.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSQ01000022",80.03,1.45e-132,477,666,532.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXY01000024",80.03,1.45e-132,477,666,532.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXS01000025",80.03,1.45e-132,477,666,532.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLWB01000035",80,1.45e-132,477,665,532,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLUD01000021",80.03,1.45e-132,477,666,532.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRC01000027",80.03,1.45e-132,477,666,532.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYZ01000021",80.03,1.45e-132,477,666,532.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSP01000022",80.03,1.45e-132,477,666,532.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLZF01000029",80,1.45e-132,477,665,532,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSH01000020",80.03,1.45e-132,477,666,532.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYY01000023",80.03,1.45e-132,477,666,532.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYC01000020",80.03,1.45e-132,477,666,532.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXZ01000020",80.03,1.45e-132,477,666,532.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRE01000049",79.767,4.05e-132,475,687,547.99929,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_FLBN01000099",81.742,3.52e-132,475,597,487.99974,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_FLCN01000004",81.742,3.52e-132,475,597,487.99974,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_JBGJJV010000032",81.711,3.52e-132,475,596,486.99756,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_JBGJJV010000032",83.527,3.04e-132,475,516,430.99932,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_FLBN01000099",82.1,1.22e-131,473,581,477.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_FLCN01000004",82.1,1.22e-131,473,581,477.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRE01000049",83.365,4.08e-131,472,529,441.00085,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRE01000049",81.588,1.66e-130,470,592,483.00096,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_FLBN01000099",84.095,1.4e-130,470,503,422.99785,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_FLCN01000004",84.095,1.4e-130,470,503,422.99785,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRC01000027",81.834,1.57e-130,470,578,473.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRE01000049",82.585,1.53e-130,470,557,459.99845,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRZ01000037",82.585,1.53e-130,470,557,459.99845,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLWB01000035",82.585,1.53e-130,470,557,459.99845,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLZF01000029",82.585,1.53e-130,470,557,459.99845,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRE01000049",83.054,1.45e-130,470,537,445.99998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_JBGJJV010000032",82.554,5.52e-130,468,556,459.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLRE01000049",83.897,6.63e-130,468,503,422.00191,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRZ01000037",81.818,6.46e-130,468,572,467.99896,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLWB01000035",81.818,6.46e-130,468,572,467.99896,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLZF01000029",81.818,6.46e-130,468,572,467.99896,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_JBGJJV010000032",83.176,1.9e-129,466,529,440.00104,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_FLBN01000099",84.032,2.25e-129,466,501,421.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_FLCN01000004",84.032,2.25e-129,466,501,421.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FLBN01000099",79.476,8.76e-129,464,687,546.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRI01000021",79.476,8.76e-129,464,687,546.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FLCN01000004",79.476,8.76e-129,464,687,546.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRO01000021",79.476,8.76e-129,464,687,546.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLXR01000021",79.476,8.76e-129,464,687,546.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRG01000021",79.476,8.76e-129,464,687,546.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLYG01000019",79.476,8.76e-129,464,687,546.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRJ01000019",79.476,8.76e-129,464,687,546.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLSM01000018",79.476,8.76e-129,464,687,546.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLSQ01000022",79.476,8.76e-129,464,687,546.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLXY01000024",79.476,8.76e-129,464,687,546.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLXS01000025",79.476,8.76e-129,464,687,546.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLUD01000021",79.476,8.76e-129,464,687,546.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRC01000027",79.476,8.76e-129,464,687,546.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLYZ01000021",79.476,8.76e-129,464,687,546.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLSP01000022",79.476,8.76e-129,464,687,546.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLSH01000020",79.476,8.76e-129,464,687,546.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLYY01000023",79.476,8.76e-129,464,687,546.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLYC01000020",79.476,8.76e-129,464,687,546.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLXZ01000020",79.476,8.76e-129,464,687,546.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRZ01000037",81.169,9.27e-129,464,616,500.00104,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLWB01000035",81.169,9.27e-129,464,616,500.00104,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLZF01000029",81.169,9.27e-129,464,616,500.00104,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRI01000021",81.661,7.33e-129,464,578,472.00058,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRO01000021",81.661,7.33e-129,464,578,472.00058,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLXR01000021",81.661,7.33e-129,464,578,472.00058,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRG01000021",81.661,7.33e-129,464,578,472.00058,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLYG01000019",81.661,7.33e-129,464,578,472.00058,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRJ01000019",81.661,7.33e-129,464,578,472.00058,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLSM01000018",81.661,7.33e-129,464,578,472.00058,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLSQ01000022",81.661,7.33e-129,464,578,472.00058,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLXY01000024",81.661,7.33e-129,464,578,472.00058,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLXS01000025",81.661,7.33e-129,464,578,472.00058,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLUD01000021",81.661,7.33e-129,464,578,472.00058,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLYZ01000021",81.661,7.33e-129,464,578,472.00058,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLSP01000022",81.661,7.33e-129,464,578,472.00058,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLSH01000020",81.661,7.33e-129,464,578,472.00058,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLYY01000023",81.661,7.33e-129,464,578,472.00058,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLYC01000020",81.661,7.33e-129,464,578,472.00058,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLXZ01000020",81.661,7.33e-129,464,578,472.00058,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRI01000021",82.406,7.14e-129,464,557,459.00142,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRO01000021",82.406,7.14e-129,464,557,459.00142,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLXR01000021",82.406,7.14e-129,464,557,459.00142,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRG01000021",82.406,7.14e-129,464,557,459.00142,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLYG01000019",82.406,7.14e-129,464,557,459.00142,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRJ01000019",82.406,7.14e-129,464,557,459.00142,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLSM01000018",82.406,7.14e-129,464,557,459.00142,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLSQ01000022",82.406,7.14e-129,464,557,459.00142,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLXY01000024",82.406,7.14e-129,464,557,459.00142,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLXS01000025",82.406,7.14e-129,464,557,459.00142,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLUD01000021",82.406,7.14e-129,464,557,459.00142,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLRC01000027",82.406,7.14e-129,464,557,459.00142,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLYZ01000021",82.406,7.14e-129,464,557,459.00142,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLSP01000022",82.406,7.14e-129,464,557,459.00142,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLSH01000020",82.406,7.14e-129,464,557,459.00142,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLYY01000023",82.406,7.14e-129,464,557,459.00142,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLYC01000020",82.406,7.14e-129,464,557,459.00142,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLXZ01000020",82.406,7.14e-129,464,557,459.00142,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_JBGJJV010000032",81.135,2.75e-128,462,599,485.99865,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRI01000021",82.44,2.86e-128,462,541,446.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRO01000021",82.44,2.86e-128,462,541,446.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLXR01000021",82.44,2.86e-128,462,541,446.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRG01000021",82.44,2.86e-128,462,541,446.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLYG01000019",82.44,2.86e-128,462,541,446.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRJ01000019",82.44,2.86e-128,462,541,446.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLSM01000018",82.44,2.86e-128,462,541,446.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLSQ01000022",82.44,2.86e-128,462,541,446.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLXY01000024",82.44,2.86e-128,462,541,446.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLXS01000025",82.44,2.86e-128,462,541,446.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLUD01000021",82.44,2.86e-128,462,541,446.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRC01000027",82.44,2.86e-128,462,541,446.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLYZ01000021",82.44,2.86e-128,462,541,446.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLSP01000022",82.44,2.86e-128,462,541,446.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLSH01000020",82.44,2.86e-128,462,541,446.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLYY01000023",82.44,2.86e-128,462,541,446.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLYC01000020",82.44,2.86e-128,462,541,446.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLXZ01000020",82.44,2.86e-128,462,541,446.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FLBI01000046",82.987,8.83e-128,460,529,439.00123,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRI01000021",82.987,8.83e-128,460,529,439.00123,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRZ01000037",82.987,8.83e-128,460,529,439.00123,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRO01000021",82.987,8.83e-128,460,529,439.00123,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLXR01000021",82.987,8.83e-128,460,529,439.00123,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRG01000021",82.987,8.83e-128,460,529,439.00123,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLYG01000019",82.987,8.83e-128,460,529,439.00123,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRJ01000019",82.987,8.83e-128,460,529,439.00123,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLSM01000018",82.987,8.83e-128,460,529,439.00123,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLSQ01000022",82.987,8.83e-128,460,529,439.00123,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLXY01000024",82.987,8.83e-128,460,529,439.00123,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLXS01000025",82.987,8.83e-128,460,529,439.00123,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLWB01000035",82.987,8.83e-128,460,529,439.00123,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLUD01000021",82.987,8.83e-128,460,529,439.00123,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLRC01000027",82.987,8.83e-128,460,529,439.00123,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLYZ01000021",82.987,8.83e-128,460,529,439.00123,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLSP01000022",82.987,8.83e-128,460,529,439.00123,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLZF01000029",82.987,8.83e-128,460,529,439.00123,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLSH01000020",82.987,8.83e-128,460,529,439.00123,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLYY01000023",82.987,8.83e-128,460,529,439.00123,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLYC01000020",82.987,8.83e-128,460,529,439.00123,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLXZ01000020",82.987,8.83e-128,460,529,439.00123,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_FLBN01000099",75.77,1.93e-127,460,974,737.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_FLCN01000004",75.77,1.93e-127,460,974,737.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRE01000049",79.671,1.46e-127,460,669,532.99899,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FLBI01000046",86.105,8.74e-128,460,439,378.00095,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FLBN01000099",86.105,8.74e-128,460,439,378.00095,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_FLCN01000004",86.105,8.74e-128,460,439,378.00095,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_JBGJJV010000032",81.611,1.08e-127,460,571,465.99881,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_FLBI01000046",79.33,4.08e-127,459,687,544.9971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLRZ01000037",79.33,4.08e-127,459,687,544.9971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLWB01000035",79.33,4.08e-127,459,687,544.9971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLZF01000029",79.33,4.08e-127,459,687,544.9971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRI01000021",81.25,3.59e-127,459,592,481,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRZ01000037",81.25,3.59e-127,459,592,481,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRO01000021",81.25,3.59e-127,459,592,481,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLXR01000021",81.25,3.59e-127,459,592,481,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRG01000021",81.25,3.59e-127,459,592,481,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLYG01000019",81.25,3.59e-127,459,592,481,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRJ01000019",81.25,3.59e-127,459,592,481,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLSM01000018",81.25,3.59e-127,459,592,481,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLSQ01000022",81.25,3.59e-127,459,592,481,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLXY01000024",81.25,3.59e-127,459,592,481,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLXS01000025",81.25,3.59e-127,459,592,481,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLWB01000035",81.25,3.59e-127,459,592,481,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLUD01000021",81.25,3.59e-127,459,592,481,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLRC01000027",81.25,3.59e-127,459,592,481,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLYZ01000021",81.25,3.59e-127,459,592,481,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLSP01000022",81.25,3.59e-127,459,592,481,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLZF01000029",81.25,3.59e-127,459,592,481,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLSH01000020",81.25,3.59e-127,459,592,481,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLYY01000023",81.25,3.59e-127,459,592,481,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLYC01000020",81.25,3.59e-127,459,592,481,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLXZ01000020",81.25,3.59e-127,459,592,481,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_FLBI01000046",80.945,4.31e-127,459,614,497.0023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRE01000049",80.945,4.31e-127,459,614,497.0023,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_JBGJJV010000032",83.698,3.04e-127,459,503,421.00094,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRE01000049",81.488,3.41e-127,459,578,471.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLRZ01000037",81.488,3.41e-127,459,578,471.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLWB01000035",81.488,3.41e-127,459,578,471.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLZF01000029",81.488,3.41e-127,459,578,471.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRI01000021",82.682,3.14e-127,459,537,444.00234,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRZ01000037",82.682,3.14e-127,459,537,444.00234,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRO01000021",82.682,3.14e-127,459,537,444.00234,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLXR01000021",82.682,3.14e-127,459,537,444.00234,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRG01000021",82.682,3.14e-127,459,537,444.00234,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLYG01000019",82.682,3.14e-127,459,537,444.00234,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRJ01000019",82.682,3.14e-127,459,537,444.00234,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLSM01000018",82.682,3.14e-127,459,537,444.00234,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLSQ01000022",82.682,3.14e-127,459,537,444.00234,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLXY01000024",82.682,3.14e-127,459,537,444.00234,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLXS01000025",82.682,3.14e-127,459,537,444.00234,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLWB01000035",82.682,3.14e-127,459,537,444.00234,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLUD01000021",82.682,3.14e-127,459,537,444.00234,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLRC01000027",82.682,3.14e-127,459,537,444.00234,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLYZ01000021",82.682,3.14e-127,459,537,444.00234,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLSP01000022",82.682,3.14e-127,459,537,444.00234,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLZF01000029",82.682,3.14e-127,459,537,444.00234,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLSH01000020",82.682,3.14e-127,459,537,444.00234,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLYY01000023",82.682,3.14e-127,459,537,444.00234,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLYC01000020",82.682,3.14e-127,459,537,444.00234,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLXZ01000020",82.682,3.14e-127,459,537,444.00234,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_FLBN01000099",83.074,3.04e-127,459,514,427.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_FLCN01000004",83.074,3.04e-127,459,514,427.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRZ01000037",81.04,1.28e-126,457,596,482.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLWB01000035",81.04,1.28e-126,457,596,482.9984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLZF01000029",81.04,1.28e-126,457,596,482.9984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRZ01000037",84.681,1.36e-126,457,470,398.0007,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLWB01000035",84.681,1.36e-126,457,470,398.0007,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLZF01000029",84.681,1.36e-126,457,470,398.0007,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FLBI01000046",83.537,1.33e-126,457,492,411.00204,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FLBN01000099",83.537,1.33e-126,457,492,411.00204,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FLCN01000004",83.537,1.33e-126,457,492,411.00204,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_JBGJJV010000032",82.505,1.13e-126,457,543,448.00215,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_JAUEGY010000142",82.202,6.4e-126,455,545,448.0009,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_FLBI01000046",80.968,4.6e-126,455,599,484.99832,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_FLBN01000099",80.968,4.6e-126,455,599,484.99832,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRI01000021",82.576,4.6e-126,455,528,436.00128,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_FLCN01000004",80.968,4.6e-126,455,599,484.99832,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRO01000021",82.576,4.6e-126,455,528,436.00128,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLXR01000021",82.576,4.6e-126,455,528,436.00128,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRG01000021",82.576,4.6e-126,455,528,436.00128,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLYG01000019",82.576,4.6e-126,455,528,436.00128,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRJ01000019",82.576,4.6e-126,455,528,436.00128,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLSM01000018",82.576,4.6e-126,455,528,436.00128,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLSQ01000022",82.576,4.6e-126,455,528,436.00128,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLXY01000024",82.576,4.6e-126,455,528,436.00128,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLXS01000025",82.576,4.6e-126,455,528,436.00128,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLUD01000021",82.576,4.6e-126,455,528,436.00128,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRC01000027",82.576,4.6e-126,455,528,436.00128,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLYZ01000021",82.576,4.6e-126,455,528,436.00128,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLSP01000022",82.576,4.6e-126,455,528,436.00128,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLSH01000020",82.576,4.6e-126,455,528,436.00128,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLYY01000023",82.576,4.6e-126,455,528,436.00128,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLYC01000020",82.576,4.6e-126,455,528,436.00128,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLXZ01000020",82.576,4.6e-126,455,528,436.00128,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FLBN01000099",82.798,4.11e-126,455,529,438.00142,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_FLCN01000004",82.798,4.11e-126,455,529,438.00142,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_FLBI01000046",75.667,9e-126,455,974,736.99658,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLRE01000049",83.603,1.61e-125,453,494,412.99882,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_JAUEGY010000142",81.195,3.36e-125,453,569,461.99955,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRZ01000037",83.466,1.41e-125,453,502,418.99932,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLWB01000035",83.466,1.41e-125,453,502,418.99932,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLZF01000029",83.466,1.41e-125,453,502,418.99932,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_FLBI01000046",82.879,1.41e-125,453,514,425.99806,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRI01000021",82.331,9.58e-125,451,532,438.00092,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRO01000021",82.331,9.58e-125,451,532,438.00092,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLXR01000021",82.331,9.58e-125,451,532,438.00092,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRG01000021",82.331,9.58e-125,451,532,438.00092,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLYG01000019",82.331,9.58e-125,451,532,438.00092,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRJ01000019",82.331,9.58e-125,451,532,438.00092,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLSM01000018",82.331,9.58e-125,451,532,438.00092,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLSQ01000022",82.331,9.58e-125,451,532,438.00092,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLXY01000024",82.331,9.58e-125,451,532,438.00092,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLXS01000025",82.331,9.58e-125,451,532,438.00092,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLUD01000021",82.331,9.58e-125,451,532,438.00092,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRC01000027",82.331,9.58e-125,451,532,438.00092,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLYZ01000021",82.331,9.58e-125,451,532,438.00092,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLSP01000022",82.331,9.58e-125,451,532,438.00092,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLSH01000020",82.331,9.58e-125,451,532,438.00092,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLYY01000023",82.331,9.58e-125,451,532,438.00092,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLYC01000020",82.331,9.58e-125,451,532,438.00092,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLXZ01000020",82.331,9.58e-125,451,532,438.00092,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRE01000049",83.333,6.21e-125,451,492,409.99836,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRZ01000037",83.333,6.21e-125,451,492,409.99836,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXR01000021",83.333,6.21e-125,451,492,409.99836,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRJ01000019",83.333,6.21e-125,451,492,409.99836,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLWB01000035",83.333,6.21e-125,451,492,409.99836,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLZF01000029",83.333,6.21e-125,451,492,409.99836,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXZ01000020",83.333,6.21e-125,451,492,409.99836,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JBGJJV010000032",83.333,6.21e-125,451,492,409.99836,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_FLBN01000099",82.386,1.87e-124,449,528,434.99808,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_FLCN01000004",82.386,1.87e-124,449,528,434.99808,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_JBGJJV010000032",84.468,2.27e-124,449,470,396.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_JBGJJV010000032",79.009,8.83e-124,448,686,542.00174,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_FLBN01000099",80.65,9.33e-124,448,615,495.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_FLCN01000004",80.65,9.33e-124,448,615,495.9975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRE01000049",83.2,6.57e-124,448,500,416,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_JBGJJV010000032",82.718,6.57e-124,448,515,425.9977,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_JBGJJV010000032",81.336,2.68e-123,446,584,475.00224,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRI01000021",84.322,2.93e-123,446,472,397.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRO01000021",84.322,2.93e-123,446,472,397.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLXR01000021",84.322,2.93e-123,446,472,397.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRG01000021",84.322,2.93e-123,446,472,397.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLYG01000019",84.322,2.93e-123,446,472,397.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRJ01000019",84.322,2.93e-123,446,472,397.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLSM01000018",84.322,2.93e-123,446,472,397.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLSQ01000022",84.322,2.93e-123,446,472,397.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLXY01000024",84.322,2.93e-123,446,472,397.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLXS01000025",84.322,2.93e-123,446,472,397.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLUD01000021",84.322,2.93e-123,446,472,397.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRC01000027",84.322,2.93e-123,446,472,397.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLYZ01000021",84.322,2.93e-123,446,472,397.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLSP01000022",84.322,2.93e-123,446,472,397.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLSH01000020",84.322,2.93e-123,446,472,397.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLYY01000023",84.322,2.93e-123,446,472,397.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLYC01000020",84.322,2.93e-123,446,472,397.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLXZ01000020",84.322,2.93e-123,446,472,397.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRI01000021",83.13,2.89e-123,446,492,408.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRO01000021",83.13,2.89e-123,446,492,408.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRG01000021",83.13,2.89e-123,446,492,408.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYG01000019",83.13,2.89e-123,446,492,408.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSM01000018",83.13,2.89e-123,446,492,408.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSQ01000022",83.13,2.89e-123,446,492,408.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXY01000024",83.13,2.89e-123,446,492,408.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXS01000025",83.13,2.89e-123,446,492,408.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLUD01000021",83.13,2.89e-123,446,492,408.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRC01000027",83.13,2.89e-123,446,492,408.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYZ01000021",83.13,2.89e-123,446,492,408.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSP01000022",83.13,2.89e-123,446,492,408.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSH01000020",83.13,2.89e-123,446,492,408.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYY01000023",83.13,2.89e-123,446,492,408.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYC01000020",83.13,2.89e-123,446,492,408.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_JBGJJV010000032",83.333,2.87e-123,446,504,419.99832,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRI01000021",84.396,9.74e-123,444,455,384.0018,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRO01000021",84.396,9.74e-123,444,455,384.0018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLXR01000021",84.396,9.74e-123,444,455,384.0018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRG01000021",84.396,9.74e-123,444,455,384.0018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLYG01000019",84.396,9.74e-123,444,455,384.0018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRJ01000019",84.396,9.74e-123,444,455,384.0018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLSM01000018",84.396,9.74e-123,444,455,384.0018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLSQ01000022",84.396,9.74e-123,444,455,384.0018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLXY01000024",84.396,9.74e-123,444,455,384.0018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLXS01000025",84.396,9.74e-123,444,455,384.0018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLUD01000021",84.396,9.74e-123,444,455,384.0018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRC01000027",84.396,9.74e-123,444,455,384.0018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLYZ01000021",84.396,9.74e-123,444,455,384.0018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLSP01000022",84.396,9.74e-123,444,455,384.0018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLSH01000020",84.396,9.74e-123,444,455,384.0018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLYY01000023",84.396,9.74e-123,444,455,384.0018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLYC01000020",84.396,9.74e-123,444,455,384.0018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLXZ01000020",84.396,9.74e-123,444,455,384.0018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_FLBI01000046",82.197,8.7e-123,444,528,434.00016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRI01000021",83.367,1.03e-122,444,499,416.00133,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRE01000049",83.367,1.03e-122,444,499,416.00133,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRZ01000037",83.367,1.03e-122,444,499,416.00133,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRO01000021",83.367,1.03e-122,444,499,416.00133,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLXR01000021",83.367,1.03e-122,444,499,416.00133,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRG01000021",83.367,1.03e-122,444,499,416.00133,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLYG01000019",83.367,1.03e-122,444,499,416.00133,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRJ01000019",83.367,1.03e-122,444,499,416.00133,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLSM01000018",83.367,1.03e-122,444,499,416.00133,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLSQ01000022",83.367,1.03e-122,444,499,416.00133,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLXY01000024",83.367,1.03e-122,444,499,416.00133,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLXS01000025",83.367,1.03e-122,444,499,416.00133,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLWB01000035",83.367,1.03e-122,444,499,416.00133,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLUD01000021",83.367,1.03e-122,444,499,416.00133,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLRC01000027",83.367,1.03e-122,444,499,416.00133,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLYZ01000021",83.367,1.03e-122,444,499,416.00133,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLSP01000022",83.367,1.03e-122,444,499,416.00133,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLZF01000029",83.367,1.03e-122,444,499,416.00133,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLSH01000020",83.367,1.03e-122,444,499,416.00133,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLYY01000023",83.367,1.03e-122,444,499,416.00133,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLYC01000020",83.367,1.03e-122,444,499,416.00133,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLXZ01000020",83.367,1.03e-122,444,499,416.00133,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRZ01000037",82.524,8.5e-123,444,515,424.9986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLWB01000035",82.524,8.5e-123,444,515,424.9986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLZF01000029",82.524,8.5e-123,444,515,424.9986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRI01000021",82.745,1.09e-122,444,510,421.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRO01000021",82.745,1.09e-122,444,510,421.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLXR01000021",82.745,1.09e-122,444,510,421.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRG01000021",82.745,1.09e-122,444,510,421.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLYG01000019",82.745,1.09e-122,444,510,421.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRJ01000019",82.745,1.09e-122,444,510,421.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLSM01000018",82.745,1.09e-122,444,510,421.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLSQ01000022",82.745,1.09e-122,444,510,421.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLXY01000024",82.745,1.09e-122,444,510,421.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLXS01000025",82.745,1.09e-122,444,510,421.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLUD01000021",82.745,1.09e-122,444,510,421.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRC01000027",82.745,1.09e-122,444,510,421.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLYZ01000021",82.745,1.09e-122,444,510,421.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLSP01000022",82.745,1.09e-122,444,510,421.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLSH01000020",82.745,1.09e-122,444,510,421.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLYY01000023",82.745,1.09e-122,444,510,421.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLYC01000020",82.745,1.09e-122,444,510,421.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLXZ01000020",82.745,1.09e-122,444,510,421.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_JAUEGY010000142",84.966,6.06e-122,442,439,373.00074,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_JBGJJV010000032",80.743,3.62e-122,442,592,477.99856,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRI01000021",82.319,3.62e-122,442,526,432.99794,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRO01000021",82.319,3.62e-122,442,526,432.99794,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLXR01000021",82.319,3.62e-122,442,526,432.99794,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRG01000021",82.319,3.62e-122,442,526,432.99794,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLYG01000019",82.319,3.62e-122,442,526,432.99794,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRJ01000019",82.319,3.62e-122,442,526,432.99794,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLSM01000018",82.319,3.62e-122,442,526,432.99794,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLSQ01000022",82.319,3.62e-122,442,526,432.99794,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLXY01000024",82.319,3.62e-122,442,526,432.99794,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLXS01000025",82.319,3.62e-122,442,526,432.99794,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLUD01000021",82.319,3.62e-122,442,526,432.99794,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRC01000027",82.319,3.62e-122,442,526,432.99794,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLYZ01000021",82.319,3.62e-122,442,526,432.99794,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLSP01000022",82.319,3.62e-122,442,526,432.99794,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLSH01000020",82.319,3.62e-122,442,526,432.99794,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLYY01000023",82.319,3.62e-122,442,526,432.99794,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLYC01000020",82.319,3.62e-122,442,526,432.99794,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLXZ01000020",82.319,3.62e-122,442,526,432.99794,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRI01000021",80.519,4.34e-122,442,616,495.99704,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRO01000021",80.519,4.34e-122,442,616,495.99704,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLXR01000021",80.519,4.34e-122,442,616,495.99704,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRG01000021",80.519,4.34e-122,442,616,495.99704,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLYG01000019",80.519,4.34e-122,442,616,495.99704,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRJ01000019",80.519,4.34e-122,442,616,495.99704,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLSM01000018",80.519,4.34e-122,442,616,495.99704,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLSQ01000022",80.519,4.34e-122,442,616,495.99704,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLXY01000024",80.519,4.34e-122,442,616,495.99704,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLXS01000025",80.519,4.34e-122,442,616,495.99704,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLUD01000021",80.519,4.34e-122,442,616,495.99704,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLRC01000027",80.519,4.34e-122,442,616,495.99704,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLYZ01000021",80.519,4.34e-122,442,616,495.99704,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLSP01000022",80.519,4.34e-122,442,616,495.99704,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLSH01000020",80.519,4.34e-122,442,616,495.99704,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLYY01000023",80.519,4.34e-122,442,616,495.99704,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLYC01000020",80.519,4.34e-122,442,616,495.99704,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLXZ01000020",80.519,4.34e-122,442,616,495.99704,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRI01000021",83.101,3.06e-122,442,503,417.99803,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRO01000021",83.101,3.06e-122,442,503,417.99803,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLXR01000021",83.101,3.06e-122,442,503,417.99803,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRG01000021",83.101,3.06e-122,442,503,417.99803,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLYG01000019",83.101,3.06e-122,442,503,417.99803,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRJ01000019",83.101,3.06e-122,442,503,417.99803,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLSM01000018",83.101,3.06e-122,442,503,417.99803,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLSQ01000022",83.101,3.06e-122,442,503,417.99803,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLXY01000024",83.101,3.06e-122,442,503,417.99803,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLXS01000025",83.101,3.06e-122,442,503,417.99803,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLUD01000021",83.101,3.06e-122,442,503,417.99803,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLRC01000027",83.101,3.06e-122,442,503,417.99803,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLYZ01000021",83.101,3.06e-122,442,503,417.99803,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLSP01000022",83.101,3.06e-122,442,503,417.99803,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLSH01000020",83.101,3.06e-122,442,503,417.99803,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLYY01000023",83.101,3.06e-122,442,503,417.99803,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLYC01000020",83.101,3.06e-122,442,503,417.99803,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLXZ01000020",83.101,3.06e-122,442,503,417.99803,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_JBGJJV010000032",85.327,3.19e-122,442,443,377.99861,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_FLBN01000099",81.475,3.32e-122,442,556,453.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_FLCN01000004",81.475,3.32e-122,442,556,453.001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_JBGJJV010000032",81.475,3.32e-122,442,556,453.001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRI01000021",81.387,1.52e-121,440,548,446.00076,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRE01000049",81.387,1.52e-121,440,548,446.00076,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRO01000021",81.387,1.52e-121,440,548,446.00076,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRG01000021",81.387,1.52e-121,440,548,446.00076,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLYG01000019",81.387,1.52e-121,440,548,446.00076,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLSM01000018",81.387,1.52e-121,440,548,446.00076,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLSQ01000022",81.387,1.52e-121,440,548,446.00076,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLXY01000024",81.387,1.52e-121,440,548,446.00076,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLXS01000025",81.387,1.52e-121,440,548,446.00076,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLUD01000021",81.387,1.52e-121,440,548,446.00076,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRC01000027",81.387,1.52e-121,440,548,446.00076,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLYZ01000021",81.387,1.52e-121,440,548,446.00076,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLSP01000022",81.387,1.52e-121,440,548,446.00076,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLSH01000020",81.387,1.52e-121,440,548,446.00076,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLYY01000023",81.387,1.52e-121,440,548,446.00076,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLYC01000020",81.387,1.52e-121,440,548,446.00076,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRE01000049",81.272,1.21e-121,440,566,459.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_JBGJJV010000032",82.095,1.12e-121,440,525,430.99875,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLRE01000049",83.974,1.36e-121,440,468,392.99832,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAUEGY010000142",82.927,1.34e-121,440,492,408.00084,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FLBI01000046",82.184,6.38e-121,438,522,429.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FLBN01000099",82.184,6.38e-121,438,522,429.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_FLCN01000004",82.184,6.38e-121,438,522,429.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_JBGJJV010000032",81.282,4.35e-121,438,577,468.99714,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLRE01000049",84.154,2e-120,436,467,392.99918,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRE01000049",85.315,2.29e-120,436,429,366.00135,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FLBI01000046",80.574,1.68e-120,436,592,476.99808,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FLBN01000099",80.607,1.68e-120,436,593,477.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_FLCN01000004",80.607,1.68e-120,436,593,477.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_JBGJJV010000032",80.357,2.02e-120,436,616,494.99912,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_JBGJJV010000032",78.483,1.98e-120,436,725,569.00175,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_FLBI01000046",81.204,7.07e-120,435,548,444.99792,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_FLBN01000099",81.204,7.07e-120,435,548,444.99792,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_FLCN01000004",81.204,7.07e-120,435,548,444.99792,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRZ01000037",81.204,7.07e-120,435,548,444.99792,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLXR01000021",81.204,7.07e-120,435,548,444.99792,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLRJ01000019",81.204,7.07e-120,435,548,444.99792,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLWB01000035",81.204,7.07e-120,435,548,444.99792,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLZF01000029",81.204,7.07e-120,435,548,444.99792,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLXZ01000020",81.204,7.07e-120,435,548,444.99792,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_JBGJJV010000032",81.204,7.07e-120,435,548,444.99792,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_JAUEGY010000142",81.204,7.07e-120,435,548,444.99792,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_JBGJJV010000032",81.095,5.63e-120,435,566,458.9977,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRZ01000037",81.853,5.23e-120,435,529,433.00237,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLWB01000035",81.853,5.23e-120,435,529,433.00237,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLZF01000029",81.853,5.23e-120,435,529,433.00237,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_JBGJJV010000032",81.853,5.23e-120,435,529,433.00237,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRI01000021",81.973,5.22e-120,435,527,431.99771,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRE01000049",81.973,5.22e-120,435,527,431.99771,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRZ01000037",81.973,5.22e-120,435,527,431.99771,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRO01000021",81.973,5.22e-120,435,527,431.99771,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLXR01000021",81.973,5.22e-120,435,527,431.99771,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRG01000021",81.973,5.22e-120,435,527,431.99771,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLYG01000019",81.973,5.22e-120,435,527,431.99771,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRJ01000019",81.973,5.22e-120,435,527,431.99771,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLSM01000018",81.973,5.22e-120,435,527,431.99771,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLSQ01000022",81.973,5.22e-120,435,527,431.99771,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLXY01000024",81.973,5.22e-120,435,527,431.99771,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLXS01000025",81.973,5.22e-120,435,527,431.99771,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLWB01000035",81.973,5.22e-120,435,527,431.99771,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLUD01000021",81.973,5.22e-120,435,527,431.99771,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLRC01000027",81.973,5.22e-120,435,527,431.99771,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLYZ01000021",81.973,5.22e-120,435,527,431.99771,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLSP01000022",81.973,5.22e-120,435,527,431.99771,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLZF01000029",81.973,5.22e-120,435,527,431.99771,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLSH01000020",81.973,5.22e-120,435,527,431.99771,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLYY01000023",81.973,5.22e-120,435,527,431.99771,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLYC01000020",81.973,5.22e-120,435,527,431.99771,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLXZ01000020",81.973,5.22e-120,435,527,431.99771,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRI01000021",83.991,5.56e-120,435,456,382.99896,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRO01000021",83.991,5.56e-120,435,456,382.99896,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLXR01000021",83.991,5.56e-120,435,456,382.99896,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRG01000021",83.991,5.56e-120,435,456,382.99896,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLYG01000019",83.991,5.56e-120,435,456,382.99896,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRJ01000019",83.991,5.56e-120,435,456,382.99896,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLSM01000018",83.991,5.56e-120,435,456,382.99896,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLSQ01000022",83.991,5.56e-120,435,456,382.99896,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLXY01000024",83.991,5.56e-120,435,456,382.99896,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLXS01000025",83.991,5.56e-120,435,456,382.99896,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLUD01000021",83.991,5.56e-120,435,456,382.99896,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRC01000027",83.991,5.56e-120,435,456,382.99896,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLYZ01000021",83.991,5.56e-120,435,456,382.99896,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLSP01000022",83.991,5.56e-120,435,456,382.99896,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLSH01000020",83.991,5.56e-120,435,456,382.99896,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLYY01000023",83.991,5.56e-120,435,456,382.99896,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLYC01000020",83.991,5.56e-120,435,456,382.99896,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLXZ01000020",83.991,5.56e-120,435,456,382.99896,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FLBI01000046",82.937,6.21e-120,435,504,418.00248,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FLBN01000099",82.937,6.21e-120,435,504,418.00248,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_FLCN01000004",82.937,6.21e-120,435,504,418.00248,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRI01000021",84.106,5.12e-120,435,453,381.00018,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRO01000021",84.106,5.12e-120,435,453,381.00018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLXR01000021",84.106,5.12e-120,435,453,381.00018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRG01000021",84.106,5.12e-120,435,453,381.00018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLYG01000019",84.106,5.12e-120,435,453,381.00018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRJ01000019",84.106,5.12e-120,435,453,381.00018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLSM01000018",84.106,5.12e-120,435,453,381.00018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLSQ01000022",84.106,5.12e-120,435,453,381.00018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLXY01000024",84.106,5.12e-120,435,453,381.00018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLXS01000025",84.106,5.12e-120,435,453,381.00018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLUD01000021",84.106,5.12e-120,435,453,381.00018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRC01000027",84.106,5.12e-120,435,453,381.00018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLYZ01000021",84.106,5.12e-120,435,453,381.00018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLSP01000022",84.106,5.12e-120,435,453,381.00018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLSH01000020",84.106,5.12e-120,435,453,381.00018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLYY01000023",84.106,5.12e-120,435,453,381.00018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLYC01000020",84.106,5.12e-120,435,453,381.00018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLXZ01000020",84.106,5.12e-120,435,453,381.00018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRZ01000037",81.992,2.97e-119,433,522,427.99824,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLXR01000021",81.992,2.97e-119,433,522,427.99824,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRJ01000019",81.992,2.97e-119,433,522,427.99824,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLWB01000035",81.992,2.97e-119,433,522,427.99824,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLZF01000029",81.992,2.97e-119,433,522,427.99824,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLXZ01000020",81.992,2.97e-119,433,522,427.99824,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_JBGJJV010000032",81.992,2.97e-119,433,522,427.99824,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLRE01000049",86.802,1.93e-119,433,394,341.99988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRZ01000037",81.216,2.01e-119,433,559,453.99744,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLWB01000035",81.216,2.01e-119,433,559,453.99744,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLZF01000029",81.216,2.01e-119,433,559,453.99744,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_JBGJJV010000032",81.076,2.02e-119,433,576,466.99776,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FLBI01000046",80.702,2.36e-119,433,570,460.0014,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FLBN01000099",80.702,2.36e-119,433,570,460.0014,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_FLCN01000004",80.702,2.36e-119,433,570,460.0014,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRI01000021",85.082,1.07e-118,431,429,365.00178,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRO01000021",85.082,1.07e-118,431,429,365.00178,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRG01000021",85.082,1.07e-118,431,429,365.00178,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLYG01000019",85.082,1.07e-118,431,429,365.00178,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLSM01000018",85.082,1.07e-118,431,429,365.00178,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLSQ01000022",85.082,1.07e-118,431,429,365.00178,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLXY01000024",85.082,1.07e-118,431,429,365.00178,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLXS01000025",85.082,1.07e-118,431,429,365.00178,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLUD01000021",85.082,1.07e-118,431,429,365.00178,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLRC01000027",85.082,1.07e-118,431,429,365.00178,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLYZ01000021",85.082,1.07e-118,431,429,365.00178,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLSP01000022",85.082,1.07e-118,431,429,365.00178,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLSH01000020",85.082,1.07e-118,431,429,365.00178,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLYY01000023",85.082,1.07e-118,431,429,365.00178,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLYC01000020",85.082,1.07e-118,431,429,365.00178,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRI01000021",82.892,7.22e-119,431,491,406.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRO01000021",82.892,7.22e-119,431,491,406.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLXR01000021",82.892,7.22e-119,431,491,406.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRG01000021",82.892,7.22e-119,431,491,406.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLYG01000019",82.892,7.22e-119,431,491,406.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRJ01000019",82.892,7.22e-119,431,491,406.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLSM01000018",82.892,7.22e-119,431,491,406.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLSQ01000022",82.892,7.22e-119,431,491,406.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLXY01000024",82.892,7.22e-119,431,491,406.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLXS01000025",82.892,7.22e-119,431,491,406.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLUD01000021",82.892,7.22e-119,431,491,406.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRC01000027",82.892,7.22e-119,431,491,406.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLYZ01000021",82.892,7.22e-119,431,491,406.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLSP01000022",82.892,7.22e-119,431,491,406.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLSH01000020",82.892,7.22e-119,431,491,406.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLYY01000023",82.892,7.22e-119,431,491,406.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLYC01000020",82.892,7.22e-119,431,491,406.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLXZ01000020",82.892,7.22e-119,431,491,406.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRI01000021",83.956,6.67e-119,431,455,381.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRO01000021",83.956,6.67e-119,431,455,381.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLXR01000021",83.956,6.67e-119,431,455,381.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRG01000021",83.956,6.67e-119,431,455,381.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLYG01000019",83.956,6.67e-119,431,455,381.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRJ01000019",83.956,6.67e-119,431,455,381.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLSM01000018",83.956,6.67e-119,431,455,381.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLSQ01000022",83.956,6.67e-119,431,455,381.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLXY01000024",83.956,6.67e-119,431,455,381.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLXS01000025",83.956,6.67e-119,431,455,381.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLUD01000021",83.956,6.67e-119,431,455,381.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRC01000027",83.956,6.67e-119,431,455,381.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLYZ01000021",83.956,6.67e-119,431,455,381.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLSP01000022",83.956,6.67e-119,431,455,381.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLSH01000020",83.956,6.67e-119,431,455,381.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLYY01000023",83.956,6.67e-119,431,455,381.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLYC01000020",83.956,6.67e-119,431,455,381.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLXZ01000020",83.956,6.67e-119,431,455,381.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_FLBI01000046",81.955,6.76e-119,431,532,436.0006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_FLBI01000046",81.183,7.18e-119,431,558,453.00114,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FLBI01000046",80.919,2.62e-118,429,566,458.00154,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRI01000021",80.919,2.62e-118,429,566,458.00154,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRZ01000037",80.919,2.62e-118,429,566,458.00154,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRO01000021",80.919,2.62e-118,429,566,458.00154,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLXR01000021",80.919,2.62e-118,429,566,458.00154,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRG01000021",80.919,2.62e-118,429,566,458.00154,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLYG01000019",80.919,2.62e-118,429,566,458.00154,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRJ01000019",80.919,2.62e-118,429,566,458.00154,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLSM01000018",80.919,2.62e-118,429,566,458.00154,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLSQ01000022",80.919,2.62e-118,429,566,458.00154,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLXY01000024",80.919,2.62e-118,429,566,458.00154,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLXS01000025",80.919,2.62e-118,429,566,458.00154,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLWB01000035",80.919,2.62e-118,429,566,458.00154,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLUD01000021",80.919,2.62e-118,429,566,458.00154,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLRC01000027",80.919,2.62e-118,429,566,458.00154,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLYZ01000021",80.919,2.62e-118,429,566,458.00154,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLSP01000022",80.919,2.62e-118,429,566,458.00154,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLZF01000029",80.919,2.62e-118,429,566,458.00154,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLSH01000020",80.919,2.62e-118,429,566,458.00154,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLYY01000023",80.919,2.62e-118,429,566,458.00154,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLYC01000020",80.919,2.62e-118,429,566,458.00154,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLXZ01000020",80.919,2.62e-118,429,566,458.00154,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_FLBI01000046",81.749,2.43e-118,429,526,429.99974,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_FLBN01000099",81.749,2.43e-118,429,526,429.99974,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_FLCN01000004",81.749,2.43e-118,429,526,429.99974,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRI01000021",81.071,2.58e-118,429,560,453.9976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRE01000049",81.004,2.58e-118,429,558,452.00232,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRO01000021",81.071,2.58e-118,429,560,453.9976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLXR01000021",81.071,2.58e-118,429,560,453.9976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRG01000021",81.071,2.58e-118,429,560,453.9976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLYG01000019",81.071,2.58e-118,429,560,453.9976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRJ01000019",81.071,2.58e-118,429,560,453.9976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLSM01000018",81.071,2.58e-118,429,560,453.9976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLSQ01000022",81.071,2.58e-118,429,560,453.9976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLXY01000024",81.071,2.58e-118,429,560,453.9976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLXS01000025",81.071,2.58e-118,429,560,453.9976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLUD01000021",81.071,2.58e-118,429,560,453.9976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRC01000027",81.071,2.58e-118,429,560,453.9976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLYZ01000021",81.071,2.58e-118,429,560,453.9976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLSP01000022",81.071,2.58e-118,429,560,453.9976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLSH01000020",81.071,2.58e-118,429,560,453.9976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLYY01000023",81.071,2.58e-118,429,560,453.9976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLYC01000020",81.071,2.58e-118,429,560,453.9976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLXZ01000020",81.071,2.58e-118,429,560,453.9976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_JBGJJV010000032",78.647,1.13e-117,427,665,523.00255,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_JAUEGY010000142",87.302,9.2e-118,427,378,330.00156,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_JBGJJV010000032",81.038,9.34e-118,427,559,453.00242,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FLBI01000046",79.233,1.11e-117,427,626,495.99858,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRE01000049",79.233,1.11e-117,427,626,495.99858,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRI01000021",81.923,9.31e-118,427,520,425.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRE01000049",81.923,9.31e-118,427,520,425.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRO01000021",81.923,9.31e-118,427,520,425.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRG01000021",81.923,9.31e-118,427,520,425.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLYG01000019",81.923,9.31e-118,427,520,425.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLSM01000018",81.923,9.31e-118,427,520,425.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLSQ01000022",81.923,9.31e-118,427,520,425.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLXY01000024",81.923,9.31e-118,427,520,425.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLXS01000025",81.923,9.31e-118,427,520,425.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLUD01000021",81.923,9.31e-118,427,520,425.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRC01000027",81.923,9.31e-118,427,520,425.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLYZ01000021",81.923,9.31e-118,427,520,425.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLSP01000022",81.923,9.31e-118,427,520,425.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLSH01000020",81.923,9.31e-118,427,520,425.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLYY01000023",81.923,9.31e-118,427,520,425.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLYC01000020",81.923,9.31e-118,427,520,425.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLRE01000049",83.476,1.12e-117,427,466,388.99816,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_FLBI01000046",81.679,8.72e-118,427,524,427.99796,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRI01000021",81.749,8.72e-118,427,526,429.99974,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRZ01000037",81.749,8.72e-118,427,526,429.99974,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRO01000021",81.749,8.72e-118,427,526,429.99974,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLXR01000021",81.749,8.72e-118,427,526,429.99974,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRG01000021",81.749,8.72e-118,427,526,429.99974,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLYG01000019",81.749,8.72e-118,427,526,429.99974,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRJ01000019",81.749,8.72e-118,427,526,429.99974,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLSM01000018",81.749,8.72e-118,427,526,429.99974,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLSQ01000022",81.749,8.72e-118,427,526,429.99974,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLXY01000024",81.749,8.72e-118,427,526,429.99974,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLXS01000025",81.749,8.72e-118,427,526,429.99974,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLWB01000035",81.749,8.72e-118,427,526,429.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLUD01000021",81.749,8.72e-118,427,526,429.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLRC01000027",81.749,8.72e-118,427,526,429.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLYZ01000021",81.749,8.72e-118,427,526,429.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLSP01000022",81.749,8.72e-118,427,526,429.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLZF01000029",81.749,8.72e-118,427,526,429.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLSH01000020",81.749,8.72e-118,427,526,429.99974,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLYY01000023",81.749,8.72e-118,427,526,429.99974,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLYC01000020",81.749,8.72e-118,427,526,429.99974,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLXZ01000020",81.749,8.72e-118,427,526,429.99974,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_JBGJJV010000032",81.679,8.72e-118,427,524,427.99796,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_JBGJJV010000032",81.835,8.74e-118,427,534,436.9989,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_JAUEGY010000142",84.848,4.97e-117,425,429,363.99792,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRI01000021",78.701,4.05e-117,425,662,521.00062,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRO01000021",78.701,4.05e-117,425,662,521.00062,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLXR01000021",78.701,4.05e-117,425,662,521.00062,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRG01000021",78.701,4.05e-117,425,662,521.00062,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLYG01000019",78.701,4.05e-117,425,662,521.00062,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRJ01000019",78.701,4.05e-117,425,662,521.00062,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLSM01000018",78.701,4.05e-117,425,662,521.00062,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLSQ01000022",78.701,4.05e-117,425,662,521.00062,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLXY01000024",78.701,4.05e-117,425,662,521.00062,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLXS01000025",78.701,4.05e-117,425,662,521.00062,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLUD01000021",78.701,4.05e-117,425,662,521.00062,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRC01000027",78.701,4.05e-117,425,662,521.00062,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLYZ01000021",78.701,4.05e-117,425,662,521.00062,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLSP01000022",78.701,4.05e-117,425,662,521.00062,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLSH01000020",78.701,4.05e-117,425,662,521.00062,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLYY01000023",78.701,4.05e-117,425,662,521.00062,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLYC01000020",78.701,4.05e-117,425,662,521.00062,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLXZ01000020",78.701,4.05e-117,425,662,521.00062,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_FLBI01000046",81.038,3.36e-117,425,559,453.00242,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_JAUEGY010000142",84,7.56e-117,425,450,378,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRC01000027",78.297,4.28e-117,425,728,570.00216,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_FLBN01000099",81.835,3.14e-117,425,534,436.9989,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_FLCN01000004",81.835,3.14e-117,425,534,436.9989,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRC01000027",85.714,1.36e-116,424,406,347.99884,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_JAUEGY010000142",88.418,1.57e-116,424,354,312.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FLBN01000099",80.742,1.22e-116,424,566,456.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_FLCN01000004",80.742,1.22e-116,424,566,456.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLWB01000035",80.405,1.25e-116,424,592,475.9976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLZF01000029",80.405,1.25e-116,424,592,475.9976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_JAUEGY010000142",88.418,1.51e-116,424,354,312.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FLBI01000046",84.615,1.16e-116,424,442,373.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FLBN01000099",84.615,1.16e-116,424,442,373.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_FLCN01000004",84.615,1.16e-116,424,442,373.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLRE01000049",83.058,4.65e-116,422,484,402.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FLBN01000099",79.073,5.16e-116,422,626,494.99698,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_FLCN01000004",79.073,5.16e-116,422,626,494.99698,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRZ01000037",81.731,4.33e-116,422,520,425.0012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLXR01000021",81.731,4.33e-116,422,520,425.0012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLRJ01000019",81.731,4.33e-116,422,520,425.0012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLWB01000035",81.731,4.33e-116,422,520,425.0012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLZF01000029",81.731,4.33e-116,422,520,425.0012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLXZ01000020",81.731,4.33e-116,422,520,425.0012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_JBGJJV010000032",81.731,4.33e-116,422,520,425.0012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_JAUEGY010000142",81.731,4.33e-116,422,520,425.0012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_FLBN01000099",81.489,4.06e-116,422,524,427.00236,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_FLCN01000004",81.489,4.06e-116,422,524,427.00236,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRZ01000037",78.55,1.89e-115,420,662,520.001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLWB01000035",78.55,1.89e-115,420,662,520.001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLZF01000029",78.55,1.89e-115,420,662,520.001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_FLBN01000099",80.859,1.56e-115,420,559,452.00181,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_FLCN01000004",80.859,1.56e-115,420,559,452.00181,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRI01000021",78.099,1.99e-115,420,726,566.99874,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRE01000049",78.099,1.99e-115,420,726,566.99874,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRO01000021",78.099,1.99e-115,420,726,566.99874,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLXR01000021",78.099,1.99e-115,420,726,566.99874,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRG01000021",78.099,1.99e-115,420,726,566.99874,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLYG01000019",78.099,1.99e-115,420,726,566.99874,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRJ01000019",78.099,1.99e-115,420,726,566.99874,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLSM01000018",78.099,1.99e-115,420,726,566.99874,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLSQ01000022",78.099,1.99e-115,420,726,566.99874,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLXY01000024",78.099,1.99e-115,420,726,566.99874,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLXS01000025",78.099,1.99e-115,420,726,566.99874,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLUD01000021",78.099,1.99e-115,420,726,566.99874,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLYZ01000021",78.099,1.99e-115,420,726,566.99874,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLSP01000022",78.099,1.99e-115,420,726,566.99874,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLSH01000020",78.099,1.99e-115,420,726,566.99874,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLYY01000023",78.099,1.99e-115,420,726,566.99874,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLYC01000020",78.099,1.99e-115,420,726,566.99874,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLXZ01000020",78.099,1.99e-115,420,726,566.99874,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLRZ01000037",84.34,1.5e-115,420,447,376.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLWB01000035",84.34,1.5e-115,420,447,376.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLZF01000029",84.34,1.5e-115,420,447,376.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRI01000021",85.468,6.33e-115,418,406,347.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRZ01000037",85.468,6.33e-115,418,406,347.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRO01000021",85.468,6.33e-115,418,406,347.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRG01000021",85.468,6.33e-115,418,406,347.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLYG01000019",85.468,6.33e-115,418,406,347.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLSM01000018",85.468,6.33e-115,418,406,347.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLSQ01000022",85.468,6.33e-115,418,406,347.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLXY01000024",85.468,6.33e-115,418,406,347.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLXS01000025",85.468,6.33e-115,418,406,347.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLUD01000021",85.468,6.33e-115,418,406,347.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLYZ01000021",85.468,6.33e-115,418,406,347.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLSP01000022",85.468,6.33e-115,418,406,347.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLSH01000020",85.468,6.33e-115,418,406,347.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLYY01000023",85.468,6.33e-115,418,406,347.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLYC01000020",85.468,6.33e-115,418,406,347.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_JBGJJV010000032",80.919,5.55e-115,418,566,458.00154,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLWB01000035",80.556,2.04e-114,416,576,464.00256,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLZF01000029",80.556,2.04e-114,416,576,464.00256,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRI01000021",78.914,2.4e-114,416,626,494.00164,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRO01000021",78.914,2.4e-114,416,626,494.00164,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXR01000021",78.914,2.4e-114,416,626,494.00164,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRG01000021",78.914,2.4e-114,416,626,494.00164,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYG01000019",78.914,2.4e-114,416,626,494.00164,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRJ01000019",78.914,2.4e-114,416,626,494.00164,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSM01000018",78.914,2.4e-114,416,626,494.00164,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSQ01000022",78.914,2.4e-114,416,626,494.00164,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXY01000024",78.914,2.4e-114,416,626,494.00164,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXS01000025",78.914,2.4e-114,416,626,494.00164,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLUD01000021",78.914,2.4e-114,416,626,494.00164,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRC01000027",78.914,2.4e-114,416,626,494.00164,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYZ01000021",78.914,2.4e-114,416,626,494.00164,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSP01000022",78.914,2.4e-114,416,626,494.00164,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSH01000020",78.914,2.4e-114,416,626,494.00164,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYY01000023",78.914,2.4e-114,416,626,494.00164,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLYC01000020",78.914,2.4e-114,416,626,494.00164,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLXZ01000020",78.914,2.4e-114,416,626,494.00164,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_FLBI01000046",83.297,2.01e-114,416,461,383.99917,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_FLBN01000099",83.297,2.01e-114,416,461,383.99917,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_FLCN01000004",83.297,2.01e-114,416,461,383.99917,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLWB01000035",80.556,2.04e-114,416,576,464.00256,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLZF01000029",80.556,2.04e-114,416,576,464.00256,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_JAUEGY010000142",85.294,1.94e-114,416,408,347.99952,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRZ01000037",81.495,1.89e-114,416,535,435.99825,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLWB01000035",81.495,1.89e-114,416,535,435.99825,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLZF01000029",81.495,1.89e-114,416,535,435.99825,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_JAUEGY010000142",82.664,2.24e-114,416,473,391.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_JAUEGY010000142",83.519,6.15e-114,416,449,375.00031,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLRE01000049",78.399,8.77e-114,414,662,519.00138,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_FLBI01000046",84.318,7.33e-114,414,440,370.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_FLBN01000099",84.318,7.33e-114,414,440,370.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_FLCN01000004",84.318,7.33e-114,414,440,370.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FLBI01000046",77.901,9.27e-114,414,724,564.00324,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FLCN01000004",77.901,9.27e-114,414,724,564.00324,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLRZ01000037",77.961,9.27e-114,414,726,565.99686,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLWB01000035",77.961,9.27e-114,414,726,565.99686,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLZF01000029",77.961,9.27e-114,414,726,565.99686,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FLBI01000046",85.185,2.95e-113,412,405,344.99925,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FLBN01000099",85.185,2.95e-113,412,405,344.99925,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRE01000049",85.185,2.95e-113,412,405,344.99925,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_FLCN01000004",85.185,2.95e-113,412,405,344.99925,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLXR01000021",85.222,2.95e-113,412,406,346.00132,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLRJ01000019",85.222,2.95e-113,412,406,346.00132,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLWB01000035",85.222,2.95e-113,412,406,346.00132,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLZF01000029",85.222,2.95e-113,412,406,346.00132,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLXZ01000020",85.222,2.95e-113,412,406,346.00132,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRI01000021",82.258,2.55e-113,412,496,407.99968,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRO01000021",82.258,2.55e-113,412,496,407.99968,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLXR01000021",82.258,2.55e-113,412,496,407.99968,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRG01000021",82.258,2.55e-113,412,496,407.99968,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLYG01000019",82.258,2.55e-113,412,496,407.99968,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRJ01000019",82.258,2.55e-113,412,496,407.99968,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLSM01000018",82.258,2.55e-113,412,496,407.99968,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLSQ01000022",82.258,2.55e-113,412,496,407.99968,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLXY01000024",82.258,2.55e-113,412,496,407.99968,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLXS01000025",82.258,2.55e-113,412,496,407.99968,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLUD01000021",82.258,2.55e-113,412,496,407.99968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRC01000027",82.258,2.55e-113,412,496,407.99968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLYZ01000021",82.258,2.55e-113,412,496,407.99968,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLSP01000022",82.258,2.55e-113,412,496,407.99968,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLSH01000020",82.258,2.55e-113,412,496,407.99968,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLYY01000023",82.258,2.55e-113,412,496,407.99968,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLYC01000020",82.258,2.55e-113,412,496,407.99968,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLXZ01000020",82.258,2.55e-113,412,496,407.99968,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRZ01000037",80.068,2.72e-113,412,592,474.00256,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRZ01000037",80.531,2.64e-113,412,565,455.00015,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLWB01000035",80.531,2.64e-113,412,565,455.00015,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLZF01000029",80.531,2.64e-113,412,565,455.00015,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLWB01000035",80.763,2.58e-113,412,577,466.00251,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLZF01000029",80.763,2.58e-113,412,577,466.00251,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLRZ01000037",78.754,1.12e-112,411,626,493.00004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLWB01000035",78.754,1.12e-112,411,626,493.00004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLZF01000029",78.754,1.12e-112,411,626,493.00004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRI01000021",83.077,8.82e-113,411,455,378.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRO01000021",83.077,8.82e-113,411,455,378.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLXR01000021",83.077,8.82e-113,411,455,378.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRG01000021",83.077,8.82e-113,411,455,378.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLYG01000019",83.077,8.82e-113,411,455,378.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRJ01000019",83.077,8.82e-113,411,455,378.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLSM01000018",83.077,8.82e-113,411,455,378.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLSQ01000022",83.077,8.82e-113,411,455,378.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLXY01000024",83.077,8.82e-113,411,455,378.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLXS01000025",83.077,8.82e-113,411,455,378.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLUD01000021",83.077,8.82e-113,411,455,378.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRC01000027",83.077,8.82e-113,411,455,378.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLYZ01000021",83.077,8.82e-113,411,455,378.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLSP01000022",83.077,8.82e-113,411,455,378.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLSH01000020",83.077,8.82e-113,411,455,378.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLYY01000023",83.077,8.82e-113,411,455,378.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLYC01000020",83.077,8.82e-113,411,455,378.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLXZ01000020",83.077,8.82e-113,411,455,378.00035,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_JBGJJV010000032",80.729,9.29e-113,411,576,464.99904,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FLBI01000046",82.452,1.04e-112,411,473,389.99796,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FLBN01000099",82.452,1.04e-112,411,473,389.99796,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRI01000021",82.452,1.04e-112,411,473,389.99796,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_FLCN01000004",82.452,1.04e-112,411,473,389.99796,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRO01000021",82.452,1.04e-112,411,473,389.99796,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRG01000021",82.452,1.04e-112,411,473,389.99796,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLYG01000019",82.452,1.04e-112,411,473,389.99796,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLSM01000018",82.452,1.04e-112,411,473,389.99796,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLSQ01000022",82.452,1.04e-112,411,473,389.99796,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLXY01000024",82.452,1.04e-112,411,473,389.99796,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLXS01000025",82.452,1.04e-112,411,473,389.99796,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLUD01000021",82.452,1.04e-112,411,473,389.99796,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRC01000027",82.452,1.04e-112,411,473,389.99796,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLYZ01000021",82.452,1.04e-112,411,473,389.99796,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLSP01000022",82.452,1.04e-112,411,473,389.99796,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLSH01000020",82.452,1.04e-112,411,473,389.99796,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLYY01000023",82.452,1.04e-112,411,473,389.99796,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLYC01000020",82.452,1.04e-112,411,473,389.99796,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLRE01000049",82.609,4.06e-112,409,483,399.00147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRI01000021",81.006,3.63e-112,409,537,435.00222,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRO01000021",81.006,3.63e-112,409,537,435.00222,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLXR01000021",81.006,3.63e-112,409,537,435.00222,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRG01000021",81.006,3.63e-112,409,537,435.00222,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLYG01000019",81.006,3.63e-112,409,537,435.00222,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRJ01000019",81.006,3.63e-112,409,537,435.00222,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLSM01000018",81.006,3.63e-112,409,537,435.00222,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLSQ01000022",81.006,3.63e-112,409,537,435.00222,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLXY01000024",81.006,3.63e-112,409,537,435.00222,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLXS01000025",81.006,3.63e-112,409,537,435.00222,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLUD01000021",81.006,3.63e-112,409,537,435.00222,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRC01000027",81.006,3.63e-112,409,537,435.00222,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLYZ01000021",81.006,3.63e-112,409,537,435.00222,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLSP01000022",81.006,3.63e-112,409,537,435.00222,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLSH01000020",81.006,3.63e-112,409,537,435.00222,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLYY01000023",81.006,3.63e-112,409,537,435.00222,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLYC01000020",81.006,3.63e-112,409,537,435.00222,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLXZ01000020",81.006,3.63e-112,409,537,435.00222,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FLBI01000046",83.973,3.51e-112,409,443,372.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FLBN01000099",83.973,3.51e-112,409,443,372.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_FLCN01000004",83.973,3.51e-112,409,443,372.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_FLBN01000099",77.762,4.31e-112,409,724,562.99688,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_JAUEGY010000142",86.387,4.06e-112,409,382,329.99834,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRZ01000037",82.056,1.19e-111,407,496,406.99776,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLWB01000035",82.056,1.19e-111,407,496,406.99776,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLZF01000029",82.056,1.19e-111,407,496,406.99776,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_JAUEGY010000142",84.975,1.5e-111,407,406,344.9985,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_MLRZ01000037",78.956,1.4e-111,407,632,499.00192,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_MLWB01000035",78.956,1.4e-111,407,632,499.00192,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_MLZF01000029",78.956,1.4e-111,407,632,499.00192,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLRZ01000037",80.589,1.2e-111,407,577,464.99853,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLRZ01000037",80.427,1.21e-111,407,562,451.99974,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLWB01000035",80.427,1.21e-111,407,562,451.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLZF01000029",80.427,1.21e-111,407,562,451.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FLBI01000046",78.012,5.28e-111,405,664,517.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FLBN01000099",78.012,5.28e-111,405,664,517.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_FLCN01000004",78.012,5.28e-111,405,664,517.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRI01000021",81.418,3.99e-111,405,522,425.00196,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRO01000021",81.418,3.99e-111,405,522,425.00196,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLXR01000021",81.418,3.99e-111,405,522,425.00196,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRG01000021",81.418,3.99e-111,405,522,425.00196,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLYG01000019",81.418,3.99e-111,405,522,425.00196,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRJ01000019",81.418,3.99e-111,405,522,425.00196,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLSM01000018",81.418,3.99e-111,405,522,425.00196,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLSQ01000022",81.418,3.99e-111,405,522,425.00196,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLXY01000024",81.418,3.99e-111,405,522,425.00196,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLXS01000025",81.418,3.99e-111,405,522,425.00196,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLUD01000021",81.418,3.99e-111,405,522,425.00196,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRC01000027",81.418,3.99e-111,405,522,425.00196,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLYZ01000021",81.418,3.99e-111,405,522,425.00196,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLSP01000022",81.418,3.99e-111,405,522,425.00196,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLSH01000020",81.418,3.99e-111,405,522,425.00196,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLYY01000023",81.418,3.99e-111,405,522,425.00196,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLYC01000020",81.418,3.99e-111,405,522,425.00196,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLXZ01000020",81.418,3.99e-111,405,522,425.00196,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLRZ01000037",80.208,4.41e-111,405,576,461.99808,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLRZ01000037",80.208,4.41e-111,405,576,461.99808,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_FLBN01000099",72.857,1.11e-110,405,1400,1019.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_FLCN01000004",72.857,1.11e-110,405,1400,1019.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRE01000049",82.241,4.85e-111,405,473,388.99993,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRZ01000037",82.241,4.85e-111,405,473,388.99993,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLXR01000021",82.241,4.85e-111,405,473,388.99993,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLRJ01000019",82.241,4.85e-111,405,473,388.99993,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLWB01000035",82.241,4.85e-111,405,473,388.99993,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLZF01000029",82.241,4.85e-111,405,473,388.99993,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLXZ01000020",82.241,4.85e-111,405,473,388.99993,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_JBGJJV010000032",82.241,4.85e-111,405,473,388.99993,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_JBGJJV010000032",86.364,4.07e-111,405,374,323.00136,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRZ01000037",80.819,1.69e-110,403,537,433.99803,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLWB01000035",80.819,1.69e-110,403,537,433.99803,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLZF01000029",80.819,1.69e-110,403,537,433.99803,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRI01000021",81.928,1.59e-110,403,498,408.00144,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRO01000021",81.928,1.59e-110,403,498,408.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLXR01000021",81.928,1.59e-110,403,498,408.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRG01000021",81.928,1.59e-110,403,498,408.00144,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLYG01000019",81.928,1.59e-110,403,498,408.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRJ01000019",81.928,1.59e-110,403,498,408.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLSM01000018",81.928,1.59e-110,403,498,408.00144,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLSQ01000022",81.928,1.59e-110,403,498,408.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLXY01000024",81.928,1.59e-110,403,498,408.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLXS01000025",81.928,1.59e-110,403,498,408.00144,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLUD01000021",81.928,1.59e-110,403,498,408.00144,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRC01000027",81.928,1.59e-110,403,498,408.00144,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLYZ01000021",81.928,1.59e-110,403,498,408.00144,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLSP01000022",81.928,1.59e-110,403,498,408.00144,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLSH01000020",81.928,1.59e-110,403,498,408.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLYY01000023",81.928,1.59e-110,403,498,408.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLYC01000020",81.928,1.59e-110,403,498,408.00144,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLXZ01000020",81.928,1.59e-110,403,498,408.00144,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FLBI01000046",83.945,5.71e-110,401,436,366.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FLBN01000099",83.945,5.71e-110,401,436,366.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_FLCN01000004",83.945,5.71e-110,401,436,366.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JBGJJV010000032",78.173,6.72e-110,401,646,504.99758,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_FLBI01000046",80.699,5.52e-110,401,544,439.00256,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLRE01000049",86.813,6.02e-110,401,364,315.99932,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLRE01000049",84.691,2.21e-109,399,405,342.99855,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_JBGJJV010000032",81.727,1.99e-109,399,498,407.00046,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_FLBI01000046",78.56,2.34e-109,399,639,501.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_FLBN01000099",78.56,2.34e-109,399,639,501.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_FLCN01000004",78.56,2.34e-109,399,639,501.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_JAUEGY010000142",85.063,2.89e-109,399,395,335.99885,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLRE01000049",80.633,7.86e-109,398,537,432.99921,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLRE01000049",83.409,8.02e-109,398,440,366.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLRE01000049",86.944,1.19e-108,398,360,312.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLRE01000049",83.108,8.19e-109,398,444,368.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_FLBI01000046",83.295,6.73e-109,398,437,363.99915,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_JAUEGY010000142",84.615,3.36e-108,396,403,340.99845,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLRE01000049",83.971,4.55e-108,396,418,350.99878,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_FLBN01000099",80.515,2.57e-108,396,544,438.0016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_FLCN01000004",80.515,2.57e-108,396,544,438.0016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_JBGJJV010000032",79.76,2.76e-108,396,583,465.0008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_MLWB01000035",80.177,2.6e-108,396,565,453.00005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_MLZF01000029",80.177,2.6e-108,396,565,453.00005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_JBGJJV010000032",78.438,3.03e-108,396,640,502.0032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_FLBI01000046",72.714,2.41e-107,394,1400,1017.996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_JBGJJV010000032",72.798,2.41e-107,394,1408,1024.99584,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_FLBI01000046",79.93,9.57e-108,394,568,454.0024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_FLBN01000099",79.93,9.57e-108,394,568,454.0024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_FLCN01000004",79.93,9.57e-108,394,568,454.0024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_JBGJJV010000032",79.965,9.57e-108,394,569,455.00085,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRI01000021",82.789,8.86e-108,394,459,380.00151,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRO01000021",82.789,8.86e-108,394,459,380.00151,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLXR01000021",82.789,8.86e-108,394,459,380.00151,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRG01000021",82.789,8.86e-108,394,459,380.00151,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLYG01000019",82.789,8.86e-108,394,459,380.00151,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRJ01000019",82.789,8.86e-108,394,459,380.00151,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLSM01000018",82.789,8.86e-108,394,459,380.00151,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLSQ01000022",82.789,8.86e-108,394,459,380.00151,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLXY01000024",82.789,8.86e-108,394,459,380.00151,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLXS01000025",82.789,8.86e-108,394,459,380.00151,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLUD01000021",82.789,8.86e-108,394,459,380.00151,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRC01000027",82.789,8.86e-108,394,459,380.00151,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLYZ01000021",82.789,8.86e-108,394,459,380.00151,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLSP01000022",82.789,8.86e-108,394,459,380.00151,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLSH01000020",82.789,8.86e-108,394,459,380.00151,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLYY01000023",82.789,8.86e-108,394,459,380.00151,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLYC01000020",82.789,8.86e-108,394,459,380.00151,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLXZ01000020",82.789,8.86e-108,394,459,380.00151,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_JBGJJV010000032",79.545,3.66e-107,392,572,454.9974,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_FLBN01000099",83.066,3.13e-107,392,437,362.99842,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_FLCN01000004",83.066,3.13e-107,392,437,362.99842,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_JAUEGY010000142",79.354,2.21e-106,390,557,442.00178,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_JBGJJV010000032",84.198,1.38e-106,390,405,341.0019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLRE01000049",83.295,1.31e-106,390,431,359.00145,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_JBGJJV010000032",80.212,1.19e-106,390,566,453.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLRE01000049",86.667,2.19e-106,390,360,312.0012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRZ01000037",85.6,1.14e-106,390,375,321,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLWB01000035",85.6,1.14e-106,390,375,321,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLZF01000029",85.6,1.14e-106,390,375,321,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_JAUEGY010000142",79.329,7.78e-106,388,566,449.00214,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_FLBI01000046",80.806,4.02e-106,388,521,420.99926,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_JAUEGY010000142",84.518,5.29e-106,388,394,333.00092,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FLBI01000046",79.371,1.7e-105,387,572,454.00212,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FLBN01000099",79.371,1.7e-105,387,572,454.00212,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_FLCN01000004",79.371,1.7e-105,387,572,454.00212,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FLBI01000046",84,1.56e-105,387,425,357,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FLBN01000099",84,1.56e-105,387,425,357,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_FLCN01000004",84,1.56e-105,387,425,357,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_JAUEGY010000142",85.372,1.84e-105,387,376,320.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_FLBN01000099",73.322,1.26e-104,385,1177,862.99994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_FLCN01000004",73.322,1.26e-104,385,1177,862.99994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLRE01000049",83.141,6e-105,385,433,360.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_MLRZ01000037",79.823,5.63e-105,385,565,450.99995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_FLBN01000099",80.614,1.87e-104,383,521,419.99894,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_FLCN01000004",80.614,1.87e-104,383,521,419.99894,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRI01000021",75.406,4.52e-104,383,862,649.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRO01000021",75.406,4.52e-104,383,862,649.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLXR01000021",75.406,4.52e-104,383,862,649.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRG01000021",75.406,4.52e-104,383,862,649.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLYG01000019",75.406,4.52e-104,383,862,649.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRJ01000019",75.406,4.52e-104,383,862,649.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLSM01000018",75.406,4.52e-104,383,862,649.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLSQ01000022",75.406,4.52e-104,383,862,649.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLXY01000024",75.406,4.52e-104,383,862,649.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLXS01000025",75.406,4.52e-104,383,862,649.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLUD01000021",75.406,4.52e-104,383,862,649.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRC01000027",75.406,4.52e-104,383,862,649.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLYZ01000021",75.406,4.52e-104,383,862,649.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLSP01000022",75.406,4.52e-104,383,862,649.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLSH01000020",75.406,4.52e-104,383,862,649.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLYY01000023",75.406,4.52e-104,383,862,649.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLYC01000020",75.406,4.52e-104,383,862,649.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLXZ01000020",75.406,4.52e-104,383,862,649.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_FLBI01000046",85.294,1.91e-104,383,374,318.99956,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_FLBN01000099",85.294,1.91e-104,383,374,318.99956,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_FLCN01000004",85.294,1.91e-104,383,374,318.99956,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRE01000049",79.391,8.63e-104,381,558,443.00178,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_JAUEGY010000142",79.428,8.63e-104,381,559,444.00252,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_MLWB01000035",79.894,7.14e-104,381,567,452.99898,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_MLZF01000029",79.894,7.14e-104,381,567,452.99898,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FLBI01000046",82.418,7.73e-104,381,455,375.0019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FLBN01000099",82.418,7.73e-104,381,455,375.0019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_FLCN01000004",82.418,7.73e-104,381,455,375.0019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FLBI01000046",83.529,7.28e-104,381,425,354.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FLBN01000099",83.529,7.28e-104,381,425,354.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_FLCN01000004",83.529,7.28e-104,381,425,354.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRI01000021",82.648,6.77e-104,381,438,361.99824,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRO01000021",82.648,6.77e-104,381,438,361.99824,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLXR01000021",82.648,6.77e-104,381,438,361.99824,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRG01000021",82.648,6.77e-104,381,438,361.99824,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLYG01000019",82.648,6.77e-104,381,438,361.99824,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRJ01000019",82.648,6.77e-104,381,438,361.99824,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLSM01000018",82.648,6.77e-104,381,438,361.99824,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLSQ01000022",82.648,6.77e-104,381,438,361.99824,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLXY01000024",82.648,6.77e-104,381,438,361.99824,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLXS01000025",82.648,6.77e-104,381,438,361.99824,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLUD01000021",82.648,6.77e-104,381,438,361.99824,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRC01000027",82.648,6.77e-104,381,438,361.99824,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLYZ01000021",82.648,6.77e-104,381,438,361.99824,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLSP01000022",82.648,6.77e-104,381,438,361.99824,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLSH01000020",82.648,6.77e-104,381,438,361.99824,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLYY01000023",82.648,6.77e-104,381,438,361.99824,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLYC01000020",82.648,6.77e-104,381,438,361.99824,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLXZ01000020",82.648,6.77e-104,381,438,361.99824,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_JBGJJV010000032",82.609,6.77e-104,381,437,361.00133,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_FLBI01000046",80.754,2.67e-103,379,504,407.00016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLWB01000035",79.181,2.78e-103,379,586,464.00066,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLZF01000029",79.181,2.78e-103,379,586,464.00066,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRZ01000037",80.497,8.71e-103,377,523,420.99931,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLWB01000035",80.497,8.71e-103,377,523,420.99931,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLZF01000029",80.497,8.71e-103,377,523,420.99931,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRI01000021",75.347,2.43e-102,377,864,650.99808,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRO01000021",75.347,2.43e-102,377,864,650.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLXR01000021",75.347,2.43e-102,377,864,650.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRG01000021",75.347,2.43e-102,377,864,650.99808,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLYG01000019",75.347,2.43e-102,377,864,650.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRJ01000019",75.347,2.43e-102,377,864,650.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLSM01000018",75.347,2.43e-102,377,864,650.99808,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLSQ01000022",75.347,2.43e-102,377,864,650.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLXY01000024",75.347,2.43e-102,377,864,650.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLXS01000025",75.347,2.43e-102,377,864,650.99808,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLUD01000021",75.347,2.43e-102,377,864,650.99808,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRC01000027",75.347,2.43e-102,377,864,650.99808,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLYZ01000021",75.347,2.43e-102,377,864,650.99808,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLSP01000022",75.347,2.43e-102,377,864,650.99808,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLSH01000020",75.347,2.43e-102,377,864,650.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLYY01000023",75.347,2.43e-102,377,864,650.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLYC01000020",75.347,2.43e-102,377,864,650.99808,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLXZ01000020",75.347,2.43e-102,377,864,650.99808,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRI01000021",75.29,2e-102,377,862,648.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRO01000021",75.29,2e-102,377,862,648.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLXR01000021",75.29,2e-102,377,862,648.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRG01000021",75.29,2e-102,377,862,648.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLYG01000019",75.29,2e-102,377,862,648.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRJ01000019",75.29,2e-102,377,862,648.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLSM01000018",75.29,2e-102,377,862,648.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLSQ01000022",75.29,2e-102,377,862,648.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLXY01000024",75.29,2e-102,377,862,648.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLXS01000025",75.29,2e-102,377,862,648.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLUD01000021",75.29,2e-102,377,862,648.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRC01000027",75.29,2e-102,377,862,648.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLYZ01000021",75.29,2e-102,377,862,648.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLSP01000022",75.29,2e-102,377,862,648.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLSH01000020",75.29,2e-102,377,862,648.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLYY01000023",75.29,2e-102,377,862,648.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLYC01000020",75.29,2e-102,377,862,648.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLXZ01000020",75.29,2e-102,377,862,648.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FLBI01000046",79.249,4.01e-102,375,559,443.00191,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FLBN01000099",79.249,4.01e-102,375,559,443.00191,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRI01000021",79.249,4.01e-102,375,559,443.00191,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_FLCN01000004",79.249,4.01e-102,375,559,443.00191,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRZ01000037",79.249,4.01e-102,375,559,443.00191,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRO01000021",79.249,4.01e-102,375,559,443.00191,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLXR01000021",79.249,4.01e-102,375,559,443.00191,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRG01000021",79.249,4.01e-102,375,559,443.00191,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLYG01000019",79.249,4.01e-102,375,559,443.00191,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRJ01000019",79.249,4.01e-102,375,559,443.00191,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLSM01000018",79.249,4.01e-102,375,559,443.00191,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLSQ01000022",79.249,4.01e-102,375,559,443.00191,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLXY01000024",79.249,4.01e-102,375,559,443.00191,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLXS01000025",79.249,4.01e-102,375,559,443.00191,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLWB01000035",79.249,4.01e-102,375,559,443.00191,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLUD01000021",79.249,4.01e-102,375,559,443.00191,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLRC01000027",79.249,4.01e-102,375,559,443.00191,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLYZ01000021",79.249,4.01e-102,375,559,443.00191,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLSP01000022",79.249,4.01e-102,375,559,443.00191,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLZF01000029",79.249,4.01e-102,375,559,443.00191,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLSH01000020",79.249,4.01e-102,375,559,443.00191,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLYY01000023",79.249,4.01e-102,375,559,443.00191,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLYC01000020",79.249,4.01e-102,375,559,443.00191,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLXZ01000020",79.249,4.01e-102,375,559,443.00191,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_JBGJJV010000032",79.249,4.01e-102,375,559,443.00191,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRI01000021",82.287,6.17e-102,375,446,367.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRO01000021",82.287,6.17e-102,375,446,367.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLXR01000021",82.287,6.17e-102,375,446,367.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRG01000021",82.287,6.17e-102,375,446,367.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLYG01000019",82.287,6.17e-102,375,446,367.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRJ01000019",82.287,6.17e-102,375,446,367.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLSM01000018",82.287,6.17e-102,375,446,367.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLSQ01000022",82.287,6.17e-102,375,446,367.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLXY01000024",82.287,6.17e-102,375,446,367.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLXS01000025",82.287,6.17e-102,375,446,367.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLUD01000021",82.287,6.17e-102,375,446,367.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRC01000027",82.287,6.17e-102,375,446,367.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLYZ01000021",82.287,6.17e-102,375,446,367.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLSP01000022",82.287,6.17e-102,375,446,367.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLSH01000020",82.287,6.17e-102,375,446,367.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLYY01000023",82.287,6.17e-102,375,446,367.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLYC01000020",82.287,6.17e-102,375,446,367.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLXZ01000020",82.287,6.17e-102,375,446,367.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_MLRZ01000037",79.718,3.32e-102,375,567,452.00106,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRI01000021",78.317,6.3e-102,375,618,483.99906,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRO01000021",78.317,6.3e-102,375,618,483.99906,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLXR01000021",78.317,6.3e-102,375,618,483.99906,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRG01000021",78.317,6.3e-102,375,618,483.99906,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLYG01000019",78.317,6.3e-102,375,618,483.99906,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRJ01000019",78.317,6.3e-102,375,618,483.99906,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLSM01000018",78.317,6.3e-102,375,618,483.99906,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLSQ01000022",78.317,6.3e-102,375,618,483.99906,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLXY01000024",78.317,6.3e-102,375,618,483.99906,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLXS01000025",78.317,6.3e-102,375,618,483.99906,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLUD01000021",78.317,6.3e-102,375,618,483.99906,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRC01000027",78.317,6.3e-102,375,618,483.99906,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLYZ01000021",78.317,6.3e-102,375,618,483.99906,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLSP01000022",78.317,6.3e-102,375,618,483.99906,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLSH01000020",78.317,6.3e-102,375,618,483.99906,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLYY01000023",78.317,6.3e-102,375,618,483.99906,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLYC01000020",78.317,6.3e-102,375,618,483.99906,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLXZ01000020",78.317,6.3e-102,375,618,483.99906,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRZ01000037",82.42,3.15e-102,375,438,360.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLWB01000035",82.42,3.15e-102,375,438,360.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLZF01000029",82.42,3.15e-102,375,438,360.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_FLBI01000046",73.152,2.72e-101,374,1177,860.99904,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRI01000021",82.327,1.39e-101,374,447,368.00169,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRO01000021",82.327,1.39e-101,374,447,368.00169,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLXR01000021",82.327,1.39e-101,374,447,368.00169,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRG01000021",82.327,1.39e-101,374,447,368.00169,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLYG01000019",82.327,1.39e-101,374,447,368.00169,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRJ01000019",82.327,1.39e-101,374,447,368.00169,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLSM01000018",82.327,1.39e-101,374,447,368.00169,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLSQ01000022",82.327,1.39e-101,374,447,368.00169,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLXY01000024",82.327,1.39e-101,374,447,368.00169,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLXS01000025",82.327,1.39e-101,374,447,368.00169,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLUD01000021",82.327,1.39e-101,374,447,368.00169,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLRC01000027",82.327,1.39e-101,374,447,368.00169,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLYZ01000021",82.327,1.39e-101,374,447,368.00169,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLSP01000022",82.327,1.39e-101,374,447,368.00169,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLSH01000020",82.327,1.39e-101,374,447,368.00169,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLYY01000023",82.327,1.39e-101,374,447,368.00169,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLYC01000020",82.327,1.39e-101,374,447,368.00169,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLXZ01000020",82.327,1.39e-101,374,447,368.00169,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_FLBI01000046",81.109,1.38e-101,374,487,395.00083,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_FLBN01000099",81.109,1.38e-101,374,487,395.00083,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_FLCN01000004",81.109,1.38e-101,374,487,395.00083,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_JBGJJV010000032",80.23,4.05e-101,372,521,417.9983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRI01000021",75.203,1.33e-100,372,863,649.00189,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRO01000021",75.203,1.33e-100,372,863,649.00189,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLXR01000021",75.203,1.33e-100,372,863,649.00189,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRG01000021",75.203,1.33e-100,372,863,649.00189,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLYG01000019",75.203,1.33e-100,372,863,649.00189,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRJ01000019",75.203,1.33e-100,372,863,649.00189,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLSM01000018",75.203,1.33e-100,372,863,649.00189,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLSQ01000022",75.203,1.33e-100,372,863,649.00189,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLXY01000024",75.203,1.33e-100,372,863,649.00189,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLXS01000025",75.203,1.33e-100,372,863,649.00189,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLUD01000021",75.203,1.33e-100,372,863,649.00189,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRC01000027",75.203,1.33e-100,372,863,649.00189,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLYZ01000021",75.203,1.33e-100,372,863,649.00189,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLSP01000022",75.203,1.33e-100,372,863,649.00189,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLSH01000020",75.203,1.33e-100,372,863,649.00189,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLYY01000023",75.203,1.33e-100,372,863,649.00189,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLYC01000020",75.203,1.33e-100,372,863,649.00189,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLXZ01000020",75.203,1.33e-100,372,863,649.00189,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_FLBI01000046",79.811,4.18e-101,372,530,422.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_FLBN01000099",79.811,4.18e-101,372,530,422.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_FLCN01000004",79.811,4.18e-101,372,530,422.9983,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_JBGJJV010000032",74.832,3.52e-100,370,894,668.99808,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRI01000021",78.155,3.53e-100,370,618,482.9979,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRO01000021",78.155,3.53e-100,370,618,482.9979,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLXR01000021",78.155,3.53e-100,370,618,482.9979,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRG01000021",78.155,3.53e-100,370,618,482.9979,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLYG01000019",78.155,3.53e-100,370,618,482.9979,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRJ01000019",78.155,3.53e-100,370,618,482.9979,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLSM01000018",78.155,3.53e-100,370,618,482.9979,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLSQ01000022",78.155,3.53e-100,370,618,482.9979,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLXY01000024",78.155,3.53e-100,370,618,482.9979,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLXS01000025",78.155,3.53e-100,370,618,482.9979,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLUD01000021",78.155,3.53e-100,370,618,482.9979,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRC01000027",78.155,3.53e-100,370,618,482.9979,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLYZ01000021",78.155,3.53e-100,370,618,482.9979,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLSP01000022",78.155,3.53e-100,370,618,482.9979,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLSH01000020",78.155,3.53e-100,370,618,482.9979,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLYY01000023",78.155,3.53e-100,370,618,482.9979,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLYC01000020",78.155,3.53e-100,370,618,482.9979,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLXZ01000020",78.155,3.53e-100,370,618,482.9979,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLRE01000049",82.192,1.47e-100,370,438,360.00096,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRE01000049",80.237,5.41e-100,368,506,405.99922,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRI01000021",79.623,1.94e-99,366,530,422.0019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRZ01000037",79.623,1.94e-99,366,530,422.0019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRO01000021",79.623,1.94e-99,366,530,422.0019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLXR01000021",79.623,1.94e-99,366,530,422.0019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRG01000021",79.623,1.94e-99,366,530,422.0019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLYG01000019",79.623,1.94e-99,366,530,422.0019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRJ01000019",79.623,1.94e-99,366,530,422.0019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLSM01000018",79.623,1.94e-99,366,530,422.0019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLSQ01000022",79.623,1.94e-99,366,530,422.0019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLXY01000024",79.623,1.94e-99,366,530,422.0019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLXS01000025",79.623,1.94e-99,366,530,422.0019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLWB01000035",79.623,1.94e-99,366,530,422.0019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLUD01000021",79.623,1.94e-99,366,530,422.0019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLRC01000027",79.623,1.94e-99,366,530,422.0019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLYZ01000021",79.623,1.94e-99,366,530,422.0019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLSP01000022",79.623,1.94e-99,366,530,422.0019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLZF01000029",79.623,1.94e-99,366,530,422.0019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLSH01000020",79.623,1.94e-99,366,530,422.0019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLYY01000023",79.623,1.94e-99,366,530,422.0019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLYC01000020",79.623,1.94e-99,366,530,422.0019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLXZ01000020",79.623,1.94e-99,366,530,422.0019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_JBGJJV010000032",79.623,1.94e-99,366,530,422.0019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRZ01000037",77.994,1.64e-98,364,618,482.00292,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLWB01000035",77.994,1.64e-98,364,618,482.00292,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLZF01000029",77.994,1.64e-98,364,618,482.00292,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRZ01000037",78.029,1.89e-98,364,619,482.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLWB01000035",78.029,1.89e-98,364,619,482.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLZF01000029",78.029,1.89e-98,364,619,482.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLWB01000035",78.632,7.7e-99,364,585,459.9972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLZF01000029",78.632,7.7e-99,364,585,459.9972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRE01000049",79.699,8.39e-99,364,532,423.99868,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FLBN01000099",78.275,2.83e-98,363,603,471.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FLCN01000004",78.275,2.83e-98,363,603,471.99825,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLRZ01000037",78.669,2.8e-98,363,586,461.00034,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_FLBN01000099",73.351,6.33e-98,363,1107,811.99557,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_FLCN01000004",73.351,6.33e-98,363,1107,811.99557,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLWB01000035",78.025,2.99e-98,363,628,489.997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLZF01000029",78.025,2.99e-98,363,628,489.997,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_JBGJJV010000032",78.06,2.99e-98,363,629,490.9974,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FLBI01000046",81.678,2.77e-98,363,453,370.00134,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FLBN01000099",81.678,2.77e-98,363,453,370.00134,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_FLCN01000004",81.678,2.77e-98,363,453,370.00134,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLRE01000049",79.962,8.77e-98,361,524,419.00088,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLRE01000049",83.503,9.61e-98,361,394,329.00182,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRI01000021",75.533,2.28e-97,361,797,601.99801,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRO01000021",75.533,2.28e-97,361,797,601.99801,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLXR01000021",75.533,2.28e-97,361,797,601.99801,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRG01000021",75.533,2.28e-97,361,797,601.99801,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLYG01000019",75.533,2.28e-97,361,797,601.99801,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRJ01000019",75.533,2.28e-97,361,797,601.99801,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLSM01000018",75.533,2.28e-97,361,797,601.99801,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLSQ01000022",75.533,2.28e-97,361,797,601.99801,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLXY01000024",75.533,2.28e-97,361,797,601.99801,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLXS01000025",75.533,2.28e-97,361,797,601.99801,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLUD01000021",75.533,2.28e-97,361,797,601.99801,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRC01000027",75.533,2.28e-97,361,797,601.99801,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLYZ01000021",75.533,2.28e-97,361,797,601.99801,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLSP01000022",75.533,2.28e-97,361,797,601.99801,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLSH01000020",75.533,2.28e-97,361,797,601.99801,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLYY01000023",75.533,2.28e-97,361,797,601.99801,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLYC01000020",75.533,2.28e-97,361,797,601.99801,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLXZ01000020",75.533,2.28e-97,361,797,601.99801,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRZ01000037",81.184,1.08e-97,361,473,384.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_JAUEGY010000142",79.434,9.04e-98,361,530,421.0002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRI01000021",82.38,3.91e-97,359,437,360.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRE01000049",82.38,3.91e-97,359,437,360.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRZ01000037",82.38,3.91e-97,359,437,360.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRO01000021",82.38,3.91e-97,359,437,360.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLXR01000021",82.38,3.91e-97,359,437,360.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRG01000021",82.38,3.91e-97,359,437,360.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLYG01000019",82.38,3.91e-97,359,437,360.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRJ01000019",82.38,3.91e-97,359,437,360.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLSM01000018",82.38,3.91e-97,359,437,360.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLSQ01000022",82.38,3.91e-97,359,437,360.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLXY01000024",82.38,3.91e-97,359,437,360.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLXS01000025",82.38,3.91e-97,359,437,360.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLWB01000035",82.38,3.91e-97,359,437,360.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLUD01000021",82.38,3.91e-97,359,437,360.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLYZ01000021",82.38,3.91e-97,359,437,360.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLSP01000022",82.38,3.91e-97,359,437,360.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLZF01000029",82.38,3.91e-97,359,437,360.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLSH01000020",82.38,3.91e-97,359,437,360.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLYY01000023",82.38,3.91e-97,359,437,360.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLYC01000020",82.38,3.91e-97,359,437,360.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLXZ01000020",82.38,3.91e-97,359,437,360.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_FLBI01000046",78.146,1.32e-96,357,604,472.00184,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_FLBN01000099",79.96,1.25e-96,357,504,402.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_FLCN01000004",79.96,1.25e-96,357,504,402.9984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_FLBI01000046",81.963,1.19e-96,357,438,358.99794,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_FLBN01000099",81.963,1.19e-96,357,438,358.99794,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_FLCN01000004",81.963,1.19e-96,357,438,358.99794,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLRE01000049",72.685,1.14e-95,355,1285,934.00225,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLRZ01000037",82.464,4.28e-96,355,422,347.99808,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLWB01000035",82.464,4.28e-96,355,422,347.99808,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLZF01000029",82.464,4.28e-96,355,422,347.99808,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_JBGJJV010000032",79.362,5.05e-96,355,533,422.99946,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_JAUEGY010000142",82.872,1.98e-95,353,397,329.00184,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_JAUEGY010000142",88.621,1.61e-95,353,290,257.0009,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRI01000021",78.078,3.61e-95,353,593,463.00254,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRO01000021",78.078,3.61e-95,353,593,463.00254,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLXR01000021",78.078,3.61e-95,353,593,463.00254,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRG01000021",78.078,3.61e-95,353,593,463.00254,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLYG01000019",78.078,3.61e-95,353,593,463.00254,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRJ01000019",78.078,3.61e-95,353,593,463.00254,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLSM01000018",78.078,3.61e-95,353,593,463.00254,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLSQ01000022",78.078,3.61e-95,353,593,463.00254,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLXY01000024",78.078,3.61e-95,353,593,463.00254,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLXS01000025",78.078,3.61e-95,353,593,463.00254,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLUD01000021",78.078,3.61e-95,353,593,463.00254,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRC01000027",78.078,3.61e-95,353,593,463.00254,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLYZ01000021",78.078,3.61e-95,353,593,463.00254,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLSP01000022",78.078,3.61e-95,353,593,463.00254,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLSH01000020",78.078,3.61e-95,353,593,463.00254,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLYY01000023",78.078,3.61e-95,353,593,463.00254,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLYC01000020",78.078,3.61e-95,353,593,463.00254,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLXZ01000020",78.078,3.61e-95,353,593,463.00254,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRZ01000037",79.842,1.62e-95,353,506,404.00052,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLWB01000035",79.842,1.62e-95,353,506,404.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLZF01000029",79.842,1.62e-95,353,506,404.00052,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRZ01000037",78.843,3.81e-95,353,553,436.00179,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLWB01000035",78.843,3.81e-95,353,553,436.00179,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLZF01000029",78.843,3.81e-95,353,553,436.00179,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLRC01000027",82.151,1.82e-95,353,437,358.99987,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_JBGJJV010000032",78.388,1.67e-95,353,583,457.00204,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRI01000021",79.323,1.82e-95,353,532,421.99836,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRO01000021",79.323,1.82e-95,353,532,421.99836,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLXR01000021",79.323,1.82e-95,353,532,421.99836,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRG01000021",79.323,1.82e-95,353,532,421.99836,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLYG01000019",79.323,1.82e-95,353,532,421.99836,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRJ01000019",79.323,1.82e-95,353,532,421.99836,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLSM01000018",79.323,1.82e-95,353,532,421.99836,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLSQ01000022",79.323,1.82e-95,353,532,421.99836,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLXY01000024",79.323,1.82e-95,353,532,421.99836,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLXS01000025",79.323,1.82e-95,353,532,421.99836,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLUD01000021",79.323,1.82e-95,353,532,421.99836,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRC01000027",79.323,1.82e-95,353,532,421.99836,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLYZ01000021",79.323,1.82e-95,353,532,421.99836,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLSP01000022",79.323,1.82e-95,353,532,421.99836,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLSH01000020",79.323,1.82e-95,353,532,421.99836,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLYY01000023",79.323,1.82e-95,353,532,421.99836,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLYC01000020",79.323,1.82e-95,353,532,421.99836,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLXZ01000020",79.323,1.82e-95,353,532,421.99836,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRI01000021",77.944,6.13e-95,351,603,470.00232,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRE01000049",77.944,6.13e-95,351,603,470.00232,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRO01000021",77.944,6.13e-95,351,603,470.00232,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLXR01000021",77.944,6.13e-95,351,603,470.00232,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRG01000021",77.944,6.13e-95,351,603,470.00232,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLYG01000019",77.944,6.13e-95,351,603,470.00232,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRJ01000019",77.944,6.13e-95,351,603,470.00232,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLSM01000018",77.944,6.13e-95,351,603,470.00232,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLSQ01000022",77.944,6.13e-95,351,603,470.00232,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLXY01000024",77.944,6.13e-95,351,603,470.00232,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLXS01000025",77.944,6.13e-95,351,603,470.00232,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLUD01000021",77.944,6.13e-95,351,603,470.00232,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRC01000027",77.944,6.13e-95,351,603,470.00232,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLYZ01000021",77.944,6.13e-95,351,603,470.00232,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLSP01000022",77.944,6.13e-95,351,603,470.00232,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLSH01000020",77.944,6.13e-95,351,603,470.00232,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLYY01000023",77.944,6.13e-95,351,603,470.00232,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLYC01000020",77.944,6.13e-95,351,603,470.00232,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLXZ01000020",77.944,6.13e-95,351,603,470.00232,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_JBGJJV010000032",79.722,5.82e-95,351,503,401.00166,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_FLBI01000046",73.171,1.37e-94,351,1107,810.00297,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FLBI01000046",77.538,2.35e-94,350,650,503.997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FLCN01000004",77.573,2.35e-94,350,651,505.00023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FLBI01000046",82.494,7.24e-94,348,417,343.99998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FLBN01000099",82.494,7.24e-94,348,417,343.99998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_FLCN01000004",82.494,7.24e-94,348,417,343.99998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_JBGJJV010000032",78.919,7.43e-94,348,555,438.00045,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRE01000049",77.855,7.75e-94,348,578,450.0019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_JAUEGY010000142",87.708,8.81e-94,348,301,264.00108,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLRZ01000037",80.921,7.75e-94,348,456,368.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLRZ01000037",79.135,8.45e-94,348,532,420.9982,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLWB01000035",79.135,8.45e-94,348,532,420.9982,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLZF01000029",79.135,8.45e-94,348,532,420.9982,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_FLBI01000046",77.875,3.51e-93,346,574,447.0025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_FLBN01000099",77.875,3.51e-93,346,574,447.0025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_FLCN01000004",77.875,3.51e-93,346,574,447.0025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLRZ01000037",77.778,2.85e-93,346,603,469.00134,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLWB01000035",77.778,2.85e-93,346,603,469.00134,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLZF01000029",77.778,2.85e-93,346,603,469.00134,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_JBGJJV010000032",77.815,2.85e-93,346,604,470.0026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_JBGJJV010000032",77.35,3.04e-93,346,649,502.0015,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_MLWB01000035",78.739,9.61e-93,344,555,437.00145,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_MLZF01000029",78.739,9.61e-93,344,555,437.00145,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FLBN01000099",78.958,9e-93,344,518,409.00244,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FLCN01000004",78.958,9e-93,344,518,409.00244,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLRE01000049",83.978,9.64e-93,344,362,304.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_FLBN01000099",77.385,1.09e-92,344,650,503.0025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FLBI01000046",78.987,1.09e-92,344,533,421.00071,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FLBN01000099",78.987,1.09e-92,344,533,421.00071,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_FLCN01000004",78.987,1.09e-92,344,533,421.00071,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLRE01000049",83.934,3.65e-92,342,361,303.00174,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRI01000021",75.632,5.74e-92,342,751,567.99632,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRO01000021",75.632,5.74e-92,342,751,567.99632,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLXR01000021",75.632,5.74e-92,342,751,567.99632,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRG01000021",75.632,5.74e-92,342,751,567.99632,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLYG01000019",75.632,5.74e-92,342,751,567.99632,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRJ01000019",75.632,5.74e-92,342,751,567.99632,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLSM01000018",75.632,5.74e-92,342,751,567.99632,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLSQ01000022",75.632,5.74e-92,342,751,567.99632,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLXY01000024",75.632,5.74e-92,342,751,567.99632,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLXS01000025",75.632,5.74e-92,342,751,567.99632,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLUD01000021",75.632,5.74e-92,342,751,567.99632,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRC01000027",75.632,5.74e-92,342,751,567.99632,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLYZ01000021",75.632,5.74e-92,342,751,567.99632,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLSP01000022",75.632,5.74e-92,342,751,567.99632,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLSH01000020",75.632,5.74e-92,342,751,567.99632,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLYY01000023",75.632,5.74e-92,342,751,567.99632,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLYC01000020",75.632,5.74e-92,342,751,567.99632,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLXZ01000020",75.632,5.74e-92,342,751,567.99632,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRI01000021",79.447,3.5e-92,342,506,402.00182,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRO01000021",79.447,3.5e-92,342,506,402.00182,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLXR01000021",79.447,3.5e-92,342,506,402.00182,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRG01000021",79.447,3.5e-92,342,506,402.00182,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLYG01000019",79.447,3.5e-92,342,506,402.00182,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRJ01000019",79.447,3.5e-92,342,506,402.00182,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLSM01000018",79.447,3.5e-92,342,506,402.00182,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLSQ01000022",79.447,3.5e-92,342,506,402.00182,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLXY01000024",79.447,3.5e-92,342,506,402.00182,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLXS01000025",79.447,3.5e-92,342,506,402.00182,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLUD01000021",79.447,3.5e-92,342,506,402.00182,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRC01000027",79.447,3.5e-92,342,506,402.00182,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLYZ01000021",79.447,3.5e-92,342,506,402.00182,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLSP01000022",79.447,3.5e-92,342,506,402.00182,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLSH01000020",79.447,3.5e-92,342,506,402.00182,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLYY01000023",79.447,3.5e-92,342,506,402.00182,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLYC01000020",79.447,3.5e-92,342,506,402.00182,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLXZ01000020",79.447,3.5e-92,342,506,402.00182,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLRE01000049",75.567,7.67e-92,342,749,565.99683,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FLBI01000046",77.72,3.61e-92,342,579,449.9988,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_JBGJJV010000032",77.682,3.61e-92,342,578,449.00196,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLRE01000049",75.567,8.24e-92,342,749,565.99683,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_JBGJJV010000032",75.126,8.24e-92,342,796,598.00296,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FLBI01000046",78.736,3.25e-92,342,522,411.00192,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_JBGJJV010000032",82.075,3.34e-92,342,424,347.998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRE01000049",77.739,1.63e-91,340,566,440.00274,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_JAUEGY010000142",77.7,1.63e-91,340,574,445.998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_FLBI01000046",81.368,1.49e-91,340,424,345.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_FLBN01000099",81.368,1.49e-91,340,424,345.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRE01000049",81.324,1.49e-91,340,423,344.00052,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_FLCN01000004",81.368,1.49e-91,340,424,345.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_JAUEGY010000142",81.368,1.49e-91,340,424,345.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRI01000021",77.835,1.68e-90,337,582,452.9997,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRZ01000037",77.835,1.68e-90,337,582,452.9997,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRO01000021",77.835,1.68e-90,337,582,452.9997,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLXR01000021",77.835,1.68e-90,337,582,452.9997,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRG01000021",77.835,1.68e-90,337,582,452.9997,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLYG01000019",77.835,1.68e-90,337,582,452.9997,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRJ01000019",77.835,1.68e-90,337,582,452.9997,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLSM01000018",77.835,1.68e-90,337,582,452.9997,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLSQ01000022",77.835,1.68e-90,337,582,452.9997,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLXY01000024",77.835,1.68e-90,337,582,452.9997,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLXS01000025",77.835,1.68e-90,337,582,452.9997,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLWB01000035",77.835,1.68e-90,337,582,452.9997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLUD01000021",77.835,1.68e-90,337,582,452.9997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRC01000027",77.835,1.68e-90,337,582,452.9997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLYZ01000021",77.835,1.68e-90,337,582,452.9997,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLSP01000022",77.835,1.68e-90,337,582,452.9997,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLZF01000029",77.835,1.68e-90,337,582,452.9997,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLSH01000020",77.835,1.68e-90,337,582,452.9997,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLYY01000023",77.835,1.68e-90,337,582,452.9997,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLYC01000020",77.835,1.68e-90,337,582,452.9997,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLXZ01000020",77.835,1.68e-90,337,582,452.9997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_JAUEGY010000142",87.805,1.82e-90,337,287,252.00035,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRE01000049",75.434,2.67e-90,337,749,565.00066,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLRE01000049",75.434,4.85e-90,337,749,565.00066,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLRE01000049",79.249,1.63e-90,337,506,400.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRI01000021",77.509,1.68e-90,337,578,448.00202,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRZ01000037",77.509,1.68e-90,337,578,448.00202,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRO01000021",77.509,1.68e-90,337,578,448.00202,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLXR01000021",77.509,1.68e-90,337,578,448.00202,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRG01000021",77.509,1.68e-90,337,578,448.00202,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLYG01000019",77.509,1.68e-90,337,578,448.00202,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRJ01000019",77.509,1.68e-90,337,578,448.00202,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLSM01000018",77.509,1.68e-90,337,578,448.00202,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLSQ01000022",77.509,1.68e-90,337,578,448.00202,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLXY01000024",77.509,1.68e-90,337,578,448.00202,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLXS01000025",77.509,1.68e-90,337,578,448.00202,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLWB01000035",77.509,1.68e-90,337,578,448.00202,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLUD01000021",77.509,1.68e-90,337,578,448.00202,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLRC01000027",77.509,1.68e-90,337,578,448.00202,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLYZ01000021",77.509,1.68e-90,337,578,448.00202,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLSP01000022",77.509,1.68e-90,337,578,448.00202,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLZF01000029",77.509,1.68e-90,337,578,448.00202,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLSH01000020",77.509,1.68e-90,337,578,448.00202,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLYY01000023",77.509,1.68e-90,337,578,448.00202,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLYC01000020",77.509,1.68e-90,337,578,448.00202,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLXZ01000020",77.509,1.68e-90,337,578,448.00202,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRE01000049",78.503,1.51e-90,337,521,409.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLRE01000049",75.434,3.4e-90,337,749,565.00066,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLRE01000049",81.731,1.9e-90,337,416,340.00096,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRI01000021",77.601,7.6e-90,335,567,439.99767,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRZ01000037",77.601,7.6e-90,335,567,439.99767,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRO01000021",77.601,7.6e-90,335,567,439.99767,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLXR01000021",77.601,7.6e-90,335,567,439.99767,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRG01000021",77.601,7.6e-90,335,567,439.99767,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLYG01000019",77.601,7.6e-90,335,567,439.99767,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRJ01000019",77.601,7.6e-90,335,567,439.99767,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLSM01000018",77.601,7.6e-90,335,567,439.99767,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLSQ01000022",77.601,7.6e-90,335,567,439.99767,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLXY01000024",77.601,7.6e-90,335,567,439.99767,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLXS01000025",77.601,7.6e-90,335,567,439.99767,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLWB01000035",77.601,7.6e-90,335,567,439.99767,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLUD01000021",77.601,7.6e-90,335,567,439.99767,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLRC01000027",77.601,7.6e-90,335,567,439.99767,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLYZ01000021",77.601,7.6e-90,335,567,439.99767,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLSP01000022",77.601,7.6e-90,335,567,439.99767,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLZF01000029",77.601,7.6e-90,335,567,439.99767,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLSH01000020",77.601,7.6e-90,335,567,439.99767,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLYY01000023",77.601,7.6e-90,335,567,439.99767,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLYC01000020",77.601,7.6e-90,335,567,439.99767,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLXZ01000020",77.601,7.6e-90,335,567,439.99767,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_JBGJJV010000032",77.526,7.6e-90,335,574,444.99924,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLRZ01000037",79.29,9.6e-90,335,507,402.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLWB01000035",79.29,9.6e-90,335,507,402.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLZF01000029",79.29,9.6e-90,335,507,402.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLRE01000049",79.208,1.07e-89,335,505,400.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRI01000021",81.132,6.94e-90,335,424,343.99968,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRZ01000037",81.132,6.94e-90,335,424,343.99968,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRO01000021",81.132,6.94e-90,335,424,343.99968,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLXR01000021",81.132,6.94e-90,335,424,343.99968,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRG01000021",81.132,6.94e-90,335,424,343.99968,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLYG01000019",81.132,6.94e-90,335,424,343.99968,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRJ01000019",81.132,6.94e-90,335,424,343.99968,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLSM01000018",81.132,6.94e-90,335,424,343.99968,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLSQ01000022",81.132,6.94e-90,335,424,343.99968,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLXY01000024",81.132,6.94e-90,335,424,343.99968,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLXS01000025",81.132,6.94e-90,335,424,343.99968,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLWB01000035",81.132,6.94e-90,335,424,343.99968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLUD01000021",81.132,6.94e-90,335,424,343.99968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLRC01000027",81.132,6.94e-90,335,424,343.99968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLYZ01000021",81.132,6.94e-90,335,424,343.99968,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLSP01000022",81.132,6.94e-90,335,424,343.99968,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLZF01000029",81.132,6.94e-90,335,424,343.99968,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLSH01000020",81.132,6.94e-90,335,424,343.99968,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLYY01000023",81.132,6.94e-90,335,424,343.99968,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLYC01000020",81.132,6.94e-90,335,424,343.99968,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLXZ01000020",81.132,6.94e-90,335,424,343.99968,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_JBGJJV010000032",81.132,6.94e-90,335,424,343.99968,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_FLBI01000046",77.68,7.48e-90,335,569,441.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_FLBN01000099",77.68,7.48e-90,335,569,441.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_FLCN01000004",77.68,7.48e-90,335,569,441.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_FLBI01000046",81.71,2.08e-89,333,421,343.9991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_FLBN01000099",81.71,2.08e-89,333,421,343.9991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_FLCN01000004",81.71,2.08e-89,333,421,343.9991,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_FLBI01000046",78.571,1.95e-89,333,518,406.99778,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRE01000049",78.503,1.95e-89,333,521,409.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLRE01000049",83.565,1.92e-89,333,359,299.99835,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLRE01000049",82.206,7.35e-89,331,399,328.00194,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FLBN01000099",77.375,7.81e-89,331,579,448.00125,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_FLCN01000004",77.375,7.81e-89,331,579,448.00125,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FLBN01000099",78.352,7.03e-89,331,522,408.99744,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_FLCN01000004",78.352,7.03e-89,331,522,408.99744,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_JBGJJV010000032",78.311,7.03e-89,331,521,408.00031,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_FLBN01000099",75.267,4.47e-88,329,748,562.99716,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_FLCN01000004",75.267,4.47e-88,329,748,562.99716,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_JBGJJV010000032",75.333,4.47e-88,329,750,564.9975,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_MLRZ01000037",81.368,2.69e-88,329,424,345.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRE01000049",77.465,3.48e-88,329,568,440.0012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_JAUEGY010000142",77.425,3.48e-88,329,567,438.99975,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLRE01000049",79.01,5.99e-88,329,505,399.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_JAUEGY010000142",83.761,1.06e-87,327,351,294.00111,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRZ01000037",78.352,9.06e-88,327,522,408.99744,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLWB01000035",78.352,9.06e-88,327,522,408.99744,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLZF01000029",78.352,9.06e-88,327,522,408.99744,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRI01000021",78.119,3.27e-87,326,521,406.99999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRZ01000037",78.119,3.27e-87,326,521,406.99999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRO01000021",78.119,3.27e-87,326,521,406.99999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLXR01000021",78.119,3.27e-87,326,521,406.99999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRG01000021",78.119,3.27e-87,326,521,406.99999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLYG01000019",78.119,3.27e-87,326,521,406.99999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRJ01000019",78.119,3.27e-87,326,521,406.99999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLSM01000018",78.119,3.27e-87,326,521,406.99999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLSQ01000022",78.119,3.27e-87,326,521,406.99999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLXY01000024",78.119,3.27e-87,326,521,406.99999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLXS01000025",78.119,3.27e-87,326,521,406.99999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLWB01000035",78.119,3.27e-87,326,521,406.99999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLUD01000021",78.119,3.27e-87,326,521,406.99999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLRC01000027",78.119,3.27e-87,326,521,406.99999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLYZ01000021",78.119,3.27e-87,326,521,406.99999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLSP01000022",78.119,3.27e-87,326,521,406.99999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLZF01000029",78.119,3.27e-87,326,521,406.99999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLSH01000020",78.119,3.27e-87,326,521,406.99999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLYY01000023",78.119,3.27e-87,326,521,406.99999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLYC01000020",78.119,3.27e-87,326,521,406.99999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLXZ01000020",78.119,3.27e-87,326,521,406.99999,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_FLBI01000046",75.134,2.08e-86,324,748,562.00232,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRI01000021",77.329,1.62e-86,324,569,440.00201,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRZ01000037",77.329,1.62e-86,324,569,440.00201,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRO01000021",77.329,1.62e-86,324,569,440.00201,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLXR01000021",77.329,1.62e-86,324,569,440.00201,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRG01000021",77.329,1.62e-86,324,569,440.00201,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLYG01000019",77.329,1.62e-86,324,569,440.00201,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRJ01000019",77.329,1.62e-86,324,569,440.00201,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLSM01000018",77.329,1.62e-86,324,569,440.00201,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLSQ01000022",77.329,1.62e-86,324,569,440.00201,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLXY01000024",77.329,1.62e-86,324,569,440.00201,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLXS01000025",77.329,1.62e-86,324,569,440.00201,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLWB01000035",77.329,1.62e-86,324,569,440.00201,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLUD01000021",77.329,1.62e-86,324,569,440.00201,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLRC01000027",77.329,1.62e-86,324,569,440.00201,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLYZ01000021",77.329,1.62e-86,324,569,440.00201,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLSP01000022",77.329,1.62e-86,324,569,440.00201,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLZF01000029",77.329,1.62e-86,324,569,440.00201,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLSH01000020",77.329,1.62e-86,324,569,440.00201,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLYY01000023",77.329,1.62e-86,324,569,440.00201,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLYC01000020",77.329,1.62e-86,324,569,440.00201,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLXZ01000020",77.329,1.62e-86,324,569,440.00201,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_JBGJJV010000032",77.329,1.62e-86,324,569,440.00201,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_JAUEGY010000142",83.573,4.57e-86,322,347,289.99831,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRI01000021",78.161,4.22e-86,322,522,408.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRO01000021",78.161,4.22e-86,322,522,408.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLXR01000021",78.161,4.22e-86,322,522,408.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRG01000021",78.161,4.22e-86,322,522,408.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLYG01000019",78.161,4.22e-86,322,522,408.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRJ01000019",78.161,4.22e-86,322,522,408.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLSM01000018",78.161,4.22e-86,322,522,408.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLSQ01000022",78.161,4.22e-86,322,522,408.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLXY01000024",78.161,4.22e-86,322,522,408.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLXS01000025",78.161,4.22e-86,322,522,408.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLUD01000021",78.161,4.22e-86,322,522,408.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLRC01000027",78.161,4.22e-86,322,522,408.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLYZ01000021",78.161,4.22e-86,322,522,408.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLSP01000022",78.161,4.22e-86,322,522,408.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLSH01000020",78.161,4.22e-86,322,522,408.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLYY01000023",78.161,4.22e-86,322,522,408.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLYC01000020",78.161,4.22e-86,322,522,408.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLXZ01000020",78.161,4.22e-86,322,522,408.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLRE01000049",81.796,4.58e-86,322,401,328.00196,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLRE01000049",84.337,2.93e-85,320,332,279.99884,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLRE01000049",79.167,1.32e-84,318,480,380.0016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_JBGJJV010000032",78.035,1.96e-84,316,519,405.00165,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_FLBI01000046",77.029,7.85e-84,315,579,445.99791,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_FLBN01000099",77.029,7.85e-84,315,579,445.99791,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_FLCN01000004",77.029,7.85e-84,315,579,445.99791,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_JBGJJV010000032",77.148,7.85e-84,315,582,449.00136,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FLBI01000046",76.431,2.92e-83,313,594,454.00014,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRE01000049",76.431,2.92e-83,313,594,454.00014,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRI01000021",82.289,9.82e-83,311,367,302.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRE01000049",80.63,9.82e-83,311,413,333.0019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRZ01000037",82.289,9.82e-83,311,367,302.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRO01000021",82.289,9.82e-83,311,367,302.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLXR01000021",82.289,9.82e-83,311,367,302.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRG01000021",82.289,9.82e-83,311,367,302.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLYG01000019",82.289,9.82e-83,311,367,302.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRJ01000019",82.289,9.82e-83,311,367,302.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLSM01000018",82.289,9.82e-83,311,367,302.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLSQ01000022",82.289,9.82e-83,311,367,302.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLXY01000024",82.289,9.82e-83,311,367,302.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLXS01000025",82.289,9.82e-83,311,367,302.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLWB01000035",82.289,9.82e-83,311,367,302.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLUD01000021",82.289,9.82e-83,311,367,302.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLRC01000027",82.289,9.82e-83,311,367,302.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLYZ01000021",82.289,9.82e-83,311,367,302.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLSP01000022",82.289,9.82e-83,311,367,302.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLZF01000029",82.289,9.82e-83,311,367,302.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLSH01000020",82.289,9.82e-83,311,367,302.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLYY01000023",82.289,9.82e-83,311,367,302.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLYC01000020",82.289,9.82e-83,311,367,302.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLXZ01000020",82.289,9.82e-83,311,367,302.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLRE01000049",82.72,9.2e-83,311,353,292.0016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_JAUEGY010000142",82.535,9.16e-83,311,355,292.99925,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRI01000021",75.103,1.63e-82,311,731,549.00293,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRO01000021",75.103,1.63e-82,311,731,549.00293,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLXR01000021",75.103,1.63e-82,311,731,549.00293,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRG01000021",75.103,1.63e-82,311,731,549.00293,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLYG01000019",75.103,1.63e-82,311,731,549.00293,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRJ01000019",75.103,1.63e-82,311,731,549.00293,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLSM01000018",75.103,1.63e-82,311,731,549.00293,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLSQ01000022",75.103,1.63e-82,311,731,549.00293,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLXY01000024",75.103,1.63e-82,311,731,549.00293,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLXS01000025",75.103,1.63e-82,311,731,549.00293,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLUD01000021",75.103,1.63e-82,311,731,549.00293,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRC01000027",75.103,1.63e-82,311,731,549.00293,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLYZ01000021",75.103,1.63e-82,311,731,549.00293,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLSP01000022",75.103,1.63e-82,311,731,549.00293,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLSH01000020",75.103,1.63e-82,311,731,549.00293,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLYY01000023",75.103,1.63e-82,311,731,549.00293,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLYC01000020",75.103,1.63e-82,311,731,549.00293,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLXZ01000020",75.103,1.63e-82,311,731,549.00293,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_JAUEGY010000142",83.239,3.79e-82,309,352,293.00128,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRZ01000037",78.85,5.86e-82,309,487,383.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLWB01000035",78.85,5.86e-82,309,487,383.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLZF01000029",78.85,5.86e-82,309,487,383.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FLBN01000099",76.263,1.36e-81,307,594,453.00222,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_FLCN01000004",76.263,1.36e-81,307,594,453.00222,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLRE01000049",74.897,7.58e-81,305,729,545.99913,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_JAUEGY010000142",79.039,4.2e-81,305,458,361.99862,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_JBGJJV010000032",78.947,2.19e-80,303,456,359.99832,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLRE01000049",82.436,1.52e-80,303,353,290.99908,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRZ01000037",82.065,1.61e-80,303,368,301.9992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLWB01000035",82.065,1.61e-80,303,368,301.9992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLZF01000029",82.065,1.61e-80,303,368,301.9992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLRE01000049",78.846,6.11e-80,302,468,368.99928,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRI01000021",80.096,1.04e-79,302,417,334.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRZ01000037",80.096,1.04e-79,302,417,334.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRO01000021",80.096,1.04e-79,302,417,334.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLXR01000021",80.096,1.04e-79,302,417,334.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRG01000021",80.096,1.04e-79,302,417,334.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLYG01000019",80.096,1.04e-79,302,417,334.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRJ01000019",80.096,1.04e-79,302,417,334.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLSM01000018",80.096,1.04e-79,302,417,334.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLSQ01000022",80.096,1.04e-79,302,417,334.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLXY01000024",80.096,1.04e-79,302,417,334.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLXS01000025",80.096,1.04e-79,302,417,334.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLWB01000035",80.096,1.04e-79,302,417,334.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLUD01000021",80.096,1.04e-79,302,417,334.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRC01000027",80.096,1.04e-79,302,417,334.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLYZ01000021",80.096,1.04e-79,302,417,334.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLSP01000022",80.096,1.04e-79,302,417,334.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLZF01000029",80.096,1.04e-79,302,417,334.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLSH01000020",80.096,1.04e-79,302,417,334.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLYY01000023",80.096,1.04e-79,302,417,334.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLYC01000020",80.096,1.04e-79,302,417,334.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLXZ01000020",80.096,1.04e-79,302,417,334.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRI01000021",76.094,6.31e-80,302,594,451.99836,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRO01000021",76.094,6.31e-80,302,594,451.99836,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLXR01000021",76.094,6.31e-80,302,594,451.99836,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRG01000021",76.094,6.31e-80,302,594,451.99836,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLYG01000019",76.094,6.31e-80,302,594,451.99836,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRJ01000019",76.094,6.31e-80,302,594,451.99836,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLSM01000018",76.094,6.31e-80,302,594,451.99836,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLSQ01000022",76.094,6.31e-80,302,594,451.99836,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLXY01000024",76.094,6.31e-80,302,594,451.99836,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLXS01000025",76.094,6.31e-80,302,594,451.99836,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLUD01000021",76.094,6.31e-80,302,594,451.99836,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRC01000027",76.094,6.31e-80,302,594,451.99836,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLYZ01000021",76.094,6.31e-80,302,594,451.99836,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLSP01000022",76.094,6.31e-80,302,594,451.99836,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLSH01000020",76.094,6.31e-80,302,594,451.99836,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLYY01000023",76.094,6.31e-80,302,594,451.99836,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLYC01000020",76.094,6.31e-80,302,594,451.99836,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLXZ01000020",76.094,6.31e-80,302,594,451.99836,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_FLBI01000046",78.821,1.96e-79,300,458,361.00018,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_FLBN01000099",78.742,1.96e-79,300,461,363.00062,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRE01000049",78.511,1.96e-79,300,470,369.0017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_FLCN01000004",78.742,1.96e-79,300,461,363.00062,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_FLBN01000099",74.725,1.27e-78,298,728,543.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_FLCN01000004",74.725,1.27e-78,298,728,543.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_JBGJJV010000032",74.795,1.27e-78,298,730,546.0035,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLRE01000049",81.818,4.84e-78,296,363,296.99934,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_JBGJJV010000032",81.522,2.75e-78,296,368,300.00096,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLRZ01000037",75.926,2.94e-78,296,594,451.00044,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLWB01000035",75.926,2.94e-78,296,594,451.00044,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLZF01000029",75.926,2.94e-78,296,594,451.00044,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRI01000021",78.557,8.1e-78,296,485,381.00145,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRE01000049",78.557,8.1e-78,296,485,381.00145,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRZ01000037",78.557,8.1e-78,296,485,381.00145,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRO01000021",78.557,8.1e-78,296,485,381.00145,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLXR01000021",78.557,8.1e-78,296,485,381.00145,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRG01000021",78.557,8.1e-78,296,485,381.00145,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLYG01000019",78.557,8.1e-78,296,485,381.00145,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRJ01000019",78.557,8.1e-78,296,485,381.00145,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLSM01000018",78.557,8.1e-78,296,485,381.00145,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLSQ01000022",78.557,8.1e-78,296,485,381.00145,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLXY01000024",78.557,8.1e-78,296,485,381.00145,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLXS01000025",78.557,8.1e-78,296,485,381.00145,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLWB01000035",78.557,8.1e-78,296,485,381.00145,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLUD01000021",78.557,8.1e-78,296,485,381.00145,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLYZ01000021",78.557,8.1e-78,296,485,381.00145,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLSP01000022",78.557,8.1e-78,296,485,381.00145,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLZF01000029",78.557,8.1e-78,296,485,381.00145,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLSH01000020",78.557,8.1e-78,296,485,381.00145,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLYY01000023",78.557,8.1e-78,296,485,381.00145,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLYC01000020",78.557,8.1e-78,296,485,381.00145,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLXZ01000020",78.557,8.1e-78,296,485,381.00145,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLRE01000049",82.899,2.57e-78,296,345,286.00155,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_MLRZ01000037",78.603,1.32e-77,294,458,360.00174,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_MLWB01000035",78.603,1.32e-77,294,458,360.00174,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_MLZF01000029",78.603,1.32e-77,294,458,360.00174,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_MLRZ01000037",76.382,1.04e-77,294,597,456.00054,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_MLWB01000035",76.382,1.04e-77,294,597,456.00054,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_MLZF01000029",76.382,1.04e-77,294,597,456.00054,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRI01000021",78.298,9.1e-78,294,470,368.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRZ01000037",78.298,9.1e-78,294,470,368.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRO01000021",78.298,9.1e-78,294,470,368.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLXR01000021",78.298,9.1e-78,294,470,368.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRG01000021",78.298,9.1e-78,294,470,368.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLYG01000019",78.298,9.1e-78,294,470,368.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRJ01000019",78.298,9.1e-78,294,470,368.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLSM01000018",78.298,9.1e-78,294,470,368.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLSQ01000022",78.298,9.1e-78,294,470,368.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLXY01000024",78.298,9.1e-78,294,470,368.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLXS01000025",78.298,9.1e-78,294,470,368.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLWB01000035",78.298,9.1e-78,294,470,368.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLUD01000021",78.298,9.1e-78,294,470,368.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLRC01000027",78.298,9.1e-78,294,470,368.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLYZ01000021",78.298,9.1e-78,294,470,368.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLSP01000022",78.298,9.1e-78,294,470,368.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLZF01000029",78.298,9.1e-78,294,470,368.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLSH01000020",78.298,9.1e-78,294,470,368.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLYY01000023",78.298,9.1e-78,294,470,368.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLYC01000020",78.298,9.1e-78,294,470,368.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLXZ01000020",78.298,9.1e-78,294,470,368.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_JBGJJV010000032",79.665,6.26e-77,292,418,332.9997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_JAUEGY010000142",81.977,4.52e-77,292,344,282.00088,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_MLWB01000035",77.606,3.27e-77,292,518,401.99908,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_MLZF01000029",77.606,3.27e-77,292,518,401.99908,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRE01000049",76.822,3.47e-77,292,535,410.9977,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRZ01000037",76.735,3.47e-77,292,533,408.99755,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLWB01000035",76.735,3.47e-77,292,533,408.99755,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLZF01000029",76.735,3.47e-77,292,533,408.99755,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_FLBI01000046",78.216,5.9e-77,292,482,377.00112,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FLBI01000046",81.102,1.18e-76,291,381,308.99862,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FLBN01000099",81.102,1.18e-76,291,381,308.99862,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_FLCN01000004",81.102,1.18e-76,291,381,308.99862,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_JBGJJV010000032",75.758,1.37e-76,291,594,450.00252,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLRC01000027",78.351,3.77e-76,291,485,380.00235,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_JAUEGY010000142",81.844,4.28e-76,289,347,283.99868,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_JBGJJV010000032",78.384,4.23e-76,289,458,358.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRI01000021",81.301,1.62e-75,287,369,300.00069,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRE01000049",81.25,1.62e-75,287,368,299,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRO01000021",81.301,1.62e-75,287,369,300.00069,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLXR01000021",81.301,1.62e-75,287,369,300.00069,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRG01000021",81.301,1.62e-75,287,369,300.00069,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLYG01000019",81.301,1.62e-75,287,369,300.00069,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRJ01000019",81.301,1.62e-75,287,369,300.00069,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLSM01000018",81.301,1.62e-75,287,369,300.00069,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLSQ01000022",81.301,1.62e-75,287,369,300.00069,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLXY01000024",81.301,1.62e-75,287,369,300.00069,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLXS01000025",81.301,1.62e-75,287,369,300.00069,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLUD01000021",81.301,1.62e-75,287,369,300.00069,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLRC01000027",81.301,1.62e-75,287,369,300.00069,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLYZ01000021",81.301,1.62e-75,287,369,300.00069,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLSP01000022",81.301,1.62e-75,287,369,300.00069,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLSH01000020",81.301,1.62e-75,287,369,300.00069,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLYY01000023",81.301,1.62e-75,287,369,300.00069,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLYC01000020",81.301,1.62e-75,287,369,300.00069,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLXZ01000020",81.301,1.62e-75,287,369,300.00069,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRI01000021",76.548,1.61e-75,287,533,408.00084,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRO01000021",76.548,1.61e-75,287,533,408.00084,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLXR01000021",76.548,1.61e-75,287,533,408.00084,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRG01000021",76.548,1.61e-75,287,533,408.00084,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLYG01000019",76.548,1.61e-75,287,533,408.00084,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRJ01000019",76.548,1.61e-75,287,533,408.00084,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLSM01000018",76.548,1.61e-75,287,533,408.00084,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLSQ01000022",76.548,1.61e-75,287,533,408.00084,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLXY01000024",76.548,1.61e-75,287,533,408.00084,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLXS01000025",76.548,1.61e-75,287,533,408.00084,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLUD01000021",76.548,1.61e-75,287,533,408.00084,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLRC01000027",76.548,1.61e-75,287,533,408.00084,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLYZ01000021",76.548,1.61e-75,287,533,408.00084,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLSP01000022",76.548,1.61e-75,287,533,408.00084,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLSH01000020",76.548,1.61e-75,287,533,408.00084,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLYY01000023",76.548,1.61e-75,287,533,408.00084,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLYC01000020",76.548,1.61e-75,287,533,408.00084,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLXZ01000020",76.548,1.61e-75,287,533,408.00084,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FLBI01000046",80.978,5.95e-75,285,368,297.99904,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FLBN01000099",80.978,5.95e-75,285,368,297.99904,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_FLCN01000004",80.978,5.95e-75,285,368,297.99904,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_FLBI01000046",78.289,7.92e-75,285,456,356.99784,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_FLBN01000099",78.289,7.92e-75,285,456,356.99784,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_FLCN01000004",78.289,7.92e-75,285,456,356.99784,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_FLBI01000046",75.926,8.11e-74,281,594,451.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_FLBN01000099",75.845,8.11e-74,281,592,449.0024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_FLCN01000004",75.845,8.11e-74,281,592,449.0024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_JBGJJV010000032",80.593,1.16e-73,281,371,299.00003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_FLBI01000046",76.367,1.13e-72,278,567,433.00089,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_MLRZ01000037",76.619,9.81e-73,278,556,426.00164,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_MLWB01000035",76.619,9.81e-73,278,556,426.00164,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_MLZF01000029",76.619,9.81e-73,278,556,426.00164,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_MLRZ01000037",80.429,1.49e-72,278,373,300.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_MLWB01000035",80.429,1.49e-72,278,373,300.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_MLZF01000029",80.429,1.49e-72,278,373,300.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FLBI01000046",80.769,6.3e-72,276,364,293.99916,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FLBN01000099",80.769,6.3e-72,276,364,293.99916,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_FLCN01000004",80.769,6.3e-72,276,364,293.99916,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_MLRZ01000037",77.027,3.3e-72,276,518,398.99986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_JBGJJV010000032",76.534,3.53e-72,276,554,423.99836,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_JBGJJV010000032",80.376,4.3e-72,276,372,298.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_JBGJJV010000032",80.72,1.86e-71,274,389,314.0008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_JBGJJV010000032",87.137,5.47e-71,272,241,210.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_MLRZ01000037",80.214,5.56e-71,272,374,300.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_MLWB01000035",80.214,5.56e-71,272,374,300.00036,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_MLZF01000029",80.214,5.56e-71,272,374,300.00036,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRE01000049",76.292,1.89e-70,270,561,427.99812,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRZ01000037",76.25,1.89e-70,270,560,427,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLWB01000035",76.25,1.89e-70,270,560,427,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLZF01000029",76.25,1.89e-70,270,560,427,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_FLBI01000046",76.354,1.64e-70,270,554,423.00116,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_FLBN01000099",76.396,1.64e-70,270,555,423.9978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_FLCN01000004",76.396,1.64e-70,270,555,423.9978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_JBGJJV010000032",75.671,1.76e-70,270,596,450.99916,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRZ01000037",86.722,7.08e-70,268,241,209.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLWB01000035",86.722,7.08e-70,268,241,209.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLZF01000029",86.722,7.08e-70,268,241,209.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_FLBN01000099",75.972,2.45e-69,267,566,430.00152,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_FLCN01000004",75.972,2.45e-69,267,566,430.00152,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_JBGJJV010000032",77.426,2.45e-69,267,474,366.99924,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRI01000021",87.446,2e-69,267,231,202.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRO01000021",87.446,2e-69,267,231,202.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLXR01000021",87.446,2e-69,267,231,202.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRG01000021",87.446,2e-69,267,231,202.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLYG01000019",87.446,2e-69,267,231,202.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRJ01000019",87.446,2e-69,267,231,202.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLSM01000018",87.446,2e-69,267,231,202.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLSQ01000022",87.446,2e-69,267,231,202.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLXY01000024",87.446,2e-69,267,231,202.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLXS01000025",87.446,2e-69,267,231,202.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLUD01000021",87.446,2e-69,267,231,202.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLRC01000027",87.446,2e-69,267,231,202.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLYZ01000021",87.446,2e-69,267,231,202.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLSP01000022",87.446,2e-69,267,231,202.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLSH01000020",87.446,2e-69,267,231,202.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLYY01000023",87.446,2e-69,267,231,202.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLYC01000020",87.446,2e-69,267,231,202.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLXZ01000020",87.446,2e-69,267,231,202.00026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRI01000021",92.432,1.14e-68,265,185,170.9992,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRO01000021",92.432,1.14e-68,265,185,170.9992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLXR01000021",92.432,1.14e-68,265,185,170.9992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRG01000021",92.432,1.14e-68,265,185,170.9992,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLYG01000019",92.432,1.14e-68,265,185,170.9992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRJ01000019",92.432,1.14e-68,265,185,170.9992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLSM01000018",92.432,1.14e-68,265,185,170.9992,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLSQ01000022",92.432,1.14e-68,265,185,170.9992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLXY01000024",92.432,1.14e-68,265,185,170.9992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLXS01000025",92.432,1.14e-68,265,185,170.9992,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLUD01000021",92.432,1.14e-68,265,185,170.9992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRC01000027",92.432,1.14e-68,265,185,170.9992,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLYZ01000021",92.432,1.14e-68,265,185,170.9992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLSP01000022",92.432,1.14e-68,265,185,170.9992,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLSH01000020",92.432,1.14e-68,265,185,170.9992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLYY01000023",92.432,1.14e-68,265,185,170.9992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLYC01000020",92.432,1.14e-68,265,185,170.9992,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLXZ01000020",92.432,1.14e-68,265,185,170.9992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_JBGJJV010000032",76.731,7.13e-69,265,520,399.0012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRI01000021",76.114,8.8e-69,265,561,426.99954,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRO01000021",76.114,8.8e-69,265,561,426.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLXR01000021",76.114,8.8e-69,265,561,426.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRG01000021",76.114,8.8e-69,265,561,426.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLYG01000019",76.114,8.8e-69,265,561,426.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRJ01000019",76.114,8.8e-69,265,561,426.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLSM01000018",76.114,8.8e-69,265,561,426.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLSQ01000022",76.114,8.8e-69,265,561,426.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLXY01000024",76.114,8.8e-69,265,561,426.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLXS01000025",76.114,8.8e-69,265,561,426.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLUD01000021",76.114,8.8e-69,265,561,426.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLRC01000027",76.114,8.8e-69,265,561,426.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLYZ01000021",76.114,8.8e-69,265,561,426.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLSP01000022",76.114,8.8e-69,265,561,426.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLSH01000020",76.114,8.8e-69,265,561,426.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLYY01000023",76.114,8.8e-69,265,561,426.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLYC01000020",76.114,8.8e-69,265,561,426.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLXZ01000020",76.114,8.8e-69,265,561,426.99954,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_JBGJJV010000032",76.067,7.56e-69,265,539,410.00113,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_FLBI01000046",79.784,4.19e-68,263,371,295.99864,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_FLBN01000099",79.784,4.19e-68,263,371,295.99864,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_FLCN01000004",79.784,4.19e-68,263,371,295.99864,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRI01000021",93.296,4.42e-68,263,179,166.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRZ01000037",93.296,4.42e-68,263,179,166.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRO01000021",93.296,4.42e-68,263,179,166.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXR01000021",93.296,4.42e-68,263,179,166.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRG01000021",93.296,4.42e-68,263,179,166.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYG01000019",93.296,4.42e-68,263,179,166.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRJ01000019",93.296,4.42e-68,263,179,166.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSM01000018",93.296,4.42e-68,263,179,166.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSQ01000022",93.296,4.42e-68,263,179,166.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXY01000024",93.296,4.42e-68,263,179,166.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXS01000025",93.296,4.42e-68,263,179,166.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLWB01000035",93.296,4.42e-68,263,179,166.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLUD01000021",93.296,4.42e-68,263,179,166.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRC01000027",93.296,4.42e-68,263,179,166.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYZ01000021",93.296,4.42e-68,263,179,166.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSP01000022",93.296,4.42e-68,263,179,166.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLZF01000029",93.296,4.42e-68,263,179,166.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSH01000020",93.296,4.42e-68,263,179,166.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYY01000023",93.296,4.42e-68,263,179,166.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLYC01000020",93.296,4.42e-68,263,179,166.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLXZ01000020",93.296,4.42e-68,263,179,166.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLRE01000049",93.296,4.42e-68,263,179,166.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRZ01000037",75.485,1.01e-67,261,567,427.99995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLWB01000035",75.485,1.01e-67,261,567,427.99995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLZF01000029",75.485,1.01e-67,261,567,427.99995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FLBI01000046",80.206,1.45e-67,261,389,312.00134,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FLCN01000004",80.206,1.45e-67,261,389,312.00134,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRC01000027",80.052,1.45e-67,261,386,309.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_FLBI01000046",75.701,3.52e-67,259,535,405.00035,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_FLBN01000099",75.701,3.52e-67,259,535,405.00035,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_FLCN01000004",75.701,3.52e-67,259,535,405.00035,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FLBI01000046",92.308,5.72e-67,259,182,168.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FLBN01000099",92.308,5.72e-67,259,182,168.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_FLCN01000004",92.308,5.72e-67,259,182,168.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_JBGJJV010000032",92.308,5.72e-67,259,182,168.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_FLBI01000046",79.57,1.56e-66,257,372,296.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_FLBN01000099",79.57,1.56e-66,257,372,296.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_FLCN01000004",79.57,1.56e-66,257,372,296.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FLBN01000099",75.309,4.72e-66,255,567,427.00203,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRI01000021",75.352,4.72e-66,255,568,427.99936,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRE01000049",75.265,4.72e-66,255,566,425.9999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FLCN01000004",75.309,4.72e-66,255,567,427.00203,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRO01000021",75.352,4.72e-66,255,568,427.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLXR01000021",75.352,4.72e-66,255,568,427.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRG01000021",75.352,4.72e-66,255,568,427.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLYG01000019",75.352,4.72e-66,255,568,427.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRJ01000019",75.352,4.72e-66,255,568,427.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLSM01000018",75.352,4.72e-66,255,568,427.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLSQ01000022",75.352,4.72e-66,255,568,427.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLXY01000024",75.352,4.72e-66,255,568,427.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLXS01000025",75.352,4.72e-66,255,568,427.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLUD01000021",75.352,4.72e-66,255,568,427.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLRC01000027",75.352,4.72e-66,255,568,427.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLYZ01000021",75.352,4.72e-66,255,568,427.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLSP01000022",75.352,4.72e-66,255,568,427.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLSH01000020",75.352,4.72e-66,255,568,427.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLYY01000023",75.352,4.72e-66,255,568,427.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLYC01000020",75.352,4.72e-66,255,568,427.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLXZ01000020",75.352,4.72e-66,255,568,427.99936,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FLBN01000099",79.949,6.75e-66,255,389,311.00161,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRI01000021",79.845,6.75e-66,255,387,309.00015,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRE01000049",79.845,6.75e-66,255,387,309.00015,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRZ01000037",79.845,6.75e-66,255,387,309.00015,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRO01000021",79.845,6.75e-66,255,387,309.00015,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXR01000021",79.845,6.75e-66,255,387,309.00015,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRG01000021",79.845,6.75e-66,255,387,309.00015,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYG01000019",79.845,6.75e-66,255,387,309.00015,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRJ01000019",79.845,6.75e-66,255,387,309.00015,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSM01000018",79.845,6.75e-66,255,387,309.00015,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSQ01000022",79.845,6.75e-66,255,387,309.00015,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXY01000024",79.845,6.75e-66,255,387,309.00015,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXS01000025",79.845,6.75e-66,255,387,309.00015,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLWB01000035",79.845,6.75e-66,255,387,309.00015,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLUD01000021",79.845,6.75e-66,255,387,309.00015,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYZ01000021",79.845,6.75e-66,255,387,309.00015,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSP01000022",79.845,6.75e-66,255,387,309.00015,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLZF01000029",79.845,6.75e-66,255,387,309.00015,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSH01000020",79.845,6.75e-66,255,387,309.00015,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYY01000023",79.845,6.75e-66,255,387,309.00015,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYC01000020",79.845,6.75e-66,255,387,309.00015,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXZ01000020",79.845,6.75e-66,255,387,309.00015,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_FLBI01000046",85.892,5.51e-66,255,241,206.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_FLBN01000099",85.892,5.51e-66,255,241,206.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_FLCN01000004",85.892,5.51e-66,255,241,206.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRI01000021",85.537,2.29e-65,254,242,206.99954,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRO01000021",85.537,2.29e-65,254,242,206.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLXR01000021",85.537,2.29e-65,254,242,206.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRG01000021",85.537,2.29e-65,254,242,206.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLYG01000019",85.537,2.29e-65,254,242,206.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRJ01000019",85.537,2.29e-65,254,242,206.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLSM01000018",85.537,2.29e-65,254,242,206.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLSQ01000022",85.537,2.29e-65,254,242,206.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLXY01000024",85.537,2.29e-65,254,242,206.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLXS01000025",85.537,2.29e-65,254,242,206.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLUD01000021",85.537,2.29e-65,254,242,206.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLRC01000027",85.537,2.29e-65,254,242,206.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLYZ01000021",85.537,2.29e-65,254,242,206.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLSP01000022",85.537,2.29e-65,254,242,206.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLSH01000020",85.537,2.29e-65,254,242,206.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLYY01000023",85.537,2.29e-65,254,242,206.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLYC01000020",85.537,2.29e-65,254,242,206.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLXZ01000020",85.537,2.29e-65,254,242,206.99954,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_FLBI01000046",75.044,2.2e-64,250,565,423.9986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_JBGJJV010000032",75.22,2.2e-64,250,569,428.0018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FLBI01000046",80.523,3.14e-64,250,344,276.99912,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRI01000021",85.897,1.02e-63,248,234,200.99898,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRO01000021",85.897,1.02e-63,248,234,200.99898,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLXR01000021",85.897,1.02e-63,248,234,200.99898,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRG01000021",85.897,1.02e-63,248,234,200.99898,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLYG01000019",85.897,1.02e-63,248,234,200.99898,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRJ01000019",85.897,1.02e-63,248,234,200.99898,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLSM01000018",85.897,1.02e-63,248,234,200.99898,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLSQ01000022",85.897,1.02e-63,248,234,200.99898,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLXY01000024",85.897,1.02e-63,248,234,200.99898,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLXS01000025",85.897,1.02e-63,248,234,200.99898,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLUD01000021",85.897,1.02e-63,248,234,200.99898,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLRC01000027",85.897,1.02e-63,248,234,200.99898,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLYZ01000021",85.897,1.02e-63,248,234,200.99898,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLSP01000022",85.897,1.02e-63,248,234,200.99898,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLSH01000020",85.897,1.02e-63,248,234,200.99898,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLYY01000023",85.897,1.02e-63,248,234,200.99898,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLYC01000020",85.897,1.02e-63,248,234,200.99898,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLXZ01000020",85.897,1.02e-63,248,234,200.99898,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRZ01000037",80.793,4.06e-63,246,328,265.00104,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLWB01000035",80.793,4.06e-63,246,328,265.00104,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLZF01000029",80.793,4.06e-63,246,328,265.00104,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FLBN01000099",72.619,4.58e-63,246,924,670.99956,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FLCN01000004",72.619,4.58e-63,246,924,670.99956,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FLBI01000046",77.951,3.43e-63,246,449,349.99999,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FLCN01000004",77.951,3.43e-63,246,449,349.99999,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FLBN01000099",77.978,1.23e-62,244,445,347.0021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRC01000027",77.803,1.23e-62,244,446,347.00138,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_JBGJJV010000032",77.679,1.6e-61,241,448,348.00192,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRI01000021",77.578,5.74e-61,239,446,345.99788,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRE01000049",77.578,5.74e-61,239,446,345.99788,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRZ01000037",77.578,5.74e-61,239,446,345.99788,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRO01000021",77.578,5.74e-61,239,446,345.99788,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXR01000021",77.578,5.74e-61,239,446,345.99788,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRG01000021",77.578,5.74e-61,239,446,345.99788,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYG01000019",77.578,5.74e-61,239,446,345.99788,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRJ01000019",77.578,5.74e-61,239,446,345.99788,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSM01000018",77.578,5.74e-61,239,446,345.99788,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSQ01000022",77.578,5.74e-61,239,446,345.99788,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXY01000024",77.578,5.74e-61,239,446,345.99788,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXS01000025",77.578,5.74e-61,239,446,345.99788,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLWB01000035",77.578,5.74e-61,239,446,345.99788,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLUD01000021",77.578,5.74e-61,239,446,345.99788,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYZ01000021",77.578,5.74e-61,239,446,345.99788,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSP01000022",77.578,5.74e-61,239,446,345.99788,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLZF01000029",77.578,5.74e-61,239,446,345.99788,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSH01000020",77.578,5.74e-61,239,446,345.99788,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYY01000023",77.578,5.74e-61,239,446,345.99788,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYC01000020",77.578,5.74e-61,239,446,345.99788,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXZ01000020",77.578,5.74e-61,239,446,345.99788,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_JBGJJV010000032",79.592,2.17e-60,237,343,273.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_JAUEGY010000142",81.081,1.65e-60,237,296,239.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FLBI01000046",79.883,7.16e-60,235,343,273.99869,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FLBN01000099",79.883,7.16e-60,235,343,273.99869,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_FLCN01000004",79.883,7.16e-60,235,343,273.99869,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRC01000027",80.183,8.79e-60,235,328,263.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRI01000021",80.183,8.79e-60,235,328,263.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRO01000021",80.183,8.79e-60,235,328,263.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXR01000021",80.183,8.79e-60,235,328,263.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRG01000021",80.183,8.79e-60,235,328,263.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYG01000019",80.183,8.79e-60,235,328,263.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRJ01000019",80.183,8.79e-60,235,328,263.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSM01000018",80.183,8.79e-60,235,328,263.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSQ01000022",80.183,8.79e-60,235,328,263.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXY01000024",80.183,8.79e-60,235,328,263.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXS01000025",80.183,8.79e-60,235,328,263.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLUD01000021",80.183,8.79e-60,235,328,263.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYZ01000021",80.183,8.79e-60,235,328,263.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSP01000022",80.183,8.79e-60,235,328,263.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSH01000020",80.183,8.79e-60,235,328,263.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYY01000023",80.183,8.79e-60,235,328,263.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLYC01000020",80.183,8.79e-60,235,328,263.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLXZ01000020",80.183,8.79e-60,235,328,263.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_FLBI01000046",72.403,9.91e-60,235,924,669.00372,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_JBGJJV010000032",72.522,9.91e-60,235,928,673.00416,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRI01000021",81.915,9.43e-60,235,282,231.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRO01000021",81.915,9.43e-60,235,282,231.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLXR01000021",81.915,9.43e-60,235,282,231.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRG01000021",81.915,9.43e-60,235,282,231.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLYG01000019",81.915,9.43e-60,235,282,231.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRJ01000019",81.915,9.43e-60,235,282,231.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLSM01000018",81.915,9.43e-60,235,282,231.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLSQ01000022",81.915,9.43e-60,235,282,231.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLXY01000024",81.915,9.43e-60,235,282,231.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLXS01000025",81.915,9.43e-60,235,282,231.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLUD01000021",81.915,9.43e-60,235,282,231.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRC01000027",81.915,9.43e-60,235,282,231.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLYZ01000021",81.915,9.43e-60,235,282,231.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLSP01000022",81.915,9.43e-60,235,282,231.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLSH01000020",81.915,9.43e-60,235,282,231.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLYY01000023",81.915,9.43e-60,235,282,231.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLYC01000020",81.915,9.43e-60,235,282,231.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLXZ01000020",81.915,9.43e-60,235,282,231.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRI01000021",93.631,6.79e-60,235,157,147.00067,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRO01000021",93.631,6.79e-60,235,157,147.00067,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLXR01000021",93.631,6.79e-60,235,157,147.00067,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRG01000021",93.631,6.79e-60,235,157,147.00067,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLYG01000019",93.631,6.79e-60,235,157,147.00067,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRJ01000019",93.631,6.79e-60,235,157,147.00067,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLSM01000018",93.631,6.79e-60,235,157,147.00067,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLSQ01000022",93.631,6.79e-60,235,157,147.00067,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLXY01000024",93.631,6.79e-60,235,157,147.00067,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLXS01000025",93.631,6.79e-60,235,157,147.00067,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLUD01000021",93.631,6.79e-60,235,157,147.00067,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLRC01000027",93.631,6.79e-60,235,157,147.00067,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLYZ01000021",93.631,6.79e-60,235,157,147.00067,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLSP01000022",93.631,6.79e-60,235,157,147.00067,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLSH01000020",93.631,6.79e-60,235,157,147.00067,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLYY01000023",93.631,6.79e-60,235,157,147.00067,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLYC01000020",93.631,6.79e-60,235,157,147.00067,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLXZ01000020",93.631,6.79e-60,235,157,147.00067,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_JBGJJV010000032",79.651,3.16e-59,233,344,273.99944,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FLCN01000004",79.651,3.16e-59,233,344,273.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_FLBN01000099",79.651,3.16e-59,233,344,273.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_JAUEGY010000142",85.463,2.04e-59,233,227,194.00101,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_MLRZ01000037",79.36,1.01e-58,231,344,272.9984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_MLWB01000035",79.36,1.01e-58,231,344,272.9984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_MLZF01000029",79.36,1.01e-58,231,344,272.9984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FLBI01000046",79.646,7.16e-59,231,339,269.99994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FLBN01000099",79.646,7.16e-59,231,339,269.99994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_FLCN01000004",79.646,7.16e-59,231,339,269.99994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_JAUEGY010000142",85.65,2.69e-58,230,223,190.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FLBI01000046",76.409,3.07e-58,230,479,365.99911,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FLBN01000099",76.421,3.07e-58,230,475,362.99975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_FLCN01000004",76.409,3.07e-58,230,479,365.99911,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_FLBI01000046",79.179,1.31e-57,228,341,270.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_FLBN01000099",79.179,1.31e-57,228,341,270.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_FLCN01000004",79.179,1.31e-57,228,341,270.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_MLWB01000035",75.556,9.26e-58,228,495,374.0022,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_MLZF01000029",75.556,9.26e-58,228,495,374.0022,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_MLWB01000035",75.453,4.31e-57,226,497,375.00141,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_MLZF01000029",75.453,4.31e-57,226,497,375.00141,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_JAUEGY010000142",80.969,3.87e-57,226,289,234.00041,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_FLBN01000099",72.008,6.21e-57,226,961,691.99688,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_FLCN01000004",72.008,6.21e-57,226,961,691.99688,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_JBGJJV010000032",85.581,7.92e-57,226,215,183.99915,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_JBGJJV010000032",76.25,3.97e-57,226,480,366,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_MLRZ01000037",79.056,1.55e-56,224,339,267.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLRE01000049",79.573,1.9e-56,224,328,260.99944,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRI01000021",85.78,5.72e-56,222,218,187.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRE01000049",85.78,5.72e-56,222,218,187.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRZ01000037",85.78,5.72e-56,222,218,187.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRO01000021",85.78,5.72e-56,222,218,187.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLXR01000021",85.78,5.72e-56,222,218,187.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRG01000021",85.78,5.72e-56,222,218,187.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLYG01000019",85.78,5.72e-56,222,218,187.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRJ01000019",85.78,5.72e-56,222,218,187.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLSM01000018",85.78,5.72e-56,222,218,187.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLSQ01000022",85.78,5.72e-56,222,218,187.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLXY01000024",85.78,5.72e-56,222,218,187.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLXS01000025",85.78,5.72e-56,222,218,187.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLWB01000035",85.78,5.72e-56,222,218,187.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLUD01000021",85.78,5.72e-56,222,218,187.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLRC01000027",85.78,5.72e-56,222,218,187.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLYZ01000021",85.78,5.72e-56,222,218,187.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLSP01000022",85.78,5.72e-56,222,218,187.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLZF01000029",85.78,5.72e-56,222,218,187.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLSH01000020",85.78,5.72e-56,222,218,187.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLYY01000023",85.78,5.72e-56,222,218,187.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLYC01000020",85.78,5.72e-56,222,218,187.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLXZ01000020",85.78,5.72e-56,222,218,187.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_JBGJJV010000032",77.778,5.72e-56,222,396,308.00088,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_JAUEGY010000142",80.836,4.9e-56,222,287,231.99932,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_MLRZ01000037",75.354,4.31e-56,222,495,373.0023,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_JBGJJV010000032",71.992,2.89e-55,220,964,694.00288,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FLBI01000046",75.817,1.28e-54,219,459,348.00003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FLBN01000099",75.817,1.28e-54,219,459,348.00003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_FLCN01000004",75.817,1.28e-54,219,459,348.00003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRI01000021",75.941,6.65e-55,219,478,362.99798,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRE01000049",75.941,6.65e-55,219,478,362.99798,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRZ01000037",75.941,6.65e-55,219,478,362.99798,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRO01000021",75.941,6.65e-55,219,478,362.99798,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXR01000021",75.941,6.65e-55,219,478,362.99798,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRG01000021",75.941,6.65e-55,219,478,362.99798,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYG01000019",75.941,6.65e-55,219,478,362.99798,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRJ01000019",75.941,6.65e-55,219,478,362.99798,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSM01000018",75.941,6.65e-55,219,478,362.99798,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSQ01000022",75.941,6.65e-55,219,478,362.99798,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXY01000024",75.941,6.65e-55,219,478,362.99798,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXS01000025",75.941,6.65e-55,219,478,362.99798,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLWB01000035",75.941,6.65e-55,219,478,362.99798,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLUD01000021",75.941,6.65e-55,219,478,362.99798,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLRC01000027",75.941,6.65e-55,219,478,362.99798,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYZ01000021",75.941,6.65e-55,219,478,362.99798,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSP01000022",75.941,6.65e-55,219,478,362.99798,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLZF01000029",75.941,6.65e-55,219,478,362.99798,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSH01000020",75.941,6.65e-55,219,478,362.99798,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYY01000023",75.941,6.65e-55,219,478,362.99798,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLYC01000020",75.941,6.65e-55,219,478,362.99798,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLXZ01000020",75.941,6.65e-55,219,478,362.99798,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_JBGJJV010000032",76.38,2.08e-54,217,453,346.0014,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRE01000049",71.859,3.74e-54,217,963,692.00217,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_JBGJJV010000032",75.202,2e-54,217,496,373.00192,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_JBGJJV010000032",75.15,9.32e-54,215,499,374.9985,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRE01000049",73.361,1.27e-53,215,732,537.00252,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_FLBI01000046",71.8,1.34e-53,215,961,689.998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRE01000049",72.03,1.29e-53,215,926,666.9978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FLBI01000046",85,3.44e-53,213,220,187,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FLBN01000099",85,3.44e-53,213,220,187,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_FLCN01000004",85,3.44e-53,213,220,187,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_JBGJJV010000032",80.556,3.52e-53,213,288,232.00128,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_JBGJJV010000032",76.823,2.34e-51,207,384,295.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_MLRZ01000037",80.277,1.64e-51,207,289,232.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_MLWB01000035",80.277,1.64e-51,207,289,232.00053,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_MLZF01000029",80.277,1.64e-51,207,289,232.00053,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_JBGJJV010000032",75.488,2.77e-51,207,461,347.99968,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_FLBI01000046",75.212,1.25e-51,207,472,355.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_FLBN01000099",75.212,1.25e-51,207,472,355.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRI01000021",75.368,1.25e-51,207,475,357.998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_FLCN01000004",75.212,1.25e-51,207,472,355.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRO01000021",75.368,1.25e-51,207,475,357.998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLXR01000021",75.368,1.25e-51,207,475,357.998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRG01000021",75.368,1.25e-51,207,475,357.998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLYG01000019",75.368,1.25e-51,207,475,357.998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRJ01000019",75.368,1.25e-51,207,475,357.998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLSM01000018",75.368,1.25e-51,207,475,357.998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLSQ01000022",75.368,1.25e-51,207,475,357.998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLXY01000024",75.368,1.25e-51,207,475,357.998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLXS01000025",75.368,1.25e-51,207,475,357.998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLUD01000021",75.368,1.25e-51,207,475,357.998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRC01000027",75.368,1.25e-51,207,475,357.998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLYZ01000021",75.368,1.25e-51,207,475,357.998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLSP01000022",75.368,1.25e-51,207,475,357.998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLSH01000020",75.368,1.25e-51,207,475,357.998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLYY01000023",75.368,1.25e-51,207,475,357.998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLYC01000020",75.368,1.25e-51,207,475,357.998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLXZ01000020",75.368,1.25e-51,207,475,357.998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_MLWB01000035",75.938,4.49e-51,206,453,343.99914,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_MLZF01000029",75.938,4.49e-51,206,453,343.99914,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRE01000049",76.235,4.5e-51,206,425,323.99875,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLRZ01000037",76.235,4.5e-51,206,425,323.99875,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLWB01000035",76.235,4.5e-51,206,425,323.99875,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLZF01000029",76.235,4.5e-51,206,425,323.99875,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRI01000021",77.867,2.76e-50,204,375,292.00125,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRZ01000037",77.867,2.76e-50,204,375,292.00125,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRO01000021",77.867,2.76e-50,204,375,292.00125,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLXR01000021",77.867,2.76e-50,204,375,292.00125,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRG01000021",77.867,2.76e-50,204,375,292.00125,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLYG01000019",77.867,2.76e-50,204,375,292.00125,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRJ01000019",77.867,2.76e-50,204,375,292.00125,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLSM01000018",77.867,2.76e-50,204,375,292.00125,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLSQ01000022",77.867,2.76e-50,204,375,292.00125,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLXY01000024",77.867,2.76e-50,204,375,292.00125,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLXS01000025",77.867,2.76e-50,204,375,292.00125,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLWB01000035",77.867,2.76e-50,204,375,292.00125,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLUD01000021",77.867,2.76e-50,204,375,292.00125,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLRC01000027",77.867,2.76e-50,204,375,292.00125,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLYZ01000021",77.867,2.76e-50,204,375,292.00125,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLSP01000022",77.867,2.76e-50,204,375,292.00125,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLZF01000029",77.867,2.76e-50,204,375,292.00125,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLSH01000020",77.867,2.76e-50,204,375,292.00125,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLYY01000023",77.867,2.76e-50,204,375,292.00125,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLYC01000020",77.867,2.76e-50,204,375,292.00125,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLXZ01000020",77.867,2.76e-50,204,375,292.00125,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_JBGJJV010000032",82.083,2.31e-50,204,240,196.9992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FLBI01000046",83.721,3.71e-50,204,215,180.00015,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FLBN01000099",83.721,3.71e-50,204,215,180.00015,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_FLCN01000004",83.721,3.71e-50,204,215,180.00015,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_MLWB01000035",76.555,6.22e-50,202,418,319.9999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_MLZF01000029",76.555,6.22e-50,202,418,319.9999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRI01000021",83.796,1.33e-49,202,216,180.99936,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRE01000049",83.796,1.33e-49,202,216,180.99936,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRZ01000037",83.796,1.33e-49,202,216,180.99936,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRO01000021",83.796,1.33e-49,202,216,180.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLXR01000021",83.796,1.33e-49,202,216,180.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRG01000021",83.796,1.33e-49,202,216,180.99936,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLYG01000019",83.796,1.33e-49,202,216,180.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRJ01000019",83.796,1.33e-49,202,216,180.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLSM01000018",83.796,1.33e-49,202,216,180.99936,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLSQ01000022",83.796,1.33e-49,202,216,180.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLXY01000024",83.796,1.33e-49,202,216,180.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLXS01000025",83.796,1.33e-49,202,216,180.99936,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLWB01000035",83.796,1.33e-49,202,216,180.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLUD01000021",83.796,1.33e-49,202,216,180.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLRC01000027",83.796,1.33e-49,202,216,180.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLYZ01000021",83.796,1.33e-49,202,216,180.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLSP01000022",83.796,1.33e-49,202,216,180.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLZF01000029",83.796,1.33e-49,202,216,180.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLSH01000020",83.796,1.33e-49,202,216,180.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLYY01000023",83.796,1.33e-49,202,216,180.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLYC01000020",83.796,1.33e-49,202,216,180.99936,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLXZ01000020",83.796,1.33e-49,202,216,180.99936,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_JBGJJV010000032",77.719,3.57e-49,200,377,293.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_JBGJJV010000032",85.279,5.98e-49,200,197,167.99963,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_JAUEGY010000142",79.167,8.07e-49,198,288,228.00096,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_JBGJJV010000032",77.839,7.18e-48,196,361,280.99879,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_FLBI01000046",80.144,9.73e-48,195,277,221.99888,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_FLBN01000099",80.144,9.73e-48,195,277,221.99888,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_FLCN01000004",80.144,9.73e-48,195,277,221.99888,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_MLRZ01000037",75.497,9.73e-48,195,453,342.00141,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_JBGJJV010000032",82.743,9.37e-48,195,226,186.99918,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRI01000021",84.772,1e-46,193,197,167.00084,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRE01000049",84.772,1e-46,193,197,167.00084,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRZ01000037",84.772,1e-46,193,197,167.00084,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRO01000021",84.772,1e-46,193,197,167.00084,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLXR01000021",84.772,1e-46,193,197,167.00084,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRG01000021",84.772,1e-46,193,197,167.00084,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLYG01000019",84.772,1e-46,193,197,167.00084,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRJ01000019",84.772,1e-46,193,197,167.00084,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLSM01000018",84.772,1e-46,193,197,167.00084,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLSQ01000022",84.772,1e-46,193,197,167.00084,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLXY01000024",84.772,1e-46,193,197,167.00084,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLXS01000025",84.772,1e-46,193,197,167.00084,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLWB01000035",84.772,1e-46,193,197,167.00084,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLUD01000021",84.772,1e-46,193,197,167.00084,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLRC01000027",84.772,1e-46,193,197,167.00084,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLYZ01000021",84.772,1e-46,193,197,167.00084,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLSP01000022",84.772,1e-46,193,197,167.00084,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLZF01000029",84.772,1e-46,193,197,167.00084,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLSH01000020",84.772,1e-46,193,197,167.00084,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLYY01000023",84.772,1e-46,193,197,167.00084,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLYC01000020",84.772,1e-46,193,197,167.00084,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLXZ01000020",84.772,1e-46,193,197,167.00084,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_MLRZ01000037",81.405,5e-47,193,242,197.0001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_MLWB01000035",81.405,5e-47,193,242,197.0001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_MLZF01000029",81.405,5e-47,193,242,197.0001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAUEGY010000142",78.819,4.4e-47,193,288,226.99872,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_FLBI01000046",82.667,3.37e-47,193,225,186.00075,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_FLBN01000099",82.667,3.37e-47,193,225,186.00075,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_FLCN01000004",82.667,3.37e-47,193,225,186.00075,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_JBGJJV010000032",75.534,1.5e-46,191,421,317.99814,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_MLRZ01000037",76.077,1.35e-46,191,418,318.00186,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_JBGJJV010000032",76.077,1.35e-46,191,418,318.00186,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRC01000027",75.969,8.49e-46,189,387,294.00003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_JBGJJV010000032",77.684,4.53e-46,189,354,275.00136,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_FLBI01000046",81.25,6.47e-46,189,240,195,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_FLBN01000099",81.25,6.47e-46,189,240,195,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_FLCN01000004",81.25,6.47e-46,189,240,195,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FLBI01000046",77.5,1.2e-45,189,360,279,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FLCN01000004",77.5,1.2e-45,189,360,279,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_JBGJJV010000032",83.333,5.42e-46,189,210,174.9993,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRC01000027",74.784,1e-45,189,464,346.99776,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_JBGJJV010000032",75.472,4.53e-46,189,424,320.00128,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRZ01000037",82.174,4.36e-46,189,230,189.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLWB01000035",82.174,4.36e-46,189,230,189.0002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLZF01000029",82.174,4.36e-46,189,230,189.0002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRI01000021",75.414,2.93e-45,187,423,319.00122,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRO01000021",75.414,2.93e-45,187,423,319.00122,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLXR01000021",75.414,2.93e-45,187,423,319.00122,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRG01000021",75.414,2.93e-45,187,423,319.00122,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLYG01000019",75.414,2.93e-45,187,423,319.00122,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRJ01000019",75.414,2.93e-45,187,423,319.00122,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLSM01000018",75.414,2.93e-45,187,423,319.00122,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLSQ01000022",75.414,2.93e-45,187,423,319.00122,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLXY01000024",75.414,2.93e-45,187,423,319.00122,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLXS01000025",75.414,2.93e-45,187,423,319.00122,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLUD01000021",75.414,2.93e-45,187,423,319.00122,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRC01000027",75.414,2.93e-45,187,423,319.00122,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLYZ01000021",75.414,2.93e-45,187,423,319.00122,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLSP01000022",75.414,2.93e-45,187,423,319.00122,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLSH01000020",75.414,2.93e-45,187,423,319.00122,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLYY01000023",75.414,2.93e-45,187,423,319.00122,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLYC01000020",75.414,2.93e-45,187,423,319.00122,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLXZ01000020",75.414,2.93e-45,187,423,319.00122,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_FLBI01000046",79.021,2.13e-45,187,286,226.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_FLBN01000099",79.021,2.13e-45,187,286,226.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_FLCN01000004",79.021,2.13e-45,187,286,226.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FLBI01000046",76.031,1.1e-44,185,388,295.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FLBN01000099",76.031,1.1e-44,185,388,295.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_FLCN01000004",76.031,1.1e-44,185,388,295.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FLBI01000046",83.092,9.99e-45,185,207,172.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FLBN01000099",83.092,9.99e-45,185,207,172.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_FLCN01000004",83.092,9.99e-45,185,207,172.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_FLBN01000099",75.297,6.98e-45,185,421,317.00037,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRI01000021",75.355,6.98e-45,185,422,317.9981,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRE01000049",75.355,6.98e-45,185,422,317.9981,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_FLCN01000004",75.297,6.98e-45,185,421,317.00037,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRO01000021",75.355,6.98e-45,185,422,317.9981,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLXR01000021",75.355,6.98e-45,185,422,317.9981,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRG01000021",75.355,6.98e-45,185,422,317.9981,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLYG01000019",75.355,6.98e-45,185,422,317.9981,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRJ01000019",75.355,6.98e-45,185,422,317.9981,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLSM01000018",75.355,6.98e-45,185,422,317.9981,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLSQ01000022",75.355,6.98e-45,185,422,317.9981,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLXY01000024",75.355,6.98e-45,185,422,317.9981,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLXS01000025",75.355,6.98e-45,185,422,317.9981,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLUD01000021",75.355,6.98e-45,185,422,317.9981,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRC01000027",75.355,6.98e-45,185,422,317.9981,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLYZ01000021",75.355,6.98e-45,185,422,317.9981,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLSP01000022",75.355,6.98e-45,185,422,317.9981,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLSH01000020",75.355,6.98e-45,185,422,317.9981,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLYY01000023",75.355,6.98e-45,185,422,317.9981,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLYC01000020",75.355,6.98e-45,185,422,317.9981,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLXZ01000020",75.355,6.98e-45,185,422,317.9981,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_FLBI01000046",79.496,6.27e-45,185,278,220.99888,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_FLBN01000099",79.496,6.27e-45,185,278,220.99888,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_FLCN01000004",79.496,6.27e-45,185,278,220.99888,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_JAUEGY010000142",78.276,6.64e-45,185,290,227.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_JBGJJV010000032",84.865,1.76e-44,185,185,157.00025,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRI01000021",75.711,3.95e-44,183,387,293.00157,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRE01000049",75.711,3.95e-44,183,387,293.00157,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRZ01000037",75.711,3.95e-44,183,387,293.00157,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRO01000021",75.711,3.95e-44,183,387,293.00157,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLXR01000021",75.711,3.95e-44,183,387,293.00157,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRG01000021",75.711,3.95e-44,183,387,293.00157,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLYG01000019",75.711,3.95e-44,183,387,293.00157,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLRJ01000019",75.711,3.95e-44,183,387,293.00157,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLSM01000018",75.711,3.95e-44,183,387,293.00157,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLSQ01000022",75.711,3.95e-44,183,387,293.00157,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLXY01000024",75.711,3.95e-44,183,387,293.00157,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLXS01000025",75.711,3.95e-44,183,387,293.00157,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLWB01000035",75.711,3.95e-44,183,387,293.00157,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLUD01000021",75.711,3.95e-44,183,387,293.00157,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLYZ01000021",75.711,3.95e-44,183,387,293.00157,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLSP01000022",75.711,3.95e-44,183,387,293.00157,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLZF01000029",75.711,3.95e-44,183,387,293.00157,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLSH01000020",75.711,3.95e-44,183,387,293.00157,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLYY01000023",75.711,3.95e-44,183,387,293.00157,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLYC01000020",75.711,3.95e-44,183,387,293.00157,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLXZ01000020",75.711,3.95e-44,183,387,293.00157,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FLBI01000046",83.756,6.02e-44,183,197,164.99932,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FLBN01000099",83.756,6.02e-44,183,197,164.99932,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_FLCN01000004",83.756,6.02e-44,183,197,164.99932,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRZ01000037",77.348,5.59e-44,183,362,279.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLWB01000035",77.348,5.59e-44,183,362,279.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLZF01000029",77.348,5.59e-44,183,362,279.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRI01000021",77.348,5.59e-44,183,362,279.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRO01000021",77.348,5.59e-44,183,362,279.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXR01000021",77.348,5.59e-44,183,362,279.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRG01000021",77.348,5.59e-44,183,362,279.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYG01000019",77.348,5.59e-44,183,362,279.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRJ01000019",77.348,5.59e-44,183,362,279.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSM01000018",77.348,5.59e-44,183,362,279.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSQ01000022",77.348,5.59e-44,183,362,279.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXY01000024",77.348,5.59e-44,183,362,279.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXS01000025",77.348,5.59e-44,183,362,279.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLUD01000021",77.348,5.59e-44,183,362,279.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRC01000027",77.285,5.59e-44,183,361,278.99885,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYZ01000021",77.348,5.59e-44,183,362,279.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSP01000022",77.348,5.59e-44,183,362,279.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSH01000020",77.348,5.59e-44,183,362,279.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYY01000023",77.348,5.59e-44,183,362,279.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLYC01000020",77.348,5.59e-44,183,362,279.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLXZ01000020",77.348,5.59e-44,183,362,279.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_FLBN01000099",77.222,5.59e-44,183,360,277.9992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLRE01000049",77.348,5.59e-44,183,362,279.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRI01000021",74.569,4.67e-44,183,464,346.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRE01000049",74.569,4.67e-44,183,464,346.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRZ01000037",74.569,4.67e-44,183,464,346.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRO01000021",74.569,4.67e-44,183,464,346.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLXR01000021",74.569,4.67e-44,183,464,346.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRG01000021",74.569,4.67e-44,183,464,346.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLYG01000019",74.569,4.67e-44,183,464,346.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLRJ01000019",74.569,4.67e-44,183,464,346.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLSM01000018",74.569,4.67e-44,183,464,346.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLSQ01000022",74.569,4.67e-44,183,464,346.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLXY01000024",74.569,4.67e-44,183,464,346.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLXS01000025",74.569,4.67e-44,183,464,346.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLWB01000035",74.569,4.67e-44,183,464,346.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLUD01000021",74.569,4.67e-44,183,464,346.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLYZ01000021",74.569,4.67e-44,183,464,346.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLSP01000022",74.569,4.67e-44,183,464,346.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLZF01000029",74.569,4.67e-44,183,464,346.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLSH01000020",74.569,4.67e-44,183,464,346.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLYY01000023",74.569,4.67e-44,183,464,346.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLYC01000020",74.569,4.67e-44,183,464,346.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLXZ01000020",74.569,4.67e-44,183,464,346.00016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRZ01000037",84.783,6.34e-44,183,184,156.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLWB01000035",84.783,6.34e-44,183,184,156.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLZF01000029",84.783,6.34e-44,183,184,156.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRI01000021",84.783,6.34e-44,183,184,156.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRE01000049",84.783,6.34e-44,183,184,156.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRO01000021",84.783,6.34e-44,183,184,156.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLXR01000021",84.783,6.34e-44,183,184,156.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRG01000021",84.783,6.34e-44,183,184,156.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLYG01000019",84.783,6.34e-44,183,184,156.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRJ01000019",84.783,6.34e-44,183,184,156.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLSM01000018",84.783,6.34e-44,183,184,156.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLSQ01000022",84.783,6.34e-44,183,184,156.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLXY01000024",84.783,6.34e-44,183,184,156.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLXS01000025",84.783,6.34e-44,183,184,156.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLUD01000021",84.783,6.34e-44,183,184,156.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLRC01000027",84.783,6.34e-44,183,184,156.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLYZ01000021",84.783,6.34e-44,183,184,156.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLSP01000022",84.783,6.34e-44,183,184,156.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLSH01000020",84.783,6.34e-44,183,184,156.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLYY01000023",84.783,6.34e-44,183,184,156.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLYC01000020",84.783,6.34e-44,183,184,156.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLXZ01000020",84.783,6.34e-44,183,184,156.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FLBI01000046",77.337,7.57e-44,182,353,272.99961,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FLCN01000004",77.337,7.57e-44,182,353,272.99961,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRI01000021",83.575,2.2e-43,182,207,173.00025,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRE01000049",83.575,2.2e-43,182,207,173.00025,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRZ01000037",83.575,2.2e-43,182,207,173.00025,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRO01000021",83.575,2.2e-43,182,207,173.00025,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLXR01000021",83.575,2.2e-43,182,207,173.00025,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRG01000021",83.575,2.2e-43,182,207,173.00025,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLYG01000019",83.575,2.2e-43,182,207,173.00025,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRJ01000019",83.575,2.2e-43,182,207,173.00025,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLSM01000018",83.575,2.2e-43,182,207,173.00025,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLSQ01000022",83.575,2.2e-43,182,207,173.00025,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLXY01000024",83.575,2.2e-43,182,207,173.00025,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLXS01000025",83.575,2.2e-43,182,207,173.00025,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLWB01000035",83.575,2.2e-43,182,207,173.00025,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLUD01000021",83.575,2.2e-43,182,207,173.00025,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLRC01000027",83.575,2.2e-43,182,207,173.00025,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLYZ01000021",83.575,2.2e-43,182,207,173.00025,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLSP01000022",83.575,2.2e-43,182,207,173.00025,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLZF01000029",83.575,2.2e-43,182,207,173.00025,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLSH01000020",83.575,2.2e-43,182,207,173.00025,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLYY01000023",83.575,2.2e-43,182,207,173.00025,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLYC01000020",83.575,2.2e-43,182,207,173.00025,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLXZ01000020",83.575,2.2e-43,182,207,173.00025,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRI01000021",75.118,1.07e-43,182,422,316.99796,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRE01000049",75.118,1.07e-43,182,422,316.99796,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRO01000021",75.118,1.07e-43,182,422,316.99796,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLXR01000021",75.118,1.07e-43,182,422,316.99796,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRG01000021",75.118,1.07e-43,182,422,316.99796,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLYG01000019",75.118,1.07e-43,182,422,316.99796,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRJ01000019",75.118,1.07e-43,182,422,316.99796,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLSM01000018",75.118,1.07e-43,182,422,316.99796,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLSQ01000022",75.118,1.07e-43,182,422,316.99796,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLXY01000024",75.118,1.07e-43,182,422,316.99796,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLXS01000025",75.118,1.07e-43,182,422,316.99796,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLUD01000021",75.118,1.07e-43,182,422,316.99796,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRC01000027",75.118,1.07e-43,182,422,316.99796,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLYZ01000021",75.118,1.07e-43,182,422,316.99796,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLSP01000022",75.118,1.07e-43,182,422,316.99796,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLSH01000020",75.118,1.07e-43,182,422,316.99796,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLYY01000023",75.118,1.07e-43,182,422,316.99796,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLYC01000020",75.118,1.07e-43,182,422,316.99796,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLXZ01000020",75.118,1.07e-43,182,422,316.99796,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRI01000021",76.031,1.31e-43,182,388,295.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRZ01000037",76.031,1.31e-43,182,388,295.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRO01000021",76.031,1.31e-43,182,388,295.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXR01000021",76.031,1.31e-43,182,388,295.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRG01000021",76.031,1.31e-43,182,388,295.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYG01000019",76.031,1.31e-43,182,388,295.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRJ01000019",76.031,1.31e-43,182,388,295.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSM01000018",76.031,1.31e-43,182,388,295.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSQ01000022",76.031,1.31e-43,182,388,295.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXY01000024",76.031,1.31e-43,182,388,295.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXS01000025",76.031,1.31e-43,182,388,295.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLWB01000035",76.031,1.31e-43,182,388,295.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLUD01000021",76.031,1.31e-43,182,388,295.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYZ01000021",76.031,1.31e-43,182,388,295.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSP01000022",76.031,1.31e-43,182,388,295.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLZF01000029",76.031,1.31e-43,182,388,295.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSH01000020",76.031,1.31e-43,182,388,295.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYY01000023",76.031,1.31e-43,182,388,295.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYC01000020",76.031,1.31e-43,182,388,295.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXZ01000020",76.031,1.31e-43,182,388,295.00028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_FLBI01000046",75.059,3.25e-43,180,421,315.99839,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_FLBN01000099",75.059,3.86e-43,180,421,315.99839,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_FLCN01000004",75.059,3.86e-43,180,421,315.99839,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_JBGJJV010000032",75.059,3.86e-43,180,421,315.99839,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FLBI01000046",83.173,2.84e-42,178,208,172.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FLBN01000099",83.173,2.84e-42,178,208,172.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_FLCN01000004",83.173,2.84e-42,178,208,172.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_MLRZ01000037",82.464,1.17e-42,178,211,173.99904,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_MLWB01000035",82.464,1.17e-42,178,211,173.99904,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_MLZF01000029",82.464,1.17e-42,178,211,173.99904,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FLBN01000099",77.054,3.52e-42,176,353,272.00062,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRI01000021",77.183,3.52e-42,176,355,273.99965,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRE01000049",77.183,3.52e-42,176,355,273.99965,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRZ01000037",77.183,3.52e-42,176,355,273.99965,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRO01000021",77.183,3.52e-42,176,355,273.99965,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXR01000021",77.183,3.52e-42,176,355,273.99965,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRG01000021",77.183,3.52e-42,176,355,273.99965,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYG01000019",77.183,3.52e-42,176,355,273.99965,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRJ01000019",77.183,3.52e-42,176,355,273.99965,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSM01000018",77.183,3.52e-42,176,355,273.99965,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSQ01000022",77.183,3.52e-42,176,355,273.99965,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXY01000024",77.183,3.52e-42,176,355,273.99965,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXS01000025",77.183,3.52e-42,176,355,273.99965,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLWB01000035",77.183,3.52e-42,176,355,273.99965,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLUD01000021",77.183,3.52e-42,176,355,273.99965,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRC01000027",77.119,3.52e-42,176,354,273.00126,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYZ01000021",77.183,3.52e-42,176,355,273.99965,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSP01000022",77.183,3.52e-42,176,355,273.99965,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLZF01000029",77.183,3.52e-42,176,355,273.99965,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSH01000020",77.183,3.52e-42,176,355,273.99965,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYY01000023",77.183,3.52e-42,176,355,273.99965,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYC01000020",77.183,3.52e-42,176,355,273.99965,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXZ01000020",77.183,3.52e-42,176,355,273.99965,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLRZ01000037",84.916,6.34e-42,176,179,151.99964,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLWB01000035",84.916,6.34e-42,176,179,151.99964,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLZF01000029",84.916,6.34e-42,176,179,151.99964,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRC01000027",84.153,6.09e-42,176,183,153.99999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLRZ01000037",84.831,1.51e-41,174,178,150.99918,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLWB01000035",84.831,1.51e-41,174,178,150.99918,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLZF01000029",84.831,1.51e-41,174,178,150.99918,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_FLBI01000046",82.212,1.52e-41,174,208,171.00096,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_FLBN01000099",82.212,1.52e-41,174,208,171.00096,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_FLCN01000004",82.212,1.52e-41,174,208,171.00096,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_FLBI01000046",74.822,1.8e-41,174,421,315.00062,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_JBGJJV010000032",82.692,1.32e-40,172,208,171.99936,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRI01000021",85.03,2.04e-40,171,167,142.0001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRO01000021",85.03,2.04e-40,171,167,142.0001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLXR01000021",85.03,2.04e-40,171,167,142.0001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRG01000021",85.03,2.04e-40,171,167,142.0001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLYG01000019",85.03,2.04e-40,171,167,142.0001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRJ01000019",85.03,2.04e-40,171,167,142.0001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLSM01000018",85.03,2.04e-40,171,167,142.0001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLSQ01000022",85.03,2.04e-40,171,167,142.0001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLXY01000024",85.03,2.04e-40,171,167,142.0001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLXS01000025",85.03,2.04e-40,171,167,142.0001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLUD01000021",85.03,2.04e-40,171,167,142.0001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLRC01000027",85.03,2.04e-40,171,167,142.0001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLYZ01000021",85.03,2.04e-40,171,167,142.0001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLSP01000022",85.03,2.04e-40,171,167,142.0001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLSH01000020",85.03,2.04e-40,171,167,142.0001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLYY01000023",85.03,2.04e-40,171,167,142.0001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLYC01000020",85.03,2.04e-40,171,167,142.0001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLXZ01000020",85.03,2.04e-40,171,167,142.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLRZ01000037",84.27,8.36e-40,169,178,150.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLWB01000035",84.27,8.36e-40,169,178,150.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLZF01000029",84.27,8.36e-40,169,178,150.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_FLBI01000046",84.524,2.29e-39,167,168,142.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_FLBN01000099",84.524,2.29e-39,167,168,142.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_FLCN01000004",84.524,2.29e-39,167,168,142.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_MLRZ01000037",84.524,2.29e-39,167,168,142.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_MLWB01000035",84.524,2.29e-39,167,168,142.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_MLZF01000029",84.524,2.29e-39,167,168,142.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_JBGJJV010000032",84.524,2.29e-39,167,168,142.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FLBI01000046",82.812,2.35e-39,167,192,158.99904,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_JBGJJV010000032",77.439,2.35e-39,167,328,253.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_MLRZ01000037",84.524,1.06e-37,161,168,142.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_MLWB01000035",84.524,1.06e-37,161,168,142.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_MLZF01000029",84.524,1.06e-37,161,168,142.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_JBGJJV010000032",84.524,1.06e-37,161,168,142.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_FLBI01000046",84.431,3.83e-37,159,167,140.99977,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_FLBN01000099",84.431,3.83e-37,159,167,140.99977,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_FLCN01000004",84.431,3.83e-37,159,167,140.99977,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_MLRZ01000037",85.906,1.3e-36,158,149,127.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_MLWB01000035",85.906,1.3e-36,158,149,127.99994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_MLZF01000029",85.906,1.3e-36,158,149,127.99994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_JBGJJV010000032",85.906,1.3e-36,158,149,127.99994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_MLRZ01000037",85.714,1.3e-36,158,154,131.99956,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_MLWB01000035",85.714,1.3e-36,158,154,131.99956,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_MLZF01000029",85.714,1.3e-36,158,154,131.99956,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_JBGJJV010000032",85.714,1.3e-36,158,154,131.99956,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_FLBI01000046",77.352,1.53e-36,158,287,222.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_FLBN01000099",77.352,1.53e-36,158,287,222.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_FLCN01000004",77.352,1.53e-36,158,287,222.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_JBGJJV010000032",83.929,1.41e-36,158,168,141.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FLBN01000099",83.929,1.41e-36,158,168,141.00072,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FLCN01000004",83.929,1.41e-36,158,168,141.00072,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRZ01000037",83.051,1.41e-36,158,177,147.00027,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLWB01000035",83.051,1.41e-36,158,177,147.00027,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLZF01000029",83.051,1.41e-36,158,177,147.00027,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_FLBI01000046",85.811,4.67e-36,156,148,127.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_FLBN01000099",85.811,4.67e-36,156,148,127.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_FLCN01000004",85.811,4.67e-36,156,148,127.00028,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_FLBI01000046",85.621,4.69e-36,156,153,131.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_FLBN01000099",85.621,4.69e-36,156,153,131.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_FLCN01000004",85.621,4.69e-36,156,153,131.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRE01000049",84.049,5.08e-36,156,163,136.99987,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_FLBI01000046",78.715,1.59e-35,154,249,196.00035,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_FLBN01000099",78.715,1.59e-35,154,249,196.00035,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_FLCN01000004",78.715,1.59e-35,154,249,196.00035,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_MLWB01000035",73.649,1.98e-35,154,444,327.00156,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_MLZF01000029",73.649,1.98e-35,154,444,327.00156,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FLBI01000046",82.584,1.64e-35,154,178,146.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FLBI01000046",76.758,1.83e-35,154,327,250.99866,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FLCN01000004",76.758,1.83e-35,154,327,250.99866,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRI01000021",84.967,1.83e-35,154,153,129.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRO01000021",84.967,1.83e-35,154,153,129.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXR01000021",84.967,1.83e-35,154,153,129.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRG01000021",84.967,1.83e-35,154,153,129.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYG01000019",84.967,1.83e-35,154,153,129.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRJ01000019",84.967,1.83e-35,154,153,129.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSM01000018",84.967,1.83e-35,154,153,129.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSQ01000022",84.967,1.83e-35,154,153,129.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXY01000024",84.967,1.83e-35,154,153,129.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXS01000025",84.967,1.83e-35,154,153,129.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLUD01000021",84.967,1.83e-35,154,153,129.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRC01000027",76.615,1.83e-35,154,325,248.99875,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRC01000027",84.967,1.83e-35,154,153,129.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYZ01000021",84.967,1.83e-35,154,153,129.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSP01000022",84.967,1.83e-35,154,153,129.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSH01000020",84.967,1.83e-35,154,153,129.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYY01000023",84.967,1.83e-35,154,153,129.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYC01000020",84.967,1.83e-35,154,153,129.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXZ01000020",84.967,1.83e-35,154,153,129.99951,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FLBN01000099",83.333,5.89e-35,152,168,139.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FLCN01000004",83.333,5.89e-35,152,168,139.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_JBGJJV010000032",83.333,5.89e-35,152,168,139.99944,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRI01000021",87.692,7.65e-35,152,130,113.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRO01000021",87.692,7.65e-35,152,130,113.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLXR01000021",87.692,7.65e-35,152,130,113.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRG01000021",87.692,7.65e-35,152,130,113.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLYG01000019",87.692,7.65e-35,152,130,113.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRJ01000019",87.692,7.65e-35,152,130,113.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLSM01000018",87.692,7.65e-35,152,130,113.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLSQ01000022",87.692,7.65e-35,152,130,113.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLXY01000024",87.692,7.65e-35,152,130,113.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLXS01000025",87.692,7.65e-35,152,130,113.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLUD01000021",87.692,7.65e-35,152,130,113.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLRC01000027",87.692,7.65e-35,152,130,113.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLYZ01000021",87.692,7.65e-35,152,130,113.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLSP01000022",87.692,7.65e-35,152,130,113.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLSH01000020",87.692,7.65e-35,152,130,113.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLYY01000023",87.692,7.65e-35,152,130,113.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLYC01000020",87.692,7.65e-35,152,130,113.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLXZ01000020",87.692,7.65e-35,152,130,113.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_JBGJJV010000032",78.226,2.05e-34,150,248,194.00048,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRE01000049",83.436,2.12e-34,150,163,136.00068,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRZ01000037",83.436,2.12e-34,150,163,136.00068,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLWB01000035",83.436,2.12e-34,150,163,136.00068,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLZF01000029",83.436,2.12e-34,150,163,136.00068,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FLBI01000046",84.667,2.77e-34,150,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FLCN01000004",84.667,2.77e-34,150,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_FLBN01000099",84.667,2.77e-34,150,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_JBGJJV010000032",84.667,2.77e-34,150,150,127.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_MLRZ01000037",73.423,9.23e-34,148,444,325.99812,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRI01000021",84.314,7.62e-34,148,153,129.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRO01000021",84.314,7.62e-34,148,153,129.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXR01000021",84.314,7.62e-34,148,153,129.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRG01000021",84.314,7.62e-34,148,153,129.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYG01000019",84.314,7.62e-34,148,153,129.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRJ01000019",84.314,7.62e-34,148,153,129.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSM01000018",84.314,7.62e-34,148,153,129.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSQ01000022",84.314,7.62e-34,148,153,129.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXY01000024",84.314,7.62e-34,148,153,129.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXS01000025",84.314,7.62e-34,148,153,129.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLUD01000021",84.314,7.62e-34,148,153,129.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRC01000027",84.314,7.62e-34,148,153,129.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYZ01000021",84.314,7.62e-34,148,153,129.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSP01000022",84.314,7.62e-34,148,153,129.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSH01000020",84.314,7.62e-34,148,153,129.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYY01000023",84.314,7.62e-34,148,153,129.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYC01000020",84.314,7.62e-34,148,153,129.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXZ01000020",84.314,7.62e-34,148,153,129.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_FLBN01000099",76.453,8.5e-34,148,327,250.00131,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRZ01000037",76.38,8.5e-34,148,326,248.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLWB01000035",76.38,8.5e-34,148,326,248.9988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLZF01000029",76.38,8.5e-34,148,326,248.9988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRE01000049",76.38,8.5e-34,148,326,248.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRI01000021",76.38,8.5e-34,148,326,248.9988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRO01000021",76.38,8.5e-34,148,326,248.9988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXR01000021",76.38,8.5e-34,148,326,248.9988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRG01000021",76.38,8.5e-34,148,326,248.9988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYG01000019",76.38,8.5e-34,148,326,248.9988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLRJ01000019",76.38,8.5e-34,148,326,248.9988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSM01000018",76.38,8.5e-34,148,326,248.9988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSQ01000022",76.38,8.5e-34,148,326,248.9988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXY01000024",76.38,8.5e-34,148,326,248.9988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXS01000025",76.38,8.5e-34,148,326,248.9988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLUD01000021",76.38,8.5e-34,148,326,248.9988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYZ01000021",76.38,8.5e-34,148,326,248.9988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSP01000022",76.38,8.5e-34,148,326,248.9988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSH01000020",76.38,8.5e-34,148,326,248.9988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYY01000023",76.38,8.5e-34,148,326,248.9988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLYC01000020",76.38,8.5e-34,148,326,248.9988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLXZ01000020",76.38,8.5e-34,148,326,248.9988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_JBGJJV010000032",73.258,4.3e-32,143,445,325.9981,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_FLBN01000099",74.648,3.88e-32,143,355,265.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_FLCN01000004",74.648,3.88e-32,143,355,265.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_JBGJJV010000032",74.648,3.88e-32,143,355,265.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_FLBI01000046",89.474,1.3e-31,141,114,102.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_FLBN01000099",89.474,1.3e-31,141,114,102.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRI01000021",89.474,1.3e-31,141,114,102.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRE01000049",89.474,1.3e-31,141,114,102.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_FLCN01000004",89.474,1.3e-31,141,114,102.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRZ01000037",89.474,1.3e-31,141,114,102.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRO01000021",89.474,1.3e-31,141,114,102.00036,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLXR01000021",89.474,1.3e-31,141,114,102.00036,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRG01000021",89.474,1.3e-31,141,114,102.00036,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLYG01000019",89.474,1.3e-31,141,114,102.00036,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRJ01000019",89.474,1.3e-31,141,114,102.00036,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLSM01000018",89.474,1.3e-31,141,114,102.00036,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLSQ01000022",89.474,1.3e-31,141,114,102.00036,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLXY01000024",89.474,1.3e-31,141,114,102.00036,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLXS01000025",89.474,1.3e-31,141,114,102.00036,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLWB01000035",89.474,1.3e-31,141,114,102.00036,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLUD01000021",89.474,1.3e-31,141,114,102.00036,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLRC01000027",89.474,1.3e-31,141,114,102.00036,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLYZ01000021",89.474,1.3e-31,141,114,102.00036,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLSP01000022",89.474,1.3e-31,141,114,102.00036,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLZF01000029",89.474,1.3e-31,141,114,102.00036,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLSH01000020",89.474,1.3e-31,141,114,102.00036,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLYY01000023",89.474,1.3e-31,141,114,102.00036,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLYC01000020",89.474,1.3e-31,141,114,102.00036,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLXZ01000020",89.474,1.3e-31,141,114,102.00036,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_JBGJJV010000032",89.474,1.3e-31,141,114,102.00036,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRC01000027",83.784,1.66e-31,141,148,124.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRI01000021",83.784,1.66e-31,141,148,124.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRE01000049",83.784,1.66e-31,141,148,124.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRZ01000037",83.784,1.66e-31,141,148,124.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRO01000021",83.784,1.66e-31,141,148,124.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXR01000021",83.784,1.66e-31,141,148,124.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRG01000021",83.784,1.66e-31,141,148,124.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYG01000019",83.784,1.66e-31,141,148,124.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLRJ01000019",83.784,1.66e-31,141,148,124.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSM01000018",83.784,1.66e-31,141,148,124.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSQ01000022",83.784,1.66e-31,141,148,124.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXY01000024",83.784,1.66e-31,141,148,124.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXS01000025",83.784,1.66e-31,141,148,124.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLWB01000035",83.784,1.66e-31,141,148,124.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLUD01000021",83.784,1.66e-31,141,148,124.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYZ01000021",83.784,1.66e-31,141,148,124.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSP01000022",83.784,1.66e-31,141,148,124.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLZF01000029",83.784,1.66e-31,141,148,124.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSH01000020",83.784,1.66e-31,141,148,124.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYY01000023",83.784,1.66e-31,141,148,124.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLYC01000020",83.784,1.66e-31,141,148,124.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLXZ01000020",83.784,1.66e-31,141,148,124.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRC01000027",77.51,4.45e-31,139,249,192.9999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_FLBI01000046",74.366,1.81e-30,137,355,263.9993,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRI01000021",74.438,1.81e-30,137,356,264.99928,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRE01000049",74.438,1.81e-30,137,356,264.99928,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRO01000021",74.438,1.81e-30,137,356,264.99928,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLXR01000021",74.438,1.81e-30,137,356,264.99928,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRG01000021",74.438,1.81e-30,137,356,264.99928,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLYG01000019",74.438,1.81e-30,137,356,264.99928,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRJ01000019",74.438,1.81e-30,137,356,264.99928,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLSM01000018",74.438,1.81e-30,137,356,264.99928,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLSQ01000022",74.438,1.81e-30,137,356,264.99928,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLXY01000024",74.438,1.81e-30,137,356,264.99928,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLXS01000025",74.438,1.81e-30,137,356,264.99928,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLUD01000021",74.438,1.81e-30,137,356,264.99928,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRC01000027",74.438,1.81e-30,137,356,264.99928,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLYZ01000021",74.438,1.81e-30,137,356,264.99928,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLSP01000022",74.438,1.81e-30,137,356,264.99928,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLSH01000020",74.438,1.81e-30,137,356,264.99928,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLYY01000023",74.438,1.81e-30,137,356,264.99928,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLYC01000020",74.438,1.81e-30,137,356,264.99928,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLXZ01000020",74.438,1.81e-30,137,356,264.99928,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRI01000021",74.51,2.88e-30,137,357,266.0007,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRO01000021",74.51,2.88e-30,137,357,266.0007,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXR01000021",74.51,2.88e-30,137,357,266.0007,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRG01000021",74.51,2.88e-30,137,357,266.0007,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYG01000019",74.51,2.88e-30,137,357,266.0007,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRJ01000019",74.51,2.88e-30,137,357,266.0007,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSM01000018",74.51,2.88e-30,137,357,266.0007,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSQ01000022",74.51,2.88e-30,137,357,266.0007,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXY01000024",74.51,2.88e-30,137,357,266.0007,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXS01000025",74.51,2.88e-30,137,357,266.0007,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLUD01000021",74.51,2.88e-30,137,357,266.0007,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYZ01000021",74.51,2.88e-30,137,357,266.0007,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSP01000022",74.51,2.88e-30,137,357,266.0007,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSH01000020",74.51,2.88e-30,137,357,266.0007,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYY01000023",74.51,2.88e-30,137,357,266.0007,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLYC01000020",74.51,2.88e-30,137,357,266.0007,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLXZ01000020",74.51,2.88e-30,137,357,266.0007,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRC01000027",74.51,2.88e-30,137,357,266.0007,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_JBGJJV010000032",75.938,5.85e-30,135,320,243.0016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FLBI01000046",86.777,5.74e-30,135,121,105.00017,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FLBN01000099",86.777,5.74e-30,135,121,105.00017,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FLCN01000004",86.777,5.74e-30,135,121,105.00017,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_JBGJJV010000032",86.777,5.74e-30,135,121,105.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRI01000021",77.108,2.07e-29,134,249,191.99892,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRE01000049",77.108,2.07e-29,134,249,191.99892,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRZ01000037",77.108,2.07e-29,134,249,191.99892,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRO01000021",77.108,2.07e-29,134,249,191.99892,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLXR01000021",77.108,2.07e-29,134,249,191.99892,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRG01000021",77.108,2.07e-29,134,249,191.99892,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLYG01000019",77.108,2.07e-29,134,249,191.99892,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLRJ01000019",77.108,2.07e-29,134,249,191.99892,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLSM01000018",77.108,2.07e-29,134,249,191.99892,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLSQ01000022",77.108,2.07e-29,134,249,191.99892,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLXY01000024",77.108,2.07e-29,134,249,191.99892,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLXS01000025",77.108,2.07e-29,134,249,191.99892,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLWB01000035",77.108,2.07e-29,134,249,191.99892,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLUD01000021",77.108,2.07e-29,134,249,191.99892,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLYZ01000021",77.108,2.07e-29,134,249,191.99892,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLSP01000022",77.108,2.07e-29,134,249,191.99892,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLZF01000029",77.108,2.07e-29,134,249,191.99892,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLSH01000020",77.108,2.07e-29,134,249,191.99892,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLYY01000023",77.108,2.07e-29,134,249,191.99892,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLYC01000020",77.108,2.07e-29,134,249,191.99892,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLXZ01000020",77.108,2.07e-29,134,249,191.99892,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FLBI01000046",75.862,2.1e-29,134,319,241.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FLCN01000004",75.862,2.1e-29,134,319,241.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FLBI01000046",75.617,7.42e-29,132,324,244.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FLCN01000004",75.617,7.42e-29,132,324,244.99908,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLRE01000049",92.308,4.33e-28,130,91,84.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_FLBN01000099",74.138,2.69e-28,130,348,258.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_FLCN01000004",74.138,2.69e-28,130,348,258.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_JBGJJV010000032",74.138,2.69e-28,130,348,258.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_FLBN01000099",75.625,2.67e-28,130,320,242,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRC01000027",75.466,2.67e-28,130,322,243.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FLBN01000099",75.549,9.78e-28,128,319,241.00131,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FLBI01000046",76.515,9.93e-28,128,264,201.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FLCN01000004",76.515,9.93e-28,128,264,201.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_JBGJJV010000032",76.604,9.93e-28,128,265,203.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLRZ01000037",87.5,3.91e-27,126,112,98,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLWB01000035",87.5,3.91e-27,126,112,98,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLZF01000029",87.5,3.91e-27,126,112,98,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_FLBI01000046",88.571,3.63e-27,126,105,92.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_FLBN01000099",88.571,3.63e-27,126,105,92.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRI01000021",88.571,3.63e-27,126,105,92.99955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRE01000049",88.571,3.63e-27,126,105,92.99955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_FLCN01000004",88.571,3.63e-27,126,105,92.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRZ01000037",88.571,3.63e-27,126,105,92.99955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRO01000021",88.571,3.63e-27,126,105,92.99955,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLXR01000021",88.571,3.63e-27,126,105,92.99955,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRG01000021",88.571,3.63e-27,126,105,92.99955,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLYG01000019",88.571,3.63e-27,126,105,92.99955,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRJ01000019",88.571,3.63e-27,126,105,92.99955,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLSM01000018",88.571,3.63e-27,126,105,92.99955,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLSQ01000022",88.571,3.63e-27,126,105,92.99955,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLXY01000024",88.571,3.63e-27,126,105,92.99955,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLXS01000025",88.571,3.63e-27,126,105,92.99955,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLWB01000035",88.571,3.63e-27,126,105,92.99955,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLUD01000021",88.571,3.63e-27,126,105,92.99955,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLRC01000027",88.571,3.63e-27,126,105,92.99955,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLYZ01000021",88.571,3.63e-27,126,105,92.99955,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLSP01000022",88.571,3.63e-27,126,105,92.99955,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLZF01000029",88.571,3.63e-27,126,105,92.99955,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLSH01000020",88.571,3.63e-27,126,105,92.99955,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLYY01000023",88.571,3.63e-27,126,105,92.99955,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLYC01000020",88.571,3.63e-27,126,105,92.99955,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLXZ01000020",88.571,3.63e-27,126,105,92.99955,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_JBGJJV010000032",88.571,3.63e-27,126,105,92.99955,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLRZ01000037",87.5,6.22e-27,126,112,98,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLWB01000035",87.5,6.22e-27,126,112,98,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLZF01000029",87.5,6.22e-27,126,112,98,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_JBGJJV010000032",75.385,3.45e-27,126,325,245.00125,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRC01000027",87.85,3.45e-27,126,107,93.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRI01000021",87.85,3.45e-27,126,107,93.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRE01000049",87.85,3.45e-27,126,107,93.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRZ01000037",87.85,3.45e-27,126,107,93.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRO01000021",87.85,3.45e-27,126,107,93.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXR01000021",87.85,3.45e-27,126,107,93.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRG01000021",87.85,3.45e-27,126,107,93.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYG01000019",87.85,3.45e-27,126,107,93.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRJ01000019",87.85,3.45e-27,126,107,93.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSM01000018",87.85,3.45e-27,126,107,93.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSQ01000022",87.85,3.45e-27,126,107,93.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXY01000024",87.85,3.45e-27,126,107,93.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXS01000025",87.85,3.45e-27,126,107,93.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLWB01000035",87.85,3.45e-27,126,107,93.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLUD01000021",87.85,3.45e-27,126,107,93.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYZ01000021",87.85,3.45e-27,126,107,93.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSP01000022",87.85,3.45e-27,126,107,93.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLZF01000029",87.85,3.45e-27,126,107,93.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSH01000020",87.85,3.45e-27,126,107,93.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYY01000023",87.85,3.45e-27,126,107,93.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYC01000020",87.85,3.45e-27,126,107,93.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXZ01000020",87.85,3.45e-27,126,107,93.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_FLBI01000046",73.851,1.25e-26,124,348,257.00148,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRI01000021",73.926,1.25e-26,124,349,258.00174,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRE01000049",73.926,1.25e-26,124,349,258.00174,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRO01000021",73.926,1.25e-26,124,349,258.00174,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLXR01000021",73.926,1.25e-26,124,349,258.00174,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRG01000021",73.926,1.25e-26,124,349,258.00174,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLYG01000019",73.926,1.25e-26,124,349,258.00174,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRJ01000019",73.926,1.25e-26,124,349,258.00174,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLSM01000018",73.926,1.25e-26,124,349,258.00174,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLSQ01000022",73.926,1.25e-26,124,349,258.00174,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLXY01000024",73.926,1.25e-26,124,349,258.00174,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLXS01000025",73.926,1.25e-26,124,349,258.00174,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLUD01000021",73.926,1.25e-26,124,349,258.00174,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRC01000027",73.926,1.25e-26,124,349,258.00174,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLYZ01000021",73.926,1.25e-26,124,349,258.00174,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLSP01000022",73.926,1.25e-26,124,349,258.00174,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLSH01000020",73.926,1.25e-26,124,349,258.00174,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLYY01000023",73.926,1.25e-26,124,349,258.00174,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLYC01000020",73.926,1.25e-26,124,349,258.00174,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLXZ01000020",73.926,1.25e-26,124,349,258.00174,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRI01000021",75.155,1.24e-26,124,322,241.9991,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRE01000049",75.155,1.24e-26,124,322,241.9991,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRZ01000037",75.155,1.24e-26,124,322,241.9991,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRO01000021",75.155,1.24e-26,124,322,241.9991,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXR01000021",75.155,1.24e-26,124,322,241.9991,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRG01000021",75.155,1.24e-26,124,322,241.9991,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYG01000019",75.155,1.24e-26,124,322,241.9991,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLRJ01000019",75.155,1.24e-26,124,322,241.9991,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSM01000018",75.155,1.24e-26,124,322,241.9991,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSQ01000022",75.155,1.24e-26,124,322,241.9991,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXY01000024",75.155,1.24e-26,124,322,241.9991,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXS01000025",75.155,1.24e-26,124,322,241.9991,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLWB01000035",75.155,1.24e-26,124,322,241.9991,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLUD01000021",75.155,1.24e-26,124,322,241.9991,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYZ01000021",75.155,1.24e-26,124,322,241.9991,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSP01000022",75.155,1.24e-26,124,322,241.9991,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLZF01000029",75.155,1.24e-26,124,322,241.9991,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSH01000020",75.155,1.24e-26,124,322,241.9991,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYY01000023",75.155,1.24e-26,124,322,241.9991,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLYC01000020",75.155,1.24e-26,124,322,241.9991,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLXZ01000020",75.155,1.24e-26,124,322,241.9991,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_FLBN01000099",76.136,4.62e-26,122,264,200.99904,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLRE01000049",78.723,7.66e-26,122,188,147.99924,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRI01000021",85.841,1.64e-25,121,113,97.00033,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRE01000049",85.841,1.64e-25,121,113,97.00033,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRZ01000037",85.841,1.64e-25,121,113,97.00033,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRO01000021",85.841,1.64e-25,121,113,97.00033,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXR01000021",85.841,1.64e-25,121,113,97.00033,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRG01000021",85.841,1.64e-25,121,113,97.00033,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYG01000019",85.841,1.64e-25,121,113,97.00033,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRJ01000019",85.841,1.64e-25,121,113,97.00033,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSM01000018",85.841,1.64e-25,121,113,97.00033,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSQ01000022",85.841,1.64e-25,121,113,97.00033,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXY01000024",85.841,1.64e-25,121,113,97.00033,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXS01000025",85.841,1.64e-25,121,113,97.00033,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLWB01000035",85.841,1.64e-25,121,113,97.00033,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLUD01000021",85.841,1.64e-25,121,113,97.00033,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRC01000027",85.841,1.64e-25,121,113,97.00033,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYZ01000021",85.841,1.64e-25,121,113,97.00033,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSP01000022",85.841,1.64e-25,121,113,97.00033,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLZF01000029",85.841,1.64e-25,121,113,97.00033,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSH01000020",85.841,1.64e-25,121,113,97.00033,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYY01000023",85.841,1.64e-25,121,113,97.00033,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYC01000020",85.841,1.64e-25,121,113,97.00033,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXZ01000020",85.841,1.64e-25,121,113,97.00033,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_FLBI01000046",89.474,1.83e-25,121,95,85.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_FLBN01000099",89.474,1.83e-25,121,95,85.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRI01000021",89.474,1.83e-25,121,95,85.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRE01000049",89.474,1.83e-25,121,95,85.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_FLCN01000004",89.474,1.83e-25,121,95,85.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRZ01000037",89.474,1.83e-25,121,95,85.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRO01000021",89.474,1.83e-25,121,95,85.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLXR01000021",89.474,1.83e-25,121,95,85.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRG01000021",89.474,1.83e-25,121,95,85.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLYG01000019",89.474,1.83e-25,121,95,85.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRJ01000019",89.474,1.83e-25,121,95,85.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLSM01000018",89.474,1.83e-25,121,95,85.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLSQ01000022",89.474,1.83e-25,121,95,85.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLXY01000024",89.474,1.83e-25,121,95,85.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLXS01000025",89.474,1.83e-25,121,95,85.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLWB01000035",89.474,1.83e-25,121,95,85.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLUD01000021",89.474,1.83e-25,121,95,85.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLRC01000027",89.474,1.83e-25,121,95,85.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLYZ01000021",89.474,1.83e-25,121,95,85.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLSP01000022",89.474,1.83e-25,121,95,85.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLZF01000029",89.474,1.83e-25,121,95,85.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLSH01000020",89.474,1.83e-25,121,95,85.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLYY01000023",89.474,1.83e-25,121,95,85.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLYC01000020",89.474,1.83e-25,121,95,85.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLXZ01000020",89.474,1.83e-25,121,95,85.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_JBGJJV010000032",89.474,1.83e-25,121,95,85.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRE01000049",85.841,1.66e-25,121,113,97.00033,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRZ01000037",85.841,1.66e-25,121,113,97.00033,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLWB01000035",85.841,1.66e-25,121,113,97.00033,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLZF01000029",85.841,1.66e-25,121,113,97.00033,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRI01000021",85.841,1.66e-25,121,113,97.00033,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRO01000021",85.841,1.66e-25,121,113,97.00033,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXR01000021",85.841,1.66e-25,121,113,97.00033,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRG01000021",85.841,1.66e-25,121,113,97.00033,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYG01000019",85.841,1.66e-25,121,113,97.00033,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRJ01000019",85.841,1.66e-25,121,113,97.00033,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSM01000018",85.841,1.66e-25,121,113,97.00033,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSQ01000022",85.841,1.66e-25,121,113,97.00033,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXY01000024",85.841,1.66e-25,121,113,97.00033,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXS01000025",85.841,1.66e-25,121,113,97.00033,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLUD01000021",85.841,1.66e-25,121,113,97.00033,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLRC01000027",85.841,1.66e-25,121,113,97.00033,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYZ01000021",85.841,1.66e-25,121,113,97.00033,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSP01000022",85.841,1.66e-25,121,113,97.00033,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSH01000020",85.841,1.66e-25,121,113,97.00033,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYY01000023",85.841,1.66e-25,121,113,97.00033,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLYC01000020",85.841,1.66e-25,121,113,97.00033,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLXZ01000020",85.841,1.66e-25,121,113,97.00033,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRI01000021",91.86,1.99e-25,121,86,78.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRO01000021",91.86,1.99e-25,121,86,78.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLXR01000021",91.86,1.99e-25,121,86,78.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRG01000021",91.86,1.99e-25,121,86,78.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLYG01000019",91.86,1.99e-25,121,86,78.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRJ01000019",91.86,1.99e-25,121,86,78.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLSM01000018",91.86,1.99e-25,121,86,78.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLSQ01000022",91.86,1.99e-25,121,86,78.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLXY01000024",91.86,1.99e-25,121,86,78.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLXS01000025",91.86,1.99e-25,121,86,78.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLUD01000021",91.86,1.99e-25,121,86,78.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLRC01000027",91.86,1.99e-25,121,86,78.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLYZ01000021",91.86,1.99e-25,121,86,78.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLSP01000022",91.86,1.99e-25,121,86,78.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLSH01000020",91.86,1.99e-25,121,86,78.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLYY01000023",91.86,1.99e-25,121,86,78.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLYC01000020",91.86,1.99e-25,121,86,78.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLXZ01000020",91.86,1.99e-25,121,86,78.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_MLRZ01000037",86.667,2.46e-24,117,105,91.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_MLWB01000035",86.667,2.46e-24,117,105,91.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_MLZF01000029",86.667,2.46e-24,117,105,91.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_JBGJJV010000032",86.667,2.46e-24,117,105,91.00035,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_FLBI01000046",87.879,1.16e-23,115,99,87.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_FLBN01000099",87.879,1.16e-23,115,99,87.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRI01000021",87.879,1.16e-23,115,99,87.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRE01000049",87.879,1.16e-23,115,99,87.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_FLCN01000004",87.879,1.16e-23,115,99,87.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRZ01000037",87.879,1.16e-23,115,99,87.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRO01000021",87.879,1.16e-23,115,99,87.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLXR01000021",87.879,1.16e-23,115,99,87.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRG01000021",87.879,1.16e-23,115,99,87.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLYG01000019",87.879,1.16e-23,115,99,87.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRJ01000019",87.879,1.16e-23,115,99,87.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLSM01000018",87.879,1.16e-23,115,99,87.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLSQ01000022",87.879,1.16e-23,115,99,87.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLXY01000024",87.879,1.16e-23,115,99,87.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLXS01000025",87.879,1.16e-23,115,99,87.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLWB01000035",87.879,1.16e-23,115,99,87.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLUD01000021",87.879,1.16e-23,115,99,87.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLRC01000027",87.879,1.16e-23,115,99,87.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLYZ01000021",87.879,1.16e-23,115,99,87.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLSP01000022",87.879,1.16e-23,115,99,87.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLZF01000029",87.879,1.16e-23,115,99,87.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLSH01000020",87.879,1.16e-23,115,99,87.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLYY01000023",87.879,1.16e-23,115,99,87.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLYC01000020",87.879,1.16e-23,115,99,87.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLXZ01000020",87.879,1.16e-23,115,99,87.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_JBGJJV010000032",87.879,1.16e-23,115,99,87.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_FLBI01000046",86.538,1.97e-23,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_FLBN01000099",86.538,1.97e-23,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRI01000021",86.538,1.97e-23,115,104,89.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRE01000049",86.538,1.97e-23,115,104,89.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_FLCN01000004",86.538,1.97e-23,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRZ01000037",86.538,1.97e-23,115,104,89.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRO01000021",86.538,1.97e-23,115,104,89.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLXR01000021",86.538,1.97e-23,115,104,89.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRG01000021",86.538,1.97e-23,115,104,89.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLYG01000019",86.538,1.97e-23,115,104,89.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRJ01000019",86.538,1.97e-23,115,104,89.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLSM01000018",86.538,1.97e-23,115,104,89.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLSQ01000022",86.538,1.97e-23,115,104,89.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLXY01000024",86.538,1.97e-23,115,104,89.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLXS01000025",86.538,1.97e-23,115,104,89.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLWB01000035",86.538,1.97e-23,115,104,89.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLUD01000021",86.538,1.97e-23,115,104,89.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLRC01000027",86.538,1.97e-23,115,104,89.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLYZ01000021",86.538,1.97e-23,115,104,89.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLSP01000022",86.538,1.97e-23,115,104,89.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLZF01000029",86.538,1.97e-23,115,104,89.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLSH01000020",86.538,1.97e-23,115,104,89.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLYY01000023",86.538,1.97e-23,115,104,89.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLYC01000020",86.538,1.97e-23,115,104,89.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLXZ01000020",86.538,1.97e-23,115,104,89.99952,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_JBGJJV010000032",76.154,1.97e-23,115,260,198.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_FLBI01000046",86.538,8.85e-24,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_FLBN01000099",86.538,8.85e-24,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_FLCN01000004",86.538,8.85e-24,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_FLBI01000046",86.538,9.95e-24,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_FLBN01000099",86.538,9.95e-24,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRI01000021",86.538,9.95e-24,115,104,89.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRE01000049",86.538,9.95e-24,115,104,89.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_FLCN01000004",86.538,9.95e-24,115,104,89.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRZ01000037",86.538,9.95e-24,115,104,89.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRO01000021",86.538,9.95e-24,115,104,89.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLXR01000021",86.538,9.95e-24,115,104,89.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRG01000021",86.538,9.95e-24,115,104,89.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLYG01000019",86.538,9.95e-24,115,104,89.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRJ01000019",86.538,9.95e-24,115,104,89.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLSM01000018",86.538,9.95e-24,115,104,89.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLSQ01000022",86.538,9.95e-24,115,104,89.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLXY01000024",86.538,9.95e-24,115,104,89.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLXS01000025",86.538,9.95e-24,115,104,89.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLWB01000035",86.538,9.95e-24,115,104,89.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLUD01000021",86.538,9.95e-24,115,104,89.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLRC01000027",86.538,9.95e-24,115,104,89.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLYZ01000021",86.538,9.95e-24,115,104,89.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLSP01000022",86.538,9.95e-24,115,104,89.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLZF01000029",86.538,9.95e-24,115,104,89.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLSH01000020",86.538,9.95e-24,115,104,89.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLYY01000023",86.538,9.95e-24,115,104,89.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLYC01000020",86.538,9.95e-24,115,104,89.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLXZ01000020",86.538,9.95e-24,115,104,89.99952,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_JBGJJV010000032",86.538,9.95e-24,115,104,89.99952,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLRZ01000037",86.667,2.71e-23,113,105,91.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLWB01000035",86.667,2.71e-23,113,105,91.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLZF01000029",86.667,2.71e-23,113,105,91.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_JBGJJV010000032",84.906,4.69e-21,106,106,90.00036,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FLBI01000046",84.906,4.69e-21,106,106,90.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FLCN01000004",84.906,4.69e-21,106,106,90.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_FLBN01000099",84.906,4.69e-21,106,106,90.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_MLRZ01000037",85.047,4.51e-21,106,107,91.00029,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_MLWB01000035",85.047,4.51e-21,106,107,91.00029,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_MLZF01000029",85.047,4.51e-21,106,107,91.00029,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_JBGJJV010000032",85.047,4.51e-21,106,107,91.00029,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_FLBI01000046",84.906,1.62e-20,104,106,90.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_FLBN01000099",84.906,1.62e-20,104,106,90.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_FLCN01000004",84.906,1.62e-20,104,106,90.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRI01000021",86.813,6.07e-20,102,91,78.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRE01000049",86.813,6.07e-20,102,91,78.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRZ01000037",86.813,6.07e-20,102,91,78.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRO01000021",86.813,6.07e-20,102,91,78.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXR01000021",86.813,6.07e-20,102,91,78.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRG01000021",86.813,6.07e-20,102,91,78.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYG01000019",86.813,6.07e-20,102,91,78.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRJ01000019",86.813,6.07e-20,102,91,78.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSM01000018",86.813,6.07e-20,102,91,78.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSQ01000022",86.813,6.07e-20,102,91,78.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXY01000024",86.813,6.07e-20,102,91,78.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXS01000025",86.813,6.07e-20,102,91,78.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLWB01000035",86.813,6.07e-20,102,91,78.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLUD01000021",86.813,6.07e-20,102,91,78.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLRC01000027",86.813,6.07e-20,102,91,78.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYZ01000021",86.813,6.07e-20,102,91,78.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSP01000022",86.813,6.07e-20,102,91,78.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLZF01000029",86.813,6.07e-20,102,91,78.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSH01000020",86.813,6.07e-20,102,91,78.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYY01000023",86.813,6.07e-20,102,91,78.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLYC01000020",86.813,6.07e-20,102,91,78.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLXZ01000020",86.813,6.07e-20,102,91,78.99983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_JBGJJV010000032",83.962,2.13e-19,100,106,88.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FLBI01000046",83.962,2.13e-19,100,106,88.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FLCN01000004",83.962,2.13e-19,100,106,88.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_FLBN01000099",83.962,2.13e-19,100,106,88.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRI01000021",85.714,2.76e-18,97.1,91,77.99974,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRE01000049",85.714,2.76e-18,97.1,91,77.99974,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRZ01000037",85.714,2.76e-18,97.1,91,77.99974,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRO01000021",85.714,2.76e-18,97.1,91,77.99974,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXR01000021",85.714,2.76e-18,97.1,91,77.99974,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRG01000021",85.714,2.76e-18,97.1,91,77.99974,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYG01000019",85.714,2.76e-18,97.1,91,77.99974,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRJ01000019",85.714,2.76e-18,97.1,91,77.99974,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSM01000018",85.714,2.76e-18,97.1,91,77.99974,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSQ01000022",85.714,2.76e-18,97.1,91,77.99974,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXY01000024",85.714,2.76e-18,97.1,91,77.99974,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXS01000025",85.714,2.76e-18,97.1,91,77.99974,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLWB01000035",85.714,2.76e-18,97.1,91,77.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLUD01000021",85.714,2.76e-18,97.1,91,77.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLRC01000027",85.714,2.76e-18,97.1,91,77.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYZ01000021",85.714,2.76e-18,97.1,91,77.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSP01000022",85.714,2.76e-18,97.1,91,77.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLZF01000029",85.714,2.76e-18,97.1,91,77.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSH01000020",85.714,2.76e-18,97.1,91,77.99974,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYY01000023",85.714,2.76e-18,97.1,91,77.99974,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLYC01000020",85.714,2.76e-18,97.1,91,77.99974,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLXZ01000020",85.714,2.76e-18,97.1,91,77.99974,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_FLBI01000046",84.694,3.05e-18,97.1,98,83.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_FLBN01000099",84.694,3.05e-18,97.1,98,83.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRI01000021",84.694,3.05e-18,97.1,98,83.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRE01000049",84.694,3.05e-18,97.1,98,83.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_FLCN01000004",84.694,3.05e-18,97.1,98,83.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRZ01000037",84.694,3.05e-18,97.1,98,83.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRO01000021",84.694,3.05e-18,97.1,98,83.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLXR01000021",84.694,3.05e-18,97.1,98,83.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRG01000021",84.694,3.05e-18,97.1,98,83.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLYG01000019",84.694,3.05e-18,97.1,98,83.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRJ01000019",84.694,3.05e-18,97.1,98,83.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLSM01000018",84.694,3.05e-18,97.1,98,83.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLSQ01000022",84.694,3.05e-18,97.1,98,83.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLXY01000024",84.694,3.05e-18,97.1,98,83.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLXS01000025",84.694,3.05e-18,97.1,98,83.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLWB01000035",84.694,3.05e-18,97.1,98,83.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLUD01000021",84.694,3.05e-18,97.1,98,83.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLRC01000027",84.694,3.05e-18,97.1,98,83.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLYZ01000021",84.694,3.05e-18,97.1,98,83.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLSP01000022",84.694,3.05e-18,97.1,98,83.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLZF01000029",84.694,3.05e-18,97.1,98,83.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLSH01000020",84.694,3.05e-18,97.1,98,83.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLYY01000023",84.694,3.05e-18,97.1,98,83.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLYC01000020",84.694,3.05e-18,97.1,98,83.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLXZ01000020",84.694,3.05e-18,97.1,98,83.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_JBGJJV010000032",84.694,3.05e-18,97.1,98,83.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRI01000021",92.424,1.27e-17,95.3,66,60.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRO01000021",92.424,1.27e-17,95.3,66,60.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLXR01000021",92.424,1.27e-17,95.3,66,60.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRG01000021",92.424,1.27e-17,95.3,66,60.99984,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLYG01000019",92.424,1.27e-17,95.3,66,60.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRJ01000019",92.424,1.27e-17,95.3,66,60.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLSM01000018",92.424,1.27e-17,95.3,66,60.99984,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLSQ01000022",92.424,1.27e-17,95.3,66,60.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLXY01000024",92.424,1.27e-17,95.3,66,60.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLXS01000025",92.424,1.27e-17,95.3,66,60.99984,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLUD01000021",92.424,1.27e-17,95.3,66,60.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLRC01000027",92.424,1.27e-17,95.3,66,60.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLYZ01000021",92.424,1.27e-17,95.3,66,60.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLSP01000022",92.424,1.27e-17,95.3,66,60.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLSH01000020",92.424,1.27e-17,95.3,66,60.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLYY01000023",92.424,1.27e-17,95.3,66,60.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLYC01000020",92.424,1.27e-17,95.3,66,60.99984,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLXZ01000020",92.424,1.27e-17,95.3,66,60.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRI01000021",92.308,1.46e-11,75,52,48.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRO01000021",92.308,1.46e-11,75,52,48.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLXR01000021",92.308,1.46e-11,75,52,48.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRG01000021",92.308,1.46e-11,75,52,48.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLYG01000019",92.308,1.46e-11,75,52,48.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRJ01000019",92.308,1.46e-11,75,52,48.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLSM01000018",92.308,1.46e-11,75,52,48.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLSQ01000022",92.308,1.46e-11,75,52,48.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLXY01000024",92.308,1.46e-11,75,52,48.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLXS01000025",92.308,1.46e-11,75,52,48.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLUD01000021",92.308,1.46e-11,75,52,48.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLRC01000027",92.308,1.46e-11,75,52,48.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLYZ01000021",92.308,1.46e-11,75,52,48.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLSP01000022",92.308,1.46e-11,75,52,48.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLSH01000020",92.308,1.46e-11,75,52,48.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLYY01000023",92.308,1.46e-11,75,52,48.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLYC01000020",92.308,1.46e-11,75,52,48.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLXZ01000020",92.308,1.46e-11,75,52,48.00016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRI01000021",93.478,5.93e-10,69.4,46,42.99988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRO01000021",93.478,5.93e-10,69.4,46,42.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLXR01000021",93.478,5.93e-10,69.4,46,42.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRG01000021",93.478,5.93e-10,69.4,46,42.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLYG01000019",93.478,5.93e-10,69.4,46,42.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRJ01000019",93.478,5.93e-10,69.4,46,42.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLSM01000018",93.478,5.93e-10,69.4,46,42.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLSQ01000022",93.478,5.93e-10,69.4,46,42.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLXY01000024",93.478,5.93e-10,69.4,46,42.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLXS01000025",93.478,5.93e-10,69.4,46,42.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLUD01000021",93.478,5.93e-10,69.4,46,42.99988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLRC01000027",93.478,5.93e-10,69.4,46,42.99988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLYZ01000021",93.478,5.93e-10,69.4,46,42.99988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLSP01000022",93.478,5.93e-10,69.4,46,42.99988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLSH01000020",93.478,5.93e-10,69.4,46,42.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLYY01000023",93.478,5.93e-10,69.4,46,42.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLYC01000020",93.478,5.93e-10,69.4,46,42.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLXZ01000020",93.478,5.93e-10,69.4,46,42.99988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_JAMKRA010000075",86.501,0,1557,1452,1255.99452,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_JAMKTM010000045",86.501,0,1557,1452,1255.99452,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_JAMKRA010000075",96.798,0,1557,937,906.99726,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_JAMKTM010000045",96.798,0,1557,937,906.99726,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLVX01000038",86.029,0,1522,1453,1250.00137,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLSZ01000019",95.203,0,1476,938,893.00414,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLSN01000023",95.203,0,1476,938,893.00414,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_MLVX01000038",94.67,0,1448,938,888.0046,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLSZ01000019",85.994,0,1445,1378,1184.99732,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_MLSN01000023",85.994,0,1445,1378,1184.99732,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSZ01000019",83.233,0,1181,1324,1102.00492,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSN01000023",83.233,0,1181,1324,1102.00492,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLSZ01000019",87.948,0,1179,1004,882.99792,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLSN01000023",87.948,0,1179,1004,882.99792,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLVX01000038",83.157,0,1175,1324,1100.99868,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_MLVX01000038",87.761,0,1168,1005,881.99805,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_JAMKRA010000075",84.516,0,1116,1156,977.00496,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_JAMKRA010000075",87.656,0,1107,964,845.00384,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_JAMKTM010000045",87.656,0,1107,964,845.00384,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JAMKRA010000075",83.82,0,1105,1199,1005.0018,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JAMKQZ010000090",83.82,0,1105,1199,1005.0018,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JAMKTM010000045",83.82,0,1105,1199,1005.0018,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_JAMKTM010000045",84.356,0,1105,1157,975.99892,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLVX01000038",87.384,0,1094,967,845.00328,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLVX01000038",84.038,0,1085,1159,974.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_JAMKRA010000075",88.623,0,1064,879,778.99617,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_JAMKQZ010000090",88.623,0,1064,879,778.99617,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_38","NZ_JAMKTM010000045",88.623,0,1064,879,778.99617,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLSZ01000019",98.311,0,1038,592,582.00112,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLSN01000023",98.311,0,1038,592,582.00112,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_MLVX01000038",98.142,0,1033,592,581.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_JAMKRA010000075",84.557,0,1027,1062,897.99534,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_JAMKRA010000075",83.659,0,1026,1126,942.00034,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_JAMKTM010000045",83.659,0,1026,1126,942.00034,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_JAMKTM010000045",84.384,0,1016,1063,897.00192,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLSZ01000019",85.895,0,1005,950,816.0025,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLSN01000023",85.895,0,1005,950,816.0025,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLVX01000038",83.23,0,1000,1127,938.0021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_JAMKRA010000075",88.028,0,994,852,749.99856,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_JAMKTM010000045",88.028,0,994,852,749.99856,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLVX01000038",97.27,0,994,586,570.0022,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_MLVX01000038",85.684,0,994,950,813.998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_JAMKRA010000075",96.791,0,989,592,573.00272,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_JAMKQZ010000090",96.791,0,989,592,573.00272,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_9439","NZ_JAMKTM010000045",96.791,0,989,592,573.00272,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLSZ01000019",85.443,0,976,948,809.99964,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLSN01000023",85.443,0,976,948,809.99964,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLVX01000038",83.677,0,974,1066,891.99682,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLSZ01000019",85.104,0,970,960,816.9984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLSN01000023",85.104,0,970,960,816.9984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_MLVX01000038",85.338,0,970,948,809.00424,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_JAMKRA010000075",97.857,0,968,560,547.9992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_JAMKTM010000045",97.857,0,968,560,547.9992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_MLVX01000038",85,0,965,960,816,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLSZ01000019",86.987,0,946,853,741.99911,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLSN01000023",86.987,0,946,853,741.99911,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLSZ01000019",98.868,0,946,530,524.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLSN01000023",98.868,0,946,530,524.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_MLVX01000038",98.868,0,946,530,524.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_JAMKRA010000075",86.808,0,942,849,736.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_JAMKQZ010000090",86.808,0,942,849,736.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_38093","NZ_JAMKTM010000045",86.808,0,942,849,736.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_MLVX01000038",86.87,0,941,853,741.0011,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_JAMKRA010000075",98.491,0,935,530,522.0023,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_3222","NZ_JAMKTM010000045",98.491,0,935,530,522.0023,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_JAMKTM010000045",94.889,0,915,587,556.99843,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_JAMKRA010000075",85.781,0,904,858,736.00098,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_JAMKQZ010000090",85.781,0,904,858,736.00098,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_8531","NZ_JAMKTM010000045",85.781,0,904,858,736.00098,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLSZ01000019",95.745,0,904,564,540.0018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLSN01000023",95.745,0,904,564,540.0018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_MLVX01000038",95.567,0,898,564,538.99788,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_JAMKRA010000075",85.631,0,894,856,733.00136,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_JAMKQZ010000090",85.631,0,894,856,733.00136,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_8693","NZ_JAMKTM010000045",85.631,0,894,856,733.00136,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_JAMKRA010000075",94.208,0,893,587,553.00096,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_JAMKRA010000075",86.158,0,889,838,722.00404,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_JAMKTM010000045",86.158,0,889,838,722.00404,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_JAMKRA010000075",85.885,0,865,836,717.9986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_JAMKTM010000045",85.885,0,865,836,717.9986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLVX01000038",86.507,0,863,793,686.00051,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_JAMKRA010000075",83.198,0,861,982,817.00436,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLSZ01000019",94.159,0,859,565,531.99835,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLSN01000023",94.159,0,859,565,531.99835,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_MLVX01000038",94.159,0,859,565,531.99835,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLVX01000038",85.749,0,857,835,716.00415,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_JAMKRA010000075",93.805,0,848,565,529.99825,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_19038","NZ_JAMKTM010000045",93.805,0,848,565,529.99825,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_JAMKTM010000045",82.892,0,845,982,813.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLSZ01000019",88.319,0,835,702,619.99938,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT_vs_bact_coverage_filtered_hits","k127_7448","NZ_MLSN01000023",88.319,0,835,702,619.99938,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLVX01000038",84.651,0,833,860,727.9986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_JAMKRA010000075",94.615,0,800,520,491.998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_JAMKTM010000045",94.615,0,800,520,491.998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLSZ01000019",94.423,0,795,520,490.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLSN01000023",94.423,0,795,520,490.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_12567","NZ_MLVX01000038",94.231,0,789,520,490.0012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLVX01000038",79.636,0,787,1154,918.99944,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_JAMKRA010000075",87.194,0,785,695,605.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_JAMKQZ010000090",87.194,0,785,695,605.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_JAMKTM010000045",87.194,0,785,695,605.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_JAMKRA010000075",87.013,0,780,693,603.00009,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_JAMKQZ010000090",87.013,0,780,693,603.00009,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_JAMKTM010000045",87.013,0,780,693,603.00009,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLSZ01000019",86.906,0,774,695,603.9967,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLSN01000023",86.906,0,774,695,603.9967,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_3687","NZ_MLVX01000038",86.906,0,774,695,603.9967,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_JAMKRA010000075",87.116,0,769,683,595.00228,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_JAMKQZ010000090",87.026,0,769,686,596.99836,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_JAMKTM010000045",87.116,0,769,683,595.00228,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_JAMKRA010000075",79.076,0,763,1190,941.0044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_JAMKTM010000045",79.076,0,763,1190,941.0044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLSZ01000019",86.969,0,763,683,593.99827,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLSN01000023",86.969,0,763,683,593.99827,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_80755","NZ_MLVX01000038",86.969,0,763,683,593.99827,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLSZ01000019",86.58,0,763,693,599.9994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLSN01000023",86.58,0,763,693,599.9994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RT_vs_bact_coverage_filtered_hits","k127_8969","NZ_MLVX01000038",86.58,0,763,693,599.9994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLSZ01000019",84.04,0,760,802,674.0008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLSN01000023",84.04,0,760,802,674.0008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_JAMKRA010000075",88.431,0,754,631,557.99961,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_JAMKTM010000045",88.431,0,754,631,557.99961,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_MLVX01000038",83.915,0,754,802,672.9983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_JAMKRA010000075",83.77,0,749,801,670.9977,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_JAMKQZ010000090",83.77,0,749,801,670.9977,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2632","NZ_JAMKTM010000045",83.77,0,749,801,670.9977,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLSZ01000019",79.406,0,741,1078,855.99668,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLSN01000023",79.406,0,741,1078,855.99668,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLSZ01000019",87.956,0,737,631,555.00236,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLSN01000023",87.956,0,737,631,555.00236,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_MLVX01000038",79.314,0,736,1078,855.00492,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLSZ01000019",89.212,0,726,584,520.99808,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_14369","NZ_MLSN01000023",89.212,0,726,584,520.99808,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLSZ01000019",86.405,0,723,662,572.0011,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLSN01000023",86.405,0,723,662,572.0011,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLSZ01000019",86.05,0,723,681,586.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLSN01000023",86.05,0,723,681,586.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT_vs_bact_coverage_filtered_hits","k127_618","NZ_MLVX01000038",87.5,0,721,632,553,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_MLVX01000038",86.254,0,717,662,571.00148,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_MLVX01000038",85.903,0,717,681,584.99943,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_JAMKRA010000075",78.454,0,715,1151,903.00554,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_JAMKQZ010000090",78.454,0,715,1151,903.00554,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_2341","NZ_JAMKTM010000045",78.454,0,715,1151,903.00554,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_JAMKRA010000075",86.916,0,715,642,558.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_JAMKQZ010000090",86.916,0,715,642,558.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_JAMKTM010000045",86.916,0,715,642,558.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_JAMKRA010000075",91.731,0,713,520,477.0012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_JAMKTM010000045",91.731,0,713,520,477.0012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLVX01000038",83.25,0,712,800,666,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_JAMKRA010000075",78.714,0,708,1104,869.00256,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_JAMKQZ010000090",78.913,0,708,1086,856.99518,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_JAMKTM010000045",78.714,0,708,1104,869.00256,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_JAMKRA010000075",83.04,0,706,796,660.9984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_JAMKTM010000045",83.04,0,706,796,660.9984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLSZ01000019",86.604,0,704,642,555.99768,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLSN01000023",86.604,0,704,642,555.99768,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_1141","NZ_MLVX01000038",86.604,0,704,642,555.99768,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_JAMKRA010000075",84.076,0,701,741,623.00316,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_JAMKTM010000045",84.076,0,701,741,623.00316,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLSZ01000019",82.957,0,701,798,661.99686,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_MLSN01000023",82.957,0,701,798,661.99686,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_JAMKRA010000075",83.952,0,699,754,632.99808,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_JAMKTM010000045",83.952,0,699,754,632.99808,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLVX01000038",88.676,0,697,574,509.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_JAMKRA010000075",88.488,0,697,582,515.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_JAMKTM010000045",88.488,0,697,582,515.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLSZ01000019",87.479,0,697,607,530.99753,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLSN01000023",87.479,0,697,607,530.99753,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLSZ01000019",91.12,0,697,518,472.0016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLSN01000023",91.12,0,697,518,472.0016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_JAMKRA010000075",88.676,0,695,574,509.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_JAMKTM010000045",88.676,0,695,574,509.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLVX01000038",88.115,0,695,589,518.99735,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLSZ01000019",89.007,0,691,564,501.99948,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_9259","NZ_MLSN01000023",89.007,0,691,564,501.99948,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_MLVX01000038",87.315,0,691,607,530.00205,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_JAMKRA010000075",83.355,0,689,757,630.99735,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_JAMKTM010000045",83.355,0,689,757,630.99735,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_JAMKRA010000075",87.925,0,688,588,516.999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_JAMKTM010000045",87.925,0,688,588,516.999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLVX01000038",83.671,0,686,741,620.00211,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLVX01000038",78.351,0,686,1104,864.99504,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_JAMKRA010000075",88.475,0,682,564,498.999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_JAMKQZ010000090",88.592,0,682,561,497.00112,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_99","NZ_JAMKTM010000045",88.475,0,682,564,498.999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLSZ01000019",83.598,0,682,756,632.00088,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLSN01000023",83.598,0,682,756,632.00088,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLVX01000038",80.613,0,680,913,735.99669,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB_vs_bact_coverage_filtered_hits","k127_11316","NZ_MLVX01000038",90.522,0,680,517,467.99874,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLSZ01000019",78.261,0,680,1104,864.00144,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_9047","NZ_MLSN01000023",78.261,0,680,1104,864.00144,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLVX01000038",87.822,0,676,583,512.00226,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLVX01000038",83.026,0,676,760,630.9976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLSZ01000019",82.663,0,675,796,657.99748,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLSN01000023",82.663,0,675,796,657.99748,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_MLVX01000038",82.663,0,675,796,657.99748,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLVX01000038",81.873,0,671,822,672.99606,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_JAMKRA010000075",81.873,0,671,822,672.99606,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_JAMKQZ010000090",81.873,0,671,822,672.99606,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_JAMKTM010000045",81.873,0,671,822,672.99606,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLVX01000038",80.592,0,671,912,734.99904,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_JAMKRA010000075",84.889,0,669,675,573.00075,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_JAMKTM010000045",84.889,0,669,675,573.00075,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLSZ01000019",86.656,0,669,607,526.00192,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLSN01000023",86.656,0,669,607,526.00192,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_JAMKRA010000075",86.054,0,669,631,543.00074,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_JAMKTM010000045",86.054,0,669,631,543.00074,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_JAMKRA010000075",83.2,0,669,750,624,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_JAMKQZ010000090",83.2,0,669,750,624,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_21342","NZ_JAMKTM010000045",83.2,0,669,750,624,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLSZ01000019",81.752,0,665,822,672.00144,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_16116","NZ_MLSN01000023",81.752,0,665,822,672.00144,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLVX01000038",81.183,0,665,845,685.99635,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_14254","NZ_JAMKQZ010000090",96.758,0,665,401,387.99958,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_MLVX01000038",83.201,0,665,756,628.99956,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_MLVX01000038",86.491,0,664,607,525.00037,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLSZ01000019",84.858,0,662,667,566.00286,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_7503","NZ_MLSN01000023",84.858,0,662,667,566.00286,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLSZ01000019",81.065,0,660,845,684.99925,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_MLSN01000023",81.065,0,660,845,684.99925,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLVX01000038",80.13,0,658,921,737.9973,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_JAMKRA010000075",88.203,0,658,551,485.99853,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_JAMKQZ010000090",88.203,0,658,551,485.99853,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5143","NZ_JAMKTM010000045",88.203,0,658,551,485.99853,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JAMKRA010000075",80.086,0,658,929,743.99894,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_JAMKTM010000045",80.086,0,658,929,743.99894,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_JAMKRA010000075",89.333,0,658,525,468.99825,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_JAMKQZ010000090",88.827,0,658,537,477.00099,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_JAMKTM010000045",89.333,0,658,525,468.99825,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLSZ01000019",81.28,0,656,844,686.0032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_MLSN01000023",81.28,0,656,844,686.0032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSZ01000019",81.154,0,656,849,688.99746,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_3002","NZ_MLSN01000023",81.154,0,656,849,688.99746,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLVX01000038",84.49,0,654,677,571.9973,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLVX01000038",80.796,0,652,854,689.99784,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLSZ01000019",89.163,0,652,526,468.99738,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_8282","NZ_MLSN01000023",89.163,0,652,526,468.99738,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_JAMKRA010000075",74.83,0,652,1621,1212.9943,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_JAMKTM010000045",74.83,0,652,1621,1212.9943,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLSZ01000019",82.392,0,651,761,627.00312,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_MLSN01000023",82.392,0,651,761,627.00312,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_JAMKRA010000075",80.285,0,651,913,733.00205,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_19338","NZ_JAMKTM010000045",80.285,0,651,913,733.00205,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLSZ01000019",88.419,0,651,544,480.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLSN01000023",88.419,0,651,544,480.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLVX01000038",89.122,0,651,524,466.99928,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSZ01000019",80.992,0,649,847,686.00224,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSN01000023",80.992,0,649,847,686.00224,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_JAMKRA010000075",80.806,0,649,844,682.00264,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_JAMKQZ010000090",80.856,0,649,841,679.99896,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_9882","NZ_JAMKTM010000045",80.806,0,649,844,682.00264,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLVX01000038",85.42,0,649,631,539.0002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_JAMKRA010000075",79.894,0,647,940,751.0036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_JAMKTM010000045",79.894,0,647,940,751.0036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLSZ01000019",89.015,0,647,528,469.9992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4986","NZ_MLSN01000023",89.015,0,647,528,469.9992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLSZ01000019",86.712,0,647,587,508.99944,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_8902","NZ_MLSN01000023",86.712,0,647,587,508.99944,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_JAMKRA010000075",87.612,0,645,557,487.99884,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_JAMKQZ010000090",87.5,0,645,560,490,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_22299","NZ_JAMKTM010000045",87.612,0,645,557,487.99884,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLVX01000038",81.026,0,645,838,678.99788,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_JAMKRA010000075",87.002,0,645,577,502.00154,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_JAMKQZ010000090",87.002,0,645,577,502.00154,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_5133","NZ_JAMKTM010000045",87.002,0,645,577,502.00154,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_MLVX01000038",88.235,0,645,544,479.9984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLSZ01000019",83.548,0,645,699,584.00052,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_2298","NZ_MLSN01000023",83.548,0,645,699,584.00052,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLSZ01000019",88.931,0,645,524,465.99844,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_19790","NZ_MLSN01000023",88.931,0,645,524,465.99844,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_JAMKRA010000075",82.54,0,643,756,624.0024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLSZ01000019",87.59,0,640,556,487.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLSN01000023",87.59,0,640,556,487.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_MLVX01000038",87.59,0,640,556,487.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_JAMKTM010000045",82.384,0,638,755,621.9992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_JAMKRA010000075",80.422,2.59e-180,636,853,685.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_JAMKQZ010000090",80.422,2.59e-180,636,853,685.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_19619","NZ_JAMKTM010000045",80.422,2.59e-180,636,853,685.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLVX01000038",84.498,1.72e-180,636,658,555.99684,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_JAMKRA010000075",83.171,2.37e-179,632,719,597.99949,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_JAMKTM010000045",83.171,2.37e-179,632,719,597.99949,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLVX01000038",79.912,3.19e-179,632,906,724.00272,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_JAMKRA010000075",88.447,1.81e-179,632,528,467.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_JAMKQZ010000090",88.697,1.81e-179,632,522,462.99834,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_9207","NZ_JAMKTM010000045",88.447,1.81e-179,632,528,467.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_JAMKRA010000075",84.195,7.89e-179,630,658,554.0031,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_JAMKTM010000045",84.195,7.89e-179,630,658,554.0031,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLVX01000038",82.166,3.5e-178,628,757,621.99662,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_JAMKRA010000075",88.224,2.28e-178,628,535,471.9984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_JAMKTM010000045",88.224,2.28e-178,628,535,471.9984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLSZ01000019",80.714,4.08e-178,628,840,677.9976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_MLSN01000023",80.714,4.08e-178,628,840,677.9976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLSZ01000019",85.366,1.04e-177,627,615,525.0009,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_7938","NZ_MLSN01000023",85.366,1.04e-177,627,615,525.0009,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLVX01000038",84.043,1.02e-177,627,658,553.00294,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLVX01000038",82.917,1.43e-176,623,720,597.0024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLSZ01000019",85.246,1.73e-176,623,610,520.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_3184","NZ_MLSN01000023",85.246,1.73e-176,623,610,520.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_JAMKRA010000075",87.85,3.84e-176,621,535,469.9975,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_JAMKTM010000045",87.85,3.84e-176,621,535,469.9975,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_JAMKRA010000075",80.572,6.83e-176,621,839,675.99908,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9288","NZ_JAMKTM010000045",80.572,6.83e-176,621,839,675.99908,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_JAMKTM010000045",85.526,4.46e-176,621,608,519.99808,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLSZ01000019",88.023,3.06e-175,619,526,463.00098,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9937","NZ_MLSN01000023",88.023,3.06e-175,619,526,463.00098,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_JAMKRA010000075",74.826,4.08e-175,619,1585,1185.9921,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_JAMKTM010000045",74.826,4.08e-175,619,1585,1185.9921,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLVX01000038",80.755,7.71e-175,617,821,662.99855,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_JAMKRA010000075",80.755,7.71e-175,617,821,662.99855,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_JAMKQZ010000090",80.755,7.71e-175,617,821,662.99855,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_JAMKTM010000045",80.755,7.71e-175,617,821,662.99855,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_JAMKRA010000075",84.043,6.22e-175,617,658,553.00294,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_JAMKTM010000045",84.043,6.22e-175,617,658,553.00294,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_JAMKRA010000075",88.735,1.72e-174,616,506,448.9991,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_JAMKTM010000045",88.735,1.72e-174,616,506,448.9991,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_JAMKRA010000075",85.386,2.07e-174,616,609,520.00074,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_JAMKRA010000075",79.558,1.15e-173,614,905,719.9999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_JAMKTM010000045",79.558,1.15e-173,614,905,719.9999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLSZ01000019",80.68,3.59e-173,612,823,663.9964,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_621","NZ_MLSN01000023",80.68,3.59e-173,612,823,663.9964,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_JAMKRA010000075",86.667,2.4e-173,612,555,481.00185,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_JAMKQZ010000090",86.667,2.4e-173,612,555,481.00185,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_21989","NZ_JAMKTM010000045",86.667,2.4e-173,612,555,481.00185,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLSZ01000019",88.155,2.71e-173,612,515,453.99825,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLSN01000023",88.155,2.71e-173,612,515,453.99825,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLVX01000038",80.39,5.42e-172,608,821,660.0019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLVX01000038",87.313,1.08e-171,606,536,467.99768,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_MLVX01000038",87.961,1.26e-171,606,515,452.99915,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLSZ01000019",83.483,1.34e-171,606,666,555.99678,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLSN01000023",83.483,1.34e-171,606,666,555.99678,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_MLVX01000038",83.483,1.34e-171,606,666,555.99678,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLSZ01000019",85.333,4.52e-171,604,600,511.998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLSN01000023",85.333,4.52e-171,604,600,511.998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLSZ01000019",85.279,4.78e-171,604,591,503.99889,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_10443","NZ_MLSN01000023",85.279,4.78e-171,604,591,503.99889,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLSZ01000019",87.313,1.38e-170,603,536,467.99768,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLSN01000023",87.313,1.38e-170,603,536,467.99768,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLSZ01000019",85.544,1.53e-170,603,588,502.99872,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLSN01000023",85.544,1.53e-170,603,588,502.99872,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_MLVX01000038",85.544,1.53e-170,603,588,502.99872,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_JAMKRA010000075",86.827,6.49e-170,601,539,467.99753,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_JAMKQZ010000090",86.827,6.49e-170,601,539,467.99753,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_JAMKTM010000045",86.827,6.49e-170,601,539,467.99753,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLSZ01000019",82.411,2.38e-169,599,705,580.99755,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLSN01000023",82.411,2.38e-169,599,705,580.99755,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_MLVX01000038",82.411,2.38e-169,599,705,580.99755,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLSZ01000019",87.194,6.4e-169,597,531,463.00014,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLSN01000023",87.194,6.4e-169,597,531,463.00014,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_MLVX01000038",87.194,6.4e-169,597,531,463.00014,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLSZ01000019",80.146,1.17e-168,597,821,657.99866,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_MLSN01000023",80.146,1.17e-168,597,821,657.99866,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_JAMKRA010000075",85.374,7.14e-169,597,588,501.99912,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_1416","NZ_JAMKTM010000045",85.374,7.14e-169,597,588,501.99912,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLSZ01000019",86.642,3.02e-168,595,539,467.00038,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLSN01000023",86.642,3.02e-168,595,539,467.00038,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_JAMKRA010000075",83.158,2.9e-168,595,665,553.0007,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_JAMKQZ010000090",83.158,2.9e-168,595,665,553.0007,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB_vs_bact_coverage_filtered_hits","k127_1042","NZ_JAMKTM010000045",83.158,2.9e-168,595,665,553.0007,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLVX01000038",84.754,2.7e-168,595,610,516.9994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_JAMKRA010000075",82.436,3.08e-168,595,706,581.99816,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_JAMKTM010000045",82.436,3.08e-168,595,706,581.99816,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLVX01000038",87.945,8.06e-168,593,506,445.0017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_JAMKRA010000075",84.95,3.52e-167,592,598,508.001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_JAMKTM010000045",84.95,3.52e-167,592,598,508.001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLSZ01000019",87.921,2.9e-167,592,505,444.00105,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_11901","NZ_MLSN01000023",87.921,2.9e-167,592,505,444.00105,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_JAMKRA010000075",80,5.46e-167,592,820,656,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_JAMKQZ010000090",80,5.46e-167,592,820,656,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_15091","NZ_JAMKTM010000045",80,5.46e-167,592,820,656,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLSZ01000019",84.925,3.77e-167,592,597,507.00225,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT_vs_bact_coverage_filtered_hits","k127_572","NZ_MLSN01000023",84.925,3.77e-167,592,597,507.00225,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLVX01000038",81.234,1.53e-166,590,778,632.00052,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16732","NZ_MLVX01000038",86.456,1.41e-166,590,539,465.99784,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLSZ01000019",82.32,1.43e-166,590,707,582.0024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLSN01000023",82.32,1.43e-166,590,707,582.0024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_2003","NZ_MLVX01000038",82.27,1.43e-166,590,705,580.0035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_3488","NZ_MLVX01000038",84.859,4.55e-166,588,601,510.00259,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_JAMKRA010000075",83.257,4.76e-166,588,657,546.99849,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_JAMKTM010000045",83.257,4.76e-166,588,657,546.99849,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15897","NZ_MLVX01000038",86.729,1.39e-165,586,535,464.00015,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLSZ01000019",88.525,5.04e-165,584,488,432.002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_16536","NZ_MLSN01000023",88.525,5.04e-165,584,488,432.002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_JAMKRA010000075",84.957,5.5e-165,584,585,496.99845,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_JAMKTM010000045",84.957,5.5e-165,584,585,496.99845,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_JAMKRA010000075",85.077,5.47e-165,584,583,495.99891,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_JAMKTM010000045",85.077,5.47e-165,584,583,495.99891,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_JAMKRA010000075",82.037,2.4e-164,582,707,580.00159,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_JAMKQZ010000090",82.037,2.4e-164,582,707,580.00159,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_8642","NZ_JAMKTM010000045",82.037,2.4e-164,582,707,580.00159,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLSZ01000019",80.715,4.95e-164,582,783,631.99845,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_12475","NZ_MLSN01000023",80.715,4.95e-164,582,783,631.99845,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_JAMKTM010000045",81.057,2.57e-164,582,776,629.00232,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_JAMKRA010000075",86.629,6.44e-164,580,531,459.99999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_JAMKQZ010000090",86.629,6.44e-164,580,531,459.99999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_984","NZ_JAMKTM010000045",86.629,6.44e-164,580,531,459.99999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_JAMKRA010000075",81.183,4.12e-163,579,744,604.00152,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_JAMKTM010000045",81.183,4.12e-163,579,744,604.00152,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLVX01000038",83.005,2.86e-163,579,659,547.00295,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_JAMKRA010000075",82.184,3.07e-163,579,696,572.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_JAMKTM010000045",82.184,3.07e-163,579,696,572.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLSZ01000019",84.708,3.29e-162,575,582,493.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLSN01000023",84.708,3.29e-162,575,582,493.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_JAMKRA010000075",80.799,5.56e-161,571,776,627.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLSZ01000019",87.885,3.79e-161,571,487,427.99995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLSN01000023",87.885,3.79e-161,571,487,427.99995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_JAMKRA010000075",87.885,3.79e-161,571,487,427.99995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_JAMKQZ010000090",87.885,3.79e-161,571,487,427.99995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_JAMKTM010000045",87.885,3.79e-161,571,487,427.99995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_JAMKRA010000075",82.242,5.35e-161,571,687,565.00254,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_JAMKTM010000045",82.242,5.35e-161,571,687,565.00254,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLSZ01000019",86.564,4.02e-161,571,521,450.99844,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLSN01000023",86.564,4.02e-161,571,521,450.99844,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLSZ01000019",84.655,5.5e-160,568,580,490.999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLSN01000023",84.655,5.5e-160,568,580,490.999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_MLVX01000038",84.655,5.5e-160,568,580,490.999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLSZ01000019",82.164,6.5e-160,568,684,562.00176,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLSN01000023",82.164,6.5e-160,568,684,562.00176,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_MLVX01000038",82.164,6.5e-160,568,684,562.00176,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLVX01000038",79.731,4.27e-159,566,819,652.99689,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_JAMKRA010000075",79.731,4.27e-159,566,819,652.99689,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_JAMKQZ010000090",79.731,4.27e-159,566,819,652.99689,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_JAMKTM010000045",79.731,4.27e-159,566,819,652.99689,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLSZ01000019",80.92,3.21e-159,566,739,597.9988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLSN01000023",80.92,3.21e-159,566,739,597.9988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT_vs_bact_coverage_filtered_hits","k127_119","NZ_MLVX01000038",87.68,1.76e-159,566,487,427.0016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_MLVX01000038",86.372,1.87e-159,566,521,449.99812,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLVX01000038",84.3,7.16e-159,564,586,493.998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLSZ01000019",81.267,1.54e-158,564,726,589.99842,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_9518","NZ_MLSN01000023",81.267,1.54e-158,564,726,589.99842,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_JAMKRA010000075",84.444,7.11e-159,564,585,493.9974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_JAMKTM010000045",84.444,7.11e-159,564,585,493.9974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_JAMKRA010000075",82.018,3.03e-158,562,684,561.00312,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_JAMKQZ010000090",82.018,3.03e-158,562,684,561.00312,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_5488","NZ_JAMKTM010000045",82.018,3.03e-158,562,684,561.00312,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_JAMKRA010000075",74.963,6.39e-158,562,1366,1023.99458,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_JAMKTM010000045",74.963,6.39e-158,562,1366,1023.99458,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLVX01000038",79.634,2.05e-156,556,820,652.9988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_JAMKRA010000075",86.444,1.14e-156,556,509,439.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_JAMKTM010000045",86.444,1.14e-156,556,509,439.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_JAMKRA010000075",88.085,1.12e-156,556,470,413.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_JAMKQZ010000090",88.223,1.12e-156,556,467,412.00141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_4131","NZ_JAMKTM010000045",88.085,1.12e-156,556,470,413.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_JAMKRA010000075",80.716,6.46e-156,555,726,585.99816,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_JAMKQZ010000090",80.716,6.46e-156,555,726,585.99816,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_JAMKTM010000045",80.716,6.46e-156,555,726,585.99816,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_JAMKRA010000075",87.759,4.41e-156,555,482,422.99838,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_JAMKQZ010000090",87.759,4.41e-156,555,482,422.99838,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_JAMKTM010000045",87.759,4.41e-156,555,482,422.99838,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_JAMKRA010000075",85.633,1.82e-155,553,529,452.99857,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_JAMKQZ010000090",85.526,1.82e-155,553,532,454.99832,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_JAMKTM010000045",85.633,1.82e-155,553,529,452.99857,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT_vs_bact_coverage_filtered_hits","k127_591","NZ_MLVX01000038",84.048,1.54e-155,553,583,489.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLSZ01000019",87.949,1.59e-155,553,473,415.99877,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLSN01000023",87.949,1.59e-155,553,473,415.99877,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3457","NZ_MLVX01000038",87.949,1.59e-155,553,473,415.99877,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLSZ01000019",78.36,9.37e-155,551,878,688.0008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLSN01000023",78.36,9.37e-155,551,878,688.0008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_MLVX01000038",78.36,9.37e-155,551,878,688.0008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_JAMKRA010000075",84.138,5.54e-155,551,580,488.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_1592","NZ_JAMKTM010000045",84.138,5.54e-155,551,580,488.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_30338","NZ_MLVX01000038",80.541,3.23e-154,549,740,596.0034,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLSZ01000019",88.767,3.11e-154,549,454,403.00218,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_9046","NZ_MLSN01000023",88.767,3.11e-154,549,454,403.00218,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLSZ01000019",78.348,1.24e-153,547,896,701.99808,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLSN01000023",78.348,1.24e-153,547,896,701.99808,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLSZ01000019",83.932,7.16e-154,547,585,491.0022,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLSN01000023",83.932,7.16e-154,547,585,491.0022,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLSZ01000019",81.349,8.67e-154,547,697,567.00253,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLSN01000023",81.349,8.67e-154,547,697,567.00253,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RT_vs_bact_coverage_filtered_hits","k127_15233","NZ_MLVX01000038",81.422,8.67e-154,547,689,560.99758,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_JAMKRA010000075",78.991,4.45e-153,545,852,673.00332,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_JAMKTM010000045",78.991,4.45e-153,545,852,673.00332,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLVX01000038",85.255,3.94e-152,542,529,450.99895,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLVX01000038",74.814,9.08e-152,542,1342,1004.00388,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLSZ01000019",82.616,3.59e-152,542,627,518.00232,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLSN01000023",82.616,3.59e-152,542,627,518.00232,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_MLVX01000038",82.616,3.59e-152,542,627,518.00232,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_2126","NZ_MLVX01000038",83.733,3.33e-152,542,584,489.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLVX01000038",82.595,4.2e-152,542,632,522.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLSZ01000019",88.546,5.71e-152,542,454,401.99884,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3824","NZ_MLSN01000023",88.546,5.71e-152,542,454,401.99884,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_JAMKRA010000075",81.711,1.4e-151,540,678,554.00058,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLSZ01000019",85.855,1.14e-151,540,509,437.00195,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLSN01000023",85.855,1.14e-151,540,509,437.00195,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_2577","NZ_MLVX01000038",85.855,1.14e-151,540,509,437.00195,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLVX01000038",80.33,6.51e-151,538,727,583.9991,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLSZ01000019",82.198,4.8e-151,538,646,530.99908,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLSN01000023",82.198,4.8e-151,538,646,530.99908,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_MLVX01000038",82.198,4.8e-151,538,646,530.99908,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLSZ01000019",85.122,1.83e-150,536,531,451.99782,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_8710","NZ_MLSN01000023",85.122,1.83e-150,536,531,451.99782,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_MLVX01000038",78.052,2.69e-150,536,893,697.00436,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLSZ01000019",83.821,6.88e-150,534,581,487.00001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_18327","NZ_MLSN01000023",83.821,6.88e-150,534,581,487.00001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLVX01000038",82.82,5.86e-150,534,617,510.9994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLSZ01000019",80.193,3.03e-149,532,727,583.00311,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_14542","NZ_MLSN01000023",80.193,3.03e-149,532,727,583.00311,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_JAMKRA010000075",82.764,2.11e-149,532,615,508.9986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_JAMKTM010000045",82.764,2.11e-149,532,615,508.9986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_JAMKRA010000075",82.043,2.23e-149,532,646,529.99778,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_JAMKQZ010000090",82.043,2.23e-149,532,646,529.99778,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_20384","NZ_JAMKTM010000045",82.043,2.23e-149,532,646,529.99778,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_JAMKTM010000045",81.416,3.03e-148,529,678,552.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_JAMKRA010000075",90.657,1.01e-147,527,396,359.00172,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_JAMKQZ010000090",90.657,1.01e-147,527,396,359.00172,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_4791","NZ_JAMKTM010000045",90.657,1.01e-147,527,396,359.00172,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_JAMKRA010000075",77.877,5.82e-147,525,895,696.99915,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_JAMKQZ010000090",77.877,5.82e-147,525,895,696.99915,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_12941","NZ_JAMKTM010000045",77.877,5.82e-147,525,895,696.99915,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLVX01000038",79.012,5.91e-147,525,810,639.9972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_JAMKRA010000075",82.381,3.63e-147,525,630,519.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_JAMKTM010000045",82.381,3.63e-147,525,630,519.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_JAMKRA010000075",78.478,4.99e-147,525,841,659.99998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_78293","NZ_MLVX01000038",76.326,1.08e-145,521,1056,806.00256,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLVX01000038",78.436,6.46e-146,521,844,661.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLVX01000038",78.967,4.49e-145,520,813,642.00171,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_JAMKRA010000075",83.813,1.49e-145,520,556,466.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_JAMKTM010000045",83.813,1.49e-145,520,556,466.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLVX01000038",78.941,3.31e-145,520,812,641.00092,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLSZ01000019",87.336,1.59e-145,520,458,399.99888,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_4038","NZ_MLSN01000023",87.336,1.59e-145,520,458,399.99888,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_JAMKRA010000075",77.727,9.51e-145,518,880,683.9976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_JAMKQZ010000090",77.727,9.51e-145,518,880,683.9976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_29247","NZ_JAMKTM010000045",77.727,9.51e-145,518,880,683.9976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLVX01000038",82.063,2.18e-144,516,630,516.9969,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLVX01000038",83.633,1.93e-144,516,556,464.99948,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_JAMKTM010000045",78.214,1.08e-143,514,840,656.9976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_JAMKRA010000075",83.303,1.26e-142,510,557,463.99771,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_JAMKQZ010000090",83.303,1.26e-142,510,557,463.99771,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_JAMKTM010000045",83.303,1.26e-142,510,557,463.99771,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLVX01000038",80,4.12e-142,508,700,560,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLVX01000038",79.034,7.27e-142,508,787,621.99758,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_JAMKRA010000075",82.421,3.52e-142,508,603,496.99863,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_JAMKTM010000045",82.421,3.52e-142,508,603,496.99863,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLSZ01000019",83.948,3.55e-142,508,542,454.99816,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_5925","NZ_MLSN01000023",83.948,3.55e-142,508,542,454.99816,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLVX01000038",80.882,3.94e-142,508,680,549.9976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLVX01000038",81.194,5.03e-141,505,670,543.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_JAMKRA010000075",78.456,7.71e-141,505,803,630.00168,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_JAMKTM010000045",78.456,7.71e-141,505,803,630.00168,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_JAMKRA010000075",75.954,1.26e-140,505,1048,795.99792,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_JAMKTM010000045",75.954,1.26e-140,505,1048,795.99792,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLVX01000038",81.476,5.05e-141,505,637,519.00212,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLSZ01000019",79.857,1.92e-140,503,700,558.999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_MLSN01000023",79.857,1.92e-140,503,700,558.999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLVX01000038",84.333,1.8e-139,499,517,436.00161,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_JAMKRA010000075",79.944,2.48e-139,499,713,570.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_JAMKQZ010000090",79.944,2.48e-139,499,713,570.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_JAMKTM010000045",79.944,2.48e-139,499,713,570.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_JAMKRA010000075",84.333,6.49e-139,497,517,436.00161,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_JAMKTM010000045",84.333,6.49e-139,497,517,436.00161,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLVX01000038",82.293,7.38e-139,497,593,487.99749,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLSZ01000019",82.948,8.45e-139,497,563,466.99724,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_MLSN01000023",82.948,8.45e-139,497,563,466.99724,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_JAMKRA010000075",81.319,8.45e-139,497,637,518.00203,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_16232","NZ_JAMKTM010000045",81.319,8.45e-139,497,637,518.00203,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLVX01000038",84.479,2.49e-138,496,509,429.99811,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_JAMKRA010000075",84.479,2.49e-138,496,509,429.99811,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_JAMKQZ010000090",84.479,2.49e-138,496,509,429.99811,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_JAMKTM010000045",84.479,2.49e-138,496,509,429.99811,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLSZ01000019",83.738,2.66e-138,496,535,447.9983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_MLSN01000023",83.738,2.66e-138,496,535,447.9983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_JAMKRA010000075",82.234,2.66e-138,496,591,486.00294,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6221","NZ_JAMKTM010000045",82.234,2.66e-138,496,591,486.00294,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_JAMKRA010000075",81.429,2.83e-138,496,630,513.0027,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_JAMKTM010000045",81.429,2.83e-138,496,630,513.0027,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLVX01000038",83.06,1.27e-137,494,549,455.9994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_JAMKRA010000075",80.455,3.92e-137,492,660,531.003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_JAMKQZ010000090",80.455,3.92e-137,492,660,531.003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_JAMKTM010000045",80.455,3.92e-137,492,660,531.003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLSZ01000019",82.245,3.5e-137,492,597,491.00265,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLSN01000023",82.245,3.5e-137,492,597,491.00265,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_JAMKRA010000075",80.867,3.91e-137,492,669,541.00023,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_JAMKTM010000045",80.867,3.91e-137,492,669,541.00023,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLSZ01000019",79.804,4.15e-137,492,713,569.00252,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLSN01000023",79.804,4.15e-137,492,713,569.00252,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLSZ01000019",84.283,1.16e-136,490,509,429.00047,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_15439","NZ_MLSN01000023",84.283,1.16e-136,490,509,429.00047,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_JAMKRA010000075",80.51,1.86e-136,490,667,537.0017,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_JAMKTM010000045",80.51,1.86e-136,490,667,537.0017,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_JAMKRA010000075",78.462,9.47e-136,488,780,612.0036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_JAMKTM010000045",78.462,9.47e-136,488,780,612.0036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLVX01000038",81.758,4.59e-136,488,603,493.00074,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_JAMKRA010000075",78.137,9.34e-136,488,805,629.00285,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_JAMKTM010000045",78.137,9.34e-136,488,805,629.00285,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLSZ01000019",82.878,5.92e-136,488,549,455.00022,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_25310","NZ_MLSN01000023",82.878,5.92e-136,488,549,455.00022,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLVX01000038",80.303,1.82e-135,486,660,529.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_MLVX01000038",82.077,1.63e-135,486,597,489.99969,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_12748","NZ_MLVX01000038",79.663,1.93e-135,486,713,567.99719,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLVX01000038",79.24,1.15e-134,484,737,583.9988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLSZ01000019",80.152,8.49e-134,481,660,529.0032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_18761","NZ_MLSN01000023",80.152,8.49e-134,481,660,529.0032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLSZ01000019",81.818,3.05e-133,479,605,494.9989,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_97","NZ_MLSN01000023",81.818,3.05e-133,479,605,494.9989,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_JAMKRA010000075",82.241,2.62e-133,479,580,476.9978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_JAMKTM010000045",82.241,2.62e-133,479,580,476.9978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_JAMKRA010000075",82.826,2.55e-133,479,559,462.99734,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_JAMKTM010000045",82.826,2.55e-133,479,559,462.99734,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLVX01000038",81.059,2.84e-133,479,623,504.99757,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_JAMKRA010000075",79.286,1.16e-132,477,700,555.002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_JAMKQZ010000090",79.286,1.16e-132,477,700,555.002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_36600","NZ_JAMKTM010000045",79.286,1.16e-132,477,700,555.002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_JAMKRA010000075",81.059,1.02e-132,477,623,504.99757,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_JAMKTM010000045",81.059,1.02e-132,477,623,504.99757,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSZ01000019",80.03,1.45e-132,477,666,532.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSN01000023",80.03,1.45e-132,477,666,532.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLVX01000038",80,1.45e-132,477,665,532,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_JAMKRA010000075",81.742,3.52e-132,475,597,487.99974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_14984","NZ_JAMKTM010000045",81.742,3.52e-132,475,597,487.99974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8236","NZ_JAMKQZ010000090",87.53,4.78e-132,475,417,365.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_JAMKRA010000075",83.689,1.4e-130,470,515,430.99835,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_JAMKTM010000045",83.689,1.4e-130,470,515,430.99835,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLVX01000038",82.585,1.53e-130,470,557,459.99845,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLVX01000038",81.818,6.46e-130,468,572,467.99896,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_JAMKRA010000075",83.626,2.25e-129,466,513,429.00138,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_JAMKTM010000045",83.626,2.25e-129,466,513,429.00138,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLSZ01000019",79.476,8.76e-129,464,687,546.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLSN01000023",79.476,8.76e-129,464,687,546.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_JAMKRA010000075",79.476,8.76e-129,464,687,546.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_JAMKQZ010000090",79.476,8.76e-129,464,687,546.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_JAMKTM010000045",79.476,8.76e-129,464,687,546.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLVX01000038",81.169,9.27e-129,464,616,500.00104,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLSZ01000019",81.661,7.33e-129,464,578,472.00058,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLSN01000023",81.661,7.33e-129,464,578,472.00058,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLSZ01000019",82.406,7.14e-129,464,557,459.00142,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_4753","NZ_MLSN01000023",82.406,7.14e-129,464,557,459.00142,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLSZ01000019",82.44,2.86e-128,462,541,446.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15298","NZ_MLSN01000023",82.44,2.86e-128,462,541,446.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLSZ01000019",82.987,8.83e-128,460,529,439.00123,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLSN01000023",82.987,8.83e-128,460,529,439.00123,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_MLVX01000038",82.987,8.83e-128,460,529,439.00123,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_JAMKRA010000075",75.77,1.93e-127,460,974,737.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_JAMKTM010000045",75.77,1.93e-127,460,974,737.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_JAMKRA010000075",86.105,8.74e-128,460,439,378.00095,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_JAMKQZ010000090",86.105,8.74e-128,460,439,378.00095,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_JAMKTM010000045",86.105,8.74e-128,460,439,378.00095,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_16738","NZ_MLVX01000038",79.33,4.08e-127,459,687,544.9971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLSZ01000019",81.25,3.59e-127,459,592,481,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLSN01000023",81.25,3.59e-127,459,592,481,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_MLVX01000038",81.25,3.59e-127,459,592,481,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_JAMKRA010000075",81.882,3.34e-127,459,574,470.00268,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_MLVX01000038",81.488,3.41e-127,459,578,471.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLSZ01000019",82.682,3.14e-127,459,537,444.00234,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLSN01000023",82.682,3.14e-127,459,537,444.00234,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB_vs_bact_coverage_filtered_hits","k127_666","NZ_MLVX01000038",82.682,3.14e-127,459,537,444.00234,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_JAMKRA010000075",83.074,3.04e-127,459,514,427.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_JAMKTM010000045",83.074,3.04e-127,459,514,427.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLVX01000038",81.04,1.28e-126,457,596,482.9984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLVX01000038",84.681,1.36e-126,457,470,398.0007,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAMKRA010000075",83.537,1.33e-126,457,492,411.00204,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAMKQZ010000090",83.537,1.33e-126,457,492,411.00204,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAMKTM010000045",83.537,1.33e-126,457,492,411.00204,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLSZ01000019",82.576,4.6e-126,455,528,436.00128,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_MLSN01000023",82.576,4.6e-126,455,528,436.00128,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_JAMKRA010000075",81.04,4.6e-126,455,596,482.9984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40476","NZ_JAMKTM010000045",81.04,4.6e-126,455,596,482.9984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_JAMKRA010000075",82.798,4.11e-126,455,529,438.00142,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_JAMKQZ010000090",82.798,4.11e-126,455,529,438.00142,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_7526","NZ_JAMKTM010000045",82.798,4.11e-126,455,529,438.00142,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLVX01000038",83.466,1.41e-125,453,502,418.99932,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLSZ01000019",82.331,9.58e-125,451,532,438.00092,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20352","NZ_MLSN01000023",82.331,9.58e-125,451,532,438.00092,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLVX01000038",83.333,6.21e-125,451,492,409.99836,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_JAMKRA010000075",82.386,1.87e-124,449,528,434.99808,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_JAMKTM010000045",82.386,1.87e-124,449,528,434.99808,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_JAMKRA010000075",81.154,2.07e-124,449,589,477.99706,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_JAMKTM010000045",81.533,7.23e-124,448,574,467.99942,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_JAMKRA010000075",80.65,9.33e-124,448,615,495.9975,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_JAMKTM010000045",80.65,9.33e-124,448,615,495.9975,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLSZ01000019",84.322,2.93e-123,446,472,397.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_32311","NZ_MLSN01000023",84.322,2.93e-123,446,472,397.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSZ01000019",83.13,2.89e-123,446,492,408.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSN01000023",83.13,2.89e-123,446,492,408.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLSZ01000019",84.396,9.74e-123,444,455,384.0018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_11123","NZ_MLSN01000023",84.396,9.74e-123,444,455,384.0018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLSZ01000019",83.367,1.03e-122,444,499,416.00133,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLSN01000023",83.367,1.03e-122,444,499,416.00133,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_MLVX01000038",83.367,1.03e-122,444,499,416.00133,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLVX01000038",82.524,8.5e-123,444,515,424.9986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLSZ01000019",82.745,1.09e-122,444,510,421.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_9270","NZ_MLSN01000023",82.745,1.09e-122,444,510,421.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_JAMKRA010000075",81.326,3.36e-122,442,573,465.99798,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLSZ01000019",82.319,3.62e-122,442,526,432.99794,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_7336","NZ_MLSN01000023",82.319,3.62e-122,442,526,432.99794,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLSZ01000019",80.519,4.34e-122,442,616,495.99704,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_16764","NZ_MLSN01000023",80.519,4.34e-122,442,616,495.99704,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLSZ01000019",83.101,3.06e-122,442,503,417.99803,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_1777","NZ_MLSN01000023",83.101,3.06e-122,442,503,417.99803,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_JAMKRA010000075",81.475,3.32e-122,442,556,453.001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_JAMKTM010000045",81.475,3.32e-122,442,556,453.001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLSZ01000019",81.387,1.52e-121,440,548,446.00076,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLSN01000023",81.387,1.52e-121,440,548,446.00076,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_JAMKRA010000075",82.184,6.38e-121,438,522,429.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_JAMKQZ010000090",82.184,6.38e-121,438,522,429.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_JAMKTM010000045",82.184,6.38e-121,438,522,429.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_JAMKTM010000045",80.847,4.48e-121,438,590,476.9973,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_JAMKRA010000075",80.607,1.68e-120,436,593,477.99951,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_JAMKQZ010000090",80.607,1.68e-120,436,593,477.99951,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_9115","NZ_JAMKTM010000045",80.607,1.68e-120,436,593,477.99951,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_MLVX01000038",81.204,7.07e-120,435,548,444.99792,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_JAMKRA010000075",81.204,7.07e-120,435,548,444.99792,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_JAMKQZ010000090",81.204,7.07e-120,435,548,444.99792,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_14085","NZ_JAMKTM010000045",81.204,7.07e-120,435,548,444.99792,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLVX01000038",81.853,5.23e-120,435,529,433.00237,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLSZ01000019",81.973,5.22e-120,435,527,431.99771,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLSN01000023",81.973,5.22e-120,435,527,431.99771,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_MLVX01000038",81.973,5.22e-120,435,527,431.99771,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLSZ01000019",83.991,5.56e-120,435,456,382.99896,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_18423","NZ_MLSN01000023",83.991,5.56e-120,435,456,382.99896,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_JAMKRA010000075",83.034,6.21e-120,435,501,416.00034,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_JAMKQZ010000090",82.937,6.21e-120,435,504,418.00248,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT_vs_bact_coverage_filtered_hits","k127_2323","NZ_JAMKTM010000045",83.034,6.21e-120,435,501,416.00034,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLSZ01000019",84.106,5.12e-120,435,453,381.00018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_1631","NZ_MLSN01000023",84.106,5.12e-120,435,453,381.00018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLVX01000038",81.992,2.97e-119,433,522,427.99824,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLVX01000038",81.216,2.01e-119,433,559,453.99744,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_JAMKTM010000045",81.424,1.98e-119,433,576,469.00224,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_JAMKRA010000075",80.702,2.36e-119,433,570,460.0014,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_JAMKTM010000045",80.702,2.36e-119,433,570,460.0014,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLSZ01000019",85.082,1.07e-118,431,429,365.00178,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_4638","NZ_MLSN01000023",85.082,1.07e-118,431,429,365.00178,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_JAMKTM010000045",81.01,7.28e-119,431,574,464.9974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLSZ01000019",82.892,7.22e-119,431,491,406.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_MLSN01000023",82.892,7.22e-119,431,491,406.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLSZ01000019",83.956,6.67e-119,431,455,381.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_4651","NZ_MLSN01000023",83.956,6.67e-119,431,455,381.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLSZ01000019",80.919,2.62e-118,429,566,458.00154,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLSN01000023",80.919,2.62e-118,429,566,458.00154,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_MLVX01000038",80.919,2.62e-118,429,566,458.00154,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_JAMKRA010000075",81.749,2.43e-118,429,526,429.99974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_JAMKQZ010000090",81.749,2.43e-118,429,526,429.99974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5067","NZ_JAMKTM010000045",81.749,2.43e-118,429,526,429.99974,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLSZ01000019",81.071,2.58e-118,429,560,453.9976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLSN01000023",81.071,2.58e-118,429,560,453.9976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLSZ01000019",81.923,9.31e-118,427,520,425.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLSN01000023",81.923,9.31e-118,427,520,425.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLSZ01000019",81.749,8.72e-118,427,526,429.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLSN01000023",81.749,8.72e-118,427,526,429.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_MLVX01000038",81.749,8.72e-118,427,526,429.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLSZ01000019",78.701,4.05e-117,425,662,521.00062,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLSN01000023",78.701,4.05e-117,425,662,521.00062,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_JAMKRA010000075",81.835,3.14e-117,425,534,436.9989,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_JAMKTM010000045",81.835,3.14e-117,425,534,436.9989,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_JAMKRA010000075",80.742,1.22e-116,424,566,456.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_JAMKQZ010000090",80.742,1.22e-116,424,566,456.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_15473","NZ_JAMKTM010000045",80.742,1.22e-116,424,566,456.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLVX01000038",80.405,1.25e-116,424,592,475.9976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_JAMKRA010000075",84.494,1.16e-116,424,445,375.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_JAMKTM010000045",84.494,1.16e-116,424,445,375.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAMKRA010000075",79.073,5.16e-116,422,626,494.99698,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAMKQZ010000090",79.073,5.16e-116,422,626,494.99698,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_JAMKTM010000045",79.073,5.16e-116,422,626,494.99698,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_MLVX01000038",81.731,4.33e-116,422,520,425.0012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_JAMKRA010000075",80.961,4.29e-116,422,562,455.00082,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_JAMKRA010000075",81.076,4.29e-116,422,576,466.99776,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_JAMKRA010000075",81.489,4.06e-116,422,524,427.00236,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_8989","NZ_JAMKTM010000045",81.489,4.06e-116,422,524,427.00236,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_MLVX01000038",78.55,1.89e-115,420,662,520.001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_JAMKRA010000075",80.859,1.56e-115,420,559,452.00181,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_8717","NZ_JAMKTM010000045",80.859,1.56e-115,420,559,452.00181,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLSZ01000019",78.099,1.99e-115,420,726,566.99874,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLSN01000023",78.099,1.99e-115,420,726,566.99874,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLVX01000038",84.34,1.5e-115,420,447,376.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLSZ01000019",85.468,6.33e-115,418,406,347.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLSN01000023",85.468,6.33e-115,418,406,347.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLVX01000038",80.556,2.04e-114,416,576,464.00256,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSZ01000019",78.914,2.4e-114,416,626,494.00164,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLSN01000023",78.914,2.4e-114,416,626,494.00164,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_JAMKRA010000075",83.297,2.01e-114,416,461,383.99917,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_JAMKQZ010000090",83.297,2.01e-114,416,461,383.99917,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_21281","NZ_JAMKTM010000045",83.297,2.01e-114,416,461,383.99917,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLVX01000038",80.556,2.04e-114,416,576,464.00256,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLVX01000038",81.495,1.89e-114,416,535,435.99825,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1150","NZ_JAMKQZ010000090",87.139,2.82e-114,416,381,331.99959,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_MLVX01000038",77.961,9.27e-114,414,726,565.99686,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_JAMKRA010000075",77.87,9.27e-114,414,723,563.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_JAMKTM010000045",77.87,9.27e-114,414,723,563.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_MLVX01000038",85.222,2.95e-113,412,406,346.00132,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLSZ01000019",82.258,2.55e-113,412,496,407.99968,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLSN01000023",82.258,2.55e-113,412,496,407.99968,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLVX01000038",80.531,2.64e-113,412,565,455.00015,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLVX01000038",80.763,2.58e-113,412,577,466.00251,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_7196","NZ_MLVX01000038",78.754,1.12e-112,411,626,493.00004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLSZ01000019",83.077,8.82e-113,411,455,378.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_1610","NZ_MLSN01000023",83.077,8.82e-113,411,455,378.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_JAMKTM010000045",80.639,9.29e-113,411,563,453.99757,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLSZ01000019",82.452,1.04e-112,411,473,389.99796,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLSN01000023",82.452,1.04e-112,411,473,389.99796,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_JAMKRA010000075",82.452,1.04e-112,411,473,389.99796,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_JAMKQZ010000090",82.452,1.04e-112,411,473,389.99796,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_JAMKTM010000045",82.452,1.04e-112,411,473,389.99796,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLSZ01000019",81.006,3.63e-112,409,537,435.00222,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLSN01000023",81.006,3.63e-112,409,537,435.00222,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_MLVX01000038",82.056,1.19e-111,407,496,406.99776,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_MLVX01000038",78.956,1.4e-111,407,632,499.00192,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_MLVX01000038",80.427,1.21e-111,407,562,451.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_JAMKRA010000075",78.012,5.28e-111,405,664,517.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_JAMKQZ010000090",78.012,5.28e-111,405,664,517.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_4757","NZ_JAMKTM010000045",78.012,5.28e-111,405,664,517.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLSZ01000019",81.418,3.99e-111,405,522,425.00196,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLSN01000023",81.418,3.99e-111,405,522,425.00196,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2878","NZ_MLVX01000038",82.241,4.85e-111,405,473,388.99993,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_MLVX01000038",80.819,1.69e-110,403,537,433.99803,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLSZ01000019",81.928,1.59e-110,403,498,408.00144,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_MLSN01000023",81.928,1.59e-110,403,498,408.00144,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_JAMKRA010000075",79.829,2.13e-109,399,585,466.99965,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_JAMKRA010000075",78.73,2.34e-109,399,630,495.999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_6875","NZ_JAMKTM010000045",78.73,2.34e-109,399,630,495.999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_4133","NZ_JAMKQZ010000090",86.364,2.1e-109,399,374,323.00136,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_JAMKRA010000075",81.653,2.57e-108,396,496,404.99888,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_30481","NZ_JAMKTM010000045",81.653,2.57e-108,396,496,404.99888,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_6274","NZ_MLVX01000038",80.177,2.6e-108,396,565,453.00005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_JAMKRA010000075",72.76,2.41e-107,394,1395,1015.002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_JAMKTM010000045",72.76,2.41e-107,394,1395,1015.002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_JAMKRA010000075",80,9.57e-108,394,565,452,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_2299","NZ_JAMKTM010000045",80,9.57e-108,394,565,452,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_JAMKRA010000075",78.846,1.06e-107,394,624,491.99904,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLSZ01000019",82.789,8.86e-108,394,459,380.00151,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_26166","NZ_MLSN01000023",82.789,8.86e-108,394,459,380.00151,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_JAMKRA010000075",83.066,3.13e-107,392,437,362.99842,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_JAMKQZ010000090",83.066,3.13e-107,392,437,362.99842,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_JAMKTM010000045",83.066,3.13e-107,392,437,362.99842,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_JAMKTM010000045",80.212,1.19e-106,390,566,453.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLVX01000038",85.6,1.14e-106,390,375,321,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_JAMKTM010000045",79.487,4.62e-106,388,585,464.99895,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_JAMKTM010000045",78.652,4.94e-106,388,623,490.00196,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_JAMKRA010000075",80.224,1.7e-105,387,536,430.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_JAMKQZ010000090",79.371,1.7e-105,387,572,454.00212,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_12039","NZ_JAMKTM010000045",80.224,1.7e-105,387,536,430.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_JAMKRA010000075",80.614,1.87e-104,383,521,419.99894,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_JAMKTM010000045",80.614,1.87e-104,383,521,419.99894,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLSZ01000019",75.406,4.52e-104,383,862,649.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLSN01000023",75.406,4.52e-104,383,862,649.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_JAMKRA010000075",85.294,1.91e-104,383,374,318.99956,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_JAMKTM010000045",85.294,1.91e-104,383,374,318.99956,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_MLVX01000038",79.894,7.14e-104,381,567,452.99898,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLSZ01000019",82.648,6.77e-104,381,438,361.99824,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLSN01000023",82.648,6.77e-104,381,438,361.99824,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15623","NZ_JAMKRA010000075",79.859,2.57e-103,379,566,452.00194,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLVX01000038",79.181,2.78e-103,379,586,464.00066,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12137","NZ_MLVX01000038",80.497,8.71e-103,377,523,420.99931,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLSZ01000019",75.347,2.43e-102,377,864,650.99808,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLSN01000023",75.347,2.43e-102,377,864,650.99808,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLSZ01000019",75.29,2e-102,377,862,648.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_15427","NZ_MLSN01000023",75.29,2e-102,377,862,648.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLSZ01000019",79.249,4.01e-102,375,559,443.00191,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLSN01000023",79.249,4.01e-102,375,559,443.00191,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_MLVX01000038",79.249,4.01e-102,375,559,443.00191,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_JAMKRA010000075",79.249,4.01e-102,375,559,443.00191,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_JAMKQZ010000090",79.249,4.01e-102,375,559,443.00191,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_5899","NZ_JAMKTM010000045",79.249,4.01e-102,375,559,443.00191,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_10278","NZ_JAMKQZ010000090",86.034,9.16e-102,375,358,308.00172,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLSZ01000019",82.287,6.17e-102,375,446,367.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_16573","NZ_MLSN01000023",82.287,6.17e-102,375,446,367.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLSZ01000019",78.317,6.3e-102,375,618,483.99906,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_27451","NZ_MLSN01000023",78.317,6.3e-102,375,618,483.99906,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2945","NZ_MLVX01000038",82.42,3.15e-102,375,438,360.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_JAMKRA010000075",73.208,2.72e-101,374,1172,857.99776,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_JAMKTM010000045",73.208,2.72e-101,374,1172,857.99776,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLSZ01000019",82.327,1.39e-101,374,447,368.00169,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2668","NZ_MLSN01000023",82.327,1.39e-101,374,447,368.00169,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLSZ01000019",75.203,1.33e-100,372,863,649.00189,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_5367","NZ_MLSN01000023",75.203,1.33e-100,372,863,649.00189,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_JAMKRA010000075",79.811,4.18e-101,372,530,422.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_JAMKQZ010000090",79.811,4.18e-101,372,530,422.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_JAMKTM010000045",79.811,4.18e-101,372,530,422.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLSZ01000019",78.155,3.53e-100,370,618,482.9979,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2658","NZ_MLSN01000023",78.155,3.53e-100,370,618,482.9979,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_JAMKRA010000075",78.803,5.95e-100,368,585,460.99755,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLSZ01000019",79.623,1.94e-99,366,530,422.0019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLSN01000023",79.623,1.94e-99,366,530,422.0019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB_vs_bact_coverage_filtered_hits","k127_1408","NZ_MLVX01000038",79.623,1.94e-99,366,530,422.0019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_19119","NZ_MLVX01000038",77.994,1.64e-98,364,618,482.00292,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_5834","NZ_MLVX01000038",78.029,1.89e-98,364,619,482.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLVX01000038",78.632,7.7e-99,364,585,459.9972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_JAMKRA010000075",78.275,2.83e-98,363,603,471.99825,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_JAMKQZ010000090",78.275,2.83e-98,363,603,471.99825,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_JAMKTM010000045",78.275,2.83e-98,363,603,471.99825,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_JAMKRA010000075",80.159,2.69e-98,363,504,404.00136,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_JAMKTM010000045",80.159,2.69e-98,363,504,404.00136,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLVX01000038",78.025,2.99e-98,363,628,489.997,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_JAMKTM010000045",81.579,2.77e-98,363,456,372.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLSZ01000019",75.533,2.28e-97,361,797,601.99801,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLSN01000023",75.533,2.28e-97,361,797,601.99801,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLSZ01000019",82.38,3.91e-97,359,437,360.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLSN01000023",82.38,3.91e-97,359,437,360.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_MLVX01000038",82.38,3.91e-97,359,437,360.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_JAMKRA010000075",79.342,3.31e-97,359,547,434.00074,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_JAMKTM010000045",81.922,1.19e-96,357,437,357.99914,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLVX01000038",82.464,4.28e-96,355,422,347.99808,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLSZ01000019",78.078,3.61e-95,353,593,463.00254,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_15681","NZ_MLSN01000023",78.078,3.61e-95,353,593,463.00254,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLVX01000038",79.842,1.62e-95,353,506,404.00052,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_MLVX01000038",78.843,3.81e-95,353,553,436.00179,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLSZ01000019",79.323,1.82e-95,353,532,421.99836,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLSN01000023",79.323,1.82e-95,353,532,421.99836,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLSZ01000019",77.944,6.13e-95,351,603,470.00232,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLSN01000023",77.944,6.13e-95,351,603,470.00232,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_JAMKRA010000075",73.195,1.37e-94,351,1108,811.0006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_6636","NZ_JAMKTM010000045",73.195,1.37e-94,351,1108,811.0006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_JAMKRA010000075",77.538,2.35e-94,350,650,503.997,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_JAMKTM010000045",77.538,2.35e-94,350,650,503.997,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_MLVX01000038",79.135,8.45e-94,348,532,420.9982,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_JAMKRA010000075",77.954,3.51e-93,346,567,441.99918,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_JAMKQZ010000090",77.875,3.51e-93,346,574,447.0025,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_JAMKTM010000045",77.954,3.51e-93,346,567,441.99918,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_872","NZ_MLVX01000038",77.778,2.85e-93,346,603,469.00134,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_MLVX01000038",78.739,9.61e-93,344,555,437.00145,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_JAMKRA010000075",78.887,9e-93,344,521,411.00127,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_JAMKQZ010000090",78.958,9e-93,344,518,409.00244,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_JAMKTM010000045",78.887,9e-93,344,521,411.00127,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_JAMKRA010000075",78.987,1.09e-92,344,533,421.00071,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_JAMKQZ010000090",78.987,1.09e-92,344,533,421.00071,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2442","NZ_JAMKTM010000045",78.987,1.09e-92,344,533,421.00071,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLSZ01000019",75.632,5.74e-92,342,751,567.99632,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLSN01000023",75.632,5.74e-92,342,751,567.99632,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLSZ01000019",79.447,3.5e-92,342,506,402.00182,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_MLSN01000023",79.447,3.5e-92,342,506,402.00182,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_JAMKRA010000075",81.368,1.49e-91,340,424,345.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_JAMKQZ010000090",81.368,1.49e-91,340,424,345.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_JAMKTM010000045",81.368,1.49e-91,340,424,345.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLSZ01000019",77.835,1.68e-90,337,582,452.9997,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLSN01000023",77.835,1.68e-90,337,582,452.9997,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_MLVX01000038",77.835,1.68e-90,337,582,452.9997,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLSZ01000019",77.509,1.68e-90,337,578,448.00202,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLSN01000023",77.509,1.68e-90,337,578,448.00202,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_MLVX01000038",77.509,1.68e-90,337,578,448.00202,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLSZ01000019",77.601,7.6e-90,335,567,439.99767,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLSN01000023",77.601,7.6e-90,335,567,439.99767,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_6492","NZ_MLVX01000038",77.601,7.6e-90,335,567,439.99767,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_JAMKRA010000075",86.755,6.56e-90,335,302,262.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_JAMKQZ010000090",86.755,6.56e-90,335,302,262.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_8791","NZ_JAMKTM010000045",86.755,6.56e-90,335,302,262.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_MLVX01000038",79.29,9.6e-90,335,507,402.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLSZ01000019",81.132,6.94e-90,335,424,343.99968,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLSN01000023",81.132,6.94e-90,335,424,343.99968,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_1931","NZ_MLVX01000038",81.132,6.94e-90,335,424,343.99968,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_JAMKRA010000075",77.68,7.48e-90,335,569,441.9992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_JAMKQZ010000090",77.68,7.48e-90,335,569,441.9992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_JAMKTM010000045",77.68,7.48e-90,335,569,441.9992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_JAMKRA010000075",81.818,2.08e-89,333,418,341.99924,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6943","NZ_JAMKTM010000045",81.818,2.08e-89,333,418,341.99924,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_22264","NZ_JAMKQZ010000090",81.306,2.37e-89,333,444,360.99864,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_JAMKRA010000075",77.375,7.81e-89,331,579,448.00125,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_JAMKQZ010000090",77.375,7.81e-89,331,579,448.00125,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_6540","NZ_JAMKTM010000045",77.375,7.81e-89,331,579,448.00125,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_JAMKRA010000075",78.352,7.03e-89,331,522,408.99744,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_JAMKQZ010000090",78.352,7.03e-89,331,522,408.99744,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_JAMKTM010000045",78.352,7.03e-89,331,522,408.99744,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_JAMKRA010000075",75.267,4.47e-88,329,748,562.99716,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_36071","NZ_JAMKTM010000045",75.267,4.47e-88,329,748,562.99716,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLVX01000038",78.352,9.06e-88,327,522,408.99744,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLSZ01000019",78.119,3.27e-87,326,521,406.99999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLSN01000023",78.119,3.27e-87,326,521,406.99999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_65074","NZ_MLVX01000038",78.119,3.27e-87,326,521,406.99999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLSZ01000019",77.329,1.62e-86,324,569,440.00201,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLSN01000023",77.329,1.62e-86,324,569,440.00201,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_5641","NZ_MLVX01000038",77.329,1.62e-86,324,569,440.00201,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_8384","NZ_JAMKQZ010000090",84.366,1.41e-86,324,339,286.00074,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLSZ01000019",78.161,4.22e-86,322,522,408.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_17406","NZ_MLSN01000023",78.161,4.22e-86,322,522,408.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_JAMKRA010000075",77.029,7.85e-84,315,579,445.99791,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_8451","NZ_JAMKTM010000045",77.029,7.85e-84,315,579,445.99791,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLSZ01000019",82.289,9.82e-83,311,367,302.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLSN01000023",82.289,9.82e-83,311,367,302.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_MLVX01000038",82.289,9.82e-83,311,367,302.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLSZ01000019",75.103,1.63e-82,311,731,549.00293,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLSN01000023",75.103,1.63e-82,311,731,549.00293,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_MLVX01000038",78.85,5.86e-82,309,487,383.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_JAMKRA010000075",76.263,1.36e-81,307,594,453.00222,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_JAMKQZ010000090",76.263,1.36e-81,307,594,453.00222,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_JAMKTM010000045",76.263,1.36e-81,307,594,453.00222,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLVX01000038",82.065,1.61e-80,303,368,301.9992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLSZ01000019",80.096,1.04e-79,302,417,334.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLSN01000023",80.096,1.04e-79,302,417,334.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_MLVX01000038",80.096,1.04e-79,302,417,334.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLSZ01000019",76.094,6.31e-80,302,594,451.99836,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLSN01000023",76.094,6.31e-80,302,594,451.99836,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_JAMKRA010000075",78.901,1.96e-79,300,455,358.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_JAMKQZ010000090",78.742,1.96e-79,300,461,363.00062,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_JAMKTM010000045",78.901,1.96e-79,300,455,358.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_JAMKRA010000075",77.885,7.03e-79,298,520,405.002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_JAMKRA010000075",74.725,1.27e-78,298,728,543.998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_3182","NZ_JAMKTM010000045",74.725,1.27e-78,298,728,543.998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080056T_vs_bact_coverage_filtered_hits","k127_20445","NZ_MLVX01000038",75.926,2.94e-78,296,594,451.00044,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_22485","NZ_JAMKQZ010000090",80.668,3.5e-78,296,419,337.99892,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLSZ01000019",78.557,8.1e-78,296,485,381.00145,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLSN01000023",78.557,8.1e-78,296,485,381.00145,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_MLVX01000038",78.557,8.1e-78,296,485,381.00145,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_15169","NZ_JAMKQZ010000090",78.557,8.1e-78,296,485,381.00145,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_MLVX01000038",78.603,1.32e-77,294,458,360.00174,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_MLVX01000038",76.382,1.04e-77,294,597,456.00054,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLSZ01000019",78.298,9.1e-78,294,470,368.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLSN01000023",78.298,9.1e-78,294,470,368.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_2553","NZ_MLVX01000038",78.298,9.1e-78,294,470,368.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_MLVX01000038",77.606,3.27e-77,292,518,401.99908,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46893","NZ_JAMKTM010000045",77.692,3.27e-77,292,520,403.9984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLVX01000038",76.735,3.47e-77,292,533,408.99755,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_19372","NZ_JAMKQZ010000090",97.076,4.66e-76,289,171,165.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLSZ01000019",81.301,1.62e-75,287,369,300.00069,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_2633","NZ_MLSN01000023",81.301,1.62e-75,287,369,300.00069,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLSZ01000019",76.548,1.61e-75,287,533,408.00084,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_MLSN01000023",76.548,1.61e-75,287,533,408.00084,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_JAMKRA010000075",80.978,5.95e-75,285,368,297.99904,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_JAMKQZ010000090",80.978,5.95e-75,285,368,297.99904,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_15148","NZ_JAMKTM010000045",80.978,5.95e-75,285,368,297.99904,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_JAMKRA010000075",78.289,7.92e-75,285,456,356.99784,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_3073","NZ_JAMKTM010000045",78.289,7.92e-75,285,456,356.99784,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_JAMKRA010000075",75.845,8.11e-74,281,592,449.0024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_24338","NZ_JAMKTM010000045",75.845,8.11e-74,281,592,449.0024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_MLVX01000038",76.619,9.81e-73,278,556,426.00164,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_MLVX01000038",80.429,1.49e-72,278,373,300.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_JAMKRA010000075",78.947,6.3e-72,276,418,329.99846,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_JAMKQZ010000090",80.769,6.3e-72,276,364,293.99916,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_43154","NZ_JAMKTM010000045",78.947,6.3e-72,276,418,329.99846,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_MLVX01000038",80.214,5.56e-71,272,374,300.00036,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLVX01000038",76.25,1.89e-70,270,560,427,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_JAMKRA010000075",76.396,1.64e-70,270,555,423.9978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_3507","NZ_JAMKTM010000045",76.396,1.64e-70,270,555,423.9978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLVX01000038",86.722,7.08e-70,268,241,209.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_JAMKRA010000075",75.972,2.45e-69,267,566,430.00152,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_JAMKTM010000045",75.972,2.45e-69,267,566,430.00152,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLSZ01000019",87.446,2e-69,267,231,202.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_9149","NZ_MLSN01000023",87.446,2e-69,267,231,202.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLSZ01000019",92.432,1.14e-68,265,185,170.9992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_46874","NZ_MLSN01000023",92.432,1.14e-68,265,185,170.9992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLSZ01000019",76.114,8.8e-69,265,561,426.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_7246","NZ_MLSN01000023",76.114,8.8e-69,265,561,426.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_JAMKRA010000075",79.784,4.19e-68,263,371,295.99864,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_2727","NZ_JAMKTM010000045",79.784,4.19e-68,263,371,295.99864,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSZ01000019",93.296,4.42e-68,263,179,166.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLSN01000023",93.296,4.42e-68,263,179,166.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_MLVX01000038",93.296,4.42e-68,263,179,166.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLVX01000038",75.485,1.01e-67,261,567,427.99995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_JAMKRA010000075",80.206,1.45e-67,261,389,312.00134,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_JAMKQZ010000090",80.206,1.45e-67,261,389,312.00134,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_JAMKTM010000045",80.206,1.45e-67,261,389,312.00134,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_JAMKRA010000075",75.701,3.52e-67,259,535,405.00035,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_JAMKQZ010000090",75.701,3.52e-67,259,535,405.00035,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_3220","NZ_JAMKTM010000045",75.701,3.52e-67,259,535,405.00035,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_JAMKRA010000075",92.737,5.72e-67,259,179,165.99923,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_JAMKTM010000045",92.737,5.72e-67,259,179,165.99923,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_4426","NZ_JAMKQZ010000090",92.308,5.72e-67,259,182,168.00056,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_JAMKRA010000075",79.57,1.56e-66,257,372,296.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_3817","NZ_JAMKTM010000045",79.57,1.56e-66,257,372,296.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLSZ01000019",75.352,4.72e-66,255,568,427.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_MLSN01000023",75.352,4.72e-66,255,568,427.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_JAMKRA010000075",75.309,4.72e-66,255,567,427.00203,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_JAMKQZ010000090",75.309,4.72e-66,255,567,427.00203,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_23175","NZ_JAMKTM010000045",75.309,4.72e-66,255,567,427.00203,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSZ01000019",79.845,6.75e-66,255,387,309.00015,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSN01000023",79.845,6.75e-66,255,387,309.00015,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLVX01000038",79.845,6.75e-66,255,387,309.00015,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_JAMKRA010000075",85.892,5.51e-66,255,241,206.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_JAMKTM010000045",85.892,5.51e-66,255,241,206.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_JAMKRA010000075",76.647,1.98e-65,254,501,384.00147,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_JAMKTM010000045",76.693,1.98e-65,254,502,384.99886,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLSZ01000019",85.537,2.29e-65,254,242,206.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230099T_vs_bact_coverage_filtered_hits","k127_16074","NZ_MLSN01000023",85.537,2.29e-65,254,242,206.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_JAMKRA010000075",76.411,1.98e-64,250,496,378.99856,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLSZ01000019",85.897,1.02e-63,248,234,200.99898,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2_vs_bact_coverage_filtered_hits","k127_1164","NZ_MLSN01000023",85.897,1.02e-63,248,234,200.99898,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLVX01000038",80.793,4.06e-63,246,328,265.00104,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_JAMKRA010000075",77.951,3.43e-63,246,449,349.99999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_JAMKQZ010000090",77.951,3.43e-63,246,449,349.99999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_JAMKTM010000045",77.951,3.43e-63,246,449,349.99999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_JAMKRA010000075",77.283,9.52e-63,244,449,347.00067,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_JAMKTM010000045",76.21,9.2e-63,244,496,378.0016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSZ01000019",77.578,5.74e-61,239,446,345.99788,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSN01000023",77.578,5.74e-61,239,446,345.99788,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLVX01000038",77.578,5.74e-61,239,446,345.99788,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSZ01000019",80.183,8.79e-60,235,328,263.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_MLSN01000023",80.183,8.79e-60,235,328,263.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_JAMKRA010000075",72.432,9.91e-60,235,925,669.996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_JAMKTM010000045",72.432,9.91e-60,235,925,669.996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLSZ01000019",81.915,9.43e-60,235,282,231.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_2792","NZ_MLSN01000023",81.915,9.43e-60,235,282,231.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLSZ01000019",93.631,6.79e-60,235,157,147.00067,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB_vs_bact_coverage_filtered_hits","k127_2117","NZ_MLSN01000023",93.631,6.79e-60,235,157,147.00067,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_JAMKRA010000075",79.651,3.16e-59,233,344,273.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_12942","NZ_JAMKTM010000045",79.651,3.16e-59,233,344,273.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_JAMKTM010000045",76.889,2.06e-59,233,450,346.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_MLVX01000038",79.36,1.01e-58,231,344,272.9984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_JAMKRA010000075",77.536,2.86e-58,230,414,320.99904,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_JAMKRA010000075",76.409,3.07e-58,230,479,365.99911,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_JAMKQZ010000090",76.409,3.07e-58,230,479,365.99911,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_JAMKTM010000045",76.409,3.07e-58,230,479,365.99911,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_JAMKRA010000075",79.179,1.31e-57,228,341,270.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_6246","NZ_JAMKTM010000045",79.179,1.31e-57,228,341,270.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02180049T_vs_bact_coverage_filtered_hits","k127_53181","NZ_MLVX01000038",75.556,9.26e-58,228,495,374.0022,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_9718","NZ_MLVX01000038",75.453,4.31e-57,226,497,375.00141,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_JAMKTM010000045",77.295,1.33e-56,224,414,320.0013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLSZ01000019",85.78,5.72e-56,222,218,187.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLSN01000023",85.78,5.72e-56,222,218,187.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_MLVX01000038",85.78,5.72e-56,222,218,187.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_JAMKRA010000075",75.758,1.28e-54,219,462,350.00196,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_JAMKQZ010000090",75.817,1.28e-54,219,459,348.00003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_JAMKTM010000045",75.758,1.28e-54,219,462,350.00196,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSZ01000019",75.941,6.65e-55,219,478,362.99798,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSN01000023",75.941,6.65e-55,219,478,362.99798,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLVX01000038",75.941,6.65e-55,219,478,362.99798,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_JAMKRA010000075",71.83,1.34e-53,215,962,691.0046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_JAMKTM010000045",71.83,1.34e-53,215,962,691.0046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_JAMKRA010000075",85,3.44e-53,213,220,187,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_JAMKQZ010000090",85,3.44e-53,213,220,187,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_24015","NZ_JAMKTM010000045",85,3.44e-53,213,220,187,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_MLVX01000038",80.277,1.64e-51,207,289,232.00053,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLSZ01000019",75.368,1.25e-51,207,475,357.998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLSN01000023",75.368,1.25e-51,207,475,357.998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_JAMKRA010000075",75.264,1.25e-51,207,473,355.99872,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_JAMKTM010000045",75.264,1.25e-51,207,473,355.99872,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080039T_vs_bact_coverage_filtered_hits","k127_6685","NZ_MLVX01000038",75.938,4.49e-51,206,453,343.99914,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_7997","NZ_MLVX01000038",76.235,4.5e-51,206,425,323.99875,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLSZ01000019",77.867,2.76e-50,204,375,292.00125,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLSN01000023",77.867,2.76e-50,204,375,292.00125,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_MLVX01000038",77.867,2.76e-50,204,375,292.00125,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_JAMKRA010000075",83.721,3.71e-50,204,215,180.00015,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_JAMKQZ010000090",83.721,3.71e-50,204,215,180.00015,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_JAMKTM010000045",83.721,3.71e-50,204,215,180.00015,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15782","NZ_MLVX01000038",76.555,6.22e-50,202,418,319.9999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLSZ01000019",83.796,1.33e-49,202,216,180.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLSN01000023",83.796,1.33e-49,202,216,180.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_37790","NZ_MLVX01000038",83.796,1.33e-49,202,216,180.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLSZ01000019",84.772,1e-46,193,197,167.00084,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLSN01000023",84.772,1e-46,193,197,167.00084,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_MLVX01000038",84.772,1e-46,193,197,167.00084,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_MLVX01000038",81.405,5e-47,193,242,197.0001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_JAMKRA010000075",82.456,3.37e-47,193,228,187.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_JAMKTM010000045",82.456,3.37e-47,193,228,187.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_JAMKRA010000075",81.25,6.47e-46,189,240,195,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_31768","NZ_JAMKTM010000045",81.25,6.47e-46,189,240,195,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_JAMKRA010000075",77.5,1.2e-45,189,360,279,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_JAMKTM010000045",77.5,1.2e-45,189,360,279,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_JAMKQZ010000090",77.5,1.2e-45,189,360,279,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLVX01000038",82.174,4.36e-46,189,230,189.0002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLSZ01000019",75.414,2.93e-45,187,423,319.00122,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLSN01000023",75.414,2.93e-45,187,423,319.00122,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_JAMKRA010000075",79.021,2.13e-45,187,286,226.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_15015","NZ_JAMKTM010000045",79.021,2.13e-45,187,286,226.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_JAMKRA010000075",75.959,1.1e-44,185,391,296.99969,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_JAMKQZ010000090",76.031,1.1e-44,185,388,295.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_JAMKTM010000045",75.959,1.1e-44,185,391,296.99969,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_JAMKRA010000075",83.092,9.99e-45,185,207,172.00044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_JAMKQZ010000090",83.092,9.99e-45,185,207,172.00044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_27940","NZ_JAMKTM010000045",83.092,9.99e-45,185,207,172.00044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLSZ01000019",75.355,6.98e-45,185,422,317.9981,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLSN01000023",75.355,6.98e-45,185,422,317.9981,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_JAMKRA010000075",75.297,6.98e-45,185,421,317.00037,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_JAMKTM010000045",75.297,6.98e-45,185,421,317.00037,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLSZ01000019",75.711,3.95e-44,183,387,293.00157,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLSN01000023",75.711,3.95e-44,183,387,293.00157,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010468T_vs_bact_coverage_filtered_hits","k127_25343","NZ_MLVX01000038",75.711,3.95e-44,183,387,293.00157,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_JAMKRA010000075",83.756,6.02e-44,183,197,164.99932,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_JAMKQZ010000090",83.756,6.02e-44,183,197,164.99932,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010691T_vs_bact_coverage_filtered_hits","k127_14515","NZ_JAMKTM010000045",83.756,6.02e-44,183,197,164.99932,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLVX01000038",77.348,5.59e-44,183,362,279.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSZ01000019",77.348,5.59e-44,183,362,279.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_17782","NZ_MLSN01000023",77.348,5.59e-44,183,362,279.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLSZ01000019",74.569,4.67e-44,183,464,346.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLSN01000023",74.569,4.67e-44,183,464,346.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02220041T_vs_bact_coverage_filtered_hits","k127_5246","NZ_MLVX01000038",74.569,4.67e-44,183,464,346.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLVX01000038",84.783,6.34e-44,183,184,156.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLSZ01000019",84.783,6.34e-44,183,184,156.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_MLSN01000023",84.783,6.34e-44,183,184,156.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_JAMKRA010000075",77.337,7.57e-44,182,353,272.99961,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_JAMKQZ010000090",77.337,7.57e-44,182,353,272.99961,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_JAMKTM010000045",77.337,7.57e-44,182,353,272.99961,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLSZ01000019",83.575,2.2e-43,182,207,173.00025,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLSN01000023",83.575,2.2e-43,182,207,173.00025,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_MLVX01000038",83.575,2.2e-43,182,207,173.00025,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLSZ01000019",75.118,1.07e-43,182,422,316.99796,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLSN01000023",75.118,1.07e-43,182,422,316.99796,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSZ01000019",76.031,1.31e-43,182,388,295.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSN01000023",76.031,1.31e-43,182,388,295.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLVX01000038",76.031,1.31e-43,182,388,295.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_JAMKRA010000075",75.059,3.86e-43,180,421,315.99839,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_JAMKTM010000045",75.059,3.86e-43,180,421,315.99839,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_JAMKRA010000075",83.173,2.84e-42,178,208,172.99984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_JAMKQZ010000090",83.173,2.84e-42,178,208,172.99984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_40909","NZ_JAMKTM010000045",83.173,2.84e-42,178,208,172.99984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_MLVX01000038",82.464,1.17e-42,178,211,173.99904,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSZ01000019",77.183,3.52e-42,176,355,273.99965,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSN01000023",77.183,3.52e-42,176,355,273.99965,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLVX01000038",77.183,3.52e-42,176,355,273.99965,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_JAMKRA010000075",74.607,4.24e-42,176,445,332.00115,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_17361","NZ_MLVX01000038",84.916,6.34e-42,176,179,151.99964,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_JAMKQZ010000090",75.897,6.09e-42,176,390,295.9983,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_9678","NZ_MLVX01000038",84.831,1.51e-41,174,178,150.99918,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_JAMKRA010000075",82.212,1.52e-41,174,208,171.00096,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160008T_vs_bact_coverage_filtered_hits","k127_4012","NZ_JAMKTM010000045",82.212,1.52e-41,174,208,171.00096,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_10433","NZ_JAMKQZ010000090",83.784,3.81e-41,174,185,155.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080073T_vs_bact_coverage_filtered_hits","k127_9960","NZ_JAMKQZ010000090",89.209,4.86e-41,172,139,124.00051,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_JAMKTM010000045",74.382,1.97e-40,171,445,330.9999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLSZ01000019",85.03,2.04e-40,171,167,142.0001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_4714","NZ_MLSN01000023",85.03,2.04e-40,171,167,142.0001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230021T_vs_bact_coverage_filtered_hits","k127_18349","NZ_MLVX01000038",84.27,8.36e-40,169,178,150.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_MLVX01000038",84.524,2.29e-39,167,168,142.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_JAMKRA010000075",84.524,2.29e-39,167,168,142.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_11411","NZ_JAMKTM010000045",84.524,2.29e-39,167,168,142.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020591T_vs_bact_coverage_filtered_hits","k127_13945","NZ_JAMKQZ010000090",85.806,1.26e-38,165,155,132.9993,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_MLVX01000038",84.524,1.06e-37,161,168,142.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_JAMKRA010000075",84.431,3.83e-37,159,167,140.99977,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230025T_vs_bact_coverage_filtered_hits","k127_12995","NZ_JAMKTM010000045",84.431,3.83e-37,159,167,140.99977,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_MLVX01000038",85.906,1.3e-36,158,149,127.99994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_MLVX01000038",85.714,1.3e-36,158,154,131.99956,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLVX01000038",83.051,1.41e-36,158,177,147.00027,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_JAMKRA010000075",83.929,1.41e-36,158,168,141.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_JAMKTM010000045",83.929,1.41e-36,158,168,141.00072,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_JAMKRA010000075",85.811,4.67e-36,156,148,127.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010359T_vs_bact_coverage_filtered_hits","k127_4318","NZ_JAMKTM010000045",85.811,4.67e-36,156,148,127.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_JAMKRA010000075",85.621,4.69e-36,156,153,131.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_12168","NZ_JAMKTM010000045",85.621,4.69e-36,156,153,131.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_JAMKRA010000075",78.715,1.59e-35,154,249,196.00035,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_JAMKQZ010000090",78.715,1.59e-35,154,249,196.00035,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_JAMKTM010000045",78.715,1.59e-35,154,249,196.00035,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02020599T_vs_bact_coverage_filtered_hits","k127_27775","NZ_MLVX01000038",73.649,1.98e-35,154,444,327.00156,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_JAMKRA010000075",76.758,1.83e-35,154,327,250.99866,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_JAMKTM010000045",76.758,1.83e-35,154,327,250.99866,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSZ01000019",84.967,1.83e-35,154,153,129.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSN01000023",84.967,1.83e-35,154,153,129.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_JAMKQZ010000090",76.758,1.83e-35,154,327,250.99866,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLSZ01000019",98.824,1.11e-34,152,85,84.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLSN01000023",98.824,1.11e-34,152,85,84.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_MLVX01000038",98.824,1.11e-34,152,85,84.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_JAMKRA010000075",98.824,1.11e-34,152,85,84.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_JAMKQZ010000090",98.824,1.11e-34,152,85,84.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_25022","NZ_JAMKTM010000045",98.824,1.11e-34,152,85,84.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_JAMKRA010000075",83.333,5.89e-35,152,168,139.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_JAMKTM010000045",83.333,5.89e-35,152,168,139.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLSZ01000019",87.692,7.65e-35,152,130,113.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240008T_vs_bact_coverage_filtered_hits","k127_11012","NZ_MLSN01000023",87.692,7.65e-35,152,130,113.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLVX01000038",83.436,2.12e-34,150,163,136.00068,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_JAMKRA010000075",84.667,2.77e-34,150,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_JAMKTM010000045",84.667,2.77e-34,150,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSZ01000019",84.314,7.62e-34,148,153,129.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSN01000023",84.314,7.62e-34,148,153,129.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLVX01000038",76.38,8.5e-34,148,326,248.9988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSZ01000019",76.38,8.5e-34,148,326,248.9988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_746","NZ_MLSN01000023",76.38,8.5e-34,148,326,248.9988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT_vs_bact_coverage_filtered_hits","k127_3109","NZ_JAMKQZ010000090",91.509,2.91e-33,147,106,96.99954,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_JAMKRA010000075",74.648,3.88e-32,143,355,265.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_JAMKTM010000045",74.648,3.88e-32,143,355,265.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLSZ01000019",89.474,1.3e-31,141,114,102.00036,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLSN01000023",89.474,1.3e-31,141,114,102.00036,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_MLVX01000038",89.474,1.3e-31,141,114,102.00036,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_JAMKRA010000075",89.474,1.3e-31,141,114,102.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230036T_vs_bact_coverage_filtered_hits","k127_18007","NZ_JAMKTM010000045",89.474,1.3e-31,141,114,102.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSZ01000019",83.784,1.66e-31,141,148,124.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLSN01000023",83.784,1.66e-31,141,148,124.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT_vs_bact_coverage_filtered_hits","k127_1163","NZ_MLVX01000038",83.784,1.66e-31,141,148,124.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLSZ01000019",74.438,1.81e-30,137,356,264.99928,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLSN01000023",74.438,1.81e-30,137,356,264.99928,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSZ01000019",74.51,2.88e-30,137,357,266.0007,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLSN01000023",74.51,2.88e-30,137,357,266.0007,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_JAMKRA010000075",88.991,5.74e-30,135,109,97.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_JAMKTM010000045",88.991,5.74e-30,135,109,97.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLSZ01000019",77.108,2.07e-29,134,249,191.99892,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLSN01000023",77.108,2.07e-29,134,249,191.99892,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_14643","NZ_MLVX01000038",77.108,2.07e-29,134,249,191.99892,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_JAMKRA010000075",75.862,2.1e-29,134,319,241.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_JAMKQZ010000090",75.862,2.1e-29,134,319,241.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_JAMKTM010000045",75.862,2.1e-29,134,319,241.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_JAMKRA010000075",75.617,7.42e-29,132,324,244.99908,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_JAMKTM010000045",75.617,7.42e-29,132,324,244.99908,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_JAMKQZ010000090",75.617,7.42e-29,132,324,244.99908,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_JAMKRA010000075",74.138,2.69e-28,130,348,258.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_JAMKTM010000045",74.138,2.69e-28,130,348,258.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_JAMKRA010000075",76.515,9.93e-28,128,264,201.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_JAMKTM010000045",76.515,9.93e-28,128,264,201.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_JAMKQZ010000090",76.515,9.93e-28,128,264,201.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030478T_vs_bact_coverage_filtered_hits","k127_15666","NZ_MLVX01000038",87.5,3.91e-27,126,112,98,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLSZ01000019",88.571,3.63e-27,126,105,92.99955,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLSN01000023",88.571,3.63e-27,126,105,92.99955,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_MLVX01000038",88.571,3.63e-27,126,105,92.99955,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_JAMKRA010000075",88.571,3.63e-27,126,105,92.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_JAMKQZ010000090",88.571,3.63e-27,126,105,92.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_15618","NZ_JAMKTM010000045",88.571,3.63e-27,126,105,92.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02290001T_vs_bact_coverage_filtered_hits","k127_18180","NZ_MLVX01000038",87.5,6.22e-27,126,112,98,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSZ01000019",87.85,3.45e-27,126,107,93.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSN01000023",87.85,3.45e-27,126,107,93.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLVX01000038",87.85,3.45e-27,126,107,93.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLSZ01000019",73.926,1.25e-26,124,349,258.00174,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLSN01000023",73.926,1.25e-26,124,349,258.00174,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSZ01000019",75.155,1.24e-26,124,322,241.9991,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLSN01000023",75.155,1.24e-26,124,322,241.9991,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT10RB_vs_bact_coverage_filtered_hits","k127_1693","NZ_MLVX01000038",75.155,1.24e-26,124,322,241.9991,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSZ01000019",85.841,1.64e-25,121,113,97.00033,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSN01000023",85.841,1.64e-25,121,113,97.00033,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLVX01000038",85.841,1.64e-25,121,113,97.00033,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLSZ01000019",89.474,1.83e-25,121,95,85.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLSN01000023",89.474,1.83e-25,121,95,85.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_MLVX01000038",89.474,1.83e-25,121,95,85.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_JAMKRA010000075",89.474,1.83e-25,121,95,85.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_JAMKQZ010000090",89.474,1.83e-25,121,95,85.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02160019T_vs_bact_coverage_filtered_hits","k127_4552","NZ_JAMKTM010000045",89.474,1.83e-25,121,95,85.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLVX01000038",85.841,1.66e-25,121,113,97.00033,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSZ01000019",85.841,1.66e-25,121,113,97.00033,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230002T_vs_bact_coverage_filtered_hits","k127_7582","NZ_MLSN01000023",85.841,1.66e-25,121,113,97.00033,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLSZ01000019",91.86,1.99e-25,121,86,78.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_6007","NZ_MLSN01000023",91.86,1.99e-25,121,86,78.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_MLVX01000038",86.667,2.46e-24,117,105,91.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLSZ01000019",87.879,1.16e-23,115,99,87.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLSN01000023",87.879,1.16e-23,115,99,87.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_MLVX01000038",87.879,1.16e-23,115,99,87.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_JAMKRA010000075",87.879,1.16e-23,115,99,87.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_JAMKQZ010000090",87.879,1.16e-23,115,99,87.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_9172","NZ_JAMKTM010000045",87.879,1.16e-23,115,99,87.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLSZ01000019",86.538,1.97e-23,115,104,89.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLSN01000023",86.538,1.97e-23,115,104,89.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_MLVX01000038",86.538,1.97e-23,115,104,89.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_JAMKRA010000075",76.062,1.97e-23,115,259,197.00058,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_JAMKQZ010000090",86.538,1.97e-23,115,104,89.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010419T_vs_bact_coverage_filtered_hits","k127_13876","NZ_JAMKTM010000045",76.062,1.97e-23,115,259,197.00058,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_JAMKRA010000075",86.538,8.85e-24,115,104,89.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_7687","NZ_JAMKTM010000045",86.538,8.85e-24,115,104,89.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLSZ01000019",86.538,9.95e-24,115,104,89.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLSN01000023",86.538,9.95e-24,115,104,89.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_MLVX01000038",86.538,9.95e-24,115,104,89.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_JAMKRA010000075",86.538,9.95e-24,115,104,89.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_JAMKQZ010000090",86.538,9.95e-24,115,104,89.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_3311","NZ_JAMKTM010000045",86.538,9.95e-24,115,104,89.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02120024T_vs_bact_coverage_filtered_hits","k127_11649","NZ_MLVX01000038",86.667,2.71e-23,113,105,91.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_JAMKRA010000075",84.906,4.69e-21,106,106,90.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_JAMKTM010000045",84.906,4.69e-21,106,106,90.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_MLVX01000038",85.047,4.51e-21,106,107,91.00029,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_JAMKRA010000075",84.906,1.62e-20,104,106,90.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_13617","NZ_JAMKTM010000045",84.906,1.62e-20,104,106,90.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSZ01000019",86.813,6.07e-20,102,91,78.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLSN01000023",86.813,6.07e-20,102,91,78.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02010687T_vs_bact_coverage_filtered_hits","k127_26427","NZ_MLVX01000038",86.813,6.07e-20,102,91,78.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_JAMKRA010000075",83.962,2.13e-19,100,106,88.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_JAMKTM010000045",83.962,2.13e-19,100,106,88.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSZ01000019",85.714,2.76e-18,97.1,91,77.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLSN01000023",85.714,2.76e-18,97.1,91,77.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02030218TII_vs_bact_coverage_filtered_hits","k127_17906","NZ_MLVX01000038",85.714,2.76e-18,97.1,91,77.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLSZ01000019",84.694,3.05e-18,97.1,98,83.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLSN01000023",84.694,3.05e-18,97.1,98,83.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_MLVX01000038",84.694,3.05e-18,97.1,98,83.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_JAMKRA010000075",84.694,3.05e-18,97.1,98,83.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_JAMKQZ010000090",84.694,3.05e-18,97.1,98,83.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02050288T_vs_bact_coverage_filtered_hits","k127_10750","NZ_JAMKTM010000045",84.694,3.05e-18,97.1,98,83.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLSZ01000019",92.424,1.27e-17,95.3,66,60.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_3291","NZ_MLSN01000023",92.424,1.27e-17,95.3,66,60.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_JAMKRA010000075",98.148,1.17e-17,95.3,54,52.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_JAMKTM010000045",98.148,1.17e-17,95.3,54,52.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSZ01000019",96.154,7.03e-15,86.1,52,50.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLSN01000023",96.154,7.03e-15,86.1,52,50.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB_vs_bact_coverage_filtered_hits","k127_3115","NZ_MLVX01000038",96.154,7.03e-15,86.1,52,50.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLSZ01000019",95.652,1.47e-11,75,46,43.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080095T_vs_bact_coverage_filtered_hits","k127_6307","NZ_MLSN01000023",95.652,1.47e-11,75,46,43.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLSZ01000019",92.308,1.46e-11,75,52,48.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02100017T_vs_bact_coverage_filtered_hits","k127_7191","NZ_MLSN01000023",92.308,1.46e-11,75,52,48.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLSZ01000019",95.652,1.45e-11,75,46,43.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_18729","NZ_MLSN01000023",95.652,1.45e-11,75,46,43.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLSZ01000019",95.652,1.34e-11,75,46,43.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB_vs_bact_coverage_filtered_hits","k127_3843","NZ_MLSN01000023",95.652,1.34e-11,75,46,43.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLSZ01000019",100,6.44e-10,69.4,37,37,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230095T_vs_bact_coverage_filtered_hits","k127_10140","NZ_MLSN01000023",100,6.44e-10,69.4,37,37,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLSZ01000019",93.478,5.93e-10,69.4,46,42.99988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02240005T_vs_bact_coverage_filtered_hits","k127_11155","NZ_MLSN01000023",93.478,5.93e-10,69.4,46,42.99988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLSZ01000019",100,2.36e-09,67.6,36,36,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02020539T_vs_bact_coverage_filtered_hits","k127_6855","NZ_MLSN01000023",100,2.36e-09,67.6,36,36,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLSZ01000019",100,2.36e-09,67.6,36,36,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_8605","NZ_MLSN01000023",100,2.36e-09,67.6,36,36,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLSZ01000019",97.436,4.06e-09,67.6,39,38.00004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLSN01000023",97.436,4.06e-09,67.6,39,38.00004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_MLVX01000038",97.436,4.06e-09,67.6,39,38.00004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_JAMKRA010000075",97.436,4.06e-09,67.6,39,38.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_JAMKQZ010000090",97.436,4.06e-09,67.6,39,38.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_2982","NZ_JAMKTM010000045",97.436,4.06e-09,67.6,39,38.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLSZ01000019",100,8.09e-09,65.8,35,35,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230101T_vs_bact_coverage_filtered_hits","k127_3114","NZ_MLSN01000023",100,8.09e-09,65.8,35,35,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLSZ01000019",100,3.23e-08,63.9,34,34,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02230120T_vs_bact_coverage_filtered_hits","k127_12260","NZ_MLSN01000023",100,3.23e-08,63.9,34,34,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLSZ01000019",97.222,1.13e-07,62.1,36,34.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLSN01000023",97.222,1.13e-07,62.1,36,34.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_MLVX01000038",97.222,1.13e-07,62.1,36,34.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_JAMKRA010000075",97.222,1.13e-07,62.1,36,34.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_JAMKQZ010000090",97.222,1.13e-07,62.1,36,34.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02080196T_vs_bact_coverage_filtered_hits","k127_7692","NZ_JAMKTM010000045",97.222,1.13e-07,62.1,36,34.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLSZ01000019",97.222,1.33e-07,62.1,36,34.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLSN01000023",97.222,1.33e-07,62.1,36,34.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_MLVX01000038",97.222,1.33e-07,62.1,36,34.99992,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_JAMKRA010000075",97.222,1.33e-07,62.1,36,34.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_JAMKQZ010000090",97.222,1.33e-07,62.1,36,34.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"CPCT02330066T_vs_bact_coverage_filtered_hits","k127_13399","NZ_JAMKTM010000045",97.222,1.33e-07,62.1,36,34.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
